cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
86255,p-dodecylbenzenesulphonic acid,204-489-3,121-65-3,,Notified C&L,185,H314:185;H302:27
86256,"Hexamethylene diisocyanate, oligomerisation product, blocked with 2-butanone oxime",617-779-3,85940-94-9,Skin Irrit. 2;Skin Sens. 1;STOT RE 2,REACH registration C&L,361,H373:270;H317:290;H315:270;Not classified:71
86260,Talbutal,204-090-4,115-44-6,Acute Tox. 3,Notified C&L,1,H301:1
86262,"5-chloro-1,3-dihydro-2H-indol-2-one",412-200-9,17630-75-0,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H412:0;H361:0;H302:0;H317:0
86264,"penthiopyrad (ISO);(RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide",606-001-8,183675-82-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
86265,"N,N,2-trimethylpropane-1,3-diamine",228-061-0,6105-72-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,39,H312:38;H302:38;H317:38;H314:39;H226:1;H335:1
86269,"Fatty acids, C18-unsatd., trimers, reaction products with triethylenetetramine",605-297-6,162627-18-1,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,41,H400:41;H410:41;H317:41
86272,"Fatty acids, C18-unsatd., trimers",500-239-5,68937-90-6,Not Classified,REACH registration C&L,576,Not classified:576
86274,L-tert-Leucine Methylamide,618-258-3,89226-12-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
86282,2'-fluoro-2-methylamino-5-nitrobenzophenone,211-998-4,735-06-8,Not Classified,REACH registration C&L,2,Not classified:2
86283,2-bromo-N-[2-(2-fluorobenzoyl)-4-nitrophenyl]acetamide,257-680-9,52130-86-6,Skin Sens. 1;STOT SE 3,Notified C&L,1,H317:1;H335:1
86286,"1-methyl-2,3-dihydroindole-2,3-dione",218-164-9,2058-74-4,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H315:43;H318:38;H335:42;H301:38;H319:5;H312:1;H302:1;H332:1
86287,"4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate)",407-410-2,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
86288,"Dihydro-5-methyl-4H-1,3,5-dithiazine",228-598-0,6302-94-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H312:1;H302:1;H332:1
86292,"2-tert-butyl-1,4-dimethoxybenzene",244-216-5,21112-37-8,Muta. 2;Aquatic Chronic 2,REACH registration C&L,280,H411:2;H341:2;H319:254;H315:268;Not classified:10
86294,Dibenzepin hydrochloride,206-255-6,315-80-0,Acute Tox. 3;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H332:1;H301:1
86296,Docosanamide,221-304-1,3061-75-4,Not Classified,REACH registration C&L,44,Not classified:44
86297,"1-(2,4-dinitrophenyl)-L-proline",216-743-0,1655-55-6,Flam. Sol. 1,Notified C&L,1,H228:1
86299,"2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptyl methacrylate",218-863-9,2261-99-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;H311:1;H330:1;H301:1
86300,Glycyrrhizic acid,215-785-7,1405-86-3,Not Classified,Notified C&L,92,Not classified:92
86304,"Balsams, copaiba, sulfurized, rhodium salts",294-751-3,91745-79-8,Flam. Sol. 1,Notified C&L,1,H228:1
86305,Potassium tetrakis(cyano-C)aurate,238-145-9,14263-59-3,Met. Corr. 1;Acute Tox. 2;Acute Tox. 1;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,11,H315:6;H330:11;H410:11;H290:7;H318:6;H300:11;H310:11;H400:11
86306,"[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]chromium",266-657-2,67352-35-6,,Notified C&L,11,H319:8;H315:8;Not classified:2;H317:1
86314,N-(2-Aminoethyl)isoquinoline-5-sulfonamide hydrochloride,601-462-1,116970-50-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
86315,"trifluralin (ISO) (containing < 0.5 ppm NPDA);α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0.5 ppm NPDA);2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0.5 ppm NPDA);N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA)",216-428-8,1582-09-8,Skin Sens. 1;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H351:0;H317:0
86317,Furametpyr,602-942-3,123572-88-3,Acute Tox. 4,Notified C&L,90,H302:90
86325,"(2R*,4S*)-1-sec-Butyl-4-{4-[4-(4- {[cis-2-(2,4-dichlorphenyl)- 2-(1,2,4-triazol-1-ylmethyl)- 1,3-dioxolan-4-yl]methoxy}phenyl) piperazin-1-yl]phenyl}- 4,5-dihydro-1,2,4-triazol-5-on",617-596-9,84625-61-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,146,H319:136;H302:146;H335:135;H315:136;H361:1
86328,Isopentyl decanoate,218-982-6,2306-91-4,Not Classified,Notified C&L,1384,Not classified:1383;H319:1;H315:1
86329,tert-butyl 2-bromo-2-methylpropionate,245-924-7,23877-12-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:39;H302:40;H335:42;H315:44;H318:4;H411:1
86333,Phenoxyacetic acid,204-556-7,122-59-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,257,H319:251;H302:244;H335:237;H315:250;H317:10;Not classified:5;H301:4
86334,Octyl octanoate,218-980-5,2306-88-9,Not Classified,REACH registration C&L,180,Not classified:180
86340,"1,2,3,6-tetrahydro-4-(p-tolyl)pyridinium chloride",276-226-0,71965-06-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
86342,2-bromo-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide,257-681-4,52130-87-7,Not Classified,REACH registration C&L,4,Not classified:1;H319:1;H335:1;H315:1;H400:1;H410:1;H302:2
86343,Bis(isopropylammonium) sulphate,264-801-9,64346-44-7,,Notified C&L,60,H319:60;H315:60
86346,"Naphthalene-1,8-dicarboxylic anhydride",201-380-2,81-84-5,Not Classified,REACH registration C&L,136,Not classified:6;H319:129;H317:84;H335:45;H315:46
86349,Ammonium lactate,208-214-8,515-98-0,Not Classified,Notified C&L,504,Not classified:446;H319:57;H335:57;H315:57;H302:1;H318:1
86350,"Copper(2+),tetrakis[N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide-.kappa.O1]-,dichloride",605-039-2,156065-03-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,84,H400:84;H410:84;H302:84
86355,"4-trans-Butyl-[1,1-bicyclohexyl]-4-trans-carbonic acid-(4-pentylphenyl)ester",601-509-6,118144-67-5,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
86365,"Imidazolium compounds, 2-C4-8-alkyl-1-(2-carboxyethyl)-4,5-dihydro-3-(hydroxyethyl), hydroxides, sodium salts",275-085-2,70983-43-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,6,H412:1;H318:1;H315:1;Not classified:5
86366,"O,O-bis(2-ethylhexyl) hydrogen dithiophosphate",227-376-0,5810-88-8,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,445,H412:4;H314:445;H318:445
86367,"Benzoic acid, 2-amino-5-iodo-, ethyl ester",608-010-2,268568-11-2,,Notified C&L,5,H319:4;H335:4;H315:4;H312:1;H302:1
86368,"5,6-dihydro-4,4,6-trimethyl-2-vinyl-4H-1,3-oxazine",245-925-2,23878-88-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
86370,4-acetamido-2-aminobenzenesulphonic acid,201-847-0,88-64-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:38;H335:38;H315:38;H411:4;H303:4;H317:4;Not classified:2
86373,"Benzoic acid, 2-[(phenylamino)carbonyl]-",610-332-3,4727-29-1,,Notified C&L,1,H314:1
86374,Gallium trifluoride,232-004-5,7783-51-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H312:38;H302:38;H332:38;H314:4
86375,m-bromopropiophenone,243-353-8,19829-31-3,,Notified C&L,5,H319:4;H315:4;H311:1;H331:1;H301:1
86376,Gelatins,232-554-6,9000-70-8,Not Classified,Notified C&L,1619,Not classified:1619
86377,"Trisodium [29H,31H-phthalocyaninetrisulphonato(5-)-N29,N30,N31,N32]cuprate(3-)",215-538-3,1330-39-8,Not Classified,REACH registration C&L,68,Not classified:65;H317:3
86379,4-phenylbutyrophenone,226-471-4,5407-91-0,Aquatic Chronic 2,Notified C&L,39,H411:38;H319:1;H335:1;H315:1
86380,"Disodium 4,4'-dinitrostilbene-2,2'-disulphonate",223-051-2,3709-43-1,Not Classified,REACH registration C&L,88,Not classified:5;H319:83;H335:81;H315:83
86383,"(1α,3aβ,4α,8aβ,9S*)-octahydro-4,8,8,9-tetramethyl-1,4-methanoazulen-2(1H)-one",238-780-1,14727-47-0,Not Classified,Notified C&L,233,Not classified:233
86385,"3-cyanomethyl-2-(4-methylphenyl)-6-methylimidozo[1,2-a]pyridine",457-480-3,,Acute Tox. 4,Notified C&L,1,H302:1
86386,2-cyano-3-(4-hydroxyphenyl)acrylic acid,248-879-1,28166-41-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,162,H319:161;H335:160;H315:161;H311:1;H331:1;H301:1;H312:1;H302:1;H332:1
86389,"Lard, sulfurized",273-310-9,68956-57-0,Not Classified,Notified C&L,1,Not classified:1
86392,N-(benzyloxycarbonyl)-L-valine,214-562-1,1149-26-4,Skin Irrit. 2;Resp. Sens. 1,Notified C&L,57,H334:38;H315:56;H317:16;Not classified:1;H319:2;H335:1
86393,asbestos,601-650-3,12001-29-5,Carc. 1A;STOT RE 1,Harmonised C&L,0,H350:0;H372:0
86394,2-hydroxy-4-(methylthio)butyric acid,209-523-0,583-91-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,3,H412:2;H318:3;H315:3
86395,Anthranilohydrazide,217-604-7,1904-58-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
86397,Methyl 2-(octylideneamino)benzoate,267-165-0,67801-44-9,Not Classified,Notified C&L,89,Not classified:89
86399,"1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate, polymer with 1-ethenylhexahydro-2H-azepin-2-one and 1-ethenyl-2-pyrrolidinone",605-734-0,174761-16-1,Aquatic Chronic 2,Notified C&L,132,H411:96;Not classified:36
86400,Methyl R-3-acetoxyhexanoate,278-626-0,77118-93-5,Not Classified,Notified C&L,88,Not classified:88
86404,Ethyl glycollate,210-798-4,623-50-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:41;H315:42
86405,(2-chloroethyl)sulphonyl chloride,216-594-1,1622-32-8,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 1,Notified C&L,45,H330:41;H314:45;H301:43;H290:1;H318:1;H302:2
86406,6-hydroxy-4-methyl-2-pyridone,225-108-7,4664-16-8,,Notified C&L,4,H319:4;H335:4;H315:4
86407,3-amino-1H-pyrazol-5-ol,258-691-1,53666-79-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
86410,N-(aminocarbonyl)-4-methylbenzenesulphonamide,216-900-3,1694-06-0,Not Classified,REACH registration C&L,7,Not classified:5;H302:2;H319:1;H335:1;H315:1
86413,"1,6-hexanediyl bismethacrylate",229-551-7,6606-59-3,Aquatic Chronic 3,REACH registration C&L,198,H412:4;H319:193;H335:191;H315:193;H411:20;Not classified:1;H317:1
86414,D-pantothenic acid,201-229-0,79-83-4,Not Classified,Notified C&L,3,Not classified:3
86416,Methyl 4-oxobutyrate,237-611-9,13865-19-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
86419,"1-Propene, 1,1,2,3,3,3-hexafluoro-, polymer with 1,1,2,2-tetrafluoroethene",607-524-4,25067-11-2,Not Classified,Notified C&L,10,Not classified:10
86421,N-phenylphenethylamine,217-099-3,1739-00-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
86424,Dimethylsilanediol,213-915-7,1066-42-8,Not Classified,Notified C&L,58,Not classified:58
86430,Benzo[b]thiophene-3-acetonitrile,221-733-4,3216-48-6,,Notified C&L,6,H312:5;H302:5;H332:5;H311:1;H331:1;H301:1;H319:1;H335:1;H315:1
86433,"Thiosulfuric acid, S-(2-hydroxy-3-sulfopropyl) ester, sodium salt (1:2)",606-927-2,22082-62-8,Not Classified,Notified C&L,1,Not classified:1
86435,Dimethylammonium dimethylcarbamate,609-917-6,4137-10-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
86436,6-aminouracil,212-854-3,873-83-6,Acute Tox. 4,Notified C&L,49,H302:44;Not classified:5
86437,(2-CARBOXYETHYL)TRIPHENYLPHOSPHONIUM BROMIDE,610-613-0,51114-94-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
86439,Mebanazine,200-615-6,65-64-5,Acute Tox. 4,Notified C&L,39,H302:39
86440,Concanavalin A,234-258-2,11028-71-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,6,H334:6;H317:6;H361:2
86441,"(5R)-5-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-3-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,5-dihydrofuran-2-one",425-980-0,,Not Classified,REACH registration C&L,62,Not classified:62
86442,Sodium phosphinate,231-669-9,7681-53-0,Not Classified,REACH registration C&L,571,Not classified:538;H319:33;H315:21
86449,Pyridoxine tripalmitate,224-470-3,4372-46-7,Not Classified,Notified C&L,3,Not classified:3
86451,Triisopropyl phosphate,208-150-0,513-02-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,71,H319:38;H335:38;H315:38;H226:71;H400:38
86456,"Dinaphtho[1,2,3-cd:3',2',1'-lm]perylene-5,10-dione, dodecyl derivs.",270-144-9,68411-74-5,Not Classified,Notified C&L,25,Not classified:25
86462,"4,4-bis(4-fluorophenyl)butyric acid",243-949-8,20662-52-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H302:1;H318:1;H315:1
86469,Phenazopyridine,202-363-2,94-78-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
86472,Cefdinir monohydrate,606-754-2,213978-34-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,52,H334:52;H317:52
86474,"2,3,4-trihydroxybenzoic acid",210-205-9,610-02-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
86475,5-methyl-3-phenylisoxazole-4-carbonyl chloride,240-915-4,16883-16-2,Skin Corr. 1B,REACH registration C&L,22,H314:21;H319:1;H302:2;H317:1;H335:1;H290:1;H318:1
86479,3-[ethyl(4-formyl-3-methylphenyl)amino]propiononitrile,204-362-2,119-97-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
86484,4-(2-nitrobutyl)morpholine,218-748-3,2224-44-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1,Notified C&L,79,H312:54;H302:78;H315:78;H410:78;H317:78;H318:78;H400:78;H311:24;Not classified:1
86488,"iprodione (ISO);3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide",253-178-9,36734-19-7,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H351:0
86489,2-phenoxyacetamide,210-713-0,621-88-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:43;H312:39;H302:39;H335:43;H315:43;H332:39
86490,Copper dilactate,240-177-3,16039-52-4,Acute Tox. 4,Notified C&L,1,H302:1
86492,Butylbenzene,203-209-7,104-51-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,40,H226:34;H319:23;H400:29;H315:22;Not classified:6;H410:7
86493,"Protein hydrolyzates, brain",293-471-9,91079-82-2,Not Classified,Notified C&L,1,Not classified:1
86496,"7-[2-(2-hydroxymethylethoxy)methylethoxy]tetramethyl-3,6,8,11-tetraoxa-7-phosphatridecane-1,13-diol",253-211-7,36788-39-3,Skin Sens. 1B;Repr. 2,REACH registration C&L,25,H361:2;H317:4;Not classified:20;H411:1;H351:1;H300:1;H332:1;H400:1
86499,"1,4-Benzenedicarboxylic acid, polymer with 1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid, 2,2-dimethyl-1,3-propanediol and hexanedioic acid",609-572-1,38702-18-0,Not Classified,Notified C&L,1,Not classified:1
86500,"3,3'-dimethoxy[1,1'-biphenyl]-4,4'-bis(diazonium) dichloride",202-106-4,91-91-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Muta. 2;Repr. 2;STOT SE 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H312:1;H302:1;H341:1;H361:1;H315:1;H370:1;H410:1;H372:1;H332:1;H400:1
86504,1-(chloroformyl)benzyl acetate,216-674-6,1638-63-7,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H314:38;H335:38;H318:38
86505,"2,4-dichloro-5-hydroxyacetanilide",429-110-0,67669-19-6,Aquatic Chronic 3,Harmonised C&L,0,H412:0
86508,"2,2,3,3-tetramethylbutane",209-855-6,594-82-1,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H410:0;H225:0;H400:0;H336:0;H304:0
86509,(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone,444-800-1,141645-23-0,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H315:0;H410:0;H317:0;H318:0;H400:0;H226:0;H373:0
86512,"Castor oil, reaction products with ethanolamine, sulfated",297-606-2,93685-53-1,Not Classified,Notified C&L,1,Not classified:1
86518,4-benzoylbutyric acid,216-113-5,1501-05-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
86520,4-anilino-3-nitro-N-phenylbenzenesulphonamide,225-862-7,5124-25-4,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,54,H411:11;H317:14;Not classified:40;H412:3
86521,"Disodium 4-amino-3-[[4-[(2,4-diaminophenyl)azo]phenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate",272-559-0,68877-33-8,Not Classified,REACH registration C&L,2044,Not classified:2044
86523,4-chloro-6-ethyl-5-fluoropyrimidine,604-010-1,137234-74-3,Acute Tox. 4;Skin Sens. 1,REACH registration C&L,30,H302:30;H317:30;H319:29;H315:29
86526,"methyl 2-(2-{[(benzyloxy)carbonyl]amino}propan-2-yl)-5,6-dihydroxypyrimidine-4-carboxylate",917-658-8,,Not Classified,REACH registration C&L,2,Not classified:2
86529,"Poly[oxy(methyl-1,2-ethanediyl)],α-butyl-ω-hydroxy-",500-003-1,9003-13-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1446,H319:946;H302:375;H315:376;Not classified:464;H412:34
86530,"2-chloro-3,4-difluoroaniline",609-257-9,36556-48-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
86531,"2,5-dimethylbenzophenone",223-740-8,4044-60-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
86538,"1,2,3,4,5,6,7,8-octahydro-1-[(4-methoxyphenyl)methyl]isoquinoline",256-950-3,51072-36-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
86544,"(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 2,2-Dihydroxyacetate",601-142-1,111969-64-3,Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,Notified C&L,77,H411:77;H373:76;H318:77
86545,Diallyl hexahydrophthalate,237-580-1,13846-31-6,Aquatic Chronic 3,REACH registration C&L,1,H412:1
86553,Mescaline hydrochloride,212-626-3,832-92-8,Acute Tox. 4,Notified C&L,39,H302:39
86554,2-methylpropane-2-thiol,200-890-2,75-66-1,Flam. Liq. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,578,H411:77;H225:132;H317:523;H319:447;H304:446;H315:29;H335:22;H318:22
86555,4-Methyl-3-(trifluoromethyl)benzoic Acid,607-883-7,261952-01-6,,Notified C&L,45,Not classified:38;H319:7;H335:6;H315:7
86556,"Poly(oxy-1,2-ethanediyl), α-[4-[[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-yl]oxy]-1,4-dioxobutyl]-ω-hydroxy-",618-345-6,9002-96-4,Not Classified,Notified C&L,11,Not classified:11
86557,Tetrahydro-6-octyl-2H-pyran-2-one,230-927-8,7370-92-5,Not Classified,Notified C&L,88,Not classified:88
86559,Hycanthone,221-463-7,3105-97-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 1B,Notified C&L,38,H350:38;H312:38;H302:38;H332:38
86562,Dicopper selenide,243-796-7,20405-64-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,212,H373:212;H400:212;H301:212;H410:212;H331:212
86570,Palladium (II) di(4-oxopent-2-en-2-oate),237-859-8,14024-61-4,Flam. Sol. 1;Self-heat. 1;Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,79,H302:5;H410:3;H317:3;H318:3;H400:3;H251:4;H228:38;H319:74;H335:35;H315:36;H312:1;H332:1;H413:2;H272:1
86574,5α-androst-16-en-3-one,242-220-1,18339-16-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,16,H312:16;H351:16;H302:16;H361:16;H332:16;H360:16
86575,DL-lysine monohydrochloride,200-739-0,70-53-1,Eye Irrit. 2,Notified C&L,39,H319:38;Not classified:1
86577,"3,6,9,12-tetrakis(carboxymethyl)-3,6,9,12-tetraazatetradecanedioic acid",212-790-6,869-52-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,103,H319:103;H335:102;H315:103
86584,"Benzoyl chloride, 2-bromo-5-methoxy-",611-407-3,56658-04-9,,Notified C&L,5,H314:5
86585,"flazasulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea",600-514-0,104040-78-0,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
86588,Ethyl piperazine-1-acetate,254-745-3,40004-08-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:38;H335:38;H315:38;H314:4;H312:1;H302:1;H332:1
86595,BORON-AMINE CATALYST,413-150-0,,Flam. Liq. 3;Skin Corr. 1A,Notified C&L,1,H226:1;H314:1
86598,"2,3-Epoxypropyl neodecanoate, oligomeric reaction products with phosphorous acid",500-336-2,157348-58-8,Eye Dam. 1,REACH registration C&L,1,H318:1
86603,(3-aminophenyl)uronium chloride,261-858-1,59690-88-9,Eye Irrit. 2,REACH registration C&L,22,H319:21;Not classified:1
86605,"2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethanol",225-267-2,4747-61-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,2,H411:1;H318:1;H315:1;Not classified:1
86607,"Dust, steelmaking",266-005-7,65996-72-7,Skin Sens. 1,REACH registration C&L,2,H317:2
86608,trans-2-Cyclododecenyl propanoic acid ethylester,601-534-2,118562-69-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
86609,"5-phenyl-3,4,6,7,8,9-hexahydro-[1]benzothiolo[2,3-e][1,4]diazepin-2-one",608-362-7,29462-18-8,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H317:1;H413:1
86615,4-azidoaniline,238-929-0,14860-64-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H311:1;H331:1;H301:1
86620,"Poly(oxy-1,2-ethanediyl), alpha-sulfo-omega-(nonylphenoxy)-, sodium salt (1:1)",618-487-9,9014-90-8,Eye Dam. 1,Notified C&L,650,H318:561;H319:75;H317:20;H315:23;H411:9;Not classified:5;H413:1
86630,5-methoxy-2-methylbenzoselenazole,220-956-4,2946-17-0,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H373:38;H400:39;H301:38;H410:39;H331:38;H300:1;H330:1
86636,"4,8-dimethyl-2-(propan-2-ylidene)-1,2,3,3a,4,5,6,8a-octahydroazulen-6-ol",616-993-4,8016-96-4,Not Classified,Notified C&L,76,Not classified:35;H315:33;H411:8;H319:16;H317:15
86637,2-pyridylformaldehyde semicarbazone,236-441-2,13370-79-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
86642,2-decenal,223-472-1,3913-71-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,265,H319:265;H315:265;H411:1;H317:1
86646,"Benzoic acid, 2-[[3-(4-methoxyphenyl)-2-methylpropylidene]amino]-, methyl ester",601-114-9,111753-62-9,Not Classified,Notified C&L,1378,Not classified:1316;H317:62;H319:1
86650,"1-Butene, polymer with ethene",607-541-7,25087-34-7,Not Classified,Notified C&L,97,Not classified:97
86651,"Dipotassium 6,6'-diapo-ψ,ψ-carotenedioate",251-431-8,33261-80-2,Not Classified,Notified C&L,5,Not classified:5
86657,Sodium alginate,618-415-6,9005-38-3,Not Classified,Notified C&L,322,Not classified:322
86658,Diethyl chloromalonate,237-913-0,14064-10-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,44,H411:2;H319:3;H302:2;H400:41;H314:41;H335:41;H318:39;H410:1;H301:1
86662,"Fatty acids, olive-oil, mixed esters with glycerol and isodecanol",293-081-9,91051-30-8,Not Classified,Notified C&L,2,Not classified:2
86663,Bitter fennel oil,616-896-7,8006-84-6,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2;STOT SE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,148,H319:105;H351:108;H341:108;H315:144;H410:104;H371:104;H317:108;H226:144;H400:104;H304:107;H411:3;H412:1;H302:2;H335:1
86665,2-Chloro-4-fluoroanisole,607-127-6,2267-25-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:43;H315:44;H225:1
86667,2-ammonio-1-methylethyl sulphate,213-134-1,926-25-0,Not Classified,Notified C&L,1,Not classified:1
86668,"Tetrahydrofuran-2,3,4,5-tetracarboxylic acid, mixed isomers",247-461-6,26106-63-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
86670,(3-mercaptopropyl)ammonium chloride,230-593-3,7211-54-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H302:1
86672,"Glycerides, C8-18 and C18-unsatd. mono- and di-",266-950-5,67701-31-9,Not Classified,REACH registration C&L,9,Not classified:9
86673,4-chloro-α-methylstyrene,216-984-1,1712-70-5,,Notified C&L,5,H319:4;H335:4;H315:4;H411:1
86674,"6-bromo-3,4-dimethoxybenzaldehyde",226-390-4,5392-10-9,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
86676,Tetrazinc trioxide sulphate,261-920-8,59766-35-7,Aquatic Chronic 4,Notified C&L,2,H413:2
86678,Carprofen,258-712-4,53716-49-7,Acute Tox. 3,Notified C&L,49,H301:48;H373:1;H361:1;H334:1;H317:1;Not classified:1
86679,Potassium 5-aminotetrazol-1-ide,681-644-5,136369-04-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H412:1;H318:1;H315:1;Not classified:1
86685,"Methyl 1H-1,2,4-triazole-3-carboxylate",480-470-5,4928-88-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,4,H319:4;H335:3;H315:4
86689,"Hydrogen [4-[4-(p-ethoxyanilino)-4'-[ethyl(m-sulphonatobenzyl)amino]benzhydrylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(m-sulphonatobenzyl)ammonium, monosodium salt",228-060-5,6104-59-2,Aquatic Chronic 3,Notified C&L,83,H412:43;Not classified:28;H319:12;H302:8;H335:3;H315:3
86693,Methyl 4-methyl-3-oxopentanoate,418-900-0,42558-54-3,Eye Dam. 1,REACH registration C&L,7,H318:2;Not classified:4;H319:1;H335:1;H315:1
86694,"Triethoxy(1H,1H,2H,2H-nonafluorohexyl)silane",600-308-0,102390-98-7,,Notified C&L,2,H319:2;H335:1;H315:2
86696,"N-(2-aminoethyl)-N'-[2-[2-(8-heptadecenyl)-4,5-dihydro-1H-imidazol-1-yl]ethyl]ethylenediamine",222-553-9,3528-65-2,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3,H410:3;H314:3;H317:3
86697,"2,6-dimethylocta-1,7-dien-3-ol",607-083-8,22460-59-9,Not Classified,REACH registration C&L,1,Not classified:1
86698,"3,4,5-trimethoxytoluene",229-239-0,6443-69-2,Not Classified,REACH registration C&L,86,Not classified:86
86700,Hectorite (clay mineral),235-340-0,12173-47-6,Eye Irrit. 2,Notified C&L,649,H319:473;Not classified:176
86701,Phenindione,201-454-4,83-12-5,Acute Tox. 3;Skin Sens. 1,Notified C&L,40,H317:39;H301:40
86703,"3-(methylamino)propane-1,2-diol",254-809-0,40137-22-2,Skin Corr. 1C,REACH registration C&L,57,H314:14;H319:43;H335:38;H315:43;H318:2
86708,"1,3-Benzenedimethanamine, reaction products with glycidyl tolyl ether",290-611-0,90194-04-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,53,H411:2;H315:2;H401:2;H317:21;H318:2;H303:2;Not classified:32;H412:19;H302:19;H314:19;H331:18;H332:1
86714,"8,9,10-trinorborn-2-ene",207-866-0,498-66-8,Flam. Sol. 2;Eye Irrit. 2;Repr. 2;Aquatic Chronic 2,REACH registration C&L,204,H411:203;H319:203;H228:204;H361:158
86717,"4,11-diamino-2,3-dihydro-3-imino-2-(3-methoxypropyl)-1H-naphth[2,3-f]isoindole-1,5,10-trione",236-518-0,13418-49-0,Not Classified,Notified C&L,48,Not classified:48
86719,"1,2-Benzisoxazole, 3-(bromomethyl)-",609-489-0,37924-85-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
86720,"Diethyl 2,3-dicyanofumarate",252-453-0,35234-88-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H302:38;H332:38
86721,"Butan-2-one O,O',O'',O'''-silanetetrayltetraoxime",251-882-0,34206-40-1,Flam. Sol. 1;Skin Sens. 1B;Eye Irrit. 2;STOT RE 2,REACH registration C&L,518,H319:512;H373:14;H228:14;H317:518;H315:504;H318:6;H312:2
86726,"2,5,7,7-tetramethyloctanal",405-690-0,114119-97-0,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0;H315:0
86728,Henicosafluoroundecanoic acid,218-165-4,2058-94-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,44,H319:41;H312:39;H302:39;H315:41;H332:39;Not classified:3;H335:1
86731,"Reaction products of cyclohexylamine and 4-alkylaniline and 1,1'-methanediylbis(4-isocyanatobenzene)",,,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,1,H317:1;H413:1
86732,"Phosphoric acid, C12-15-branched and linear alkyl esters, potassium salts",306-295-5,96792-59-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,9,H318:6;H315:6;Not classified:3
86734,"2-Bromo-4,6-difluoroaniline",610-183-4,444-14-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Notified C&L,44,H411:42;H319:40;H312:40;H302:44;H335:40;H315:40;H332:40
86736,"1,4:3,6-dianhydro-2,5-di-O-methyl-D-glucitol",226-159-8,5306-85-4,Not Classified,REACH registration C&L,115,Not classified:114;H319:1
86738,Calcium bis(5-oxo-L-prolinate),250-602-4,31377-05-6,Not Classified,REACH registration C&L,8,Not classified:8
86739,[(trifluoromethyl)thio]benzene,207-270-0,456-56-4,Flam. Liq. 3,Notified C&L,44,H226:44;H319:6;H335:5;H315:6
86743,Bufexamac,219-451-1,2438-72-4,Not Classified,Notified C&L,3,Not classified:1;H302:1;H317:1
86744,"Tetrasodium 3-[[5-[[4-chloro-6-[[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-2-sulphonatophenyl]azo]-4-hydroxy-5-[(1-oxopropyl)amino]naphthalene-2,7-disulphonate",279-368-1,80019-42-7,Aquatic Chronic 2,REACH registration C&L,36,H411:4;Not classified:25;H334:3;H319:3;H317:2
86747,"1,2-Cyclopentanedicarboxylic acid, 4-oxo-, (1R,2R)-rel-",614-156-8,67885-97-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,34,H319:34;H335:34;H315:34
86750,S-furfuryl propanethioate,261-562-2,59020-85-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1376,H319:1376;H315:1376
86754,Retinyl palmitate,201-228-5,79-81-2,Repr. 1B;Aquatic Chronic 4,REACH registration C&L,589,H413:373;H360:459;Not classified:54;H361:77;H315:132;H372:43;H412:26;H362:1
86756,Caesium dichromate,236-879-4,13530-67-1,Ox. Sol. 2;Skin Corr. 1B;Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H314:38;H410:42;H317:42;H350:42;H272:38;H400:42
86757,"Aromatic hydrocarbons, distn. residues, naphthalene-rich",308-487-4,98072-36-7,Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 2,REACH registration C&L,249,H319:48;H361:60;H332:24;H335:24;H373:72;H411:137;H340:185;H350:185;H315:185;H302:135;H410:48;H400:48;H304:50;H336:20;H226:50;Not classified:4
86760,"Carrot, ext.",284-545-1,84929-61-3,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1662,H319:1317;H412:8;H315:40;H317:1640;H304:1639;H318:3;H411:1445;H226:1631;Not classified:21;H410:2;H400:2
86761,"Amides, coco, N,N-bis(hydroxyethyl)",271-657-0,68603-42-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1804,H318:882;H315:1538;H319:722;H412:448;Not classified:254;H411:55;H341:35;H373:18;H335:17;H400:4;H317:4;H351:2;H302:1
86765,"N'-[2-(dimethylamino)ethyl]-N,N-dimethylethylenediamine",254-966-5,40538-81-6,Flam. Liq. 4;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4,Notified C&L,2,H312:2;H302:2;H314:2;H317:2;H227:2;H332:2
86766,Dequalinium chloride,208-330-9,522-51-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,67,H319:66;H335:66;H315:66;Not classified:1
86767,4-chloropyrocatechol,218-381-9,2138-22-9,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1
86770,"2,5-dihydro-2,5-dioxofuran-3-acetic acid",228-663-3,6318-55-4,Skin Corr. 1B,Notified C&L,44,H314:44
86771,"3,6,9,12,15-pentaazaheptadecane-1,17-diamine",224-542-4,4403-32-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33,H312:33;H302:33;H314:33;H410:33;H317:33;H318:33;H400:33
86773,Benzilonium bromide,213-885-5,1050-48-2,Not Classified,Notified C&L,1,Not classified:1
86775,"β-d-Glucopyranosiduronic acid, [3β,16α,21β(Z),22α]-22-(acetyloxy)-16,24,28-trihydroxy-21-[(2-methyl-1-oxo-2-butenyl)oxy]olean-12-en-3-yl O-β-d-glucopyranosyl-(1→2)-O-[β-d-glucopyranosyl-(1→4)]-",247-619-4,26339-90-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1
86776,"Alcohols, C12-18, ethers with polyethylene glycol mono-me ether",617-780-9,85940-95-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,6,H318:6;H315:6
86777,"1,2,4-triazole",206-022-9,288-88-0,Acute Tox. 4;Eye Irrit. 2;Repr. 2,Harmonised C&L,0,H319:0;H302:0;H361:0
86779,[No public or meaningful name is available],803-015-8,13106-24-6,Eye Irrit. 2,Notified C&L,38,H319:38
86780,Sulfadimidine,200-346-4,57-68-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,20,H319:8;H315:8;Not classified:9;H362:1;H334:2;H317:2;H361:1
86782,"3,5-dichlorosulphanilamide",244-799-6,22134-75-4,,Notified C&L,6,H319:6;H335:5;H315:6
86784,"3-ethyl 4,5-dihydro-5-oxo-1-(4-sulphophenyl)-1H-pyrazole-3-carboxylate",229-016-8,6402-06-8,Not Classified,Notified C&L,1,Not classified:1
86795,9-bata-D-Arabinofuranosyl-2-fluoroadenine phosphate,616-242-0,75607-67-9,Muta. 2;Repr. 2,Notified C&L,81,H361:54;H341:79;H350:24;H372:24;H360:27;H373:2;H362:1;H302:1;H319:1;H335:1;H315:1
86796,Potassium tetrachloroaurate,237-190-1,13682-61-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:44;H315:44;H302:3;H290:2;H412:1;H314:1
86797,3-octyl acetate,225-471-1,4864-61-3,Flam. Liq. 3,Notified C&L,1449,H226:1286;Not classified:121;H319:42;H315:42;H332:1;H335:1
86798,Digold sulphide,215-123-7,1303-60-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
86799,(isononanoato-O)(neodecanoato-O)nickel,287-592-6,85551-28-6,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H341:0;H410:0;H334:0;H317:0;H372:0;H350:0;H360:0;H400:0
86802,"1-0xa-7-azacyclopentadecan-15-one,13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy 3,5,8,10,12,14-hexamethyl-7-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-,(2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-",604-472-4,145435-72-9,Skin Irrit. 2;Eye Irrit. 2;Repr. 2,Notified C&L,41,H319:41;H361:41;H315:41
86803,Opipramol,206-254-0,315-72-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H400:38;H410:38;H302:39;H412:1
86804,"2-methylthiopyrimidine-4,6-diol",217-839-5,1979-98-2,,Notified C&L,5,H319:5;H335:5;H315:5
86805,Coniine hydrochloride,209-111-0,555-92-0,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1;H330:1
86806,Fluphenazine dihydrochloride,205-674-1,146-56-5,Acute Tox. 3;Repr. 1A,Notified C&L,65,H360:48;H301:44;H302:20;H330:10;H315:11;H370:10;H317:10;H318:10;H362:10;H372:10;H312:1;H332:1;H319:1;H413:1;H300:1
86807,"(-)-3,7-dimethyloct-6-en-1-ol",231-415-7,7540-51-4,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,327,H319:155;H317:279;H315:327;H335:38;H411:12;Not classified:1
86808,"Sodium bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-)",266-658-8,67352-37-8,Aquatic Chronic 2,REACH registration C&L,2580,H411:3;Not classified:2494;H412:83
86809,tert-butylphenyl diphenyl phosphate,260-391-0,56803-37-3,Not Classified,Notified C&L,87,Not classified:77;H400:9;H332:8;H410:1;H319:1;H335:1;H330:1;H315:1;H413:1;H317:1;H373:1
86812,1-cyanovinyl acetate,221-303-6,3061-65-2,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3,Notified C&L,39,H315:39;H318:39;H310:39;H301:39;H331:38
86814,"Propanoic acid, 2-hydroxy-, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester, (2S)-",612-179-8,61597-98-6,Aquatic Chronic 3,REACH registration C&L,14,H412:13;Not classified:1
86819,"Caesalpinia brasiliensis, ext.",294-932-7,91771-41-4,Not Classified,Notified C&L,1,Not classified:1
86820,"N-(2,4-dinitrophenyl)-3-phenyl-L-alanine",216-742-5,1655-54-5,Flam. Sol. 1,Notified C&L,1,H228:1
86821,Decanal,203-957-4,112-31-2,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2205,H319:1999;H412:2020;H315:519;Not classified:68;H335:44;H411:4;H312:3;H302:3;H332:3;H317:1;H304:1;H400:1;H410:1
86823,Chromic acid,231-801-5,7738-94-5,Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 1;Resp. Sens. 1;Muta. 2;Carc. 1B;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,99,H314:40;H341:23;H361:50;H330:49;H410:99;H334:49;H317:99;H318:24;H300:33;H350:99;H310:47;H400:88;H340:27;H372:27;H301:17;H271:26;H311:3;H272:1
86824,Bacitracin,215-786-2,1405-87-4,Not Classified,Notified C&L,8,Not classified:3;H319:4;H317:5;H335:4;H315:4
86833,Menthyl acetate,201-911-8,89-48-5,Aquatic Chronic 2,REACH registration C&L,1646,H411:1646
86834,3-amino-N-ethyl-4-phenoxy-N-phenylbenzenesulphonamide,257-517-1,51929-55-6,Skin Sens. 1,Notified C&L,38,H317:38
86837,"Naphtha (petroleum), light steam-cracked arom.;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",271-264-4,68527-23-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
86840,Tetradecylbenzene,215-950-3,1459-10-5,Asp. Tox. 1,Notified C&L,1,H304:1
86844,"Butane-1,2,3,4-tetrol",231-418-3,7541-59-5,Not Classified,Notified C&L,159,Not classified:159
86845,2-[2-(2-thienyl)ethyl]benzoic acid,216-595-7,1622-54-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
86848,p-tolyl 3-oxo-3-phenylpropionate,267-164-5,67801-43-8,Not Classified,Notified C&L,88,Not classified:88
86852,"O-(6-Chlorobenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium Tetrafluoroborate",608-824-8,330641-16-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H302:1;H318:1;H314:1
86853,"Fatty acids, C3-24 and C10-18-unsatd., reaction products with boric acid, diethanolamine, ethanolamine and triethanolamine",307-944-5,97808-26-9,Not Classified,Notified C&L,1,Not classified:1
86857,2-chloronicotinonitrile,229-550-1,6602-54-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,49,H319:47;H312:42;H302:48;H335:46;H315:47;H332:46;H311:5;H301:1;H331:1
86858,"Lithium sulphide, anhydrous",235-228-1,12136-58-2,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,69,H314:64;H318:2;H301:65;H261:29;H319:4;H335:4;H315:5;H228:4;H260:1
86859,"Distearic acid, diester with hexaglycerol",252-010-1,34424-97-0,Not Classified,Notified C&L,1,Not classified:1
86864,"4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo[3,4-e][1,4]diazepin-7(1H)-one monohydrochloride",251-668-7,33754-49-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H302:1;H332:1
86865,Bis(2-ethylhexyl) phosphonate,222-904-6,3658-48-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,109,H410:2;H319:59;H400:2;H315:102;H335:58;H318:43;Not classified:7
86871,LITHIUMMANGANAT-13070,426-770-1,,Not Classified,Notified C&L,1,Not classified:1
86872,"Amides, C16-18, N,N-bis(hydroxyethyl)",271-654-4,68603-40-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,29,H318:29;H315:29
86874,"9-(2-carboxyphenyl)-2,3,6,7,12,13,16,17-octahydro-1H,5H,11H,15H-xantheno[2,3,4-ij:5,6,7-i'j']diquinolizin-18-ium perchlorate",276-345-8,72102-91-1,Ox. Sol. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H272:1;H315:1
86876,Bromotrimethylstannane,213-916-2,1066-44-0,Acute Tox. 2;Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H312:38;H319:38;H330:42;H315:38;H410:42;H372:38;H300:42;H310:42;H301:38;H400:42
86877,3-chloro-p-cresol,210-439-1,615-62-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,48,H312:47;H302:47;H335:47;H315:48;H318:47;H332:47;H400:4;H319:1
86878,2-chloro-3-methoxypyridine,258-039-6,52605-96-6,,Notified C&L,5,H319:5;H335:5;H315:5
86881,"1,3-dihydro-3-oxoisobenzofuran-1-ylidenebis(6-hydroxy-5-methyl-m-phenylenemethylenenitrilo)tetra-acetic acid",219-318-8,2411-89-4,Not Classified,Notified C&L,5,Not classified:5
86882,"[1aR-(1aα,4aα,7α,8aS*)]-octahydro-4,4,8,8-tetramethyl-4a,7-methano-4aH-naphth[1,8a-b]oxirene",247-851-6,26619-69-2,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1547,H411:1324;H315:1324;Not classified:223
86884,11-cyanoundecanoic acid,227-373-4,5810-18-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H312:38;H302:38;H335:38;H315:38;H332:38
86887,Mercaptosuccinic acid,200-736-4,70-49-5,Acute Tox. 4,Notified C&L,125,H302:117;H319:63;H335:61;H315:63;H317:14;Not classified:8;H400:1;H410:1
86889,"reaction product of diphenylmethanediisocyanate, toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)",430-950-5,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
86894,"Oils, vegetable",273-313-5,68956-68-3,Not Classified,Notified C&L,164,Not classified:161;H413:3;H319:1
86895,3-bromo-4-fluorotoluene,207-201-4,452-62-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
86899,Methyl 2-[[2-(phenylmethylene)octylidene]amino]benzoate,267-798-2,67924-13-4,Not Classified,Notified C&L,89,Not classified:89
86900,Oltipraz,264-736-6,64224-21-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
86903,"Disodium 2,2'-(9,10-dioxoanthracene-1,4-diyldiimino)bis(5-methylsulphonate)",224-546-6,4403-90-1,Aquatic Chronic 4,REACH registration C&L,386,H413:19;Not classified:206;H319:116;H412:48;H411:41;H315:39;H317:1
86906,"Formaldehyde, oligomeric reaction products with 1-chloro-2,3-epoxypropane and phenol",500-006-8,9003-36-5,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,820,H411:750;H317:743;H315:740;H319:408;Not classified:51;H413:13;H311:1
86911,"3-Pyridinecarboxylic acid, 2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-, compd. with 2-propanamine (1:1)",617-240-2,81510-83-0,Not Classified,Notified C&L,3,Not classified:3
86912,"2,3-dimethylbutyric acid",238-208-0,14287-61-7,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H302:1;H335:1;H314:1
86916,Sodium m-(diethylamino)benzenesulphonate,225-861-1,5123-63-7,Eye Dam. 1,Notified C&L,42,H318:42
86919,Methyl L-phenylalaninate hydrochloride,231-383-4,7524-50-7,,Notified C&L,6,H319:5;H335:5;H315:5;H312:1;H302:1;H332:1;Not classified:1
86924,"2,3-Difluorobenzaldehyde",607-944-8,2646-91-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H226:46;H319:47;H335:46;H315:47
86926,"1,3-bis(trimethylsilyl)urea",242-177-9,18297-63-7,Flam. Sol. 1,Notified C&L,44,H228:40;H319:4;H335:4;H315:4;H302:1
86927,2-Methylpropyl (R)-2-hydroxypropanoate,612-178-2,61597-96-4,Eye Irrit. 2,Notified C&L,38,H319:38
86931,"Hydrocarbons, C4;Petroleum gas",289-339-5,87741-01-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H340:0;H350:0;H220:0;Not classified:0
86934,"9-oxo-9H-thioxanthene-3-carboxylic acid 10,10-dioxide",257-392-3,51762-52-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H302:2;H335:2;H315:2
86937,"N-(2,2-dimethoxyethyl)phthalimide",248-412-1,27328-34-3,Aquatic Acute 1,Notified C&L,38,H400:38
86938,[2-[(2-hydroxyethyl)[2-(stearoyloxy)ethyl]amino]ethyl]methylbis[2-(stearoyloxy)ethyl]ammonium hydrogen sulphate,281-551-6,83968-70-1,Not Classified,Notified C&L,1,Not classified:1
86939,1-METHYL-1H-PYRAZOLE,618-896-2,930-36-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H226:55;H319:53;H335:52;H315:54;H302:1
86940,"2,6-dichloronicotinic acid",609-561-1,38496-18-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H302:40;H335:47;H315:48;H312:1;H332:1
86941,Potassium chlorotrioxochromate,240-174-7,16037-50-6,Ox. Sol. 2;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H319:38;H335:38;H315:38;H410:42;H317:42;H272:42;H350:42;H400:42
86947,"1-Octadecanaminium, N,N-dimethyl-N-octadecyl-, (SP-4-2)-[[]29H,31H-phthalocyanine-2-sulfonato(3-)-[?]N29,[?]N30,[?]N31,[?]N32]cuprate(1-) (1:1)",615-157-6,70750-63-9,Not Classified,Notified C&L,75,Not classified:75
86948,Cefapirin,244-466-5,21593-23-7,Skin Sens. 1;Resp. Sens. 1;Carc. 2,REACH registration C&L,41,H351:4;H334:41;H317:6
86950,"Rutabaga, ext.",294-403-0,91722-02-0,Not Classified,Notified C&L,1,Not classified:1
86951,"Protein hydrolyzates, chicken-egg white",293-474-5,91079-84-4,Resp. Sens. 1,Notified C&L,2,H334:2
86956,"Fatty acids, C12-20 and C12-20-unsatd., compds. with triethanolamine",292-801-9,90990-37-7,Not Classified,Notified C&L,1,Not classified:1
86957,1-(2-(Dimethylamino)-1-(4-Methoxyphenyl)ethyl)cyclohexanol hydrochloride,619-421-1,99300-78-4,Eye Irrit. 2,Notified C&L,60,H319:48;H362:10;H302:18;H411:4;H332:4;H370:2;H372:1;Not classified:1;H360:1;H412:1
86958,Methyl 4-bromobutyrate,225-523-3,4897-84-1,,Notified C&L,8,H319:8;H315:8;H335:2;H302:1
86961,Distrontium diphosphate,237-461-4,13812-81-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
86962,"Phosphoric acid, aluminium sodium salt",232-090-4,7785-88-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,18,H319:10;H317:10;H335:10;H315:10;H318:6;Not classified:2
86966,"4,6-dimethyl-2-pyridylamine",226-470-9,5407-87-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H302:40;H335:39;H315:40;H312:1;H332:1
86967,"Phenol, 3-bromo-5-chloro-",611-435-6,56962-04-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H311:1;H332:1;H301:1
86980,(E)-4'-hydroxy-3'-methoxycinnamic acid,208-679-7,537-98-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:50;H335:49;H315:50;Not classified:1
86982,"1,2-Ethanediamine, N-(2-aminoethyl)-, reaction products with bisphenol A diglycidyl ether homopolymer",270-141-2,68411-71-2,Acute Tox. 4,Notified C&L,42,H302:37;H331:1;H314:3;H317:4;H318:2;H332:2;H319:2;H315:2;H351:1;H335:1
86984,2-benzyl-2-dimethylamino-4'-morpholinobutyrophenone,404-360-3,119313-12-1,Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H400:0;H410:0;H360:0
86989,Methyl 3-methylanthranilate,244-847-6,22223-49-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
86990,"Hexadecasodium [ethane-1,2-diylbis[[(phosphonatomethyl)imino]ethane-2,1-diyl[(phosphonatomethyl)imino]ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate",299-571-9,93892-84-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
86991,Tetradecyl isooctadecanoate,304-203-8,94247-26-4,Not Classified,Notified C&L,3,Not classified:3
86994,"(2,6-dichlorophenyl)acetonitrile",221-730-8,3215-64-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H319:46;H312:40;H302:40;H335:44;H315:46;H332:39;H311:5;H301:5;H331:5
87000,"1-amino-4-(3-amino-4-sulphoanilino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",204-926-8,128-99-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38;H315:38
87002,Benzyl carbamate,210-710-4,621-84-1,Aquatic Chronic 3,Notified C&L,1,H412:1
87003,Indium trifluoride,232-005-0,7783-52-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H335:39;H315:39;H330:4;H314:4;H301:4
87005,"2-[[2,2-bis[[(1-oxoallyl)oxy]methyl]butoxy]methyl]-2-ethyl-1,3-propanediyl diacrylate",302-434-9,94108-97-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2616,H319:2407;H335:2132;H315:2134;Not classified:209;H411:95
87007,"2,4-dibromotoluene",250-689-9,31543-75-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
87008,"6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole",416-490-8,162208-01-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
87009,Ketotifen,252-099-7,34580-13-7,,Notified C&L,2,H302:1;Not classified:1
87010,"1,6-diphenylhexa-1,3,5-triene",217-011-3,1720-32-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,129,H319:128;H335:129;H315:128;H410:1;H302:1
87015,1-(benzyl)quinolinium chloride,239-695-2,15619-48-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,93,H318:39;H335:38;H315:39;H412:34;H302:54
87018,"4-trans-Methoxy-4-trans-pentyl-[1,1-bicyclohexyl]",600-341-0,102714-95-4,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
87019,"Neodecanoic acid, neodymium salt",600-768-2,106726-11-8,Not Classified,REACH registration C&L,14,Not classified:14
87024,S-ethyl N-cyclohexylthiocarbamate,214-482-7,1134-23-2,Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,44,H332:3;H400:2;H410:2;H317:2;H302:39;Not classified:3;H413:1
87025,"1,2,3-tris(1,2,2,6,6-pentamethyl-4-piperidyl) 4-tridecyl butane-1,2,3,4-tetracarboxylate",283-678-2,84696-72-0,Skin Irrit. 2,Notified C&L,47,H315:47
87026,"3-[[4-[(6,7-dichlorobenzothiazol-2-yl)azo]-3-methylphenyl]ethylamino]propiononitrile",278-932-4,78520-83-9,Not Classified,Notified C&L,4,Not classified:4
87030,2-chloro-5-fluorotoluene,251-508-6,33406-96-1,,Notified C&L,8,H226:8;H319:7;H335:6;H315:7
87035,"3,5-dinitrosalicylic acid",210-204-3,609-99-4,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,93,H302:50;H318:6;H335:45;H315:46;Not classified:39;H319:8;H301:4;H312:3;H332:3;H314:2;H240:1
87040,Benzothiazol-2-yl diethyldithiocarbamate,202-408-6,95-30-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
87044,Dimethoxymethylsilane,240-914-9,16881-77-9,Flam. Liq. 2,REACH registration C&L,97,H225:36;H311:57;H302:57;Not classified:5;H318:5;H335:5;H315:6;H319:2;H312:1;H332:1
87045,Diethyl terephthalate,211-249-1,636-09-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,10,H319:10;H335:10;H315:10
87047,"(S)-2,2,3-trimethylcyclopent-3-ene-1-ethyl acetate",253-212-2,36789-59-0,Not Classified,Notified C&L,88,Not classified:88
87048,"2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-3-[2-[2-methoxy-5-methyl-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-8-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-",615-619-7,718596-80-6,Not Classified,Notified C&L,6,Not classified:3;H317:3;H318:3
87054,"Distillates (petroleum), steam-cracked heavy tar light;Cracked kerosine;[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 °C to 250 °C (212 °F to 482 °F).]",309-940-9,101631-15-6,Asp. Tox. 1,Harmonised C&L,0,H304:0
87056,decachlorotetrasilane,921-774-4,13763-19-4,Skin Corr. 1A,REACH registration C&L,2,H314:2
87057,"2-bromo-4,6-dinitroaniline",217-329-2,1817-73-8,,Notified C&L,5,H341:4;H319:1;H228:1;H315:1
87058,"fenpropimorph (ISO);cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine",266-719-9,67564-91-4,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H411:0;H302:0;H361:0;H315:0
87059,3-(chloromethyl)benzoyl chloride,263-799-7,63024-77-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,45,H314:45;H318:41;H335:4;H290:1
87060,"Benzene, 2,4-dichloro-1-fluoro-",604-366-8,1435-48-9,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,43,H411:43;H302:43;H315:43;H226:39;H373:42;H332:1
87061,"Lauric acid, compound with 2,2',2''-nitrilotriethanol (1:1)",218-749-9,2224-49-9,,Notified C&L,40,H319:40
87066,2-chloroethyl methanesulphonate,222-672-6,3570-58-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,39,H312:38;H351:38;H302:39;H332:38;H319:1;H315:1
87069,"1,1,1,2,2,3,3-heptachloropropane",209-856-1,594-89-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38;H335:38;H315:38
87070,"Verrucarin A, 7'-deoxo-7'-(1-hydroxyethyl)-, [7'R(R)]-",238-783-8,14729-29-4,Acute Tox. 2,Notified C&L,38,H300:38
87080,Hyssop oil,616-895-1,8006-83-5,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,152,H411:114;H302:119;H317:114;H226:152;H304:114
87082,"Fatty acids, palm kernel-oil, compds. with triethanolamine",293-082-4,91051-31-9,Not Classified,Notified C&L,3,Not classified:3
87083,"Bis(butan-2-olato)(ethyl 3-oxobutyrato-O1',O3)aluminium",246-455-0,24772-51-8,,Notified C&L,7,H319:6;H315:6;H335:2;Not classified:1;H226:1
87084,"azinphos-methyl (ISO);O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate",201-676-1,86-50-0,Acute Tox. 2;Acute Tox. 3;Skin Sens. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H311:0;H410:0;H317:0;H300:0;H400:0
87085,3-hydroxypentanoic acid,600-307-5,10237-77-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
87086,MCPA (ISO);4-chloro-o-tolyloxyacetic acid,202-360-6,94-74-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H315:0;H410:0;H318:0;H400:0
87089,2-(2-nonyl-2-imidazolin-1-yl)ethanol,253-521-2,37478-68-5,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,12,H400:10;H410:10;H314:10;Not classified:2
87094,"α,α,6,6-tetramethylbicyclo[3.1.1]hept-2-ene-2-propionaldehyde",251-718-8,33885-52-8,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,224,H400:1;H410:1;H317:19;Not classified:205
87100,Dipotassium titanium trioxide,234-748-6,12030-97-6,Not Classified,Notified C&L,8,Not classified:8
87102,"Benzene, diethenyl-, homopolymer",618-372-3,9003-69-4,Eye Irrit. 2,Notified C&L,40,H319:39;Not classified:1
87104,2-ethylhexyl nitrate,248-363-6,27247-96-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,771,H411:751;H312:768;H302:728;H332:770;H304:23;H319:2;H315:2;H335:1;H311:1;Not classified:1;H410:1;H400:1
87106,"Concentrated filtrate of the neutralized reaction product of 5-[2-(methylthio)alkyl]imidazolidine-2,4-dione and potassium carbonate",442-790-3,,Not Classified,REACH registration C&L,2,Not classified:2
87109,4-methoxyphenylacetonitrile,203-206-0,104-47-2,Acute Tox. 3,Notified C&L,50,H301:49;H412:8;H311:1;H331:1;H319:1;H315:1;Not classified:2
87117,"Sodium [5-chloro-3-[[4,5-dihydro-3-methyl-5-oxo-1-(3-sulphophenyl)-1H-pyrazol-4-yl]azo]-2-hydroxybenzenesulphonato(4-)]chromate(1-)",280-068-8,82933-90-2,Aquatic Chronic 2,REACH registration C&L,6,H411:4;Not classified:2
87118,"2-(2-quinolyl)-1H-indene-1,3(2H)-dione",201-453-9,83-08-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
87119,"Disodium 6,6'-diapo-ψ,ψ-carotenedioate",251-432-3,33261-81-3,Not Classified,Notified C&L,5,Not classified:5
87120,"7,7'-(carbonyldiimino)bis[4-hydroxy-3-[(6-sulpho-2-naphthyl)azo]naphthalene-2-sulphonic] acid, sodium salt",280-767-8,83763-79-5,Not Classified,Notified C&L,1,Not classified:1
87122,Tracer Yellow D-100,432-170-0,,Not Classified,Notified C&L,1,Not classified:1
87124,Di(2-pyridyl)amine,214-864-3,1202-34-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:38;H315:39;H302:1
87126,"1,8-DIAZABICYCLO[5.4.0]UNDEC-7-ENE PHENOL SALT",611-564-8,57671-19-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,94,H319:38;H302:94;H315:38;H318:25;H314:56;H412:9
87135,Mepyramine,202-102-2,91-84-9,Acute Tox. 4,REACH registration C&L,43,H302:43;H334:38;H319:2;H361:2;H335:2;H315:2
87144,"1,5,10-trimethylcyclododeca-1,5,9-triene",244-218-6,21115-77-5,Skin Irrit. 2;Aquatic Chronic 1,REACH registration C&L,66,H410:28;H315:28;H413:38
87146,Manganese hydrogen phosphate,257-147-0,51349-94-1,Eye Irrit. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,5,H319:3;H412:3;H373:3;Not classified:2
87147,Rhodium(3+) acetate,247-460-0,26105-49-7,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,83,H411:83;H317:83;H318:83
87149,"Barium, acetate tallow fatty acids complexes",269-207-3,68201-19-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,12,H302:12;H332:12
87151,"Butea frondosa, ext.",297-052-1,93333-82-5,Not Classified,Notified C&L,2,Not classified:2
87153,"3-(acetylamino)-5-amino-2,4,6-triiodobenzoic acid",216-987-8,1713-07-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
87154,Tetrapotassium (1-hydroxyethylidene)bisphosphonate,238-928-5,14860-53-8,Not Classified,Notified C&L,96,Not classified:64;H319:15;H302:32;H318:10;H315:11
87155,"4-(1,1,3,3-tetramethylbutyl)phenol;4-tert-octylphenol",205-426-2,140-66-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H318:0;H315:0
87156,"3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-, 4-[(4-C7-17-branched alkylphenyl)azo] derivs.",307-585-4,97660-72-5,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,14,H317:13;H413:13;Not classified:1
87158,"1,1-dimethoxydodecane",238-659-3,14620-52-1,Not Classified,Notified C&L,113,Not classified:113
87159,Methyl hydrogen glutarate,216-116-1,1501-27-5,,Notified C&L,5,H319:5;H315:5;H335:1
87160,2-(bromomethyl)-4-nitroanisole,223-471-6,3913-23-3,Skin Corr. 1B,Notified C&L,38,H314:38
87161,2-chloro-5-nitroanisole,213-768-9,1009-36-5,Acute Tox. 4,Notified C&L,41,H302:38;H319:3;H335:2;H315:3
87163,Iron dihydroxide,242-456-5,18624-44-7,Not Classified,Notified C&L,1,Not classified:1
87165,"Disodium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O']cuprate(2-)",254-356-9,39208-15-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
87168,"(Z)-2-[(3,4-dihydroxyphenyl)methylene]-6-hydroxy-2H-benzofuran-3-one",204-366-4,120-05-8,Not Classified,Notified C&L,2,Not classified:2
87169,Lard,263-100-5,61789-99-9,Not Classified,Notified C&L,1,Not classified:1
87171,"Fatty acids, C14-18 and C16-18-unsatd., compds. with N-tallow alkyltrimethylenediamines",297-831-6,93763-13-4,Not Classified,Notified C&L,1,Not classified:1
87174,"1,2-Propanediol alginate",618-414-0,9005-37-2,Not Classified,Notified C&L,120,Not classified:120
87181,sec-butyl methacrylate,221-073-7,2998-18-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H226:38;H319:38;H335:38;H315:38
87184,Triammonium hexachlororhodate,239-364-2,15336-18-2,Eye Dam. 1,Notified C&L,5,H318:3;H319:2;H315:2
87185,Sulfaguanidine,200-345-9,57-67-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,52,H411:3;H319:46;H335:45;H315:46;Not classified:4;H302:2;H312:1;H332:1
87186,"5,6-dihydro-2H-pyran-3-carbaldehyde",236-515-4,13417-49-7,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H227:1;H335:1;H315:1
87187,"2,4,6-trichlorophenyl isothiocyanate",244-798-0,22134-07-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H335:39;H315:39;H312:4;H302:4;H332:4;H314:4
87189,"Hydrocarbons, C6, n-alkanes, iso-alkanes, cyclics, n-hexane rich",925-292-5,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,23,H411:22;H361:23;H315:23;H225:23;H373:23;H336:23;H304:23
87191,5-methoxy-2-methylsulphanilic acid,229-319-5,6471-78-9,Eye Dam. 1,REACH registration C&L,3,H318:1;H319:2;H315:2;H312:1;H302:1;H335:1;H332:1
87195,"2-amino-5-cyano-N,3-dimethylbenzamide",619-946-6,890707-29-6,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,2,H319:2;H302:2
87196,"Slags, ferrous metal, blast furnace",266-002-0,65996-69-2,Not Classified,REACH registration C&L,56,Not classified:56
87199,Cobalt Lithium Manganese Nickel Oxide,480-390-0,,Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,45,H412:45;H330:45;H334:44;H317:44;H372:45;H350:45;H360:44;H319:11;H315:11
87200,Digold trioxide,215-122-1,1303-58-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,122,H319:122;H315:122
87201,"Phosphoric acid, C12-15-branched and linear alkyl esters, sodium salts",306-296-0,96792-60-8,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
87205,Heptyl butyrate,227-526-5,5870-93-9,Not Classified,Notified C&L,91,Not classified:90;H315:1
87206,"Tetrasodium 4,4'-bis[[4-[bis(2-hydroxypropyl)amino]-6-[(4-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-stilbene-2,2'-disulphonate",267-097-1,67786-25-8,Not Classified,REACH registration C&L,182,Not classified:182
87210,"Reaction products of cyclohexylamine, alkan-1-amine and 1,1'-methanediylbis(4-isocyanatobenzene)",,,Aquatic Chronic 4,REACH registration C&L,1,H413:1
87211,"(Z)-3,7-dimethylocta-2,6-dienal",203-379-2,106-26-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,268,H319:158;H317:268;H315:268
87212,4-phenylbutenone,204-555-1,122-57-6,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1839,H400:17;H412:7;H317:1788;H315:1528;H319:117;Not classified:50;H335:52;H226:25;H334:11;H411:2
87214,4-aminobenzonitrile,212-850-1,873-74-5,Acute Tox. 4;Acute Tox. 3;Acute Tox. 3;Muta. 2;Aquatic Chronic 3,REACH registration C&L,65,H412:7;H302:8;H341:6;H311:12;H331:9;H319:58;H301:57;H318:2;H315:5;H335:4
87216,"1-(2,6,6-trimethyl-2-cyclohexen-1-yl)hepta-1,6-dien-3-one",201-225-9,79-78-7,Not Classified,Notified C&L,1594,Not classified:1545;H411:49;H317:49
87217,2-pentylidenecyclopentan-1-one,240-477-4,16424-35-4,Skin Sens. 1,Notified C&L,113,H317:113
87218,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with diethylenetriamine and triethylenetetramine",500-608-0,161278-18-8,,Notified C&L,1,H311:1;H412:1;H314:1;H317:1
87222,"9(10H)-Anthracenone, 10-β-D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (10S)-",610-650-2,5133-19-7,Acute Tox. 4,Notified C&L,1,H302:1
87225,"Tris(2,2,6,6-tetramethylheptane-3,5-dionato-O,O')praseodymium",239-522-0,15492-48-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
87230,2-oxoazetidinium 4-acetate,249-083-7,28562-53-0,Skin Corr. 1B;Resp. Sens. 1,Notified C&L,40,H314:40;H334:39;H318:1
87232,"Naphtha (petroleum), clay-treated light straight-run;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C",271-263-9,68527-22-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
87234,"Pentanedioic acid, 1,5-bis[2-[2-(1-methylethyl)-3-oxazolidinyl]ethyl] ester",618-313-1,89911-09-1,Not Classified,Notified C&L,27,Not classified:27
87240,"reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10´-diamino-6,6',13,13´-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10´[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate",430-200-7,,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
87242,"Hydrogen chlorotrioxochromate(1-) , compound with 2,2'-bipyridine (1:1)",278-569-1,76899-34-8,Ox. Sol. 2;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 1B;Aquatic Acute 1,Notified C&L,42,H319:38;H335:38;H315:38;H311:38;H272:38;H350:42;H301:38;H400:42;H331:38;H410:4;H317:4
87245,"N,N-diethylhydroxylamine",223-055-4,3710-84-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,548,H411:286;H312:414;H335:317;H332:382;H226:497;H319:182;H302:87;H315:160;Not classified:50;H331:32;H341:5;H314:1;H413:1
87248,(4-bromophenyl)diphenylphosphine,211-996-3,734-59-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
87250,Pyrethrins and Pyrethroids,232-319-8,8003-34-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,164,H312:154;H302:154;H400:155;H332:158;H410:153;Not classified:6;H311:4;H301:4;H319:1;H331:1
87251,"Benzenesulfonamide, 4-amino-, sodium salt (1:1)",600-159-1,10103-15-8,Not Classified,Notified C&L,1,Not classified:1
87258,Trimethyltin chloride,213-917-8,1066-45-1,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,47,H330:47;H300:47;H400:47;H310:47;H410:47;Not classified:2;H319:1;H315:1
87259,"2-chloro-N,N-dimethyl-3-oxobutyramide",227-372-9,5810-11-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,39,H412:39;H302:38;H315:39;H317:39;H318:39;H351:1;H335:1;H301:1
87260,salts of benzidine [,208-519-6,531-85-1,Acute Tox. 4;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H350:0;H400:0;H410:0;H302:0
87266,"Glycerides, C14-18 and C16-18-unsatd. mono- and di-",266-951-0,67701-32-0,Not Classified,Notified C&L,207,Not classified:207
87270,"2,4'-bipyridine",209-467-7,581-47-5,,Notified C&L,6,H311:4;H301:4;H319:2;H312:2;H302:2;H335:1;H315:2;H332:2
87272,"tetraphenyl propane-2,2-diyldibenzene-4,1-diyl bis(phosphate)",611-829-8,5945-33-5,Aquatic Chronic 4,Notified C&L,138,H413:113;Not classified:25
87273,4-(4-Brom-5-propyl-tetrahydropyran-2-yl)-phenol,917-991-9,,Not Classified,REACH registration C&L,2,Not classified:2
87275,Avidins,215-783-6,1405-69-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
87276,M100907,604-124-1,139290-65-6,Aquatic Acute 1,Notified C&L,38,H400:38
87277,6-deoxy-L-β-galactose,219-452-7,2438-80-4,Not Classified,Notified C&L,12,Not classified:12
87281,2-methylbenzothiazol-5-ylamine dihydrochloride,251-204-3,32770-99-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
87289,"4-amino-5-hydroxy-3-[(4-nitrophenyl)azo]-6-(phenylazo)naphthalene-2,7-disulphonic acid",221-501-2,3121-74-2,Not Classified,Notified C&L,3,Not classified:3
87290,1-ethylpyridinium bromide,217-607-3,1906-79-2,,Notified C&L,6,H319:5;H335:4;H315:5;Not classified:1
87292,Cyclandelate,207-271-6,456-59-7,Eye Irrit. 2,Notified C&L,39,H319:38;H400:1;H410:1
87296,"N-[(1,1-dimethylethoxy)carbonyl]-β-alanine",221-979-2,3303-84-2,Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:4;H314:2;H335:4;Not classified:1;H315:2
87297,2-acetamidobenzoic acid,201-914-4,89-52-1,Acute Tox. 4,Notified C&L,43,H302:42;H319:5;H335:5;H315:5
87298,"Rape oil, oxidized",305-871-3,95193-59-2,Not Classified,REACH registration C&L,492,Not classified:492
87303,dibenzylphenylsulfonium hexafluoroantimonate,417-760-8,134164-24-2,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0;H317:0;H372:0;H318:0
87306,"N-Decyl-N-isononyl-N,N-dimethylammonium chloride",604-092-9,138698-36-9,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,12,H400:12;H410:12;H302:12;H314:12
87307,"Resins, Manila elemi",232-557-2,9000-75-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1421,H315:1409;H410:1404;H317:1410;H226:1404;H400:1406;H304:1408;H302:36;Not classified:10;H411:4;H228:1;H351:1;H341:1;H314:1;H412:1;H312:1
87309,"Resin acids and Rosin acids, tall-oil, maleated, potassium salts",293-637-0,91081-33-3,Not Classified,Notified C&L,3,Not classified:3
87311,Etorphine,238-535-9,14521-96-1,Acute Tox. 2;Acute Tox. 2;Repr. 2,Notified C&L,1,H300:1;H361:1;H330:1
87312,3-Aminopyrrolidine dihydrochloride,600-494-3,103831-11-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
87313,Barium bis[2-chloro-5-[(2-hydroxy-1-naphthyl)azo]toluene-4-sulphonate],225-935-3,5160-02-1,Not Classified,REACH registration C&L,430,Not classified:335;H302:94;H332:94;H317:1;H301:1
87315,"Phenols, ammonia liquor ext.;Alkaline Extract;[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700°C (1292°F)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.]",284-881-9,84988-93-2,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
87322,4-bromobut-1-ene,225-937-4,5162-44-7,Flam. Liq. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,54,H319:54;H225:54;H334:52;H335:52;H317:10;H315:3;H302:1;H341:1
87336,"Tall oil, calcium salt",269-120-0,68187-71-3,,Notified C&L,1,Not classified:1
87343,"Benzenemethanesulfonic acid, α,4-dihydroxy-",615-951-2,732937-24-5,Not Classified,Notified C&L,1,Not classified:1
87346,Dipotassium oxide,235-227-6,12136-45-7,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,599,H314:424;H318:334;Not classified:171;H302:5;H335:10;H319:4;H315:4
87347,4-methyl-7-sodiooxy-2H-1-benzopyran-2-one,227-790-1,5980-33-6,Not Classified,Notified C&L,1,Not classified:1
87348,"9-fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17-valerate",251-669-2,33755-46-3,Repr. 2;Lact.;STOT RE 2,Notified C&L,3,H373:1;H362:1;H361:2;H312:1
87350,"Gum benzoin, Siam",232-556-7,9000-72-0,Skin Sens. 1B,REACH registration C&L,1471,H317:1322;H412:1289;Not classified:148;H319:1;H315:3;H318:5;H372:3;H302:1;H335:1
87351,"Trisodium [2-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-5-hydroxy-6-[(2-hydroxy-5-sulphophenyl)azo]naphthalene-1,7-disulphonato(5-)]cuprate(3-)",240-175-2,16038-15-6,,Notified C&L,3,H317:1;Not classified:2
87355,"1,2,3,4-tetrahydro-4-methylnaphthalen-1-one",243-355-9,19832-98-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
87356,sodium azide,247-852-1,26628-22-8,Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H300:0;H400:0
87359,"2,2',2''-[nitrilotris(ethane-2,1-diyloxy)trisethanol",259-136-6,54384-48-4,Not Classified,Notified C&L,63,Not classified:56;H302:7;H318:7;H315:7
87361,Cinepazet,245-927-3,23887-41-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
87363,"Methyl 2,3-dihydroxybenzoate",219-317-2,2411-83-8,,Notified C&L,1,H319:1;H335:1;H315:1
87365,"2,2'-ethanediylidenedinitrilodiphenol",214-560-0,1149-16-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:41;H315:42
87367,Potassium ethyl oxalate,217-606-8,1906-57-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:1;H302:1;H332:1;H319:1;H315:1
87368,"Citrus medica acida, ext.",297-608-3,93685-55-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,62,H315:52;H410:51;H317:52;H226:52;H400:51;H304:52;Not classified:10;H411:1
87371,(3S)-3-amino-4-methoxy-4-oxobutanoic acid,605-818-7,17812-32-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
87374,"Pyridine-2,3-diyldiamine",207-200-9,452-58-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H302:38;H335:43;H315:44;H312:5;H332:5;H301:7;H311:1;H331:1
87376,Succinylsulfathiazole,204-141-0,116-43-8,Skin Sens. 1,Notified C&L,41,H317:40;Not classified:1;H334:2
87378,6-methylisoquinoline,255-794-3,42398-73-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:2;H302:1
87382,"Leach residues, cadmium cake",293-309-7,91053-44-0,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 1B;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,8,H340:7;H330:8;H315:7;H360:7;H410:8;H334:7;H317:7;H372:8;H318:8;H350:8;H301:7;H400:8;H302:1;H341:1;H361:1
87384,"Bromomethyl tricyclo[3.3.1.13,7]dec-1-yl ketone",225-860-6,5122-82-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:39;H315:39;H302:1;H318:1;H314:1
87387,Diethyl dichloromalonate,243-550-9,20165-81-5,Acute Tox. 4,Notified C&L,38,H302:38
87390,Yohimbine,205-672-0,146-48-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,27,H311:26;H331:26;H301:27
87391,"Formaldehyde, oligomeric reaction products with phenol",500-005-2,9003-35-4,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,739,H319:159;H412:10;H317:365;H312:127;H302:200;Not classified:147;H335:127;H315:85;H410:71;H318:73;H351:3;H341:4;H332:3;H314:1
87392,Dimethyl isophthalate,215-951-9,1459-93-4,Eye Irrit. 2,REACH registration C&L,82,H319:47;Not classified:35;H315:1
87395,4-amino-N-(2-ethylhexyl)benzenesulphonamide,258-799-9,53817-09-7,Aquatic Chronic 2,Notified C&L,84,H411:84
87396,Probenecid,200-344-3,57-66-9,Acute Tox. 4,Notified C&L,139,H302:139;H319:4;H335:4;H315:4;H351:1;H361:1
87397,"(2,3,4,5,6-pentafluorophenyl)acetyl chloride",212-624-2,832-72-4,Skin Corr. 1B,Notified C&L,1,H314:1
87403,Cefroxadine,257-391-8,51762-05-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
87404,"Amides, C6-18, N-[3-(dimethylamino)propyl]",308-484-8,98072-33-4,Skin Corr. 1B;Aquatic Acute 1,Notified C&L,8,H400:7;H410:7;H314:7;H319:1;H335:1;H315:1
87405,Aminofunctional Fluid,600-354-1,102782-92-3,Skin Irrit. 2,Notified C&L,111,H315:109;H318:31;H319:5;Not classified:1
87407,"6H-Purin-6-one, 2-amino-1,9-dihydro-9-[[1-(hydroxymethyl)-2-(phenylmethoxy)ethoxy]methyl]-",601-584-5,119089-68-8,Not Classified,Notified C&L,1,Not classified:1
87408,4-aminosalicylic acid,200-613-5,65-49-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,51,H319:51;H335:11;H315:12
87409,"AZIRIDINE, HOMOPOLYMER",618-346-1,9002-98-6,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1103,H411:1079;H319:673;H302:1054;H317:373;H318:296;H412:14;H301:12;Not classified:1;H315:3;H410:1;H400:1;H335:1;H312:1;H314:1
87412,4-chlorobenzylic alcohol,212-852-2,873-76-7,Not Classified,Notified C&L,46,Not classified:44;H319:1;H335:1;H315:1;H312:1;H302:1;H332:1
87413,1-(3-chlorophenyl)-4-(3-chloropropyl)piperazinium chloride,258-038-0,52605-52-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,77,H411:23;H319:65;H302:14;H315:65;H317:1;H335:50;Not classified:1
87416,"Hydrogen 9-(2,4-disulphonatophenyl)-3,6-bis(ethylamino)-2,7-dimethylxanthylium, monosodium salt",227-528-6,5873-16-5,,Notified C&L,1,Not classified:1
87419,"Resin acids and Rosin acids, maleated, calcium salts",294-402-5,91722-01-9,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 4,REACH registration C&L,3,H317:3;H413:2;H318:3
87420,Gold trihydroxide,215-120-0,1303-52-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,74,H319:74;H335:74;H315:74
87422,"Hexanedioic acid, polymer with 1,2-propanediol",607-544-3,25101-03-5,,Notified C&L,34,Not classified:34
87424,"3,3',4,4',5,5'-hexamethoxybenzoic anhydride",217-010-8,1719-88-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
87426,"2-Methyl-4,6-dichloropyrimidine",605-815-0,1780-26-3,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,51,H411:42;H302:42;H317:42;H314:6;H319:3;H335:3;H315:3;H318:1
87429,"1,4'-bipiperidyl",225-522-8,4897-50-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:45;H335:44;H315:45;H314:5;H302:1
87433,"1,2,3-tris(2,2,6,6-tetramethyl-4-piperidyl) 4-tridecyl butane-1,2,3,4-tetracarboxylate",283-677-7,84696-71-9,Not Classified,Notified C&L,1,Not classified:1
87440,"3,4,5,6-tetrachloro-2-(trichloromethyl)pyridine",214-481-1,1134-04-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
87441,Zirconium(4+) methacrylate,267-604-6,67893-01-0,,Notified C&L,1,H319:1;H335:1;H315:1
87447,"1,4,5-trideoxy-1,4-imino-5-(p-methoxyphenyl)-D-xylo-pentitol 3-acetate",245-269-7,22862-76-6,Acute Tox. 3,Notified C&L,63,H301:62;H311:18;H331:17;H330:1;H300:1;H361:1
87457,Barium oxalate,208-216-9,516-02-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H312:42;H302:42;H332:42
87467,Thiobenzanilide,211-248-6,636-04-4,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38,H400:38;H302:38
87468,fenamiphos (ISO);ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate,244-848-1,22224-92-6,Acute Tox. 2;Acute Tox. 2;Eye Irrit. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H330:0;H410:0;H300:0;H310:0;H400:0
87470,"1,1'-Biphenyl, 4-fluoro-4'-(trans-4-propylcyclohexyl)-",617-989-5,87260-24-0,Not Classified,Notified C&L,1,Not classified:1
87473,1H-indole-1-propionamide,244-149-1,21017-50-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
87479,"[(-)-(4-amino-2-hydroxy-4-oxobutyl)trimethylammonium](1R,3S)-1,2,2-Trimethyl-1,3-cyclopentanedicarboxylic acid monocarboxylate",925-384-5,,Not Classified,Notified C&L,1,Not classified:1
87481,Manganese trifluoride,232-006-6,7783-53-1,Ox. Sol. 2;Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,199,H319:198;H312:194;H335:198;H315:198;H272:194;H332:198;H301:195;H302:4;H311:1
87482,"Alpha,alpha',2,3,5,6-hexachloro-4-xylene",214-090-6,1079-17-0,Skin Corr. 1B,Notified C&L,39,H314:39;H290:1;H318:1
87484,Pyrene,204-927-3,129-00-0,Not Classified,REACH registration C&L,157,Not classified:42;H319:83;H335:83;H315:83;H400:103;H410:111;H302:4;H332:4;H413:4;H330:2
87489,"Salt of 1-[(5α,6β,14β,18S)-3,6-dimethoxy-17-methyl-7,8-didehydro-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-18-yl]ethanone and tartaric acid (1:1)",604-177-0,14022-24-3,Acute Tox. 4,Notified C&L,1,H302:1
87490,Methyl 4-chloroformylbutyrate,216-115-6,1501-26-4,Skin Corr. 1B,Notified C&L,44,H314:44
87491,"Reaction mass of 2-methyl-3-{[(2R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl]oxy}propan-1-ol and 2-methyl-3-{[(2S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl]oxy}propan-1-ol",416-210-4,128119-70-0,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1536,H411:1536;H319:1536
87495,"4'-fluoro-4-(8-fluoro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)butyrophenone hydrochloride",250-688-3,31540-62-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H331:38;H301:38
87499,6-chlorobenzothiazol-2-ylamine hydrochloride,263-261-1,61827-71-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H302:1
87501,"2,2'-thiodiethanethiol",222-671-0,3570-55-6,Acute Tox. 3;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,100,H400:21;H410:26;H317:34;H301:29;H332:76;H319:12;H312:7;H335:12;H315:12;H302:1;H330:1;Not classified:2
87502,Clonazepam,216-596-2,1622-61-3,Not Classified,Notified C&L,162,Not classified:157;H412:3;H362:2;H361:3;H413:1;H336:2;H360:1
87504,"Trisodium 5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(4-sulphonato-1-naphthyl)azo]naphthalene-2,7-disulphonate",277-439-1,73398-41-1,Not Classified,Notified C&L,2,Not classified:2
87505,"§N-{5-[bis(2-alkoxyalkyl)amino]-2-[(2-alkyl- heterapolycarbocyc-yl)diazenyl]phenyl}acetamide, polybromo",442-610-3,,Not Classified,Notified C&L,1,Not classified:1
87506,4-Fluoro-3-hydroxybenzonitrile,606-089-8,186590-04-5,,Notified C&L,4,H312:2;H332:2;H301:3;H319:2;H335:2;H315:2;H311:1;H331:1
87510,"Benzenesulfonic acid, 2-methyl-5-nitro-, alkaline condition products, lithium salts",265-516-2,65150-80-3,,Notified C&L,48,Not classified:48
87511,"1,3,4-Octadecanetriol, 2-amino-, sulfate (2:1) (salt), D-ribo- (8CI)",917-270-9,29790-50-9,Eye Irrit. 2,REACH registration C&L,2,H319:2
87512,"[1S-(1α,2β,3α,5α)]-pinane-3-methylammonium chloride",260-693-2,57357-84-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
87519,"1-Ethoxy-2,3-difluoro-4-(trans-4-pentylcyclohexyl)-benzene",603-009-3,124729-02-8,Not Classified,Notified C&L,1,Not classified:1
87523,4-Chloro-2-cyanopyridine,606-272-2,19235-89-3,Acute Tox. 3;Eye Dam. 1,Notified C&L,53,H318:49;H301:50;H319:3;H315:3;H312:2;H302:3;H332:2;H335:2
87524,(E)-1-[trans-4-(E-Propen-1-yl)-cyclohexyl]-2-[trans-4-(4-methoxyphenyl)-cyclohexyl]-ethene,605-707-3,174079-92-6,Aquatic Chronic 4,Notified C&L,2,H413:2;Not classified:1
87530,"1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride",415-660-9,70918-74-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H311:0;H301:0;H373:0;H331:0
87531,"α-chloro-α,α-diphenylacetyl chloride",220-798-6,2902-98-9,Skin Corr. 1B;STOT SE 3,Notified C&L,38,H314:38;H335:38
87533,Antimony chloride oxide,232-238-8,7791-08-4,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1;H332:1
87534,"Alkenes, C9-13-branched, C10-rich",295-253-9,91994-95-5,Flam. Liq. 3;Asp. Tox. 1;Aquatic Acute 1,REACH registration C&L,6,H226:6;H400:6;H410:6;H304:6
87535,Potassium undecafluorocyclohexanesulphonate,221-465-8,3107-18-4,Not Classified,Notified C&L,5,Not classified:5
87538,1-(chloromethyl)naphthalene,201-678-2,86-52-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,56,H312:54;H302:56;H318:8;H314:56;H290:1
87543,4-chloro-o-xylene,210-438-6,615-60-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:43;H335:42;H315:46;H411:3;H373:3;H317:3;H311:1;H331:1;H301:1
87544,Trityl hexafluorophosphate,207-112-0,437-17-2,Skin Corr. 1B,Notified C&L,43,H314:43
87545,8-bromoadenosine,220-959-0,2946-39-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
87553,1-(Acryloyloxy)-3-(methacryloyloxy)-2-propanol (stabilized with MEHQ),605-599-8,1709-71-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1,Notified C&L,121,H302:82;H317:120;H318:121;H315:121
87557,"Octadecenoic acid, compound with 2,2'-(octadec-9-enylimino)diethanol (1:1)",308-460-7,98072-11-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,10,H319:6;H317:6;H315:6;Not classified:3;H300:1
87558,Quercetin-3-o-glucopyranoside,640-533-1,482-35-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
87560,"Reaction product of benzene-1,2:4,5-tetracarboxylic dianhydride, Octadecylamine, (Z)-Octadec-9-enylamine and hexamethylenediamine",925-766-1,,Not Classified,Notified C&L,2,Not classified:2
87562,Dimethylphosphine oxide,230-591-2,7211-39-4,,Notified C&L,3,H319:3;H302:2;H335:3;H315:3;H312:1;H412:1;H332:1;H402:1;H226:1
87563,"Tyrosine, N-(aminocarbonyl)-3-methoxy-O,α-dimethyl-",608-271-2,28861-00-9,Skin Sens. 1,REACH registration C&L,1,H317:1
87565,"1,3-isobenzofurandione, reaction products with methylquinoline and quinoline",232-318-2,8003-22-3,Skin Sens. 1,REACH registration C&L,192,H317:33;Not classified:104;H319:44;H335:44;H315:44;H361:11;H341:11
87569,Hydrogen bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-),256-606-2,50497-83-1,Not Classified,Notified C&L,3,Not classified:3
87570,1-ethylpyrrolidine,230-840-5,7335-06-0,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,39,H225:39;H314:39;H318:1
87573,4-[(tert-Butoxycarbonylamino)methyl]pyridine,601-040-7,111080-65-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:38;H335:38;H315:39
87574,"6-ethoxy-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline",240-546-9,16489-90-0,Acute Tox. 4,Notified C&L,39,H302:39;H319:1;H335:1;H315:1
87576,"2,6-dinitro-p-cresol",210-203-8,609-93-8,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H300:40;H335:39;H315:40
87578,diisopropyl ether,203-560-6,108-20-3,Flam. Liq. 2;STOT SE 3,Harmonised C&L,0,H336:0;H225:0
87584,4-phenylbut-3-yn-2-one,217-327-1,1817-57-8,Acute Tox. 4,Notified C&L,43,H302:38;H319:5;H315:5
87586,"Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, molybdatephosphate",263-797-6,63022-09-3,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,90,H319:83;H412:83;H302:83;H400:7;H410:7;H318:7
87587,"2,3-dimethoxybenzaldehyde",201-677-7,86-51-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
87588,"(5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione",928-889-9,,Not Classified,Notified C&L,1,Not classified:1
87589,"2,4-D (ISO);2,4-dichlorophenoxyacetic acid",202-361-1,94-75-7,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT SE 3;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H335:0;H317:0;H318:0
87590,"(2,5-dioxopyrrolidin-1-yl) 4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexane-1-carboxylate",613-734-7,64987-85-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,82,H319:82;H335:81;H315:82
87595,Palladium(II) acetate,222-164-4,3375-31-3,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,333,H400:243;H410:243;H317:261;H318:330;H302:240;H413:15;Not classified:3;H319:3;H335:1;H315:2;H411:1
87596,Etoposide,251-509-1,33419-42-0,Acute Tox. 4;Carc. 1B,Notified C&L,136,H350:135;H302:135;Not classified:1;H312:2;H340:7;H360:7;H372:1;H332:1;H373:1
87606,"Boronic acid, (4-ethylphenyl)-",613-145-5,63139-21-9,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,9,H319:8;H302:3;H335:6;H315:7;H312:1;H332:1
87608,Diethyl phenylphosphonite,216-676-7,1638-86-4,Skin Irrit. 2;Skin Sens. 1B;Acute Tox. 2,REACH registration C&L,89,H330:85;H317:85;H315:89;H319:4;H335:4
87609,Magnesium potassium titanium oxide,436-900-9,,Not Classified,REACH registration C&L,2,Not classified:2
87610,Valerophenone,213-767-3,1009-14-9,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
87612,(3-fluoro-4'-propyl[biphenyl]-4-yl)boronic acid,618-687-6,909709-42-8,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H410:2;H319:3;H400:2;H315:1
87614,4-allylanisole,205-427-8,140-67-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1849,H319:23;H412:72;H302:1846;H315:80;H317:1836;H341:1821;H351:1820;H335:4;H410:1;Not classified:2;H312:1
87615,"6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-propionaldehyde",251-717-2,33885-51-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1584,H319:1328;H302:1328;H315:1328;H410:1328;H317:1328;H400:1328;Not classified:256
87619,tetrahydrothiopyran-3-carboxaldehyde,407-330-8,61571-06-0,Eye Dam. 1;Aquatic Chronic 3;Repr. 1B,Harmonised C&L,0,H412:0;H360:0;H318:0
87622,3-bromophenylhydrazine hydrochloride,248-362-0,27246-81-7,Skin Corr. 1B,Notified C&L,44,H314:38;H319:6;H335:5;H315:6
87623,2-bromobenzenethiol,228-665-4,6320-02-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:38;H335:38;H315:38;H314:7;H301:6;H312:1;H302:1;H318:1;H332:1;H311:2;H330:1;H331:1
87626,"Bis(6-methylheptane-2,4-dionato-O,O')nickel",238-536-4,14522-99-7,Skin Sens. 1,Notified C&L,1,H317:1
87628,"D-glucopyranoside methyl 2,6-dioleate",280-069-3,82933-91-3,Not Classified,Notified C&L,126,Not classified:126
87629,Oxazole,206-020-8,288-42-6,Flam. Liq. 2;Eye Dam. 1,Notified C&L,51,H225:51;H318:46;H314:5
87632,p-phenylene diisocyanate,203-207-6,104-49-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A;Acute Tox. 2;Resp. Sens. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,119,H411:77;H319:79;H335:8;H330:79;H315:119;H334:117;H317:78;H312:39;H302:39;H318:40;H332:39;H373:16;H301:1;H331:1
87633,"4,4'-oxybis(benzene-1-sulphonyl) dichloride",204-488-8,121-63-1,Met. Corr. 1;Skin Corr. 1C,REACH registration C&L,8,H314:8;H290:2;H318:1
87639,Isopropyl methanesulphonate,213-132-0,926-06-7,Acute Tox. 4;Skin Corr. 1B;Muta. 2;Carc. 2,Notified C&L,42,H351:42;H302:41;H341:42;H314:41;H319:1;H361:1;H315:1;H301:1
87642,2-chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamide,264-980-3,64628-44-0,Acute Tox. 2,Notified C&L,196,H330:194;H400:2;H410:2
87646,Ethylbenzoylacrylate (raw),438-510-4,15121-89-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,31,H312:31;H302:31;H315:31;H410:31;H317:31;H318:31;H400:31
87651,"1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone",411-180-9,92836-10-7,Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H373:0;H302:0
87653,"Butanoic acid, 4-(4-chloro-2-methylphenoxy)-, ethyl ester",600-564-3,10443-70-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1;H302:1
87654,"1,8-diiodooctane",246-456-6,24772-63-2,Aquatic Chronic 4,Notified C&L,43,H413:38;H319:5;H315:5
87656,"1,3-Butadiene, homopolymer, hydroxy-terminated",614-926-3,69102-90-5,Not Classified,Notified C&L,18,Not classified:18
87660,"3,5-dimethoxytoluene",224-048-9,4179-19-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1418,H319:1415;H335:1414;H315:1415;Not classified:3
87661,5-butyldihydro-4-methylfuran-2(3H)-one,254-357-4,39212-23-2,Not Classified,Notified C&L,277,Not classified:238;H319:39;H335:38;H315:39
87662,"Butyrospermum parkii, ext., oleins, hydrogenated",297-053-7,93333-83-6,Not Classified,Notified C&L,1,Not classified:1
87664,"Naphtha (petroleum), clay-treated full-range straight-run;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C",271-262-3,68527-21-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
87665,Dexamethasone 21-isonicotinate,218-866-5,2265-64-7,,Notified C&L,3,H312:1;H373:2;H302:1;H332:1;H361:2;H362:1
87668,"Ethanol, 2,2'-iminobis-, N-tallow alkyl derivs., N-oxides",263-179-6,61791-46-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,139,H319:2;H315:100;H410:2;H226:2;H400:102;H318:59;H317:39;Not classified:37;H314:2
87670,2-chlorobenzyl alcohol,241-801-7,17849-38-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
87673,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 3-aminomethyl-3,5,5-trimethylcyclohexylamine and 2-piperazin-1-ylethylamine",500-609-6,161278-19-9,,Notified C&L,1,H312:1;H412:1;H302:1;H314:1;H317:1
87674,Oxfendazole,258-714-5,53716-50-0,Eye Irrit. 2,Notified C&L,77,H319:39;H410:35;H373:35;H400:35;H360:35;H302:1;H334:1;H361:1;H341:1;Not classified:1
87675,"Biphenyl-2,5-diol",214-091-1,1079-21-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:38;H315:39;H302:4
87680,Disodium tetrahydroxyzincate,235-342-1,12179-14-5,Skin Corr. 1A;Aquatic Chronic 1,Notified C&L,4,H410:4;H314:4
87681,"4-amino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one",201-452-3,83-07-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,100,H319:92;H302:99;H335:88;H315:90;Not classified:2
87683,Pentyl acrylate,221-074-2,2998-23-4,,Notified C&L,1,H411:1;H319:1;H335:1;H315:1
87689,"5-hydroxy-α,α,4-trimethylcyclohex-3-ene-1-methanol",207-868-1,498-71-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H312:1;H302:1;H332:1
87692,5-Methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide,616-254-6,75706-12-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,262,H319:257;H315:257;H335:257;H301:261;H372:9;H360:12;H302:1;H361:1;H411:2;H332:1
87693,Diisotridecyl phenyl phosphite,267-466-7,67874-37-7,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,3,H412:2;H317:2;Not classified:1
87694,"2-Amino-5-Chloro-N,3-Dimethylbenzamide",618-233-7,890707-28-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,14,H302:14;H332:13;H411:1
87695,Ethyl 3-oxovalerate,225-593-5,4949-44-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
87697,(Methylsulphonyl)acetic acid,607-581-5,2516-97-4,,Notified C&L,8,H319:7;H335:7;H315:7;Not classified:1
87702,"sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate",407-800-2,136213-75-7,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
87705,DL-6-oxobornane-10-sulphonic acid,227-527-0,5872-08-2,Not Classified,REACH registration C&L,54,Not classified:7;H314:47;H318:2
87708,"S-1,3-benzothiazol-2-yl (2Z)-(2-amino-1,3-thiazol-4-yl)[(trityloxy)imino]ethanethioate",700-114-7,143183-03-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H319:1;H335:1;H315:1;H400:1;H410:1
87709,Tributylborane,204-554-6,122-56-5,Pyr. Liq. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,182,H250:182;H314:181;H318:139;H302:42
87710,"2-Naphthalenol, 1-[[4-(phenylazo)phenyl]azo]-, ar-heptyl ar',ar''-Me derivs.",296-120-8,92257-31-3,Repr. 2;STOT RE 2;Aquatic Chronic 4,REACH registration C&L,1273,H373:31;H361:551;H413:29;Not classified:504;H400:201;H351:17
87711,1-allyl-3-chloro-4-fluorobenzene,406-630-6,121626-73-1,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
87715,4-bromobenzyl alcohol,212-851-7,873-75-6,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,7,H319:7;H412:4;H335:3;H315:3
87718,"Sodium hydrogen [6R-[6α,7β(R*)]]-3-(acetoxymethyl)-7-[(5-amino-5-carboxylato-1-oxopentyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",257-390-2,51762-04-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,39,H334:39;H317:39
87722,chlorfenprop-methyl;methyl 2-chloro-3-(4-chlorophenyl)propionate,238-413-5,14437-17-3,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H312:0;H400:0;H302:0
87725,Rhodium triiodide,239-521-5,15492-38-3,Aquatic Chronic 4,Notified C&L,3,H413:3
87726,(R)-2-(4-Hydroxyphenoxy)propanic acid,618-996-6,94050-90-5,Eye Dam. 1,Notified C&L,195,H318:195
87734,Tripotassium tetra(cyano-C)cuprate(3-),238-146-4,14263-73-1,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H330:1;H300:1;H400:1;H310:1;H410:1
87735,2-butyloctan-1-ol,223-470-0,3913-02-8,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,131,H411:55;H400:73;Not classified:58;H410:28;H319:1
87740,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 3-aminomethyl-3,5,5-trimethylcyclohexylamine and trimethylhexane-1,6-diamine",921-334-1,,,Notified C&L,1,H312:1;H412:1;H302:1;H314:1;H317:1
87745,"2,6,8-Trimethyl-4-nonylpolyethylene glycolether",612-043-8,60828-78-6,Eye Dam. 1,Notified C&L,1313,H318:827;H319:486;H412:512;H315:160;H411:27;H302:1;H413:1
87746,D-glucitol,200-061-5,50-70-4,Not Classified,Notified C&L,1277,Not classified:1277
87747,"trans-cyclopentane-1,2-diol",225-757-6,5057-99-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
87749,"Pyrrolo[3,4-c]pyrrole-1,4-dione, 3,6-bis([1,1'-biphenyl]-4-yl)-2,5-dihydro-",618-223-2,88949-33-1,Not Classified,Notified C&L,42,Not classified:42
87754,Disodium fluorophosphate,233-433-0,10163-15-2,Acute Tox. 4,REACH registration C&L,70,H302:64;H319:5;H315:8;H335:5;H301:4;H318:3;Not classified:1
87757,Essential Oil of Piper nigrum L. (Family: Piperaceae). Obtained by the steam distillation of dried unripe berries.,616-894-6,8006-82-4,Flam. Liq. 3;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,190,H226:189;H319:184;H400:146;H410:146;H315:186;H317:147;H304:148;H335:39;H411:3
87758,Diammonium phosphonate,244-797-5,22132-71-4,Eye Irrit. 2,REACH registration C&L,101,H319:97;Not classified:4;H315:2
87760,"(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane",433-820-6,118058-74-5,Eye Irrit. 2,Harmonised C&L,0,H319:0
87761,"Octa-1,7-diene",223-054-9,3710-30-3,Flam. Liq. 2;Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,102,H400:36;H410:36;H225:102;H304:102;H412:65
87768,"Alkanes, C18-70",275-017-1,70913-86-9,Not Classified,Notified C&L,60,Not classified:60
87770,"Estr-4-ene-3,17-dione",211-995-8,734-32-7,Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,11,H411:1;H351:2;H302:11;H362:1;H410:1;H360:2;H400:1;H361:7;H312:2;H341:1;H319:1;H315:1;H334:1;H332:1
87771,"2,4,8,10-tetra(tert-butyl)-6-hydroxy-12H-dibenzo[d,g][1,3,2]dioxaphosphocin 6-oxide, sodium salt",286-344-4,85209-91-2,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,218,H411:87;H332:92;Not classified:101;H412:30;H361:4
87772,"reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate",432-100-9,,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
87773,3-methyl-1-(4-nitrophenyl)-5-pyrazolone,229-018-9,6402-09-1,Not Classified,REACH registration C&L,76,Not classified:38;H302:38;H317:38
87775,"2-ethylhexyl 2,4-dichlorophenoxyacetate",217-673-3,1928-43-4,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,185,H400:184;H410:184;H302:185;H317:185;H318:2;H412:1;H335:1
87778,Ethylphosphonic dichloride,213-918-3,1066-50-8,Acute Tox. 1;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,42,H311:38;H300:38;H331:38;H314:42;H330:4
87779,"Propanedioic acid, (acetylamino)[7-chloro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-yl]-, diethyl ester",620-280-3,59469-46-4,Not Classified,Notified C&L,1,Not classified:1
87781,"Benzenesulfonic acid, C10-60-alkyl derivs.",295-008-6,91782-38-6,,Notified C&L,1,Not classified:1
87783,"2,3'-bipyridine",209-468-2,581-50-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3;Muta. 2;Carc. 2,Notified C&L,1,H319:1;H351:1;H341:1;H335:1;H315:1;H332:1;H301:1
87785,"Glycerides, C14-18 mono- and di-",266-952-6,67701-33-1,Not Classified,REACH registration C&L,340,Not classified:340
87788,"Butane, 2,2,3-trichloro-1,1,1,3,4,4,4-heptafluoro-",608-889-2,335-44-4,,Notified C&L,5,H319:5;H335:5;H315:5
87789,"3,5-bis(hydroxymethyl)-p-cresol",202-036-4,91-04-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:44;H315:45;Not classified:1
87796,"2,3-dichlorotoluene",251-203-8,32768-54-0,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,76,H411:5;H315:1;H332:38;Not classified:33
87797,N-L-alanyl-L-tyrosine,221-305-7,3061-88-9,Not Classified,REACH registration C&L,3,Not classified:3
87799,"1,3-diethyl 2-(6-chlorohexyl)propanedioate",600-098-0,100476-78-6,Not Classified,Notified C&L,1,Not classified:1
87804,(2-carboxyphenyl)acetic acid,201-913-9,89-51-0,,Notified C&L,7,H319:7;H335:6;H315:7
87805,"Hydroxybutyl Methacrylate, 94%, mixture of isomers",470-740-0,,Not Classified,Notified C&L,1,Not classified:1
87806,"Methyl 2-[(3,5,5-trimethylhexylidene)amino]benzoate",267-162-4,67801-42-7,Not Classified,Notified C&L,89,Not classified:89
87807,"7,7'-(carbonyldiimino)bis[4-hydroxy-3-[(6-sulpho-2-naphthyl)azo]naphthalene-2-sulphonic] acid, sodium salt, compound with 2,2'-(methylimino)diethanol",280-768-3,83763-80-8,,Notified C&L,34,Not classified:34
87808,7-CHLORO-3-METHYL BENZO[B]THIOPHENE,605-751-3,17514-68-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,REACH registration C&L,2,H312:1;H302:2;H332:1;H315:1;H400:1;H410:1;H317:1
87813,"N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-4-[[2-methoxy-5-methyl-4-[(methylamino)sulphonyl]phenyl]azo]naphthalene-2-carboxamide",257-515-0,51920-12-8,Not Classified,REACH registration C&L,168,Not classified:168
87821,2-chlorobenzophenone,225-936-9,5162-03-8,,Notified C&L,8,H319:7;H335:6;H315:7;H302:1
87825,"ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;benzoylprop-ethyl (ISO)",244-845-5,22212-55-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0
87831,"2-[[]4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethanol",618-344-0,9002-93-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,367,H319:134;H302:288;H315:131;H412:82;H410:80;H318:175;H411:83;H400:37;Not classified:17;H314:1;H413:2;H335:2
87835,"4-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)benzoic acid",241-117-9,17057-04-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3;H312:1;H302:1;H332:1
87836,"2-methylpropane-1,2-diol",209-198-5,558-43-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
87839,triflumizole (ISO);(1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine,614-708-8,68694-11-1,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H302:0;H373:0;H317:0;H400:0;H360:0;H410:0
87840,"2-Oxazolidinone, 5-[[4-(hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-",600-799-1,1071765-44-0,,Notified C&L,2,H302:2
87843,"N,N,N',N'-tetramethyl-2,2'-oxybis(ethylamine)",221-220-5,3033-62-3,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,498,H302:475;H314:495;H311:488;H318:365;H332:352;H412:87;H331:99;H330:46;H301:23;H312:10;H319:2;H226:1
87845,"reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;2-isopropyl-N-hydroxyethyl 1,3-oxazolidine",429-990-6,,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0;H318:0
87847,"1-Tridecanol, branched",292-294-4,90583-90-7,Not Classified,Notified C&L,6,Not classified:6
87856,"Soybean oil, monoester with triglycerol",271-716-0,68605-19-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
87861,Ethyl 2-methylnicotinate,217-013-4,1721-26-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:38;H315:39
87862,"Fatty acids, C14-18 and C16-18-unsatd., esters with propylene glycol, sulfated, sodium salts",288-460-0,85736-50-1,Not Classified,Notified C&L,5,Not classified:5
87863,"estra-1,3,5(10)-triene-3,17β-diol 17-heptanoate",225-599-8,4956-37-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,66,H312:39;H351:64;H302:39;H332:39;H362:24;H360:25;H350:1;H373:1;H361:1
87865,3-methyldodecanoic acid,236-805-0,13490-36-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
87871,xylene,215-535-7,1330-20-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Harmonised C&L,0,H226:0;H312:0;H332:0;H315:0
87872,3-methoxybenzamide,227-379-7,5813-86-5,,Notified C&L,4,H319:4;H335:4;H315:4
87875,Calcium bis[3-hydroxy-4-(phenylazo)-2-naphthoate],228-899-7,6371-76-2,Acute Tox. 4,Notified C&L,1,H302:1
87876,"3',4'-dichlorocinnamic acid",214-866-4,1202-39-7,,Notified C&L,4,H319:4;H335:4;H315:4
87879,"α,α'-azinodi-o-cresol",213-500-0,959-36-4,Acute Tox. 4,Notified C&L,48,H302:40;H319:8;H335:8;H315:8;Not classified:1
87880,"2,5-dibromotoluene",210-437-0,615-59-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:45;H335:43;H315:45;H225:3;H312:1;H302:1;H332:1
87886,5-(2-aminoethyl)-4-hydroxypyrocatechol hydrobromide,211-247-0,636-00-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
87889,"Formaldehyde, polymer with oxirane and phenol, methyl ether",614-871-5,68988-31-8,Not Classified,Notified C&L,39,Not classified:39
87897,Pyrimidinetetrayltetraamine sulphate,226-393-0,5392-28-9,Eye Irrit. 2,Notified C&L,35,H319:34;H335:11;H315:11;Not classified:1
87898,Carbarsone,204-484-6,121-59-5,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38;H331:38;H301:38
87901,"4,4'-bis[4-[bis(2-hydroxyethyl)amino]-6-anilino-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonic acid",224-548-7,4404-43-7,Not Classified,REACH registration C&L,130,Not classified:92;H319:38
87904,Gentiobiose,209-074-0,554-91-6,Not Classified,Notified C&L,2,Not classified:2
87909,"2,5-dichlorophenyl dichlorophosphate",258-694-8,53676-18-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H318:38
87912,Benzenesulphonamide,202-637-1,98-10-2,Acute Tox. 4,Notified C&L,285,H302:285
87919,5-chloro-1-methyl-4-nitroimidazole,225-521-2,4897-25-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H319:46;H335:45;H315:46;H317:1;H312:1;H302:1;H332:1
87922,2-hydroxy-4-methylvaleric acid,207-860-8,498-36-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1374,H319:1374;H315:1374
87931,Lithium perchlorate,232-237-2,7791-03-9,Ox. Sol. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT RE 2,Notified C&L,162,H302:88;H314:83;H318:83;H373:83;H271:110;H319:47;H272:47;H335:47;H315:47;H270:4;Not classified:1
87935,Bis-sec-butyl peroxydicarbonate,243-424-3,19910-65-7,Org. Perox. C;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,12,H319:12;H242:12;H315:12
87936,Octylphenol,266-717-8,67554-50-1,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H400:1;H410:1;H318:1;H315:1
87937,Diiron lithium tetraoxide,235-050-4,12063-07-9,Not Classified,Notified C&L,1,Not classified:1
87940,"5,5'-[(4-methyl-1,3-phenylene)bis(azo)]bis[toluene-2,4-diamine]",224-764-1,4482-25-1,Aquatic Chronic 4,REACH registration C&L,6,H413:6
87942,"Hydrogen [1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-) , compound with 3-[(2-ethylhexyl)oxy]propylamine (1:1)",276-857-1,72812-34-1,Not Classified,REACH registration C&L,2067,Not classified:18;H413:2049
87945,"Fatty acids, tall-oil",263-107-3,61790-12-3,Not Classified,Notified C&L,1611,Not classified:1416;H317:164;H319:23;H335:21;H315:23;H412:8;H334:6
87949,Trihydrogen bis[3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulphonato(3-)]chromate(3-),242-848-6,19154-31-5,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H318:2
87951,Physostigmine salicylate,200-343-8,57-64-7,Acute Tox. 2;Acute Tox. 2,Notified C&L,45,H300:42;H330:41;Not classified:3
87958,Tetraphenylsilane,213-881-3,1048-08-4,Not Classified,Notified C&L,1,Not classified:1
87959,"Tail gas (petroleum), vacuum residues thermal cracker;Petroleum gas;[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",270-815-6,68478-34-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H340:0;H350:0;H220:0;Not classified:0
87961,"Fatty acids, rape-oil, erucic acid-low",296-916-5,93165-31-2,Not Classified,Notified C&L,36,Not classified:36
87965,"2,4-DB (ISO);4-(2,4-dichlorophenoxy)butyric acid",202-366-9,94-82-6,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0
87968,1-Hydroxy-3-nitro-4-(3-hydroxypropylamino)benzene,618-889-4,92952-81-3,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,14,H411:14;H315:14
87969,"4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridine hydrochloride",217-836-9,1978-61-6,Eye Irrit. 2,Notified C&L,39,H319:39;H302:1;H335:1;H315:1
87970,"3,3'-dichlorobenzidine;3,3'-dichlorobiphenyl-4,4'-ylenediamine",202-109-0,91-94-1,Acute Tox. 4;Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H317:0;H400:0;H350:0;H410:0
87977,"4,5,6-Trichloropyrimidine",605-816-6,1780-27-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2,H319:2;H312:2;H302:2;H315:2;H332:2;H335:1
87984,α-Amanitin,245-432-2,23109-05-9,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;STOT RE 2,Notified C&L,41,H300:41;H373:40;H310:41;H330:41
87986,Copper zinc carbonate hydroxide,613-591-0,64418-04-8,Not Classified,Notified C&L,22,Not classified:22
87994,"Sugarcane, fermented, ext.",294-859-0,91770-72-8,Flam. Liq. 2,Notified C&L,1378,H225:1377;H319:87;H336:91;H318:4;Not classified:1
87999,Citronellal,203-376-6,106-23-0,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1980,H319:1967;H317:1928;H315:1979;H411:1588;H335:46;H412:26;Not classified:1
88002,"N,N,N',N'-tetramethyl-1-butene-1,3-diamine",241-361-6,17336-84-4,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2,Notified C&L,1,H330:1;H314:1;H301:1
88007,Ethyl perfluorooctanoate,221-468-4,3108-24-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
88009,"Butane-1,4-diyl diacetoacetate",235-873-9,13018-41-2,Not Classified,Notified C&L,5,Not classified:5
88014,"2-ethyl-2-[[(1-oxoisooctadecyl)oxy]methyl]-1,3-propanediyl bis(isooctadecanoate)",271-347-5,68541-50-4,Not Classified,REACH registration C&L,49,Not classified:49
88023,"Phenol, 4,4'-(3,3,5-trimethylcyclohexylidene)bis-",603-320-4,129188-99-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
88024,Dodecyl 3-mercaptopropionate,228-969-7,6380-71-8,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38
88029,4-benzoylbenzoic acid,210-286-0,611-95-0,,Notified C&L,7,H319:7;H335:6;H315:7
88030,Ethyl trifluoroacetate,206-851-6,383-63-1,Flam. Liq. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,79,H319:25;H412:15;H225:78;H302:40;H335:42;H315:42;H318:44;H314:11;H301:1
88033,4-Chloro-1-iodo-2-nitrobenzene,611-150-7,5446-05-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
88035,Metaraminol hydrogen (+)-tartrate,251-502-3,33402-03-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H311:39;H331:38;H301:39;H330:1
88036,Abhrak,601-648-2,12001-26-2,Not Classified,Notified C&L,684,Not classified:484;H372:85;H319:135;H335:136;H315:67;H373:76;H411:1;H350:2
88037,Sodium 3-chloro-4-(5-hydroxy-3-methyl-4-(3-(phenylaminosulphonyl)phenylazo)-1H-pyrazole-1-yl)benzenesulphonate,228-814-3,6359-91-7,Not Classified,Notified C&L,3,Not classified:3
88039,"Resin acids and Rosin acids, esters with glycerol and diethylene glycol",288-327-7,85711-66-6,Not Classified,Notified C&L,1,Not classified:1
88041,Etilefrine,211-910-4,709-55-7,Acute Tox. 3;Aquatic Chronic 3,Notified C&L,2,H412:1;H301:1;H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
88042,"Tallow, hydrogenated, reaction products with diethanolamine",269-121-6,68187-73-5,Not Classified,Notified C&L,2,Not classified:2
88045,"4,4-Methylenediphenylene-bis(dimethylurea)",423-370-9,10097-09-3,Aquatic Chronic 3,REACH registration C&L,33,H412:32;Not classified:1
88046,3-aminobiphenyl-4-ol,214-484-8,1134-36-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H312:40;H335:41;H315:42
88047,"9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium chloride",201-383-9,81-88-9,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2534,H412:2380;H302:292;H318:2489;H371:20;Not classified:23;H312:13;H332:14;H340:10;H341:11;H301:6;H319:5;H335:7;H315:6;H351:11;H411:1;H317:1;H413:2;H300:1;H373:1
88049,"(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)cyclohexan-1-ol",272-556-4,68877-29-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,287,H319:226;H315:276;H411:57;H400:10;Not classified:1
88050,"Styrene, oligomers",500-008-9,9003-53-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2684,H226:2176;H319:2179;H332:2176;H315:2179;Not classified:381;H335:119;H360:6;H350:1;H318:1
88051,2-(3-oxobenzo[b]thien-2(3H)-ylidene)benzo[b]thiophene-3(2H)-one,208-336-1,522-75-8,Not Classified,REACH registration C&L,2093,Not classified:2088;H317:3;H319:1;H335:1;H315:1;H318:1
88053,"Bicyclo[2.2.1]heptane, 2-ethylidene-6-methoxy-",801-856-5,31996-77-7,Flam. Liq. 3;Aquatic Chronic 2,Notified C&L,10,H226:10;H411:10
88057,Tripotassium hexachloroiridate,237-854-0,14024-41-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H312:38;H302:38;H335:38;H315:38;H332:38
88062,Phenethyl 2-methylcrotonate,259-774-5,55719-85-2,Not Classified,Notified C&L,122,Not classified:121;H319:1;H315:1
88066,"Hexahydro-N-[3-[[[(hexahydro-2-oxo-1H-azepin-1-yl)carbonyl]amino]methyl]-3,5,5-trimethylcyclohexyl]-2-oxo-1H-azepine-1-carboxamide",259-920-8,55954-19-3,Not Classified,Notified C&L,25,Not classified:25
88070,"Spinels, chromium iron manganese brown",271-411-2,68555-06-6,Not Classified,REACH registration C&L,14,Not classified:14
88077,2-methyl-4-oxo-4H-pyran-3-yl isobutyrate,265-755-2,65416-14-0,Skin Sens. 1B,Notified C&L,1448,H317:1362;Not classified:86;H302:24
88080,"3-allyl(dihydro)furan-2,5-dione",231-412-0,7539-12-0,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,39,H311:38;H302:38;H318:37;H315:38;H319:1;H314:1
88089,2-chloro-N-ethylpropionamide,267-099-2,67791-81-5,,Notified C&L,1,H302:1
88090,Acedoben,209-114-7,556-08-1,Not Classified,REACH registration C&L,13,Not classified:6;H319:7;H335:6;H315:7
88094,"3,5-dinitrobenzohydrazide",220-790-2,2900-63-2,Skin Sens. 1,Notified C&L,38,H317:38
88095,"2,2-bis(methylthio)propane",478-900-1,6156-18-9,Flam. Liq. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H319:1;H225:1
88097,N-[2-[(2-hydroxyethyl)amino]ethyl]oleamidemonoacetate,269-711-3,68310-43-0,,Notified C&L,1,H319:1;H315:1
88099,"3-hydroxy-1,2,3-benzotriazin-4(3H)-one",248-916-1,28230-32-2,Expl. 1.1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H201:38;H335:38;H315:39
88100,Dodec-2-enedioic acid,229-019-4,6402-36-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
88101,2-bromo-1-(bromomethyl)-4-fluorobenzene,612-094-6,61150-57-0,Skin Corr. 1B,Notified C&L,1,H314:1
88103,4-amino-3-hydroxynaphthalene-1-sulphonic acid,204-147-3,116-63-2,,Notified C&L,10,H319:7;H335:6;H315:7;Not classified:2;H411:1;H341:1;H412:1
88104,"4-methylpenta-1,3-diene",213-137-8,926-56-7,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,51,H225:41;H304:40;H319:12;H335:12;H315:12;H411:1;H317:1
88107,Dibarium sodium pentaniobate,235-586-9,12323-03-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H302:42;H332:42
88109,"9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethylxanthylium chloride",213-584-9,989-38-8,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,1300,H302:545;H318:1022;H410:769;H317:86;H301:670;H400:711;H411:208;H340:116;H360:116;H361:48;H341:48;Not classified:21;H319:34;H312:2;H335:2;H315:2
88112,4-chloro-3-pyridinesulphonamide,251-434-4,33263-43-3,Aquatic Chronic 2,REACH registration C&L,47,H411:2;H319:44;H335:44;H315:44;H302:6;Not classified:1
88123,"N,N-diethyl-o-toluidine",210-119-1,606-46-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H312:1;H302:1;H315:1;H332:1
88127,reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate,419-000-0,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
88130,Digitonin,234-255-6,11024-24-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,Notified C&L,103,H311:100;H330:95;H301:103;H331:6;H373:3;H310:1;Not classified:1
88134,Potassium superoxide,234-746-5,12030-88-5,Ox. Sol. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,280,H271:275;H314:280;H318:96;H272:5
88135,2-(trifluoromethyl)benzenesulfonyl isocyanate,617-763-6,85813-73-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,34,H319:34;H302:34;H335:34;H315:34;H334:34
88137,S-ethyl trifluorothioacetate,206-852-1,383-64-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H225:40;H335:39;H315:39
88142,Protopine,204-999-6,130-86-9,Acute Tox. 4,Notified C&L,6,H302:4;H301:2
88144,"3,3'-[iminobis(ethyleneimino)]dipropiononitrile",221-737-6,3216-99-7,Not Classified,Notified C&L,9,Not classified:9
88149,Ethyl propiolate,210-795-8,623-47-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,51,H226:50;H319:51;H335:48;H315:51;H301:5;H225:1;H312:1;H302:1;H332:1
88151,"(Z)-1-[2-(2,4-dichlorophenyl)-2-[[(2,4-dichlorophenyl)oxy]imino]ethyl]-1H-imidazole mononitrate",264-730-3,64211-46-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,27,H302:24;H332:26;H400:2;H410:2;Not classified:1
88153,Trimethylsilylacetylene,213-919-9,1066-54-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,80,H319:44;H225:56;H335:43;H315:66;H318:22;H312:1;H314:1;H301:1;H331:1
88157,Erbium trinitrate,233-436-7,10168-80-6,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:3;H272:3;H335:3;H315:4;H411:1;H318:1
88159,6-chlorobenzothiazol-2-ylamine,202-402-3,95-24-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:44;H302:51;H335:43;H315:44
88160,Sulphuric [2H2]acid,237-464-0,13813-19-9,Skin Corr. 1A,Notified C&L,46,H314:46;H290:1;H318:1
88162,Iodotrimethylsilane,240-171-0,16029-98-4,Flam. Liq. 2;Skin Corr. 1B;STOT SE 3,REACH registration C&L,56,H225:55;H335:4;H314:56;H332:5;H226:1;H318:1
88163,N-[3-(dimethylamino)propyl]palmitamide phosphate,280-570-7,83721-44-2,,Notified C&L,33,Not classified:33
88164,Methyl (E)oct-3-enoate,252-450-4,35234-16-3,Not Classified,Notified C&L,1,Not classified:1
88171,Zorgol 48,920-427-4,,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H319:1;H315:1;H317:1;H226:1
88172,"2,2-dimethyl-3-(3-methylpent-4-en-1-yl)oxirane",604-772-5,15103-27-2,Flam. Liq. 3,REACH registration C&L,1,H226:1
88174,"(E,E,E)-2,7-dimethylocta-2,4,6-trienedial",225-756-0,5056-17-7,Not Classified,REACH registration C&L,85,Not classified:85
88176,2-iodobenzylic alcohol,225-933-2,5159-41-1,,Notified C&L,7,H319:7;H315:7;H335:2
88178,2-amino-5-chlorobenzenesulphonic acid,205-119-3,133-74-4,Not Classified,REACH registration C&L,9,Not classified:2;H319:7;H335:7;H315:7;H314:1
88182,Thiophosphonic acid,242-763-4,19028-32-1,Not Classified,Notified C&L,3,Not classified:3
88184,Dinoseb acetate,220-560-1,2813-95-8,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H311:38;H410:38;H301:38;H360:38;H400:38
88185,"N,N-dibutylethylenediamine",222-558-6,3529-09-7,Skin Corr. 1B,Notified C&L,43,H314:43;H318:1
88187,Edetate sodium tetrahydrate,603-569-9,13235-36-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,614,H319:553;H302:575;H335:497;H315:552;H318:56;H373:15;H332:15;Not classified:6;H412:1;H411:1
88199,"Sodium 1-amino-4-[[3,5-bis[[(chloroacetyl)amino]methyl]-2,4,6-trimethylphenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",279-365-5,80010-51-1,Skin Sens. 1B,REACH registration C&L,31,H317:27;H412:15;Not classified:3
88201,"2,2'-phenyliminodiethanol",204-368-5,120-07-0,Skin Sens. 1;Eye Dam. 1;STOT SE 1;Aquatic Chronic 3,REACH registration C&L,233,H370:90;H412:122;H317:122;H318:200;H302:143;H335:74;H315:74;H319:33;H371:32;H373:4
88202,"1-Tetradecene, polymer with 1-dodecene, distn. residues, hydrogenated, C36-84 fraction",618-142-2,883233-91-8,Not Classified,REACH registration C&L,1,Not classified:1
88204,"1,2,3-thiadiazol-5-amine",223-868-4,4100-41-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H302:3;H315:2
88205,"6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one",421-320-0,118289-55-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
88206,Benzhydryl alcohol,202-033-8,91-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,61,H319:50;H335:49;H315:49;H411:6;H412:4;H302:1;H300:1
88207,Pentamidine isetionate,205-424-1,140-64-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H317:39;H335:40;H315:40;H361:1
88208,"Glycerides, coco mono-, ethoxylated",614-595-5,68553-03-7,Not Classified,Notified C&L,36,Not classified:36
88209,"Fatty acids, tall-oil, zinc salts",263-106-8,61790-11-2,Not Classified,Notified C&L,5,Not classified:5
88212,"4,4'-ethylenedi-3-toluidine",245-268-1,22856-62-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:39;H312:39;H302:39;H335:38;H315:39;H332:39
88213,1-o-tolylbiguanide,202-268-6,93-69-6,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,209,H412:56;H317:120;H318:136;H302:111;H335:70;H315:72;H319:46;Not classified:27;H332:6
88214,"1,3-dimethyltricyclo[3.3.1.13,7]decane",211-870-8,702-79-4,Flam. Liq. 3;Asp. Tox. 1,REACH registration C&L,53,H226:53;H304:4;H315:1
88216,"2,3-dibromopropene",208-155-8,513-31-5,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,Notified C&L,45,H302:40;H332:40;H318:42;H341:4;H335:5;H315:6;H319:2;H312:2
88219,"2-nitro-N-phenylbenzene-1,4-diamine",220-494-3,2784-89-6,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,50,H319:50;H302:50;H317:49;H335:1;H315:1
88221,"Mentha arvensis piperascens, ext.",294-486-3,91722-84-8,Not Classified,Notified C&L,98,Not classified:36;H411:52;H317:52;H315:62;H302:26;H319:10;H304:11
88222,barium peroxide,215-128-4,1304-29-6,Ox. Sol. 2;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H332:0;H272:0;H302:0
88229,isopropyl acetate,203-561-1,108-21-4,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H336:0;H225:0
88232,TI 435-Triazan,458-660-4,,Skin Sens. 1,Notified C&L,1,H317:1
88237,Tris(isopropenyloxy)vinylsilane,239-362-1,15332-99-7,Not Classified,REACH registration C&L,85,Not classified:2;H226:83;H319:16;H335:16;H315:16
88239,Disodium tetrabromopalladate(2-),256-605-7,50495-13-1,Skin Irrit. 2,Notified C&L,42,H315:42;H319:4;H335:4
88246,"(9α,13α,14α)-7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methylmorphinan-6-one",204-094-6,115-53-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
88247,"Hydrocarbons, C1-4, debutanizer fraction;Petroleum gas",271-261-8,68527-19-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H340:0;H350:0;H220:0;Not classified:0
88254,Bis(p-chlorophenyl)acetic acid,201-451-8,83-05-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,39,H312:38;H351:39;H302:39;H332:38
88259,"Gas oils (petroleum), straight-run",265-043-1,64741-43-1,Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,380,H411:367;H373:267;H332:229;H226:199;H304:300;H340:103;H350:103;H330:38
88260,N-acetylsulphanilyl chloride,204-485-1,121-60-8,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,183,H314:96;H318:17;H400:84;H410:84;H335:54;Not classified:1;H317:1;H371:1;H312:1;H302:1;H315:2;H290:1;H332:1;H319:1
88268,"Benzene, (1-methylethyl)-, oxidized, polyphenyl residues",269-798-8,68333-89-1,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Muta. 2;Aquatic Chronic 3,REACH registration C&L,4,H312:4;H412:4;H302:4;H341:4;H314:4;H332:4
88269,"2,3-dihydro-2-methyl-1H-indol-1-amine",250-683-6,31529-46-1,Acute Tox. 4,REACH registration C&L,4,H302:4
88270,"2-[(4-chloro-2-nitrophenyl)azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutyramide",235-462-4,12236-62-3,Not Classified,REACH registration C&L,393,Not classified:393
88272,"4-(2,2-dimethyl-6-methylenecyclohexyl)-3-buten-2-one",201-223-8,79-76-5,Not Classified,Notified C&L,90,Not classified:89;H411:1
88274,"N,N-diethylbenzene-1,4-diammonium sulphate",228-500-6,6283-63-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,54,H319:4;H312:11;H302:54;H335:4;H315:3;Not classified:3;H314:1;H318:1
88279,"2-(3-hydroxypropyl)-6-[(3-hydroxypropyl)amino]-1H-benz[de]isoquinoline-1,3(2H)-dione",258-203-7,52821-24-6,Not Classified,REACH registration C&L,4,Not classified:4
88280,2-chloro-1-methylpyridinium trifluoromethanesulphonate,281-789-0,84030-18-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
88286,Aesculin,208-517-5,531-75-9,Not Classified,REACH registration C&L,33,Not classified:33
88288,"Trihydrogen bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]chromate(3-)",236-672-9,13463-42-8,,Notified C&L,2,Not classified:2
88290,Dinonylphenyl polyoxyethylene >14 EO,618-488-4,9014-93-1,Eye Irrit. 2,Notified C&L,1142,H319:652;Not classified:464;H410:59;H302:82;H315:79;H318:23;H412:3
88291,Decacarbonyldirhenium,238-202-8,14285-68-8,Acute Tox. 4,Notified C&L,44,H332:39;H330:4;H301:5;H331:1
88294,1-(butylamino)-4-[(2-ethylhexyl)amino]anthraquinone,287-289-9,85455-53-4,Not Classified,Notified C&L,1,Not classified:1
88295,"Naphthalene-2,6-diol",209-465-6,581-43-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,133,H319:133;H335:132;H315:133;H312:1;H302:1;H332:1
88297,"D-Ribose, 5-(dihydrogen phosphate), barium salt (1:1)",239-750-0,15673-79-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:38;H332:38;H331:1;H301:1
88298,4-(2-benzothiazol-2-ylthio)aniline,247-204-8,25712-17-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
88304,N-(p-nitrophenyl)-p-toluenesulphonamide,211-994-2,734-25-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
88305,2-amino-6-methylpyrimidin-4-ol,223-612-1,3977-29-5,Not Classified,Notified C&L,6,Not classified:4;H319:2;H335:1;H315:2
88307,"Fats and Glyceridic oils, Pentaclethra macroloba seed",617-902-0,866620-18-0,Not Classified,Notified C&L,3,Not classified:3
88311,"Methyl 3,5-dinitrosalicylate",245-144-7,22633-33-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
88312,"2,4-dichloro-6-nitrophenol",210-202-2,609-89-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
88314,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with acrylic acid and dipropylamine",500-333-6,153270-36-1,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4,Notified C&L,1,H312:1;H314:1;H317:1;H332:1;H226:1
88317,Sodium benzenethiosulphonate,217-558-8,1887-29-2,Not Classified,Notified C&L,1,Not classified:1
88320,Benzilic acid nortropine ester,605-360-8,16444-19-2,Not Classified,Notified C&L,2,Not classified:1;H412:1;H302:1
88322,"Fatty acids, safflower-oil, Me esters",271-715-5,68605-14-1,Not Classified,Notified C&L,1,Not classified:1
88323,"1H-Pyrazole-3-carboxylic acid, 4,4'-[carbonylbis[imino(3-sulfo-4,1-phenylene)imino(6-chloro-1,3,5-triazine-4,2-diyl)imino(6-sulfo-3,1-phenylene)azo]]bis[4,5-dihydro-5-oxo-1-(4-sulfophenyl)-, hexasodium salt",275-010-3,70900-42-4,Not Classified,Notified C&L,3,Not classified:3
88325,"3,3-dimethoxypropiononitrile",260-842-1,57597-62-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H312:40;H302:40;H332:40;H319:1;H315:1
88326,trimethylopropane tri(3-aziridinylpropanoate);(TAZ),257-765-0,52234-82-9,Eye Dam. 1;Skin Sens. 1;Muta. 2,Harmonised C&L,0,H341:0;H317:0;H318:0
88329,"Ammonium 2,4-dichlorophenoxyacetate",218-986-8,2307-55-3,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,3,H411:3;H302:3;H317:3;H318:3
88331,O-acetylsalicylic acid,200-064-1,50-78-2,Acute Tox. 4,REACH registration C&L,244,H302:229;H319:68;H335:61;H315:63;H301:14;H360:6;Not classified:3;H371:1;H334:2;H373:1;H361:3;H317:1
88334,"Petrolatum (petroleum), oxidized, Bu ester",292-642-5,90669-48-0,Not Classified,REACH registration C&L,444,Not classified:444
88336,Thionicotinamide,225-036-6,4621-66-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H302:44;H335:43;H315:44
88339,"1H-Tetrazole-1-acetic acid, 2,5-dihydro-5-thioxo-, sodium salt (1:1)",601-243-0,113221-74-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:38;H335:38;H315:38;H332:1;H312:1;H242:1;H302:1;H318:1
88352,"Tylosin, [R-(R*,R*)]-2,3-dihydroxybutanedioate (salt)",215-781-5,1405-54-5,Not Classified,Notified C&L,65,Not classified:52;H334:13;H317:13;H319:3;H410:1;H335:1;H315:1;H400:1
88354,"2-[((4-Dimethylamino)phenyl)azo]-1,3-dimethyl-1H-imidazolium chloride",602-845-6,12270-25-6,Not Classified,Notified C&L,4,Not classified:2;H319:1;H302:2;H335:1;H315:1;H332:1;H400:1;H410:1
88355,"[4-[[4-anilino-1-naphthyl][4-(dimethylamino)phenyl]methylene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium acetate",280-898-0,83803-79-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,142,H319:91;H302:93;H315:91;H400:92;H410:92;Not classified:49;H318:1
88356,tert-butyl carbazate,212-795-3,870-46-2,Flam. Sol. 1,REACH registration C&L,52,H228:52;H312:33;H302:33;H301:1
88369,"2,5-Furandione, dihydro-, mono-C30-53-2-alkenyl derivs.",275-089-4,70983-55-0,Not Classified,Notified C&L,2,Not classified:2
88370,"1,2,3,4-tetrahydronaphthalen-1-ol",208-459-0,529-33-9,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,131,H319:131;H302:131;H315:91;H335:1
88372,2-ethylhexyl 2-hydroxyethyl hydrogen phosphate,288-843-2,85909-40-6,Not Classified,Notified C&L,1,Not classified:1
88373,"2-ethylhexanoic acid, copper salt",244-846-0,22221-10-9,Acute Tox. 4;Eye Dam. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,272,H400:240;H410:238;H302:251;H361:22;H411:2;H318:2;Not classified:1
88375,"Reaction Product of MDI, Octadecylamine, Magnesiumhydroxide, 1-Decene, homopolymer, hydrogenated and fatty acids, C5-9, tetraesters with pentaerythritol",924-226-2,,Not Classified,Notified C&L,1,Not classified:1
88377,2-Bromoacetamide,614-427-0,683-57-8,Acute Tox. 3;Skin Corr. 1B,Notified C&L,49,H314:48;H301:49;H318:2;H311:1;H331:1;H319:1;H315:1;H332:1
88378,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ester with 2-hydroxy-1,2,3-propanetricarboxylic acid (3:1), 4-ester with sulfobutanedioic acid (1:1), monododecyl ether, disodium salt",605-376-5,164780-83-0,Not Classified,Notified C&L,1,Not classified:1
88381,Vanadium trichloride oxide,231-780-2,7727-18-6,Skin Corr. 1C;Aquatic Chronic 3,REACH registration C&L,102,H412:4;H314:97;H301:94;H411:33;H311:33;H318:33;Not classified:5;H370:1;H371:1;H332:1;H290:1
88384,"(2S, 3aS, 7aS)-1[(S)-N-[(S)-1-carboxybutyl]alanil]hexahydro-2-indole carboxylicacid, salt with tert-butyl amine",600-798-6,107133-36-8,Acute Tox. 4;Repr. 2,Notified C&L,16,H302:10;H361:11;H362:1;H360:2;H319:2;Not classified:1;H332:1
88385,"4,4'-dimethyl-2,2'-bipyridyl",214-483-2,1134-35-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
88391,Diammineplatinum(II) nitrite,238-203-3,14286-02-3,Expl. 1.1;Eye Dam. 1,REACH registration C&L,139,H201:1;H318:96;H400:84;H410:84;H317:85;H319:38;H335:38;H315:38;H314:4;H334:1;H272:1;H302:1
88392,"2,2,3-trimethylcyclopent-3-ene-1-ethanol",217-600-5,1901-38-8,Not Classified,Notified C&L,88,Not classified:88
88393,"Butane-1,2-diol",209-527-2,584-03-2,Eye Irrit. 2,REACH registration C&L,131,H319:93;Not classified:38
88394,"1,3-bis(1,1,2,2-tetrafluoroethoxy)benzene",223-476-3,3914-19-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
88397,Diisooctyl phosphonate,252-873-4,36116-84-4,Not Classified,Notified C&L,34,Not classified:34
88399,"N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide",444-780-4,452962-97-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
88400,"Ethene, homopolymer, chlorinated, chlorosulfonated",614-217-9,68037-39-8,Not Classified,Notified C&L,160,Not classified:99;H373:61
88402,4-Hydroxyphenyl-alpha-D-glucopyranoside,617-561-8,84380-01-8,Acute Tox. 4,Notified C&L,53,H302:53
88405,Manganese dinitrate,233-828-8,10377-66-9,Ox. Sol. 2;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT RE 2,REACH registration C&L,326,H302:263;H314:275;H318:223;H272:200;H373:174;H412:156;H372:100;Not classified:33;H413:6;H319:10;H351:4;H335:10;H315:10;H312:2;H332:2
88406,2-tert-butylcyclohexanol,236-806-6,13491-79-7,Eye Irrit. 2,Notified C&L,1581,H319:1287;Not classified:294;H335:1;H315:1
88407,"Balsams, tolu",232-550-4,9000-64-0,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1505,H411:1402;H302:1340;H317:1494;H319:116;H315:116;H413:50;Not classified:10;H412:3;H370:1;H318:1
88409,Warfarin sodium,204-929-4,129-06-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Repr. 1A;STOT RE 1,Notified C&L,104,H330:52;H372:51;H300:104;H310:52;H360:104;H412:3;H370:1
88411,"Oils, Ilex paraguayensis",614-791-0,68916-96-1,Aquatic Chronic 3,Notified C&L,50,H412:49;Not classified:1
88412,"2-Methyl-2-propenoic acid methyl ester polymer with 1,1-dichloroethene and 2-propenenitrile",607-652-0,25214-39-5,Not Classified,Notified C&L,103,Not classified:83;H319:20
88414,"Benzenesulfonamide, 4-chloro-N-(2-chloro-4-nitrophenyl)-3-(trifluoromethyl)-",600-788-1,106917-52-6,Acute Tox. 3;Aquatic Acute 1,Notified C&L,38,H400:38;H301:38
88415,"metosulam (ISO);N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide",410-240-1,139528-85-1,Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H373:0;H400:0;H351:0
88418,isostearic acid monoisopropanolamide,431-540-9,,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
88423,Disodium 7-acetamido-4-hydroxy-3-[[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2-sulphonate,282-052-6,84083-04-5,Not Classified,Notified C&L,1,Not classified:1
88424,"3,4,5-trimethoxybenzaldehyde oxime",254-350-6,39201-89-3,,Notified C&L,4,H319:4;H335:4;H315:4
88426,sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate,426-520-1,71420-85-4,Skin Sens. 1,Harmonised C&L,0,H317:0
88427,nickel acetate,239-086-1,14998-37-9,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H302:0;H341:0;H410:0;H334:0;H317:0;H372:0;H350:0;H332:0;H360:0;H400:0
88431,1-chloro-4-(4-nitrophenoxy)benzene,217-405-5,1836-74-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H317:38;H318:38
88432,Decyl D-glucoside,259-218-1,54549-25-6,Not Classified,Notified C&L,268,Not classified:156;H314:55;H304:55;H318:77;H319:35;H315:1
88435,citral,226-394-6,5392-40-5,Skin Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H315:0
88438,4'-methoxyacetophenone,202-815-9,100-06-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1746,H319:79;H302:1746;H315:126
88446,Citrus paradisi,600-007-4,8016-20-4,,Notified C&L,5,H315:5;H317:5;H226:5;H410:5;H304:5;H400:2
88447,Polymercaptan 358,478-120-1,,Not Classified,Notified C&L,1,Not classified:1
88450,"Methyl 2-amino-4-[[(2,5-dichlorophenyl)amino]carbonyl]benzoate",261-853-4,59673-82-4,Not Classified,REACH registration C&L,37,Not classified:37
88451,"Deca-1,9-diyne",217-012-9,1720-38-3,,Notified C&L,7,H226:5;H304:1;H319:2;H335:2;H315:2
88454,"Ethanol, 2,2'-iminobis-, N-tallow alkyl derivs.",263-177-5,61791-44-4,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Aquatic Acute 1,Notified C&L,863,H302:818;H314:853;H317:634;H290:571;H400:721;H318:255;H410:92;H411:9;H319:8;H315:6;H412:3;Not classified:3
88457,"Diisopropyl 3,3'-[(2,5-dichloro-1,4-phenylene)bis[iminocarbonyl(2-hydroxy-3,1-naphthylene)azo]]bis[4-methylbenzoate]",275-639-3,71566-54-6,Not Classified,REACH registration C&L,88,Not classified:88
88459,1-bromo-4-propylheptane,603-775-9,133894-35-6,Not Classified,REACH registration C&L,3,Not classified:3
88461,5-chloro-1-ethyl-2-methyl-1H-imidazole,225-520-7,4897-22-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
88463,Isopropyl chloroformate,203-563-2,108-23-6,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2,REACH registration C&L,180,H330:160;H225:180;H302:179;H314:97;H315:83;H318:85;H317:38;H312:18;H332:18;H331:2;H301:1
88465,2-(4-nitrophenyl)propionic acid,243-423-8,19910-33-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
88467,2-methoxy-4-(trifluoromethyl)pyridine-3-sulfonyl chloride,606-871-9,219715-41-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H319:1;H315:1
88468,Iodine monochloride,232-236-7,7790-99-0,Acute Tox. 2;Acute Tox. 3;Skin Corr. 1A;STOT SE 3,REACH registration C&L,58,H311:10;H300:10;H314:58;H335:14;H334:39;H312:5;H302:5;H318:1;Not classified:1
88469,Diphenylcarbamoyl chloride,201-450-2,83-01-2,Skin Corr. 1B;Skin Sens. 1,REACH registration C&L,48,H314:48;H317:41;H290:2;H318:2;H302:1
88470,"3,3'-(2,4,8,10-tetraoxaspiro[5.5]undecan-3,9-ylene)bis(propylamine)",244-461-8,21587-74-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H302:40;H335:39;H315:40;H317:1;H314:1
88472,(Z)-hexadec-11-enal,258-876-7,53939-28-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,138,H319:132;H400:132;H335:131;H315:132;H332:6
88474,"Steroids, soya hydroxy",603-328-8,129311-52-0,Not Classified,Notified C&L,22,Not classified:22
88476,"Reaction mass of 6-(2-ethyl-6-methylanilino)-5-(4-{4-[ethyl(3-sulfobenzyl) amino] phenylazo} phenylazo)-4-hydroxynaphthalene-2-sulfonic acid, sodium and/or disodium salt(s) and 6-(2-ethyl-6-methylanilino)-5-(4-{4-[ethyl(4-sulfobenzyl) amino] phenylazo} phenylazo)-4-hydroxynaphthalene-2-sulfonic acid, sodium and/or disodium salt(s)",475-080-7,,Aquatic Chronic 3,REACH registration C&L,39,H412:39
88479,Bis(formato-O)dioxouranium,241-063-6,16984-59-1,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1,Notified C&L,1,H400:1;H331:1;H301:1
88480,"2,4-dibromophenol",210-436-5,615-58-7,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:45;H300:44;H335:43;H315:45;H412:6;H312:3;H302:3;H332:3;H311:1;H301:1;H331:1
88482,"3,5-bis(β-D-glucopyranosyloxy)-7-hydroxy-2-(4-hydroxyphenyl)-1-benzopyrylium chloride",241-360-0,17334-58-6,Not Classified,Notified C&L,2,Not classified:2
88484,N-methylhexadecylamine,236-514-9,13417-08-8,,Notified C&L,34,Not classified:33;H318:1;H335:1;H315:1
88487,"Sodium bis[2,4-dihydro-4-[[2-hydroxy-5-(methylsulphonyl)-4-nitrophenyl]azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-)",276-075-0,71839-91-3,Aquatic Chronic 2,REACH registration C&L,93,H411:84;Not classified:9
88491,"Naphthenic acids, sodium salts",263-108-9,61790-13-4,Aquatic Chronic 2,Notified C&L,444,H411:442;Not classified:1;H319:1
88495,"3,5-dichloropyridin-4-amine",245-304-6,22889-78-7,Acute Tox. 2;Acute Tox. 1;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 1;STOT SE 3,Notified C&L,196,H335:194;H330:84;H315:195;H318:123;H300:84;H310:84;H319:72;H302:45;H312:6;H332:6;H413:1;Not classified:1
88505,"Oils, fish, oxidized",269-122-1,68187-75-7,Not Classified,REACH registration C&L,21,Not classified:21
88506,"Rubus occidentalis, ext.",272-819-3,68915-99-1,Flam. Liq. 1,Notified C&L,75,H224:25;Not classified:25;H226:25
88512,Sodium α-hydroxy-p-methoxytoluene-α-sulphonate,251-503-9,33402-67-4,Not Classified,Notified C&L,6,Not classified:6
88517,Iocetamic acid,240-173-1,16034-77-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
88521,Fumagillin,245-433-8,23110-15-8,Acute Tox. 4,Notified C&L,43,H302:41;H312:1;H332:1;H361:2;H372:1
88522,(17α)-17-hydroxy-3-oxoandrost-4-ene-17-carbonitrile,278-780-9,77881-13-1,Not Classified,REACH registration C&L,1,Not classified:1
88523,"4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide",413-300-5,56187-04-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
88527,Nitro-tert-butane,209-851-4,594-70-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H225:38;H335:42;H315:43;H228:5
88531,(1S)-1-[3-[(1E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propanol,608-251-3,287930-77-2,Aquatic Chronic 4,Notified C&L,93,H413:93
88532,4-pentylphenyl 4-(hexyloxy)benzoate,253-933-2,38444-15-4,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
88546,PEG-10 Tridecyl ether,607-463-3,24938-91-8,Eye Dam. 1,Notified C&L,865,H318:740;H302:325;H411:98;H319:110;H315:64;H400:78;Not classified:15;H412:17;H301:1;H314:1
88547,"geraniol; (2E)-3,7-dimethylocta-2,6-dien-1-ol",203-377-1,106-24-1,Skin Sens. 1,Harmonised C&L,0,H317:0
88548,"5-[(2,3-dihydro-6-methyl-2-oxo-1H-benzimidazol-5-yl)azo]barbituric acid",276-344-2,72102-84-2,Not Classified,REACH registration C&L,261,Not classified:261
88549,Flocoumafen,618-367-6,90035-08-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H330:38;H410:38;H372:38;H300:38;H310:38;H400:38
88555,p-toluenesulphonyl cyanide,242-849-1,19158-51-1,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,40,H312:40;H314:40;H332:40;H318:39;H302:2
88557,Ethyl chlorodifluoroacetate,206-850-0,383-62-0,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1,Notified C&L,46,H225:46;H318:39;H314:45;H319:1;H335:1;H315:1
88561,1-methylphenanthrene,212-622-1,832-69-9,Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H400:38;H410:38;H351:38;H302:38;Not classified:3
88562,"4,4'-dimethylbenzophenone",210-287-6,611-97-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
88564,Ethinylestradiol,200-342-2,57-63-6,Acute Tox. 4;Carc. 1B,Notified C&L,127,H350:98;H302:64;H410:82;H372:54;H360:85;H351:25;H362:25;H400:27;H312:2;H332:2;H413:1
88565,"sodium 2,4-dihydroxy-3,3-dimethylbutanoate",606-203-6,1902-01-8,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,84,H314:84;H318:84
88566,Tetraphenylgermanium,213-880-8,1048-05-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:43;H312:38;H302:38;H335:42;H315:43;H332:38
88568,Sodium 4-chloro-3-(5-hydroxy-3-methyl-4-phenylazopyrazol-1-yl)benzenesulphonate,228-813-8,6359-90-6,Not Classified,Notified C&L,15,Not classified:15
88570,2-(Methylthio)benzeneboronic acid,605-521-2,168618-42-6,,Notified C&L,9,H319:9;H335:7;H315:9;H302:1
88575,"Linseed oil, sulfated, sodium salts",296-476-4,92704-44-4,Not Classified,Notified C&L,1,Not classified:1
88576,Loxapine,217-835-3,1977-10-2,Acute Tox. 3,REACH registration C&L,160,H301:160;Not classified:1
88579,"2,3-dihydro-1,3,3-trimethylspiro(indole-2,3'-(3H)naphth(2,1-b)(1,4)oxazine",404-480-6,27333-47-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
88582,cyclopentyl chloroformate,411-460-0,50715-28-1,Flam. Liq. 3;Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Acute Tox. 3;STOT RE 2,Harmonised C&L,0,H302:0;H317:0;H318:0;H226:0;H373:0;H331:0
88583,"Heptanal, oligomeric reaction products with aniline",500-007-3,9003-50-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,17,H319:1;H315:1;H410:1;H373:1;H317:1;H400:1;Not classified:16
88589,"Reaction mass of (2E)-2-Benylidene-5,6-dimethoxy-3,3-dimethylindan-1-one and (2Z)-2-Benylidene-5,6-dimethoxy-3,3-dimethylindan-1-one",486-080-1,,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H410:1
88590,(butanedione dioximato)disodium,262-523-2,60908-54-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:38;H315:39;H302:1
88595,Cobalt(II) 4-oxopent-2-en-2-olate,237-855-6,14024-48-7,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,87,H411:38;H302:84;H317:46;H318:77;H360:3;H400:39;H312:39;H361:73;H332:40;H319:7;H335:4;H315:5;H334:6;Not classified:2;H410:1;H351:2;H341:1
88597,(2H10)-2-methylpropan-2-ol,258-288-0,53001-22-2,Flam. Liq. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H319:38;H225:38;H332:38;H335:38;Not classified:3
88603,"(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide",415-030-3,120298-38-6,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H317:0
88604,"Resin acids and Rosin acids, tall-oil, barium salts",294-400-4,91722-00-8,Not Classified,Notified C&L,1,Not classified:1
88606,Sodium 5-nitroguaiacolate,614-038-6,67233-85-6,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,80,H411:78;H302:78;H242:13;H318:13;H319:2;H315:2
88611,5-amino-6-methoxynaphthalene-2-sulphonic acid,201-671-4,86-45-3,Not Classified,Notified C&L,1,Not classified:1
88613,"Pentasodium salt of N-(5-{[4-chloro-6-({8-hydroxy-3,6-disulfo-7-[(E)-(1-sulfonaphthalen-2-yl)diazenyl]naphthalen-1-yl}amino)-1,3,5-triazin-2-yl]amino}-2-sulfo-4-[(Z)-{4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazenyl]phenyl)-β-alanine",442-040-5,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
88617,"7-[[2-[(aminocarbonyl)amino]-4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]phenyl]azo]naphthalene-1,3,6-trisulphonic, acid sodium salt",297-569-2,93658-87-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,5,H334:5;H317:5
88618,2-Methoxy-nicotinic acid,605-381-2,16498-81-0,Eye Irrit. 2,Notified C&L,49,H319:48;H335:4;H315:5;Not classified:1;H312:2;H302:2;H332:2
88619,Triammonium iron(3+) trioxalate,220-952-2,2944-67-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:1;H312:2;H302:2;H335:1;H315:1;H332:1
88627,2-oxo-2H-chromene-3-carboxylic acid,208-518-0,531-81-7,Acute Tox. 3,Notified C&L,44,H301:44;H319:1;H315:1
88628,6(or 8)-(sec-butyl)quinoline,269-204-7,68198-80-1,Acute Tox. 4,Notified C&L,126,H302:126
88639,1-methoxyhexane,225-263-0,4747-07-3,Flam. Liq. 2;Acute Tox. 4,REACH registration C&L,1610,H225:188;H302:64;H226:1422
88640,"N,N-dimethylhexanamide",227-406-2,5830-30-8,Acute Tox. 4,Notified C&L,43,H302:43
88641,"Panthenol , DL-form",240-540-6,16485-10-2,Not Classified,REACH registration C&L,330,Not classified:330
88643,"(9Z,12Z)-octadeca-9,12-dien-1-ol",208-038-1,506-43-4,Not Classified,Notified C&L,12,Not classified:12
88646,C.I. Reactive Yellow 107,609-873-8,408504-19-8,Not Classified,Notified C&L,1,Not classified:1
88647,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with trimethylhexane-1,6-diamine",500-332-0,153195-44-9,Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,143,H400:4;H410:4;H314:11;H318:5;Not classified:86;H411:47;H302:53;H317:53;H412:6;H335:1
88651,"Hexamethylene diisocyanate, oligomers, blocked with 3,5-Dimethylpyrazole",928-912-2,,Not Classified,Notified C&L,83,Not classified:83
88656,Pentyl 2-methylbutyrate,268-244-2,68039-26-9,Not Classified,Notified C&L,90,Not classified:90
88663,Brucine sulfate,611-586-8,5787-00-8,Acute Tox. 2;Acute Tox. 2;Aquatic Chronic 3,Notified C&L,1,H300:1;H412:1;H330:1
88665,Diethyl(2-phenoxyethyl)amine,200-809-0,74-40-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
88670,"4,4'-dihydroxybenzophenone",210-288-1,611-99-4,Eye Irrit. 2,REACH registration C&L,53,H319:52;H317:42;H335:50;H315:51
88672,1-chloro-4-(3-chloro-1-methoxypropyl)benzene,229-624-3,6630-41-7,Acute Tox. 4,Notified C&L,38,H302:38
88677,Methyl o-anisate,210-118-6,606-45-1,Not Classified,Notified C&L,275,Not classified:235;H319:40;H335:39;H315:40
88679,"pentapotassium 2,2’,2’’,2’’’,2’’’’-(ethane-1,2-diylnitrilo)pentaacetate",404-290-3,7216-95-7,Eye Irrit. 2;Acute Tox. 4;STOT RE 2,Harmonised C&L,0,H319:0;H373:0;H332:0
88683,reaction mass of: sodium 2-(C,411-250-9,,Skin Sens. 1,Harmonised C&L,0,H317:0
88685,tert-butyl 3-oxobutanoate,216-904-5,1694-31-1,Not Classified,REACH registration C&L,79,Not classified:79
88688,Cytidine,200-610-9,65-46-3,Not Classified,Notified C&L,5,Not classified:5
88689,"3,3'-dihydroxy-4,4'-methylenedi(2-naphthoic acid)",204-998-0,130-85-8,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,68,H410:6;H319:67;H400:6;H302:6;H335:51;H315:61;Not classified:1
88690,"1,2-dichloro-2-ethoxyethane",210-794-2,623-46-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:39;H335:38;H315:39;H226:39;H312:1;H341:1;H332:1
88693,"3,7,11-trimethyldodeca-1,6,10-trien-3-ol,mixed isomers",230-597-5,7212-44-4,Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2181,H410:2178;H319:1911;H400:770;H317:273;H335:1;H315:2;Not classified:1
88694,ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate,414-450-4,88805-65-6,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H317:0;H315:0
88695,"Protein hydrolyzates, egg",293-476-6,91079-86-6,Not Classified,Notified C&L,17,Not classified:17
88696,Nerol,203-378-7,106-25-2,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,2090,H319:664;H317:1631;H315:2030;H318:1359;H335:48;H400:3;Not classified:2;H412:2;H314:1;H301:1
88697,"3,3'-(ethylenediimino)bispropiononitrile",221-738-1,3217-00-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
88701,N-methyl-4-(p-formylstyryl)pyridinium methylsulfate,418-240-3,74401-04-0,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
88704,"1,3-dichlorobut-2-ene",213-138-3,926-57-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,44,H312:38;H319:43;H302:38;H335:42;H226:44;H331:39;H411:4;H315:5;H301:6;H314:1;H332:1
88705,"(S)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazoletriylium phosphate",250-920-3,32093-35-9,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,8,H412:7;H302:7;Not classified:1
88707,C.I. Acid Blue 324,618-132-8,88264-80-6,Not Classified,Notified C&L,4,Not classified:4
88708,"5-amino-1,3-dihydro-2H-benzimidazol-2-one",202-401-8,95-23-8,Aquatic Chronic 3,REACH registration C&L,42,H412:41;H319:2;H315:1;H302:1
88710,"Oils, almond",616-913-8,8007-69-0,Not Classified,Notified C&L,86,Not classified:86
88712,Methyl 2-chloronicotinate,254-805-9,40134-18-7,Eye Irrit. 2,Notified C&L,41,H319:41;H335:2;H315:3
88713,Piperidine-1-propylamine,222-557-0,3529-08-6,Acute Tox. 4;Skin Corr. 1B,Notified C&L,129,H302:129;H314:127;H335:2;H315:2;H318:2;H227:2
88717,"Acetic acid, decyl ester, branched",270-817-7,68478-36-4,Not Classified,Notified C&L,113,Not classified:113
88721,6-methyl-4-(2-methyl-1-propenyl)oct-5-en-2-one,267-160-3,67801-40-5,Not Classified,Notified C&L,88,Not classified:88
88723,"Silane, trimethoxy[3-(oxiranylmethoxy)propyl]-, reaction products with wollastonite (Ca(SiO3))",309-529-4,100402-91-3,Not Classified,Notified C&L,40,Not classified:40
88729,sodium hydrogensulphate,231-665-7,7681-38-1,Eye Dam. 1,Harmonised C&L,0,H318:0
88730,Tetrabutylammonium dihydrogen phosphate,226-947-1,5574-97-0,Not Classified,Notified C&L,11,Not classified:6;H319:5;H315:5;H302:1
88732,5-CHLORO-3-METHYL PENTENYL ACETATE,923-532-3,,Not Classified,REACH registration C&L,1,Not classified:1
88737,Phenyl 2-pyridyl ketone,202-034-3,91-02-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,49,H319:47;H315:47;H335:44;Not classified:1;H302:1
88742,Oxytetracycline hydrochloride,218-161-2,2058-46-0,Repr. 2,Notified C&L,148,H361:137;H410:25;H362:33;Not classified:21;H319:15;H317:10;H360:10;H335:5;H315:4;H411:1;H312:1;H302:1;H332:1;H400:2;H311:1;H334:1
88744,Benzenesulphonyl chloride,202-636-6,98-09-9,Acute Tox. 4;Skin Corr. 1A;Eye Irrit. 2A,REACH registration C&L,150,H319:23;H302:148;H314:150;H334:44;H317:44;H332:43;H318:37;H290:2;H312:1;H335:1;Not classified:1
88747,2-(2-(1-hydroxycyclopentyl)-2-phenylacetoxy)ethyldimethylammonium chloride,227-521-8,5870-29-1,,Notified C&L,5,H302:3;Not classified:1;H317:1;H312:1;H371:1;H332:1
88748,2'-chloroacetoacetanilide,202-269-1,93-70-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,167,H312:128;H412:128;H302:128;H332:128;H319:39;H335:38;H315:39
88754,2-(2-amino-4-nitroanilino)ethanol,260-450-0,56932-44-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:46;H335:46;H315:45;H302:2;Not classified:1
88755,Trihydrogen hexafluoroaluminate,257-148-6,51350-73-3,Not Classified,Notified C&L,25,Not classified:25
88756,3-nitrophenol,209-073-5,554-84-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,54,H302:54;H318:46;H315:47;H335:4;H311:5;H373:6;H319:4;Not classified:2;H370:1;H372:1;H331:1;H312:2;H332:2
88760,Dimethylbis[(1-oxoneodecyl)oxy]stannane,273-028-6,68928-76-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Aquatic Chronic 3,REACH registration C&L,649,H412:124;H302:452;H317:133;H315:147;H413:381;H361:365;H372:431;H301:123;H400:74;H410:74;H304:65;H411:19;H373:17;H319:1;H312:1;H335:1;H332:1
88763,Isopropenyl acetate,203-562-7,108-22-5,Flam. Liq. 2;STOT SE 3,REACH registration C&L,321,H226:3;H225:321;H335:159;Not classified:2;H319:1
88766,4-(benzylamino)-4-oxoisocrotonic acid,239-361-6,15329-69-8,,Notified C&L,4,H319:4;H335:4;H315:4
88767,"1-Butanol, 4-(methylthio)-",606-585-4,20582-85-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,114,H312:113;H302:113;H332:113;Not classified:1
88770,"3,5-diiodoanthranilic acid",210-201-7,609-86-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H302:43;H335:42;H315:43
88771,α-methylpiperidine-1-ethylamine,251-886-2,34217-60-2,Flam. Liq. 4;Skin Corr. 1B,Notified C&L,1,H314:1;H227:1
88772,"L-Glutamic acid, N-coco acyl derivs., disodium salts",269-085-1,68187-30-4,Eye Irrit. 2,REACH registration C&L,177,H319:176;Not classified:1
88778,"2-amino-5,6-dimethyl-1H-pyrimidin-4-one",223-611-6,3977-23-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,131,H319:131;H335:131;H315:131
88781,4'-sulphamoylacetanilide,204-486-7,121-61-9,Not Classified,REACH registration C&L,5,Not classified:4;H312:1;H302:1;H332:1
88782,Dactinomycin,200-063-6,50-76-0,Acute Tox. 1;Carc. 1A;Repr. 1A,Notified C&L,321,H300:321;H350:279;H360:277;H334:1;H317:1;H361:2
88783,3-phenylpropyl 2-butenoate,272-979-4,68922-07-6,Not Classified,Notified C&L,1,Not classified:1
88788,Zinc cyanamidate,243-944-0,20654-08-4,Not Classified,Notified C&L,26,Not classified:25;H410:1
88789,"2,3-dicyano-p-benzoquinone",225-037-1,4622-04-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Acute 1,Notified C&L,1,H319:1;H335:1;H315:1;H301:1;H400:1;H331:1
88791,Diethyl isopropylmalonate,212-068-0,759-36-4,Not Classified,Notified C&L,1,Not classified:1
88792,4-(2-carboxyindol-3-yl)butyric acid,250-682-0,31529-29-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
88793,"1,5-Naphthalenedisulfonic acid, 2-[2-[8-[[4-[[2-[(2-chloroethyl)sulfonyl]ethyl]amino]-6-[[3-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfo-2-naphthalenyl]diazenyl]-",620-146-4,144446-39-9,Eye Dam. 1,Notified C&L,1,H318:1
88795,Ethyl 4'-hydroxy-3'-methoxycinnamate,223-745-5,4046-02-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
88797,4-chloro-2-nitrobenzenediazonium tetrachlorozincate (2:1),238-148-5,14263-89-9,Acute Tox. 4,Notified C&L,49,H302:49;H411:9;H335:9;H318:9
88798,"1,2-dihydropyridazine-3,6-dione, monopotassium salt",249-000-4,28382-15-2,Not Classified,Notified C&L,7,Not classified:7
88801,p-anisyl(2-pyridyl)amine,258-202-1,52818-63-0,,Notified C&L,1,H302:1
88805,Heptane-1-thiol,216-678-8,1639-09-4,Flam. Liq. 3,Notified C&L,154,H226:154;H315:23;H335:5;H319:1
88806,"(2RS, 3SR)-3-(6-chloro-5-fluoro-4-pyrimidinyl)-2-(2,4- difluorphenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol hydrochloride",928-729-8,,Skin Sens. 1A;Eye Dam. 1;Repr. 1B,REACH registration C&L,1,H360:1;H317:1;H318:1
88807,Pramocaine,205-425-7,140-65-8,Not Classified,Notified C&L,1,Not classified:1
88808,Zinc toluate,259-382-4,54874-20-3,Not Classified,Notified C&L,1,Not classified:1
88811,"1,1'-methylenebis[4-fluorobenzene]",207-274-2,457-68-1,Acute Tox. 4,REACH registration C&L,1,H302:1
88812,"(E)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one",201-224-3,79-77-6,Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,1777,H411:1737;H401:4;Not classified:40;H400:1
88813,"Kieselguhr, calcined",293-303-4,91053-39-3,Not Classified,Notified C&L,405,Not classified:238;H373:153;H371:13;H372:1
88815,4-aminobenzaldehyde,209-115-2,556-18-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38;H317:38
88816,"2-Propenoic acid, 4-[[(4-benzoylphenoxy)carbonyl]oxy]butyl ester",603-491-5,131513-00-3,Flam. Liq. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,84,H400:84;H412:84;H225:84;H317:84
88817,"5-(acetylamino)-4-hydroxy-3-[[2-methoxy-5-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonic acid",233-319-0,10116-15-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
88818,Samarium tribromide,237-347-4,13759-87-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
88819,2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate,408-010-0,88558-41-2,Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H332:0;H318:0
88821,"N,N-diethyl-β-alanine hydrochloride",239-751-6,15674-67-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,129,H319:129;H335:128;H315:129
88824,4-hydroxybutyraldehyde,247-205-3,25714-71-0,,Notified C&L,1,H319:1
88825,"Barium oxide, obtained by calcining witherite",215-127-9,1304-28-5,Ox. Sol. 1;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,342,H271:89;H314:172;H318:136;H301:161;H302:171;H332:283;H412:32;H319:34;H331:29;H315:48;H371:15;Not classified:5;H373:4;H335:5;H370:1;H372:1
88826,Titanium(4+) octadecan-1-olate,225-866-9,5128-29-0,Flam. Sol. 2,Notified C&L,1,H228:1
88830,Calcium 4-[(4-chloro-3-sulphonatophenyl)azo]-3-hydroxy-2-naphthoate,231-411-5,7538-59-2,Not Classified,Notified C&L,14,Not classified:14
88832,Allopurinol,206-250-9,315-30-0,Acute Tox. 3;Skin Sens. 1,Notified C&L,141,H317:134;H301:74;H411:3;H362:3;H302:9;H400:5;H410:6;H312:3;H332:3;H360:2;H319:2;H335:3;H315:3;H318:1;H412:2;H361:3;H341:1;H373:1
88835,"4,4'-[(1,10-dioxodecane-1,10-diyl)bis(oxy)]bis(2,2,6,6-tetramethylpiperidine-1-oxidanyl)",417-440-8,2516-92-9,Not Classified,REACH registration C&L,86,Not classified:84;H317:1;H413:1
88840,"1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione",401-570-7,89415-87-2,Ox. Sol. 1;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1,Harmonised C&L,0,H302:0;H314:0;H317:0;H400:0;H271:0;H331:0
88844,Trade name: 3M(TM) NOVEC(TM) ENGINEERED FLUID HFE-7000,484-450-7,,Not Classified,Notified C&L,1,Not classified:1
88845,Indolin-6-ylamine hydrochloride,248-915-6,28228-73-1,Acute Tox. 3;Aquatic Chronic 3,Notified C&L,38,H412:38;H301:38
88848,4-chloro-2-fluoro-5-nitrotoluene,242-225-9,18349-11-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
88853,beta -Hydroxypyruvic acid,619-885-5,1113-60-6,Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H302:38;H314:38
88854,"dodecyl 3,4,5-trihydroxybenzoate",214-620-6,1166-52-5,Skin Sens. 1,Harmonised C&L,0,H317:0
88855,reaction products of diisopropanolamine with formaldehyde (1:4),432-440-8,220444-73-5,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Carc. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H351:0;H302:0;H314:0;H317:0
88865,"Naphtha (petroleum), full-range straight-run;Low boiling point naphtha;[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-042-6,64741-42-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
88866,7-(diethylamino)-3-(5-methylbenzoxazol-2-yl)-2-benzopyrone,252-093-4,34564-13-1,Not Classified,Notified C&L,6,Not classified:6
88875,Potassium tantalum trioxide,234-747-0,12030-91-0,Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38
88880,"Gas oils (petroleum), steam-cracked;Cracked gasoil;[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C",271-260-2,68527-18-4,Carc. 1B,Harmonised C&L,0,H350:0
88885,"2,2'-(ethylenedioxy)diethanol",203-953-2,112-27-6,Not Classified,REACH registration C&L,2462,Not classified:2394;H332:29;H319:43;H335:35;H315:35
88886,Phosphorisocyanatidic dichloride,212-794-8,870-30-4,Acute Tox. 3;Skin Corr. 1B,Notified C&L,38,H314:38;H301:38
88888,2-Fluoro-4-iodobenzonitrile,604-024-8,137553-42-5,Acute Tox. 3,Notified C&L,1,H301:1
88892,"nitrofen (ISO);2,4-dichlorophenyl 4-nitrophenyl ether",217-406-0,1836-75-5,Acute Tox. 4;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H302:0;H410:0;H350:0;H360:0;H400:0
88897,"Trisodium 7-[2-[(aminocarbonyl)amino]-4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]azo]naphthalene-1,3,6-trisulphonate",260-696-9,57359-00-9,Not Classified,Notified C&L,5,Not classified:3;H315:2
88898,2-[2-(tetrahydrofurfuryloxy)ethoxy]ethanol,258-200-0,52814-38-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
88901,2-ethylhexyl lactate,228-503-2,6283-86-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,115,H319:60;H317:37;H315:60;Not classified:55
88904,1-chloro-2-methylpropan-2-ol,209-196-4,558-42-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2B;STOT SE 3,REACH registration C&L,47,H226:47;H319:8;H335:7;H315:8;H312:1;H302:1;H332:1
88905,6-chloropiperonyl chloride,245-678-0,23468-31-7,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,42,H314:42;H335:38;H318:38
88908,"Butyl 2,4-dichlorophenoxyacetate",202-364-8,94-80-4,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,146,H400:143;H410:143;H302:146;H317:143;H312:3;H332:3
88912,[11B]boron trifluoride,243-946-1,20654-88-0,Press. Gas (Comp.);Skin Corr. 1A;Acute Tox. 2,Notified C&L,62,H281:39;H314:62;H330:62;H280:1;H318:1
88913,"4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane",225-039-2,4627-10-5,Flam. Liq. 3,Notified C&L,39,H226:39;H319:1;H335:1;H315:1
88914,"Naphtha (petroleum), light polymn.",614-725-0,68783-11-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,4,H411:4;H315:4;H225:1;H336:4;H304:4;H226:1;H361:1;H224:2
88917,2-nitrophenylhydrazine,221-222-6,3034-19-3,Flam. Sol. 1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H302:41;H335:40;H315:41;H228:40;H412:1;H242:1
88921,"1-Pentene, chlorinated, epoxidized, distn. residues",304-798-4,94279-53-5,Flam. Liq. 3;Met. Corr. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;Muta. 1B;Carc. 1B,Notified C&L,84,H319:83;H340:84;H315:84;H311:84;H330:84;H317:84;H290:83;H350:84;H301:84;H226:84;H320:1;H331:1
88923,Tranylcypromine sulphate,236-807-1,13492-01-8,Acute Tox. 2;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H300:38;H331:38
88926,2-[[4-[bis(2-hydroxyethyl)amino]-o-tolyl]azo]-5-nitrobenzonitrile,235-460-3,12236-25-8,Aquatic Chronic 3,REACH registration C&L,24,H412:18;Not classified:6
88929,"Carbonic acid, bis(1,1-dimethylethyl) ester",609-007-9,34619-03-9,Not Classified,Notified C&L,1,Not classified:1
88932,acetic anhydride,203-564-8,108-24-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Harmonised C&L,0,H226:0;H302:0;H332:0;H314:0
88933,(3-aminophenyl)urea,247-201-1,25711-72-2,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,5,H319:5;H317:4;H335:2;H315:3
88935,"Octa-1,4-diene",227-132-3,5675-25-2,Flam. Liq. 2;Eye Irrit. 2,Notified C&L,39,H319:38;H225:39
88937,"tris(η5-cyclopenta-2,4-dien-1-yl)samarium",215-075-7,1298-55-1,Flam. Sol. 2;Water-react. 2,Notified C&L,42,H228:42;H261:38
88939,"1,1,2,3,3-pentamethylindan",214-868-5,1203-17-4,,REACH registration C&L,3,Not classified:3
88940,"Allspice, ext.",284-540-4,84929-57-7,Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 3,Notified C&L,1471,H319:1425;H412:1422;H351:1424;H341:1384;H317:1425;H304:89;Not classified:46;H411:2;H302:1;H226:1
88941,"Disodium [29H,31H-phthalocyaninedisulphonato(4-)-N29,N30,N31,N32]cuprate(2-)",215-537-8,1330-38-7,Not Classified,Notified C&L,2289,Not classified:2278;H317:9;H319:2;H315:1
88942,8-formyl-1-naphthoic acid,227-377-6,5811-87-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
88945,Diisotridecyl phthalate,248-368-3,27253-26-5,Not Classified,Notified C&L,1,Not classified:1
88947,"9-oxo-9H-thioxanthene-3-carbonitrile 10,10-dioxide",257-396-5,51762-94-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H312:38;H302:38;H335:38;H315:38;H332:38
88952,"Pine, Pinus mugo, ext.",290-163-6,90082-72-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,176,H411:5;H319:42;H315:12;H317:175;H226:176;H304:175;H410:170;H400:134
88953,"Phosphoric acid, zinc salt",237-583-8,13847-22-8,Not Classified,Notified C&L,2,Not classified:1;H400:1;H410:1
88960,[3-[(1-benzylcycloheptyl)oxy]propyl]dimethylammonium hydrogen fumarate,238-204-9,14286-84-1,Acute Tox. 4,Notified C&L,65,H302:65;H311:1
88961,"3a,4,7,7a-tetrahydro-4-methyl-1H-indene",231-021-5,7413-02-7,Not Classified,Notified C&L,1,Not classified:1
88963,Trichloro(cyclohexyl)silane,202-639-2,98-12-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,57,H314:57;H318:53;H290:1
88968,Bitoscanate,223-741-3,4044-65-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,43,H319:38;H335:38;H315:38;H334:42;H301:43;H312:4;H314:5;H410:4;H332:4;H400:4;H318:1
88971,"2,4-dichlorobenzoic acid",200-067-8,50-84-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,239,H319:205;H302:235;H335:204;H315:205
88975,Dimethyl[2-[(2-methyl-1-oxoallyl)oxy]ethyl][3-(trimethoxysilyl)propyl]ammonium chloride,250-762-5,31681-13-7,Not Classified,Notified C&L,26,Not classified:26
88984,Anisoyl chloride,202-816-4,100-07-2,Skin Corr. 1B,REACH registration C&L,76,H314:74;Not classified:2;H302:1;H335:1;H318:2
88985,sulphanilic acid;4-aminobenzenesulphonic acid,204-482-5,121-57-3,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0;H315:0
88987,dipotassium peroxodisulphate;potassium persulphate,231-781-8,7727-21-1,Ox. Sol. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H319:0;H302:0;H335:0;H315:0;H334:0;H317:0;H272:0
88988,"(2E)-1,1,4,4-tetramethoxybut-2-ene",626-693-5,6068-62-8,Skin Irrit. 2,Notified C&L,65,H315:40;Not classified:25;H319:2;H335:1
88996,"Sulfurous acid, monosodium salt, reaction products with formaldehyde and melamine",286-031-2,85186-46-5,Not Classified,Notified C&L,5,Not classified:2;H319:2;H335:2;H315:2;H317:1
89001,Dec-2-enoic acid,223-475-8,3913-85-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,88,H319:88;H315:88
89008,Pigment Yellow 214,433-240-3,,Not Classified,REACH registration C&L,35,Not classified:35
89009,"Pentanedioic acid, 2-methyl-, 1,5-dimethyl ester",604-181-2,14035-94-0,Not Classified,Notified C&L,6,Not classified:6
89011,"Hydrogen bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-) , compound with 3-[(2-ethylhexyl)oxy]propylamine (1:1)",276-859-2,72812-36-3,Not Classified,Notified C&L,2050,Not classified:2050
89016,Diethylammonium iodide,243-358-5,19833-78-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
89019,"reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate",427-650-1,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
89021,"4-trans-Butyl-[1,1-bicyclohexyl]-4-trans-carbonic acid-(4-propylphenyl)ester",601-508-0,118144-66-4,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
89022,"3,7,7-trimethylbicyclo[4.1.0]hept-3-ene-2-methanol",274-601-3,70424-76-9,Not Classified,REACH registration C&L,1,Not classified:1
89023,2-methylbenzophenone,205-032-0,131-58-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,466,H319:442;H335:442;H315:442;H302:24
89029,Chlortetracycline,200-341-7,57-62-5,Acute Tox. 4,Notified C&L,129,H302:128;Not classified:1
89035,[No public or meaningful name is available],483-280-0,,Not Classified,Notified C&L,2,Not classified:2
89036,"Siloxanes and Silicones, di-Me, hydroxy-terminated, reaction products with Me hydrogen siloxanes and 2-[[3-(trimethoxysilyl)propoxy]methyl]oxirane",604-931-9,153890-18-7,Not Classified,Notified C&L,1,Not classified:1
89038,"benzyl violet 4B; α-[4-(4-dimethylamino-α-{}{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate",216-901-9,1694-09-3,Carc. 2,Harmonised C&L,0,H351:0
89040,"Silane, trimethoxy[3-(oxiranylmethoxy)propyl]-, reaction products with cristobalite (SiO2)",309-525-2,100402-87-7,Not Classified,Notified C&L,5,Not classified:5
89041,hydrogenated decyl olive oil esters,924-579-2,,Acute Tox. 3;Eye Irrit. 2B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H319:2;H400:2;H301:2
89043,Benzyl propionate,204-559-3,122-63-4,Not Classified,REACH registration C&L,1634,Not classified:1634
89048,"Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]",270-813-5,68478-32-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H340:0;H350:0;H220:0;Not classified:0
89051,3-pentanol,209-526-7,584-02-1,Flam. Liq. 3;Skin Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H226:0;H332:0;H335:0;H315:0
89055,"3-(bromomethyl)-1,2,4,5-tetrafluorobenzene",258-289-6,53001-73-3,,Notified C&L,6,H314:6;H319:1;H312:1;H302:1;H318:1;H332:1
89061,"pirimicarb (ISO);2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamate",245-430-1,23103-98-2,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H351:0;H410:0;H317:0;H301:0;H400:0;H331:0
89064,Capcure 3-800LC,600-806-8,107231-36-7,Not Classified,Notified C&L,9,Not classified:9
89068,Cedrene,234-257-7,11028-42-5,Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1416,H400:1415;H410:1415;H304:1416;H411:1
89069,Hexahydro-α-methyl-1H-azepine-1-ethanol,278-781-4,77883-50-2,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38,H319:38;H301:38
89071,"Diammonium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']manganate(2-)",304-037-6,94233-07-5,Not Classified,REACH registration C&L,4,Not classified:4
89072,Zinc fluoride,232-001-9,7783-49-5,Acute Tox. 3;Skin Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,53,H411:2;H315:51;H332:2;H301:9;H400:3;H318:42;H335:49;H319:7;H311:3;H331:2;H410:1;H302:2;H314:1;H330:1
89075,Dibutyl [[bis[(2-ethylhexyl)oxy]phosphinothioyl]thio]succinate,270-220-1,68413-48-9,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,42,H317:6;H413:6;Not classified:36
89077,"3,7-dimethyloctan-1-ol",203-374-5,106-21-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1791,H411:1679;H319:1666;H315:1728;Not classified:63;H335:42;H410:6
89089,"Hydrogen bis[N-[7-hydroxy-8-[(2-hydroxy-5-nitrophenyl)azo]-1-naphthyl]acetamidato(2-)]chromate(1-) , compound with dicyclohexylamine (1:1)",276-074-5,71839-90-2,Repr. 1B,Notified C&L,83,H360:83
89092,2-aminobutan-1-ol,202-488-2,96-20-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,144,H400:110;H302:139;H318:59;H314:114;H319:25;H315:25;H411:13;H410:13;Not classified:5
89094,"Tetrasodium hydrogen bis[5-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzene-x,3-disulphonato(4-)]chromate(5-)",271-349-6,68541-69-5,Not Classified,Notified C&L,2039,Not classified:2039
89095,Ammonium iron(III) trimethylenediaminetetraacetate hemihydrate,400-660-3,111687-36-6,Aquatic Chronic 2,Notified C&L,2,H411:2
89098,"1,3-Dioxolane, 2-(4-bromophenyl)-2-methyl-",610-128-4,4360-68-3,Aquatic Chronic 3,Notified C&L,24,H412:24
89099,Ethyl 4-hydroxyphenylacetate,241-197-5,17138-28-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:1;H315:2;Not classified:1
89100,Baclofen,214-486-9,1134-47-0,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3;Repr. 1B,Notified C&L,58,H319:43;H335:42;H315:43;H360:39;H334:42;H317:42;H301:53;H336:9;H361:11;H302:5;H311:1;H331:1
89101,1-(4-nitrophenyl)-3-(4-phenylazophenyl)triazene,226-395-1,5392-67-6,Acute Tox. 4;Skin Sens. 1,Notified C&L,39,H302:39;H317:38;H332:1;H312:1;H242:1
89102,"6-bromo-3-methyl-3H-dibenz[f,ij]isoquinoline-2,7-dione",201-381-8,81-85-6,Not Classified,REACH registration C&L,2,Not classified:2
89104,"Castor oil, sulfated, sodium salt",269-123-7,68187-76-8,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,394,H319:279;H412:104;Not classified:82;H318:33;H315:76;H317:1
89108,Hydroquinine,208-334-0,522-66-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H332:1;H302:1;H317:1
89109,7-hydroxyheptane-1-nitrile,241-896-5,17976-80-6,Acute Tox. 4,REACH registration C&L,1,H302:1
89111,"Dodecyl dihydrogen phosphate, potassium salt",251-504-4,33403-10-0,Not Classified,Notified C&L,5,Not classified:4;H319:1;H315:1
89118,asbestos,601-649-8,12001-28-4,Carc. 1A;STOT RE 1,Harmonised C&L,0,H350:0;H372:0
89126,2-methylundecanoic acid,246-164-9,24323-25-9,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,1286,H412:1286;H315:1286
89128,Chloro(diphenyl)methane,202-031-7,90-99-3,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,58,H319:44;H315:43;H411:6;H314:9;H318:3;H335:2;H312:1;H302:1;H332:1
89130,p-pentylphenyl p-anisate,253-932-7,38444-13-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H319:38;H315:38;H317:39;H400:38;H410:38;Not classified:1
89133,ammonium perchlorate;[containing ≥ 80 % of 0-30 µm particles],232-235-1,7790-98-9,Expl. 1.1;Ox. Sol. 1,Harmonised C&L,0,H201:0;H271:0
89135,2-hydroxy-4-morpholinepropanesulphonic acid,269-989-6,68399-77-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,94,H319:93;H335:92;H315:93;Not classified:1
89139,"Resin acids and Rosin acids, tall oil, fumarated, compds. with triethanolamine",293-633-9,91081-30-0,Not Classified,Notified C&L,3,Not classified:3
89140,Pectin,232-553-0,9000-69-5,Not Classified,Notified C&L,64,Not classified:63;H319:1;H315:1
89144,"Steroids, hydroxy",271-413-3,68555-08-8,Not Classified,Notified C&L,120,Not classified:113;H319:7;H315:7
89147,Diiron tritartrate,220-953-8,2944-68-5,Not Classified,Notified C&L,2,Not classified:2
89149,1-chloro-2-methylpropane,208-157-9,513-36-0,Flam. Liq. 2,REACH registration C&L,57,H225:55;Not classified:4
89151,cyprodinil (ISO);4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine,601-785-8,121552-61-2,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H317:0
89152,D-tyrosine,209-112-6,556-02-5,,Notified C&L,50,Not classified:41;H319:9;H335:8;H315:9
89153,5-chloro-2-phenoxyaniline,202-266-5,93-67-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;Aquatic Chronic 4,REACH registration C&L,44,H319:42;H302:1;H341:1;H413:1;H315:42;H335:39;Not classified:2
89156,Tributyl(undec-10-enoyloxy)stannane,249-643-0,29457-48-5,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H312:38;H315:38;H410:38;H372:38;H301:38;H400:38
89160,Sodium p-[[p-(diethylamino)phenyl]azo]benzenesulphonate,263-716-4,62758-12-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H319:53;H335:51;H315:53
89161,"Dihydro-3-[3-(triethoxysilyl)propyl]furan-2,5-dione",297-566-6,93642-68-3,Eye Irrit. 2,REACH registration C&L,4,H319:3;Not classified:1
89165,"L-Lysine, N6-(2,2,2- trifluoroacetyl)-",600-027-3,10009-20-8,Not Classified,REACH registration C&L,2,Not classified:2
89168,2-methylbutyric acid,204-145-2,116-53-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,1747,H312:1743;H302:1743;H318:1440;H314:1746;H411:1;H317:1;H226:1;H304:1;H332:1;Not classified:1;H311:1;H301:1;H290:1;H227:1
89181,"Alcohols, C12-14",279-420-3,80206-82-2,Skin Irrit. 2;Aquatic Acute 1,REACH registration C&L,712,H400:658;H315:178;H412:83;Not classified:40;H319:17;H318:14;H410:7
89187,"Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-(tetradecyloxy)-, sodium salt",610-539-9,50546-32-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,33,H318:33;H315:33
89189,"Hydrogen bis[2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-)",251-436-5,33270-70-1,Not Classified,Notified C&L,2079,Not classified:2077;H411:2;H319:2
89190,2-bromobenzoic acid,201-848-6,88-65-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H302:39;H335:45;H315:47;H312:1;H332:1
89192,"2-(2H-BENZOTRIAZOL-2-YL)-4-METHYL-6-[2-METHYL-3-[1,3,3,3-TETRAMETHYL-1-[(TRIMETHYLSILYL)OXY]DISILOXANYL]PROPYL]PHENOL",422-940-4,,Not Classified,REACH registration C&L,2,Not classified:2
89194,"Amides, tallow, hydrogenated, N-[2-[(2-hydroxyethyl)amino]ethyl], glycolates (salts)",271-658-6,68603-47-4,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,28,H411:28;H318:28;H360:6
89196,"12-hydroxyoctadecanoic acid, calcium lithium salt",261-279-4,58478-76-5,Not Classified,Notified C&L,6,Not classified:6
89197,(4-chlorophenyl) 2-pyridyl ketone,228-662-8,6318-51-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
89198,trans-2-Fluor-4-(4-propylcyclohexyl)-phenylboronacid,605-173-1,159119-10-5,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1;H317:1;Not classified:1
89205,"3,4,5-trimethylaniline",216-679-3,1639-31-2,,Notified C&L,1,H311:1;H330:1;H411:1;H301:1
89206,"1,4,10-trioxa-7,13-diazacyclopentadecane",250-530-3,31249-95-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
89208,Bis(2-ethylhexanoato-O)dioxomolybdenum,303-971-1,94232-43-6,Not Classified,Notified C&L,1,Not classified:1
89213,Potassium niobate,234-744-4,12030-85-2,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1,H319:1;H317:1
89216,"Cobalt, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, sulfonated, sodium salts",290-971-9,90294-83-0,Skin Sens. 1;Eye Dam. 1;Muta. 2,REACH registration C&L,1,H341:1;H317:1;H318:1
89219,"1-Tridecanamine, N-tridecyl-, branched, compds. with molybdenum hydroxide oxide",608-158-8,280130-32-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,441,H400:441;H410:441;H318:441;H315:441
89220,Dihexyl disulphide,234-022-9,10496-15-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
89222,"Benzenesulfonamide, 4-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthracenyl)oxy]-N-(3-ethoxypropyl)-",602-624-4,12236-11-2,,Notified C&L,1,Not classified:1
89226,Ethyl cyanoformate,210-797-9,623-49-4,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,46,H314:46;H311:45;H301:45;H226:46;H331:41;H330:5;H318:1;H300:1;H310:1
89230,Strontium fluoride,232-000-3,7783-48-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:41;H335:39;H315:40;H332:9;Not classified:2;H312:4;H302:2;H413:1;H311:1
89232,"Zinc sulfide (ZnS), manganese-doped",272-554-3,68877-27-0,Not Classified,REACH registration C&L,6,Not classified:4;H319:1;H413:1;H335:1;H315:1;H317:2;H400:1;H410:1;H334:1
89235,Testosterone enantate,206-253-5,315-37-7,Acute Tox. 4;Carc. 1B;Repr. 2,Notified C&L,60,H350:40;H302:59;H361:39;H312:18;H351:19;H332:18;H360:20;H413:1;H362:2;H372:1;H373:1
89237,"1,7-dibromoheptane",224-910-4,4549-31-9,Acute Tox. 2,Notified C&L,40,H300:39;H319:1;H302:1;H411:1
89239,Tridec-2-enenitrile,245-142-6,22629-49-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1524,H400:1475;H410:1475;H319:441;H315:31;H317:24;Not classified:18
89241,4-(2-pyridyl)benzonitrile,250-921-9,32111-34-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H312:1;H302:1;H315:1;H332:1
89249,Praseodymium triiodide,237-466-1,13813-23-5,Skin Sens. 1;Repr. 1B,Notified C&L,43,H317:42;H360:38;H334:4;Not classified:1
89254,S-propyl thioacetate,218-984-7,2307-10-0,Not Classified,Notified C&L,134,Not classified:90;H312:39;H319:39;H335:38;H315:39;H226:44;H302:1;H332:1
89255,Proligestone,245-922-6,23873-85-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,18,H312:18;H351:18;H302:18;H332:18;H360:18
89256,"2-[(2-acetamido-6,9-dihydro-6-oxo-1H-purin-9-yl]methoxy]ethyl acetate",278-077-7,75128-73-3,Not Classified,REACH registration C&L,14,Not classified:7;H319:6;H316:2;H335:4;H315:6;H302:1
89258,1-[(2-chloro-4-nitrophenyl)azo]-2-naphthol,220-562-2,2814-77-9,Not Classified,REACH registration C&L,318,Not classified:278;H319:40;H413:38;H302:2;H315:2
89259,"Undecanedioic acid, compound with 2,2',2''-nitrilotriethanol (1:2)",285-131-3,85030-07-5,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
89260,N-[2-[(2-aminoethyl)amino]ethyl]isooctadecan-1-amide,268-664-6,68133-06-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
89263,2-acetamido-2-deoxy-D-glucono-δ-lactone,242-761-3,19026-22-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
89265,C.I. Pigment Blue 12,603-632-0,1325-77-5,Not Classified,Notified C&L,1,Not classified:1
89273,Decan-1-ol,203-956-9,112-30-1,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,3526,H319:3246;H412:834;H411:2344;Not classified:47;H410:80;H400:128;H312:73;H302:40;H335:218;H318:40;H225:40;H336:40;H315:1839;H332:181;H331:38;H371:1;H361:1;H304:1
89279,DL-2-(4-chlorophenyl)propanoic acid,213-351-1,938-95-4,Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2,Notified C&L,43,H319:43;H317:39;H301:38;H335:4;H315:4;H302:1
89281,Pentafluorobenzenesulphonyl chloride,212-620-0,832-53-1,Skin Corr. 1B,Notified C&L,49,H314:49;H290:2;H318:2;H319:1;H335:2
89282,"2,3,4,6-Tetra-O-benzyl-D-glucopyranose",432-870-6,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H302:2;H335:2;H315:2
89283,1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one,429-040-0,272460-97-6,Eye Dam. 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H318:0
89284,2-Bromo-5-nitrobenzotrifluoride,609-288-8,367-67-9,,Notified C&L,6,H319:6;H312:6;H302:6;H335:5;H315:6;H332:6
89285,"Bis (2,4-dicumylphenoxy) pentaerythritol diphosphite",921-072-8,154862-43-8,Aquatic Chronic 2,Notified C&L,89,H411:71;H413:18
89286,Cefalonium,226-948-7,5575-21-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,17,H334:17;H317:17
89290,"1,1-diethoxyoctane",259-385-0,54889-48-4,Flam. Liq. 3,Notified C&L,89,H226:89
89291,Oxybenzone,205-031-5,131-57-7,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1862,H411:313;H400:164;H319:1416;H335:1399;H315:1416;Not classified:141;H410:86;H373:3
89293,"5-(4-hydroxyphenyl)-5-phenylimidazolidine-2,4-dione",220-492-2,2784-27-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
89294,"2-Methyloctane-1,8-diamine",700-111-0,148528-05-6,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H302:2;H317:2;H314:2
89296,"2,2,2-trifluoro-1-(trifluoromethyl)ethyl toluene-p-sulphonate",266-887-3,67674-48-0,,Notified C&L,6,H319:6;H335:5;H315:6
89297,"Phosphoric acid, C12-14-branched and linear alkyl esters, compds. with triethanolamine",306-292-9,96792-57-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H318:8;H315:8
89299,"Diethyl 2,5-dihydroxyterephthalate",227-522-3,5870-38-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:39;H315:39;Not classified:1
89303,2-aminoethyl hydrogen sulphate,213-135-7,926-39-6,Acute Tox. 4,REACH registration C&L,101,H302:101;H319:99;H335:98;H315:99
89306,"Slimes and Sludges, blast furnace and steelmaking",266-006-2,65996-73-8,Not Classified,REACH registration C&L,5,Not classified:5
89308,5-Chloro-2-Phenoxyphenyl Acetic Acid,615-228-1,70958-20-2,Aquatic Chronic 3,Notified C&L,17,H412:17;H319:1;H341:1
89310,"Fatty acids, C12-18 and C16-18-unsatd., zinc salts",288-463-7,85736-53-4,Not Classified,Notified C&L,6,Not classified:6
89314,"Naphtha (petroleum), heavy straight-run;Low boiling point naphtha;[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-041-0,64741-41-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
89315,"1,1,2,3,3,6-hexamethylindan-5-yl methyl ketone",239-360-0,15323-35-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1563,H400:1525;H410:1562;H302:1563;H312:1;H332:1
89317,"3-amino-4-chlorobenzoic acid, hexadecyl ester",419-700-6,143269-74-3,Aquatic Chronic 2,Harmonised C&L,0,H411:0
89326,Ethanediylidenetetrakisphenol,231-782-3,7727-33-5,Not Classified,Notified C&L,95,Not classified:55;H400:39;H410:40;H318:40
89328,Sodium bromate,232-160-4,7789-38-0,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,336,H319:222;H302:302;H335:125;H315:222;H272:197;H351:6;H350:137;H271:139;H341:41;H301:14;Not classified:1;H318:1;H317:1
89329,1-(Benzyloxy)-3-bromobenzene,610-958-7,53087-13-1,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H400:39;H410:39;H317:39;H318:39;H319:1;H335:1;H315:1
89331,"5-[(S)-4-Carboxy-4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyrylamino]-2-nitro-benzoic acid",926-197-1,2561176-48-3,Skin Sens. 1B;Eye Dam. 1,Notified C&L,1,H317:1;H318:1
89333,Azacyclonol,204-092-5,115-46-8,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,16,H319:15;H302:16;H315:2
89334,"1,4-dihydroxy-3-methyl-2-naphthyl 4-aminobenzoate",238-809-8,14748-94-8,Aquatic Acute 1,Notified C&L,39,H400:38;H302:1
89337,4-(4-nitrophenylazo)resorcinol,200-808-5,74-39-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,46,H319:44;H315:44;H335:5;Not classified:2
89342,"2,5,7-trimethyl-2-decene-6,8-dione",237-584-3,13851-06-4,Not Classified,Notified C&L,113,Not classified:113
89344,4-aminotoluene-2-sulphonanilide,201-221-7,79-72-1,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,40,H302:40;H318:2
89347,"2-aminoethanol, monoester with boric acid",233-829-3,10377-81-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,37,H319:26;H335:25;H315:26;Not classified:11;H302:1
89349,Ethyl indol-3-ylglyoxylate,256-954-5,51079-10-8,Eye Irrit. 2,Notified C&L,38,H319:38
89352,"Bis(phenoxyphenoxy)benzene, mixed isomers",250-685-7,31533-76-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
89359,"Isononanoic acid, C16-18 (even numbered)-alkyl esters",601-141-6,111937-03-2,Not Classified,REACH registration C&L,96,Not classified:96
89360,Benzyl-dimethyl-hydrogenated tallow ammonium montmorillonite clay,400-060-1,,Not Classified,Notified C&L,36,Not classified:36
89361,Pentacarbonyliron,236-670-8,13463-40-6,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 2;Acute Tox. 1;STOT RE 1,Notified C&L,128,H330:127;H372:84;H300:127;H225:128;H310:88;H311:40;H220:1;H331:1;H301:1
89363,"2,3-dimethylnaphthalene",209-463-5,581-40-8,Acute Tox. 4,Notified C&L,41,H302:38;Not classified:3
89367,"1,4-dioxane-2,6-dione",224-761-5,4480-83-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45;H312:1;H302:1;H332:1
89369,Clotiapine,218-162-8,2058-52-8,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4,H400:4;H410:4;H301:3;H302:1;H332:1
89373,"Linseed oil, potassium salt",271-713-4,68605-13-0,Eye Irrit. 2,Notified C&L,1,H319:1
89375,N-vinylacetamide,225-989-8,5202-78-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:40;H302:40;H315:40
89376,"Trisodium 4-[[5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-2-sulphonatophenyl]azo]-4,5-dihydro-5-oxo-1-(4-sulphonatophenyl)-1H-pyrazole-3-carboxylate",275-012-4,70900-45-7,Not Classified,Notified C&L,1,Not classified:1
89378,N-methylisopropylamine,225-266-7,4747-21-1,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,125,H314:125;H318:87;H225:125;H301:86;H331:86
89379,Holmium trinitrate,233-438-8,10168-82-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,3,H411:1;H318:1;H315:2;Not classified:1;H319:1;H272:1;H335:1
89383,"Alcohols, C4-18, reaction products with phosphorus oxide (P2O5)",296-088-5,92257-02-8,Skin Corr. 1C;Aquatic Chronic 3,Notified C&L,9,H412:9;H314:9
89385,Tetraethylammonium p-toluenesulphonate,211-992-1,733-44-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:43;H315:45
89390,1-Bromo-4-butylbenzene,472-210-4,41492-05-1,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:1;H410:1;H315:2;H319:1
89391,"m,m'-[carbonylbis[imino(3-methoxy-p-phenylene)azo]]bis(benzenesulphonic) acid, sodium salt, compound with 2,2',2''-nitrilotriethanol",300-891-9,93964-44-4,Not Classified,Notified C&L,1,Not classified:1
89392,"2,5-dimethylbenzothiazole",202-404-4,95-26-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H302:44;H335:43;H315:44
89393,Methyl (R)-(-)-3-hydroxybutyrate,223-610-0,3976-69-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,47,H319:41;H335:41;H315:46;H318:5;Not classified:1
89394,1-iodo-2-nitrobenzene,210-200-1,609-73-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H319:44;H312:43;H302:43;H335:43;H315:44;H332:43;H311:1;H331:1
89399,Hexadecyl laurate,244-071-8,20834-06-4,Not Classified,Notified C&L,1,Not classified:1
89400,"Benzene, 1,2-dimethyl-, mono-C10-14-branched alkyl derivs., C12-rich",290-555-7,90171-16-7,Aquatic Chronic 4,Notified C&L,30,H413:30
89404,Dichloromethyloctadecylsilane,225-931-1,5157-75-5,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,47,H302:1;H318:3;H314:43;Not classified:5;H290:2;H411:1;H335:1;H301:1
89408,2-chloroethylammonium chloride,212-793-2,870-24-6,Skin Corr. 1C;Muta. 2,REACH registration C&L,121,H314:72;H341:72;H319:49;H335:47;H315:49;H290:13
89409,Dicopper sulphide,244-842-9,22205-45-4,Not Classified,REACH registration C&L,28,Not classified:27;H413:1
89410,"1-Tetradecene, polymer with 1-dodecene, distn. residues, hydrogenated, C24-84 fraction",618-143-8,883233-93-0,Not Classified,REACH registration C&L,1,Not classified:1
89412,Butyl isocyanatoacetate,241-114-2,17046-22-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H319:44;H312:39;H302:39;H335:44;H315:44;H332:43;H334:4;H301:1;H331:1
89415,"1-β-D-arabinofuranosyl-(1H,3H)-pyrimidine-2,4-dione",221-386-9,3083-77-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Muta. 2;Repr. 2;STOT RE 2,Notified C&L,3,H319:1;H312:1;H302:1;H341:1;H335:1;H315:1;H361:2;H332:1;H373:1;Not classified:1
89418,"Ethyl 1,2,3-thiadiazole-5-carboxylate",223-866-3,4100-14-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H302:2;H335:3;H315:3
89419,3-fluoro-4-hydroxyphenylacetic acid,207-275-8,458-09-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:45;H315:45
89422,"1,2-bis(6-methyl-2-pyridyl)ethanediol",229-621-7,6630-20-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
89425,"Cedrus deodara, ext.",294-939-5,91771-47-0,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1413,H411:126;H317:3;H315:3;H304:1385;Not classified:1
89432,"3,3-dimethylbutene",209-195-9,558-37-2,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,69,H319:55;H335:39;H315:55;H225:69;H304:69;H336:24;Not classified:1
89433,"(3R-trans)-dihydro-2,5-dioxofuran-3,4-diyl diacetate",228-502-7,6283-74-5,Eye Dam. 1,REACH registration C&L,49,H318:5;H319:44;H335:43;H315:44
89440,Diyttrium disilicate,238-205-4,14286-95-4,Not Classified,Notified C&L,1,Not classified:1
89442,"Castor oil, sulfated, ammonium salt",269-124-2,68187-77-9,Eye Irrit. 2,REACH registration C&L,211,H319:40;H318:129;Not classified:42;H315:49;H335:18
89443,Indium trihydroxide,243-947-7,20661-21-6,STOT RE 1;Aquatic Chronic 3,REACH registration C&L,49,H412:1;H372:2;H319:46;H335:41;H315:46;Not classified:1
89444,Benzenesulphonic acid,202-638-7,98-11-3,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,318,H302:153;H314:262;H290:145;H318:107;H319:21;H335:24;H315:23;Not classified:1
89445,methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate,422-110-1,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
89447,MCPB (ISO);4-(4-chloro-o-tolyloxy) butyric acid,202-365-3,94-81-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
89448,"Cyclopentanol, 2-methyl-",607-314-2,24070-77-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,37,H319:37;H302:33;H332:33;H315:37;H335:4
89449,Diphenyl methylphosphonate,231-388-1,7526-26-3,Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,50,H311:49;H411:49;H301:50
89451,1-hexyl isothiocyanate,224-549-2,4404-45-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,44,H319:40;H335:40;H315:40;H311:40;H301:40;H331:40;H312:4;H302:4;H332:4;H314:4
89453,Disodium 2-naphthyl phosphate,250-763-0,31681-98-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
89454,3-Fluoro-4-hydroxybenzaldehyde,609-839-2,405-05-0,,Notified C&L,8,H319:8;H335:6;H315:8
89459,"(5R-trans)-6-(β-D-glucopyranosyloxy)-5,6-dihydro-5-vinyl-1H,3H-pyrano[3,4-c]pyran-1-one",244-070-2,20831-76-9,Acute Tox. 4,Notified C&L,41,H302:41
89462,DOWFAX(R) 2A0,417-920-7,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,55,H411:55;H319:55;H315:55
89464,Diammonium tetratungsten tridecaoxide,235-638-0,12398-61-7,Not Classified,Notified C&L,7,Not classified:7
89471,"Sulfuric acid, mixed cetyl and oleyl esters, sodium salts",286-030-7,85186-45-4,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
89474,Fenfluramine,207-276-3,458-24-2,Acute Tox. 3,Notified C&L,38,H301:38
89479,"Oils, lanolin",274-559-6,70321-63-0,Not Classified,Notified C&L,195,Not classified:195
89481,Neopentylamine,227-378-1,5813-64-9,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B,Notified C&L,44,H225:43;H302:41;H314:43;Not classified:1;H312:1;H332:2;H318:1
89483,"2,2'-(2,5-dichloro-1,4-phenylene)bis(1H-anthra[1,2-d]imidazole-6,11-dione)",255-078-0,40783-05-9,Not Classified,REACH registration C&L,6,Not classified:6
89485,"2,6-dimethoxytoluene",227-131-8,5673-07-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
89486,Sandalwood oil,616-898-8,8006-87-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,66,H319:38;H317:38;H335:38;H315:38;Not classified:27;H314:1;H318:1
89488,"[octachloro-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper",215-536-2,1330-37-6,Not Classified,Notified C&L,1,Not classified:1
89489,Gum tragacanth,232-552-5,9000-65-1,Not Classified,Notified C&L,191,Not classified:191
89491,"Hydrogen bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-) , compound with 3-[(2-ethylhexyl)oxy]propylamine (1:1)",276-858-7,72812-35-2,Not Classified,Notified C&L,2046,Not classified:2046
89492,"Poly(oxy-1,2-ethanediyl), α-(3-carboxy-1-oxosulfopropyl)-ω-hydroxy-, ethers with lanolin alcs., disodium salts",614-753-3,68890-92-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,7,H319:7;H315:7
89495,Methyl cyclopentylphenylglycolate,243-359-0,19833-96-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:2;H335:2;H315:2;H312:1;H302:1;Not classified:1
89498,"3-propanolide;1,3-propiolactone",200-340-1,57-57-8,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;Carc. 1B,Harmonised C&L,0,H330:0;H319:0;H350:0;H315:0
89501,"1,3-bis(propan-2-yl) 2-(1,3-dithiolan-2-ylidene)propanedioate",610-537-8,50512-35-1,Acute Tox. 4,Notified C&L,127,H302:127
89503,"Pine, Pinus mugo pumilio, ext.",290-164-1,90082-73-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1375,H315:1345;H410:1349;H317:1349;H226:1375;H400:1323;H304:1349
89504,"Hydrocarbons, C9-C10, n-alkanes, isoalkanes, cyclics, < 2% aromatics",920-935-6,,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H226:1;H412:1;H336:1;H304:1
89505,"Phosphoric acid, barium salt",237-582-2,13847-18-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:2;H332:2
89508,Ascorbic acid,200-066-2,50-81-7,Not Classified,Notified C&L,554,Not classified:539;H315:10;H319:3;H318:2;H314:1
89512,"Disodium N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamate",231-022-0,7413-34-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;Repr. 1B,Notified C&L,2,H319:2;H341:1;H315:2;H301:2;H360:2;H340:1;H335:1;H311:1;H331:1
89515,"2,3-epoxypropyltrimethylammonium chloride ...%;glycidyl trimethylammonium chloride ...%",221-221-0,3033-77-0,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H312:0;H412:0;H302:0;H341:0;H361:0;H317:0;H318:0;H350:0;H373:0
89521,4-methoxypiperidine,223-742-9,4045-24-3,Acute Tox. 4,Notified C&L,42,H302:40;H319:3;H312:2;H335:3;H315:3;H332:2;H314:1
89523,"Fatty acids, C14-18 and C16-18-unsatd., reaction products with diethylenetriamine, di-Et sulfate-quaternized",288-461-6,85736-51-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:1;H315:1;Not classified:1
89524,"Fatty acids, C18-unsatd., dimers, polymers with oleic acid and triethylenetetramine",614-339-2,68154-62-1,Skin Corr. 1B;Skin Sens. 1,Notified C&L,11,H314:10;H317:11;H411:1;H318:1;H315:1
89526,"2,4-dihydro-5-methyl-3H-pyrazol-3-one",203-565-3,108-26-9,Not Classified,REACH registration C&L,101,Not classified:12;H400:84;H410:84;H319:5;H335:4;H315:5
89527,3-hydroxy-4-[(2-methoxy-5-nitrophenyl)azo]-N-(3-nitrophenyl)naphthalene-2-carboxamide,229-313-2,6471-49-4,Not Classified,REACH registration C&L,108,Not classified:108
89528,"Trisodium bis[4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzene-1-sulphonato(3-)]cobaltate(3-)",279-075-9,79135-28-7,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,38,H319:2;H412:2;Not classified:36
89534,"2,2'-azobis[2-methylpropionamidine] dihydrochloride",221-070-0,2997-92-4,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0,H302:0;H317:0
89535,2-ethylhexyl isononanoate,275-637-2,71566-49-9,Not Classified,Notified C&L,497,Not classified:497
89539,[No public or meaningful name is available],478-710-9,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,11,H302:11;H413:11;H318:11
89540,"1,2-dihydro-4-(isopropylamino)-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one monohydrochloride",242-222-2,18342-39-7,Acute Tox. 4,Notified C&L,39,H302:38;Not classified:1
89541,"Bis(pentane-2,4-dionato-O,O')magnesium",237-857-7,14024-56-7,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,10,H412:5;H302:8;H319:3;H312:2;H315:3;H332:2;Not classified:1;H335:1;H317:1;H318:1
89545,"(R)-(+)-p-(1,2,2-trimethylcyclopentyl)toluene",241-061-5,16982-00-6,Acute Tox. 4,Notified C&L,69,H302:61;H304:8
89547,Tetraaluminium tricarbide,215-076-2,1299-86-1,Water-react. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:44;H261:45;H335:44;H315:44;H228:4;Not classified:1
89552,"2,4-dimethylhexane",209-649-6,589-43-5,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H410:0;H225:0;H400:0;H336:0;H304:0
89556,2-hydroxypropyl carbazate,266-373-9,66470-91-5,Acute Tox. 4,Notified C&L,25,H302:25
89558,3-(Diisobutoxy-thiophosphorylsulfanyl)-2-methyl-propionic acid,434-070-2,,Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,87,H412:4;H317:87;H318:87
89560,"1,3-dibromopropan-2-ol",202-489-8,96-21-9,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,43,H319:40;H351:40;H335:39;H315:40;H301:39;H226:43
89563,[No public or meaningful name is available],473-800-4,,Not Classified,Notified C&L,1,Not classified:1
89566,"3,5-bis(acetylamino)benzoic acid",231-804-1,7743-39-7,Acute Tox. 4,Notified C&L,39,H302:39;H319:1;H335:1;H315:1
89567,Ethyl trichloroacetate,208-212-7,515-84-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H302:41;H335:39;H315:41;H312:1;H332:1
89570,Dodecane-2-thiol,238-369-7,14402-50-7,Flam. Liq. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,46,H411:46;H319:46;H225:46
89572,Silibinin,245-302-5,22888-70-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:43;H335:43;H315:43;Not classified:5;H302:4;H312:1;H332:1
89574,"6-bromo-1H,3H-naphtho[1,8-cd]pyran-1,3-dione",201-382-3,81-86-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:41;H335:40;H315:41;Not classified:9
89577,C.I. Acid Black 71,603-242-0,127830-14-2,,Notified C&L,2,H412:1;Not classified:1
89579,"1-Ethyl-3-methoxytricyclo[2.2.1.02,6]heptane",608-690-0,31996-78-8,Aquatic Chronic 2,Notified C&L,126,H411:126
89581,"1,5-dimethylbicyclo[3.2.1]octan-8-one oxime",278-079-8,75147-23-8,Flam. Sol. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,1391,H412:1391;H228:24;H302:1391
89592,Bis(2-ethylhexyl) sebacate,204-558-8,122-62-3,Not Classified,REACH registration C&L,371,Not classified:367;H302:4
89593,"Tail gas (petroleum), saturate gas recovery plant, C1-2-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]",270-814-0,68478-33-1,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H340:0;H350:0;H220:0;Not classified:0
89596,2-chloro-2-nitropropane,209-853-5,594-71-8,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H226:38;H319:38;H302:38
89597,[No public or meaningful name is available],480-220-5,,Not Classified,Notified C&L,33,Not classified:33
89603,"Potentilla tormentilla, ext.",285-390-2,85085-66-1,Not Classified,Notified C&L,1,Not classified:1
89605,Diammonium tetrachlorocuprate,239-690-5,15610-76-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H319:39;H302:39;H335:1;H315:1
89607,4-Chloro-benzamidine; hydrochloride,604-389-3,14401-51-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,4,H319:4;H312:1;H302:1;H335:3;H315:4;H332:1
89616,Citronellol,203-375-0,106-22-9,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1647,H319:1069;H317:1642;H315:1589;H411:261;H413:21;H334:2;H410:1;H335:3;Not classified:1;H318:2
89617,Iron trifluoride,232-002-4,7783-50-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,58,H312:40;H302:40;H332:40;H314:54;H311:17;H331:13;H301:17;H330:4
89623,Aminoguanidinium nitrate,233-682-5,10308-82-4,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H272:44;H335:44;H315:44;Not classified:1
89625,"Alcohols, C11-15-secondary",268-011-5,67989-40-6,Not Classified,REACH registration C&L,283,Not classified:177;H318:83;H220:18;H319:5
89629,(-)-Gallocatechin gallate,636-979-1,4233-96-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:38;H335:39;H315:39
89631,"N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine",426-150-0,121246-28-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H317:0
89634,Chlornitrofen,217-407-6,1836-77-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
89636,Ferrocenemetaboric acid,235-272-1,12152-94-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
89637,"3-chloropentane-2,4-dione",216-902-4,1694-29-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H226:39;H319:40;H335:39;H315:40;H225:1
89638,"1-(2,5-difluorophenyl)ethan-1-one",217-837-4,1979-36-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
89639,5-chloro-2-hydroxy-4-methylbenzophenone,272-140-2,68751-90-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
89640,Ethylhydrocupreine,208-333-5,522-60-1,Acute Tox. 4,Notified C&L,38,H302:38
89642,"2,5-dichlorophenyl isocyanate",226-396-7,5392-82-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44;H311:38;H334:43;H317:38;H301:43;H331:38;H330:6;H300:1
89643,"Sulfonic acids, C13-17-sec-alkane",288-328-2,85711-67-7,Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,42,H412:37;H314:37;H302:5;H318:5;H315:5
89647,4-(trans-4-propylcyclohexyl)acetophenone,406-700-6,78531-61-0,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
89648,"3,5-di-tert-butyl-4-hydroxybenzaldehyde",216-592-0,1620-98-0,,Notified C&L,9,H319:9;H335:8;H315:9
89653,"N,N'-dibenzylethylenediammonio [2S-[2α,5α,6β(S*)]]-bis[6-[(aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate]",251-438-6,33276-75-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
89654,"Sodium p-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",228-811-7,6359-86-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
89657,Metobromuron,221-301-5,3060-89-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H302:38;H332:38;Not classified:3;H373:1;H410:1;H317:1
89659,(7-methoxynaphthalen-1-yl)acetonitrile,461-670-1,,Aquatic Chronic 2,REACH registration C&L,3,H411:3
89661,Nonyltriphenylphosphonium bromide,262-521-1,60902-45-6,,Notified C&L,4,H319:4;H335:4;H315:4
89665,"reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane",412-950-7,131812-67-4,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
89666,Uracross P 3307,420-990-1,,Not Classified,Notified C&L,1,Not classified:1
89667,"3,7-dimethyl-3,6-octadienal",259-777-1,55722-59-3,Skin Sens. 1,Notified C&L,104,H317:104;H319:13;H315:13
89668,Benzhydrylamine,202-032-2,91-00-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,51,H319:45;H302:50;H335:44;H315:45;H314:5;H311:1;H330:1;H301:1;H332:1;H318:1
89670,"Trisodium 4-amino-5-hydroxy-3-[[4-[[4-[(4-hydroxyphenyl)azo]phenyl]amino]-3-sulphonatophenyl]azo]-6-(phenylazo)naphthalene-2,7-disulphonate",288-040-7,85631-90-9,Aquatic Chronic 2,Notified C&L,1,H411:1
89672,"1-(2-chlorophenyl)-1H-pyrrole-2,5-dione",214-869-0,1203-24-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H302:39;H318:38;H335:39;H315:39;H319:1
89673,chlorosulphonic acid,232-234-6,7790-94-5,Skin Corr. 1A;STOT SE 3,Harmonised C&L,0,H314:0;H335:0
89674,"Oxirane, 2-phenyl-, polymer with oxirane, mono(3,5,5-trimethylhexyl) ether",620-266-7,303150-42-7,Aquatic Chronic 3,Notified C&L,1,H412:1
89675,Reaction mass of 3-(Trihydroxy)silylpropyl phosphonic acid ethyl/methyl ester tetra sodium salts,607-104-0,225375-65-5,Not Classified,REACH registration C&L,84,Not classified:84
89687,4-chloro-α-cyclopropylbenzyl alcohol,242-107-7,18228-43-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
89690,Cyclohex-1-enylacetic acid,242-172-1,18294-87-6,Not Classified,Notified C&L,94,Not classified:88;H319:6;H335:6;H315:6
89691,2'-methylacetoacetanilide,202-267-0,93-68-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,246,H312:243;H302:246;H332:239;H330:11
89695,2-methylbut-2-ene,208-156-3,513-35-9,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Muta. 2;Carc. 2;Aquatic Chronic 2,REACH registration C&L,340,H411:221;H351:55;H302:267;H341:176;H315:103;H225:204;H336:93;H304:110;H350:83;Not classified:69;H224:67;H332:22
89696,"Calcium 3,5,5-trimethylhexanoate",264-731-9,64216-15-5,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,16,H319:16;H302:16
89698,DL-cysteine,222-160-2,3374-22-9,Acute Tox. 4,Notified C&L,46,H302:43;Not classified:3;H312:2;H332:2;H315:4;H319:3;H335:3
89701,Diacetoxymethylvinylsilane,220-954-3,2944-70-9,Skin Corr. 1B,Notified C&L,2,H314:2;H312:1;H302:1;H318:1;H332:1
89704,"N-(4-amino-9,10-dihydro-3-methoxy-9,10-dioxo-1-anthryl)benzenesulphonamide",274-040-4,69563-51-5,Skin Sens. 1;STOT RE 2,REACH registration C&L,37,H373:2;H317:3;Not classified:34
89705,1-benzothiophene-2-carboxylic acid,613-148-1,6314-28-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45;H302:1
89707,7-chloro-4-hydroxyquinoline-3-carboxylic acid,201-673-5,86-47-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
89708,"Distillates (petroleum), heavy straight-run",272-817-2,68915-96-8,Asp. Tox. 1;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,233,H332:165;H373:165;H411:165;H304:149;H226:74;Not classified:123
89709,UU,441-210-6,,Not Classified,Notified C&L,2,Not classified:2
89710,"Fatty acids, coco, esters with polyethylene glycol ether with glycerol (3:1)",614-593-4,68553-02-6,Not Classified,Notified C&L,2,Not classified:2
89712,"Urea, reaction products with formaldehyde and glyoxal, methylated",276-341-6,72102-47-7,Not Classified,Notified C&L,1,Not classified:1
89713,"L-Glutamic acid, N-coco acyl derivs., monosodium salts",269-087-2,68187-32-6,Not Classified,REACH registration C&L,90,Not classified:46;H319:44
89717,Undec-2-enonitrile,245-141-0,22629-48-7,Not Classified,Notified C&L,1374,Not classified:1374
89721,Trimethyl[2-(1-oxobutoxy)ethyl]ammonium perchlorate,243-700-3,20292-68-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
89722,"1-Bromo-2,3-difluorobenzene",609-564-8,38573-88-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:44;H315:45;H226:1
89725,Methyl α-styryl ether,225-265-1,4747-15-3,Skin Sens. 1,Notified C&L,38,H317:38
89726,Methyl dichloroacetate,204-146-8,116-54-1,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,59,H319:59;H332:55;H335:58;H315:59;H226:3;H341:1;H311:1;H301:1;H331:1;H320:1
89727,"3-Quinolinecarboxylic acid, 6,7,8-trifluoro-1-(formylmethylamino)-1,4-dihydro-4-oxo, ethyl ester",600-051-4,100276-65-1,Not Classified,REACH registration C&L,4,Not classified:4
89729,"Fatty acids, fish-oil, mixed with fish oil, oxidized, sulfited, sodium salts",307-948-7,97808-30-5,Not Classified,Notified C&L,2,Not classified:2
89731,"Dodecanedioic acid, compound with 2,2',2''-nitrilotriethanol (1:2)",285-132-9,85030-08-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,568,H319:2;H315:2;Not classified:566
89732,"4'-trans-Butyl-[1,1'-bicyclohexyl]-4-on",618-848-0,92413-47-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H410:1
89735,"3,7-bis(diethylamino)phenoxazin-5-ium trichlorozincate",251-437-0,33273-26-6,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4,H400:2;H410:2;H318:2;H301:2;Not classified:2
89736,"Zinc 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate (1:2)",269-988-0,68399-76-8,Not Classified,Notified C&L,1,Not classified:1
89739,"Amides, tall-oil fatty, N-[2-[(2-hydroxyethyl)amino]ethyl]",271-659-1,68603-50-9,Eye Irrit. 2,Notified C&L,443,H319:442;H400:1;H410:2;H302:1;H314:1;H317:1;H315:1
89741,"4-phenylpiperidine-4-carboxylic acid, compound with toluene-p-sulphonic acid",281-391-7,83949-32-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H302:3;H335:2;H315:2
89744,1-chloro-2-(dichloromethyl)benzene,201-849-1,88-66-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H319:46;H302:46;H335:46;H315:46;H351:6;H290:33
89746,Octyl decanoate,218-983-1,2306-92-5,Not Classified,Notified C&L,22,Not classified:22
89748,Fluorometholone,207-041-5,426-13-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H312:39;H302:39;H332:39;H373:4;H361:5;H372:1;H318:1
89753,"6,7-dimethoxy-2-benzopyrone",204-369-0,120-08-1,Acute Tox. 3;Eye Irrit. 2,Notified C&L,40,H319:39;H301:40
89755,Propamidine isetionate,205-423-6,140-63-6,Not Classified,Notified C&L,1,Not classified:1
89756,o-(1-methylheptyl)phenol,242-459-1,18626-98-7,Acute Tox. 4;Skin Corr. 1C;Aquatic Chronic 1,REACH registration C&L,59,H410:59;H302:59;H314:59;H318:3
89758,Sulpiride,239-753-7,15676-16-1,Not Classified,REACH registration C&L,7,Not classified:4;H361:2;H312:1;H302:1;H332:1
89760,Ethyl iodoacetate,210-796-3,623-48-3,Acute Tox. 2;Skin Corr. 1B,Notified C&L,43,H300:42;H314:42;H319:1;H335:1;H315:1;H311:1;H301:1;H331:1
89761,DL-tyrosine,209-113-1,556-03-6,,Notified C&L,48,Not classified:41;H319:7;H335:6;H315:7
89762,"Spruce, Picea abies, ext.",294-855-9,91770-69-3,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1409,H319:1409;H315:1409;H410:1409;H317:1409;H400:1409;H304:1409;H226:121
89763,"Sage, Salvia triloba, ext.",285-391-8,85085-68-3,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,2,H412:1;H317:2;H411:1;H319:1;H302:1;H315:1;H371:1;H226:1;H304:1
89765,"Acetone, oligomeric reaction products with diphenylamine",500-009-4,9003-79-6,Not Classified,Notified C&L,3,Not classified:3
89770,diboron trioxide;boric oxide,215-125-8,1303-86-2,Repr. 1B,Harmonised C&L,0,H360:0
89772,"Dibutylborinic acid, ethanolamine ester",606-290-0,19324-14-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
89775,Lanthanum triiodide,237-465-6,13813-22-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
89781,Samarium(3+) acetate,233-950-1,10465-27-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
89782,"trans-2-methylpenta-1,3-diene",213-136-2,926-54-5,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40;H225:40;H304:39;H411:1;H317:1
89784,"Strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1)",269-710-8,68310-42-9,Acute Tox. 2;Acute Tox. 2;Aquatic Chronic 3,Harmonised C&L,0,H300:0;H412:0;H330:0
89785,"Octahydro-3,8,8-trimethyl-6-methylene-1H-3a,7-methanoazulen-5-ol",248-917-7,28231-03-0,Aquatic Chronic 2,Notified C&L,1552,H411:1286;Not classified:266
89788,Sodium [2-[[[5-[(2-chloro-5-sulphophenyl)azo]-2-hydroxyphenyl]methylene]amino]benzoato(3-)]hydroxychromate(1-),285-669-9,85118-16-7,Not Classified,Notified C&L,2,Not classified:2
89790,"Silane, trimethoxy[3-(oxiranylmethoxy)propyl]-, reaction products with quartz",309-527-3,100402-89-9,STOT RE 1,Notified C&L,1,H372:1
89793,2-isopropyl-6-methyl-1H-pyrimidin-4-one,220-561-7,2814-20-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
89794,"Glutamic anhydride, N-benzoyl- (7CI)",618-770-7,91569-94-7,Not Classified,Notified C&L,1,Not classified:1
89795,"5-(Acetyl-(3-(acetyl-(3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodophenyl)amino)-2- hydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide; 5,5'-((2-Hydroxytrimethylene)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodoisophthalamide);",618-837-0,92339-11-2,Not Classified,Notified C&L,1,Not classified:1
89797,"N,N-dimethylbutane-1,4-diamine",222-559-1,3529-10-0,,Notified C&L,5,H314:5
89798,"(salicylato-O1,O2)silver",242-760-8,19025-97-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H312:38;H302:38;H335:38;H315:38
89805,1-bromodecane,203-955-3,112-29-8,Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,52,H319:7;H315:7;H400:44;H410:6;H332:2;H317:1;H335:1
89806,"Hydrocarbons, C7-C9, n-alkanes, isoalkanes, cyclics",920-750-0,,Flam. Liq. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,23,H411:22;H336:23;H225:23;H304:23;H315:2;H410:1
89807,sodium fluoride,231-667-8,7681-49-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0,H319:0;H315:0;H301:0
89810,"2,2,2-trichloro-1-ethoxyethanol",208-211-1,515-83-3,Acute Tox. 4,Notified C&L,42,H302:42
89811,2-(4-hydroxyphenyl)propionic acid,213-352-7,938-96-5,Acute Tox. 3;Eye Irrit. 2,Notified C&L,44,H319:44;H301:38;H335:5;H315:6
89812,"Reaction mass of trans-Cyclohexadecen-8-one, cis-Cyclohexadecen-8-one, trans-Cyclohexadecen-7-one, cis-Cyclohexadecen-7-one",448-300-4,,Skin Irrit. 2;Aquatic Acute 1,REACH registration C&L,2,H400:2;H315:2
89814,"Tetrakis(2-ethylhexane-1,3-diolato)titanium",226-949-2,5575-43-9,Not Classified,REACH registration C&L,116,Not classified:64;H318:1;H315:5;H319:51;H226:6
89816,(2-acetoxyethyl)trimethylammonium iodide,218-862-3,2260-50-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H302:39;H335:47;H315:48
89818,Allyl trifluoroacetate,206-853-7,383-67-5,Flam. Liq. 2;Skin Corr. 1B;STOT SE 3,Notified C&L,45,H225:45;H335:40;H314:45;H318:1;H319:1
89820,Sodium 4-[[4-(anilino)phenyl]azo]benzenesulphonate,209-071-4,554-73-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:39;H335:39;H315:39;Not classified:1;H312:1;H302:1;H332:1
89824,2-methoxyethanethiol,234-021-3,10494-75-4,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H332:2;H301:2;H226:2
89828,Sodium (Z)-N-[2-[(2-hydroxyethyl)(1-oxo-9-octadecenyl)amino]ethyl]glycinate,301-904-0,94087-11-3,Not Classified,Notified C&L,2,Not classified:2
89835,5-chlorosalicylaldehyde,211-244-4,635-93-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,49,H319:48;H400:42;H335:47;H315:48;Not classified:1
89837,"Hexacarbonylbis(η5-cyclopenta-2,4-dien-1-yl)dimolybdenum",235-156-0,12091-64-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H312:38;H302:38;H332:38;H330:4;H301:4
89839,"sodium (1.0-1.95)/lithium (0.05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate",413-470-0,134595-59-8,Skin Sens. 1,Harmonised C&L,0,H317:0
89841,"Phosphoric acid, isooctyl ester, compd. with 2,2'-iminobis[ethanol]",272-389-7,68815-68-9,Skin Corr. 1B,Notified C&L,2,H314:2
89842,Mill scale (ferrous metal),266-007-8,65996-74-9,Not Classified,REACH registration C&L,79,Not classified:79
89844,Amidinomalonamide hydrochloride,252-095-5,34570-17-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,44,H319:44;H335:44;H315:44
89845,4-[(4-chloro-2-nitrophenyl)azo]-3-hydroxy-N-(2-methylphenyl)naphthalene-2-carboxamide,229-314-8,6471-50-7,Not Classified,Notified C&L,34,Not classified:34
89846,"2,3-Epoxypropyl neodecanoate, oligomeric reaction products with cyclohexane-1,2-dicarboxylic anhydride and propylidenetrimethanol",500-334-1,154565-28-3,Aquatic Chronic 4,REACH registration C&L,20,H413:2;Not classified:18
89851,p-anisic acid,202-818-5,100-09-4,Not Classified,REACH registration C&L,221,Not classified:73;H319:148;H302:143;H315:156;H335:80;H311:8;H332:8;H400:8;H331:8
89852,"(7Z,9E)-dodecadienyl acetate",259-812-0,55774-32-8,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,210,H411:172;H315:210;H319:38;H335:38
89855,Nitrogen,231-783-9,7727-37-9,Press. Gas (Comp.),Notified C&L,1043,H280:745;H281:260;Not classified:47;H319:1;H340:1;H335:1;H315:1;H350:1;H332:1
89860,"1,2,3,4,5-pentamethylcyclopentadiene",223-743-4,4045-44-7,Flam. Liq. 3,Notified C&L,52,H226:51;H319:1;H312:1;H302:1;H335:1;H315:1;H332:1;H413:1
89863,"L-Phenylalanine, 4-bromo-, ethyl ester",607-430-3,247566-38-7,Not Classified,Notified C&L,11,Not classified:11
89867,"2,5-dichlorobenzoic acid",200-065-7,50-79-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:47;H335:46;H315:47;Not classified:3;H312:1;H302:1;H332:1
89870,"3-Amino-2,6-dibromopyridine",609-749-3,39856-57-0,Acute Tox. 3;Eye Dam. 1,Notified C&L,40,H318:38;H301:38;H319:2;H315:2;H302:1;H335:1;H332:1
89871,C.I. Direct Red 239,611-951-1,60202-35-9,Not Classified,Notified C&L,1,Not classified:1
89872,(E)-2-decenal,223-474-2,3913-81-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1476,H319:1475;H315:1438;H400:39;H317:38
89873,"2,5-di-tert-pentylhydroquinone",201-222-2,79-74-3,Acute Tox. 4;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,49,H302:49;H401:1;H317:1;H400:48;H410:48;H319:1;H315:1
89877,"1-Tetradecene, polymer with 1-dodecene, hydrogenated, distn. residues, C24-42 fraction",618-144-3,883233-94-1,Asp. Tox. 1;Acute Tox. 4,Notified C&L,1,H332:1;H304:1
89879,"Thiocyanic acid, compound with piperidine (1:1)",244-843-4,22205-64-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,38,H312:38;H412:38;H302:38;H332:38
89883,"1,5-diamino-4,8-dihydroxy(4-hydroxyphenyl)anthraquinone",250-684-1,31529-83-6,Not Classified,Notified C&L,57,Not classified:57
89888,2-bromobenzaldehyde,229-622-2,6630-33-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,100,H319:100;H335:95;H315:100;H302:6;Not classified:2;H312:2;H332:2
89890,"4-trans-Propyl-[1,1-bicyclohexyl]-4-trans-carbonic acid-(4-trans-pentylcyclohexyl)-ester",600-340-5,102714-92-1,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
89891,pyrithione zinc; (,236-671-3,13463-41-7,Acute Tox. 3;Eye Dam. 1;Acute Tox. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H330:0;H410:0;H360:0;H372:0;H318:0;H301:0;H400:0
89893,"Oils, linaloe",616-897-2,8006-86-8,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1;H315:1
89896,"3,3'-[carbonylbis[imino(3-methoxy-p-phenylene)azo]]bis(benzenesulphonic) acid",247-203-2,25712-08-7,Not Classified,Notified C&L,3,Not classified:3
89897,trans-1-methyl-4-(1-methylvinyl)cyclohex-2-en-1-ol,230-595-4,7212-40-0,Not Classified,Notified C&L,88,Not classified:88
89899,Europium tribromide,237-349-5,13759-88-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
89901,"2,6-dimethylnaphthalene",209-464-0,581-42-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H400:42;H410:39;Not classified:3
89903,Lead disalicylate,239-839-4,15748-73-9,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H302:40;H410:40;H400:39;H332:40;H360:40;H373:40;Not classified:1;H361:1;H228:1
89907,Chlorzoxazone,202-403-9,95-25-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,208,H319:207;H302:208;H335:206;H315:207;H336:1
89909,Gadolinium trinitrate,233-437-2,10168-81-7,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H400:1;H410:1;H318:2;H319:3;H272:3;H335:3;H315:3;Not classified:1
89919,3-Fluoro-4-hydroxybenzonitrile,609-838-7,405-04-9,,Notified C&L,7,H319:7;H312:5;H302:5;H335:6;H315:7;H332:5;H311:2;H301:2;H331:2
89920,"Dodecyl dihydrogen phosphate, compound with morpholine (1:1)",264-808-7,64346-58-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
89922,"2,4-dibromoaniline",210-434-4,615-57-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H315:43;H335:42;H301:39;H302:5;H311:4;H332:5;H312:1
89923,"3-(3,5-di-tert-butyl-4-hydroxybenzyl)benzothiazole-2-thione",404-890-5,,Not Classified,Notified C&L,1,Not classified:1
89929,"N-(4-(3-chloro-5-trifluoromethyl-2-pyridinyl-oxy)- 3,5-dichloro-phenyl-aminocarbonyl)-2,6-difluorobenzamide",615-292-0,71422-67-8,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,130,H319:89;H400:89;Not classified:41
89930,Prop-2-ene-1-thiol,212-792-7,870-23-5,Flam. Liq. 2;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1446,H332:1313;H319:1325;H225:1446;H302:1379;H331:4;H335:4;H312:2
89933,"1-(3,5-dichloro-4-hydroxyphenyl)ethan-1-one",241-113-7,17044-70-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
89939,"1-Naphthalenemethanamine, a-methyl-",610-076-2,42882-31-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;STOT SE 3,REACH registration C&L,126,H312:2;H302:2;H335:41;H315:42;H317:2;H318:85;H411:83;H314:84;H301:84;H319:40;H311:1;H331:1
89949,"Benzene, 1,3-diisocyanatomethyl-, trimer",620-208-0,9019-85-6,Skin Sens. 1;Eye Irrit. 2,Notified C&L,25,H319:25;H317:25
89954,Hex-5-yn-3-ol,243-304-0,19780-84-8,Acute Tox. 4,Notified C&L,112,H302:108;H226:57;H318:53
89956,Diisooctyl dodecanedioate,286-937-8,85392-86-5,Not Classified,Notified C&L,17,Not classified:17
89957,"N,N'-diphenyl-p-phenylenediamine;N,N'-diphenyl-1,4-benzenediamine",200-806-4,74-31-7,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
89959,1-methylisoquinoline,217-017-6,1721-93-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
89962,"4-chloro-3,5-dinitrotoluene",226-080-9,5264-65-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
89963,"tris(η5-2,4-cyclopentadien-1-yl)cerium",215-073-6,1298-53-9,Flam. Sol. 2;Water-react. 1,Notified C&L,38,H260:38;H228:38
89966,Cyclohexylisopropylamine,214-798-5,1195-42-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H226:43;H319:42;H335:42;H315:42;H314:1;H318:1
89967,"Tallow, calcium salt",269-678-5,68309-87-5,Not Classified,Notified C&L,10,Not classified:10
89969,"Tetrakis(2,4-di-tert-butylphenyl) [1,1-biphenyl]-4,4'-diylbisphosphonite",254-037-4,38613-77-3,Not Classified,Notified C&L,128,Not classified:95;H400:33;H410:33;H332:33
89975,Fentanyl dihydrogen citrate,213-588-0,990-73-8,Acute Tox. 2;Acute Tox. 2;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1,Notified C&L,66,H330:62;H334:58;H317:58;H300:66;H310:60;H336:4;H362:5;H412:4;Not classified:1;H319:1;H361:2;H335:1;H315:1;H370:1
89976,Gemcitabine,619-100-6,95058-81-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Muta. 1B;Carc. 2;Repr. 1B;STOT RE 1;Aquatic Chronic 2,Notified C&L,4,H411:1;H319:3;H312:2;H340:2;H302:1;H351:1;H315:3;H372:1;H360:2;H361:2
89980,"Savory, Satureja montana, ext.",290-280-2,90106-57-3,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1,Notified C&L,260,H302:223;H314:219;H317:223;H318:190;H226:220;H304:223;Not classified:37;H411:36;H315:4;H319:2;H335:1
89983,Barium sulfate,231-784-4,7727-43-7,Not Classified,REACH registration C&L,1785,Not classified:1626;H302:108;H332:108;H319:31;H373:41;H335:4;H315:1;H371:1;H411:1
89984,(5or8)-aminonaphthalene-2-sulphonic acid,257-269-4,51548-48-2,Not Classified,REACH registration C&L,44,Not classified:40;H412:2;H319:1;H315:1;H314:1
89985,Barium bromide,234-140-0,10553-31-8,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,110,H302:110;H332:110
89991,Tetramethylammonium hexafluorophosphate,209-194-3,558-32-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H319:40;H312:38;H302:38;H335:39;H315:40;H332:39;H314:4;H301:5
89993,4-(isopropyl)-1-methylcyclohex-3-en-1-ol,209-585-9,586-82-3,Not Classified,Notified C&L,88,Not classified:78;H319:10;H315:10
89996,Clanobutin,250-232-3,30544-61-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,17,H319:17;H335:17;H315:17
89997,"Disodium 3,3'-[carbonylbis[imino(3-methoxy-4,1-phenylene)azo]]bis[benzenesulphonate]",233-316-4,10114-86-0,Aquatic Chronic 3,REACH registration C&L,2121,H412:7;Not classified:2113;H319:1
90000,"salts of 4,4'-bi-o-toluidine;salts of 3,3'-dimethylbenzidine;salts of o-tolidine",210-322-5,612-82-8,Acute Tox. 4;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H350:0;H411:0;H302:0
90001,"Glycerides, C16-18 and C18-unsatd. di-",309-700-3,100684-28-4,Not Classified,Notified C&L,6,Not classified:6
90002,"Poly(oxy(methyl-1,2-ethanediyl)), .alpha.-(2-methyl-1-oxo-2- propenyl)-.omega.-hydroxy- (4-PO)",609-674-6,39420-45-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,612,H319:481;H315:481;Not classified:78;H412:53;H335:39;H317:1
90005,"Hydrocarbons, C6-20, polymers, hydrogenated",614-968-2,69430-35-9,Not Classified,Notified C&L,187,Not classified:172;H319:15
90009,"D-Glucitol, 1-deoxy-1-[methyl(1-oxononyl)amino]-",617-694-1,85261-19-4,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,1,H318:1;H315:1
90010,"Dichlorobis[1,1'-thiobis[ethane]]platinum",239-454-1,15442-57-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
90012,(trichloromethyl)oxirane,221-384-8,3083-23-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,1,H312:1;H319:1;H351:1;H302:1;H335:1;H315:1;H332:1;H226:1;H373:1
90015,"[2-hydroxy-3-[[(2-hydroxyphenyl)methylene]amino]-5-nitrobenzene-1-sulphonato(3-)-N3,O2,O3]chromium",263-341-6,61931-84-8,Not Classified,Notified C&L,5,Not classified:5
90019,Duasyn Black NB-SF,479-630-7,,Expl. 1.1,Notified C&L,2037,H201:2037
90022,Butyl metaborate,600-197-9,101-36-0,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38
90023,"6-[methyl(phenylsulphonyl)amino]hexanoic acid, compound with 2-aminoethanol (1:1)",278-071-4,75113-57-4,,Notified C&L,1,H319:1;H315:1
90024,3-bromopropyne,203-447-1,106-96-7,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;STOT SE 3,REACH registration C&L,50,H314:8;H335:44;H318:2;H225:46;H301:49;H319:42;H315:42;H224:4;H330:1;H361:2;H300:1;H373:2;H336:2;H304:2
90028,"4-methoxy-3,5-dimethylpyridine-2-methanol",289-258-5,86604-78-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,63,H319:59;H335:58;H315:59;H302:4
90029,"2-Butanone, peroxide",215-661-2,1338-23-4,Org. Perox. D;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,268,H242:203;H302:210;H318:158;H314:207;Not classified:58;H241:4;H330:1;H203:1;H332:1
90034,3-(tris(hydroxymethyl)methylamino)propane-1-sulphonic acid,249-954-1,29915-38-6,Not Classified,Notified C&L,123,Not classified:120;H319:2;H335:2;H315:2;H312:1;H302:1
90035,"Phosphoric acid, aluminium iron salt",242-767-6,19034-12-9,Not Classified,Notified C&L,1,Not classified:1
90036,2-fluoro-5-trifluoromethylpyridine,400-290-2,69045-82-5,Flam. Liq. 3;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H226:0;H412:0;H317:0
90037,Lead cyanamidate,244-073-9,20837-86-9,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,33,H302:30;H410:33;H332:33;H360:33;H373:33;H319:3;H317:3;H400:26
90041,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-thiazolyl]-1-oxo-2-penten-1-yl]amino]-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R,7R)-",600-697-7,105889-80-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,2,H334:2;H317:2
90043,4-fluorotoluidine,207-208-2,452-71-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,48,H319:48;H312:43;H302:47;H335:43;H315:48;H332:47;H311:5;H373:5;H330:1;H301:1
90044,Tri-O-acetyl-5-deoxy-D-ribofuranose,253-335-1,37076-71-4,Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H371:1
90049,"spiroxamine (ISO);8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine",601-505-4,118134-30-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H312:0;H302:0;H361:0;H315:0;H410:0;H317:0;H400:0;H332:0;H373:0
90052,Samarium triiodide,237-468-2,13813-25-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
90055,"Phenol, 2,4,6-tris[(dimethylamino)methyl]-, reaction products with 5-amino-1,3,3-trimethylcyclohexanemethanamine and bisphenol A-epichlorohydrin polymer",600-830-9,1075253-94-9,Not Classified,Notified C&L,19,Not classified:19
90057,"Cyclohexanol, oxidized, non-acidic by-products, distn. residues",308-541-7,98072-84-5,Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H302:1;H332:1;H335:1;H315:1
90058,"Tetrasodium 2-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-5-sulphonato-1-naphthyl]azo]-7-sulphonato-1-naphthyl]azo]benzene-1,4-disulphonate",274-352-0,70161-16-9,Aquatic Acute 3,REACH registration C&L,60,H412:2;H402:2;Not classified:49;H317:9
90059,2-isopropylaminoethanol,203-681-4,109-56-8,Not Classified,Notified C&L,137,Not classified:89;H312:47;H302:48;H335:46;H315:48;H318:47;H319:1
90062,"9H-fluorene-2,7-diamine dihydrochloride",236-924-8,13548-69-1,,Notified C&L,5,H351:4;H302:5;H341:4;H319:1;H315:1
90065,Oxaprozin,244-296-1,21256-18-8,Aquatic Chronic 2,Notified C&L,3,H411:1;H412:1;H319:1;H302:1;H315:1
90068,3-(p-methoxyphenyl)propionic acid,217-678-0,1929-29-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3
90071,"Sulfuric acid, mono-C10-16-alkyl esters, magnesium salts",268-365-0,68081-97-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,443,H319:441;H302:442;H315:443;H318:2
90074,8'-apo-β-caroten-8'-al,214-171-6,1107-26-2,Not Classified,Notified C&L,115,Not classified:110;H317:5;H413:5
90075,"trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole",265-829-4,65576-45-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3;H302:1
90076,Ethyl N-acetyl-N-butyl-β-alaninate,257-835-0,52304-36-6,Eye Irrit. 2,Notified C&L,159,H319:153;Not classified:6;H302:1;H317:1;H315:1
90079,2-chloro-4-isocyanatoanisole,249-005-1,28395-76-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H312:38;H302:38;H335:38;H315:38;H332:38
90081,"(2S-cis)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one",255-799-0,42399-49-5,Not Classified,REACH registration C&L,52,Not classified:9;H319:42;H335:41;H315:42;H302:1;H411:1
90082,Natural gas condensates (petroleum);Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C,265-047-3,64741-47-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
90090,Tetramethyllead,200-897-0,75-74-1,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 1;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H302:38;H330:42;H410:42;H300:42;H400:42;H332:38;H310:42;H360:42;H226:38;H373:42
90091,"2,4,5-Trifluorobenzaldehyde",605-382-8,165047-24-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H226:46;H319:46;H335:45;H315:46;H302:1
90092,"1-(2,3-dimethyl –bicyclo[2.2.1]heptan)-ethanone",472-300-3,854737-10-3,Aquatic Chronic 4,Notified C&L,1,H413:1
90095,Diphenyl carbonate,203-005-8,102-09-0,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,221,H411:57;H302:209;H400:84;H410:84;Not classified:12;H317:2;H319:1;H335:1;H315:1;H371:1
90098,"2-bromo-1,1-difluoroethylene",206-624-1,359-08-0,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,4,H280:4;H220:4
90100,"3-(N,N-dimethylcarbamoylimido)-1,1-dimethylurea",233-951-7,10465-78-8,Not Classified,REACH registration C&L,4,Not classified:2;H319:2;H335:2;H315:2
90103,atropine,200-104-8,51-55-8,Acute Tox. 2;Acute Tox. 2,Harmonised C&L,0,H300:0;H330:0
90110,m-propylphenol,210-675-5,621-27-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;STOT SE 3,Notified C&L,67,H312:38;H302:63;H335:38;H314:42;H332:25;H317:25;H318:25
90112,"2-aminopropane-1,3-diol",208-584-0,534-03-2,Eye Dam. 1,REACH registration C&L,121,H318:64;H314:59
90113,"2-methyl-4-[[4-[[4-[(3-tolyl)amino]phenyl][4-[(3-tolylimino]-2,5-cyclohexadien-1-ylidene]methyl]phenyl]amino]benzenesulphonic acid",229-139-7,6417-46-5,Not Classified,Notified C&L,70,Not classified:70
90118,5α-androstan-3β-ol,214-952-1,1224-92-6,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38
90122,"Spearmint, Mentha spicata crispata, ext.",294-854-3,91770-68-2,Asp. Tox. 1,Notified C&L,118,H304:118;H411:4;H317:4;H315:4
90123,"Poly(oxy-1,2-ethanediyl), α-(carboxymethyl)-ω-[(9Z)-9-octadecen-1-yloxy]-",611-563-2,57635-48-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,659,H318:540;H315:655;H319:119;Not classified:31
90125,Disodium α-glycerophosphate,216-304-3,1555-56-2,Not Classified,Notified C&L,46,Not classified:46
90126,Silicon disulphide,237-344-8,13759-10-9,,Notified C&L,4,H319:4;H335:4;H315:4;H261:4;H301:4
90130,"2-Oxepanone, polymer with 1,4-butanediol",608-670-1,31831-53-5,Not Classified,REACH registration C&L,5,Not classified:5
90132,"Tall oil, reaction products with triethylenetetramine",293-755-2,91082-42-7,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H314:1;H317:1
90133,"3,4-Difluorobenzaldehyde",608-940-9,34036-07-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:45;H315:45;H302:5
90138,"2,4,4,6-tetrabromocyclohexa-2,5-dienone",243-638-7,20244-61-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
90139,p-nitrophenyl myristate,238-653-0,14617-85-7,Skin Irrit. 2,Notified C&L,38,H315:38
90143,"Sodium 2,5-dichloro-4-[[5-cyano-2,6-bis[(2-hydroxyethyl)amino]-4-methyl-3-pyridyl]azo]benzenesulphonate",277-359-7,73287-63-5,Not Classified,Notified C&L,83,Not classified:83
90145,3-phenylpyridine,213-762-6,1008-88-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,200,H319:200;H335:199;H315:200
90146,"monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex",603-171-5,126851-40-9,Aquatic Chronic 3,Notified C&L,39,H412:35;Not classified:4
90150,1-(4-iodophenyl)ethan-1-one,236-372-8,13329-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
90151,"Cyclopenta-2,4-dien-1-ylsodium",225-636-8,4984-82-1,Water-react. 1;Skin Corr. 1B,Notified C&L,69,H260:39;H314:68;H261:4;H224:4;H319:1;H351:1;H225:1;H335:1
90154,"Cheese, Parmesan, ext.",307-827-9,97765-72-5,Not Classified,Notified C&L,10,Not classified:10
90156,"Bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate",226-826-3,5493-45-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,109,H319:87;H317:109;H335:61;H315:87;H412:42;H411:1
90157,"Fatty acids, C18-unsatd., dimers, oligomeric reaction product with C18 unsatd. and triethanolamine",928-752-3,,Not Classified,REACH registration C&L,2,Not classified:2
90159,6-aminohexan-1-ol,223-748-1,4048-33-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:47;H315:48
90163,"3-methoxyestra-2,5(10)-dien-17-one",241-893-9,17976-32-8,Repr. 2;Lact.;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,7,H410:1;H400:1;H362:1;H361:1;Not classified:6
90164,"Fatty acids, C14-18 and C18-unsatd., branched and linear, esters with neopentyl glycol",284-957-1,85005-25-0,Not Classified,REACH registration C&L,29,Not classified:29
90166,"Oxidase, monoamine",232-623-0,9001-66-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,2,H334:2;H317:1
90168,"3,4,5-trimethoxybenzoic acid",204-248-2,118-41-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,100,H319:59;H335:58;H315:59;Not classified:40;H302:3
90178,Propan-2-[2H]ol,223-616-3,3979-51-9,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H336:39;H225:39;Not classified:1
90183,Pentachloropyridine,218-535-5,2176-62-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,98,H319:98;H302:98;H335:97;H315:98;H410:59;H317:93;H400:97;H334:38;H312:1;H332:1
90185,"1,8-dibromooctane",224-912-5,4549-32-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:38;H315:39;H302:1
90195,Morpholino(phenyl)acetonitrile,239-242-9,15190-10-0,Acute Tox. 4,Notified C&L,38,H302:38
90196,Bromazepam,217-322-4,1812-30-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:42;H302:48;H335:42;H315:42;H336:1;H362:1;H361:1
90198,(2-ethylhexyl) hydrogen phthalate,224-477-1,4376-20-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H319:38;H315:38;H302:1
90201,Epoxy Resin T1800,930-447-5,,Acute Tox. 4,Notified C&L,1,H302:1
90203,"Glycerides, lanolin mono-",296-471-7,92704-39-7,Not Classified,Notified C&L,1,Not classified:1
90209,"methyl 3-chloro-2,2-dimethylpropanoate",606-782-5,21491-96-3,Flam. Liq. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H317:1;H227:1
90211,3-(CHLOROMETHYL)BENZONITRILE,613-587-9,64407-07-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:38;H302:38;H315:38;H314:2;H318:1;H290:1;H301:2
90212,2-thiouracil,205-508-8,141-90-2,Carc. 2,Notified C&L,51,H351:47;Not classified:4
90214,"Sodium 3-(trimethylsilyl)[2,2,3,3-2H4]propionate",246-286-2,24493-21-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
90218,5-chloro-1-phenyl-1H-tetrazole,238-065-4,14210-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H228:1
90220,Tris(2-hydroxypropyl)ammonium p-isododecylbenzenesulphonate,300-142-6,93922-06-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,18,H318:18;H315:18
90221,METOSULAM TECHNICAL,410-240-1,,Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H410:89;H373:89;H400:89;H351:89
90222,Triphenylborane,213-504-2,960-71-4,Flam. Sol. 1,Notified C&L,44,H228:44;H318:4;H319:2;H335:1;H315:2
90227,(ethoxycarbonylmethyl)triphenylphosphonium bromide,216-230-1,1530-45-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
90228,Phenothiazine,202-196-5,92-84-2,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3448,H302:3186;H373:3163;H317:3351;H400:322;H410:323;H412:2956;H319:209;H315:183;H335:80;Not classified:26;H411:24;H312:17;H351:17;H332:17;H413:2;H370:1
90230,"1-Butanol, C4-6-dicarboxylates",290-854-2,90268-52-3,Flam. Liq. 3;Aquatic Chronic 2,Notified C&L,83,H226:83;H411:83
90247,"Benzo-1,3-dioxole-5-propionic acid",220-565-9,2815-95-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H302:38;H335:43;H315:43
90251,2-acetamidoethyl acetate,240-317-3,16180-96-4,Eye Irrit. 2,Notified C&L,38,H319:38
90254,Liothyronine sodium,200-223-5,55-06-1,,Notified C&L,4,H302:2;H373:1;H319:1;H312:1;H332:1;Not classified:1
90257,"1,2-oxazol-3-amine",605-748-7,1750-42-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
90259,4-methylcyclohexylamine hydrochloride,608-873-5,33483-65-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
90264,"Amines, C8-10-alkyl",287-631-7,85566-21-8,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1,Notified C&L,22,H400:22;H302:22;H318:22;H314:22
90268,"Diphosphoric acid, copper salt",233-279-4,10102-90-6,Eye Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,10,H411:7;H319:7;H400:7;H332:5;H410:7;H335:1;H315:2;H302:1;H317:1
90273,Auranofin,251-801-9,34031-32-8,Acute Tox. 3;Repr. 2,Notified C&L,44,H361:43;H301:44;H360:1;H318:1;H317:1
90275,tin(II) methanesulphonate,401-640-7,53408-94-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0;H317:0;H314:0
90276,Everzol Red CDN Crude,483-940-8,,Skin Sens. 1,Notified C&L,1,H317:1
90279,Cycloheptatrienylium hexafluorophosphate(1-),249-761-2,29663-54-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,39,H312:38;H302:38;H314:39;H318:39;H332:38
90280,Hydrazinium acetate,230-845-2,7335-65-1,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H311:41;H410:40;H317:41;H350:41;H301:41;H400:40;H331:40;H412:1
90281,"1-octadecyl hydrogen 2-sulphosuccinate, compound with 2,2',2''-nitrilotri[ethanol] (1:2)",303-770-9,94213-65-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
90282,"2,6-xylidine;2,6-dimethylaniline",201-758-7,87-62-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H312:0;H351:0;H302:0;H335:0;H315:0;H332:0
90284,"2,2'-[(phenylmethyl)imino]bisethanol",202-934-6,101-32-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,40,H302:38;H318:38;H319:2;H315:2
90287,demeton-S-methyl (ISO);S-2-ethylthioethyl dimethyl phosphorothioate,213-052-6,919-86-8,Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H311:0;H411:0;H301:0
90289,"1,3,5-trithiane",206-029-7,291-21-4,Eye Irrit. 2,Notified C&L,41,H319:39;H312:1;H302:1;H332:1;H301:1
90299,Chloric acid,232-233-0,7790-93-4,Ox. Liq. 1;Skin Corr. 1B,Notified C&L,38,H271:38;H314:38
90302,2-[2-(2-hydroxyethoxy)ethoxy]ethyl oleate,233-561-7,10233-14-4,Not Classified,Notified C&L,1,Not classified:1
90305,"1,1,3,3-tetrachloroacetone",211-172-3,632-21-3,Acute Tox. 3;Acute Tox. 2,Notified C&L,39,H310:39;H301:39
90307,"Ethanesulfonic acid, 2-(methylamino)-, N-coco acyl derivs., sodium salts",263-174-9,61791-42-2,Eye Irrit. 2,REACH registration C&L,161,H319:102;Not classified:55;H318:37;H302:3;H315:3
90313,"2,2'-[[4-[(2-bromo-6-chloro-4-nitrophenyl)azo]-3-chlorophenyl]imino]bisethanol",241-481-9,17464-91-4,Not Classified,REACH registration C&L,4,Not classified:4
90314,"lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-)",414-280-0,149626-00-6,Aquatic Chronic 2,Harmonised C&L,0,H411:0
90322,(3-chloropropyl)methoxydimethylsilane,242-055-5,18171-14-7,Flam. Liq. 3,REACH registration C&L,1,H226:1
90330,Ammonium N-methyl-N-(1-oxododecyl)glycinate,268-130-2,68003-46-3,Eye Dam. 1,REACH registration C&L,2,H318:2
90332,"Undecan-1-ol, ethoxylated",500-084-3,34398-01-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1186,H319:524;H302:983;H318:655;H411:65;H335:42;H315:137;H412:45;Not classified:7;H400:1
90339,"Sodium bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]cobaltate(1-)",276-072-4,71839-88-8,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,266,H400:265;H410:265;H317:265;Not classified:1
90340,Sodium (4-nitrophenyl)methanesulfonate,609-277-8,36639-50-6,Not Classified,Notified C&L,1,Not classified:1
90342,"Sulfuric acid, mono-C10-16-alkyl esters, potassium salts",272-676-7,68908-46-3,Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H318:1;H332:1;H228:1
90343,"Phosphoric acid, hexyl ester",270-935-9,68511-03-5,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,536,H314:444;H318:444;Not classified:92
90346,2-acetylbenzoic acid,209-413-2,577-56-0,,Notified C&L,8,H319:8;H335:7;H315:8
90348,Dodecylammonium acetate,217-956-1,2016-56-0,Not Classified,Notified C&L,32,Not classified:31;H302:1
90351,2-iodoanisole,208-456-4,529-28-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
90352,"P-AMINO-N,N-BIS(2-ETHYLHEXYL)BENZAMIDE",617-541-9,84166-90-5,Aquatic Chronic 4,Notified C&L,38,H413:38
90354,Heptafluorobutyraldehyde,206-783-7,375-02-0,,Notified C&L,5,H319:5;H335:5;H315:5
90355,"Lard, hydrogenated",277-297-0,73138-67-7,Not Classified,Notified C&L,2,Not classified:2
90357,(Z)-α-(methoxyimino)furan-2-acetic acid,254-591-7,39684-61-2,Not Classified,Notified C&L,1,Not classified:1
90358,Benz[d]isoxazole,205-983-1,271-95-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,161,H319:161;H335:161;H315:161
90362,Ethyl hydroxycarbamate,209-648-0,589-41-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:2;H302:2;H332:2;H319:1;H335:1;H315:1
90364,(tetrahydrofuryl)methyl phenylacetate,226-534-6,5421-00-1,Not Classified,Notified C&L,88,Not classified:88
90365,4-heptyloxybenzoyl chloride,255-077-5,40782-54-5,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H314:38;H335:38;H318:38
90369,1-phenyl-2-[(phenylmethyl)thio]ethan-1-one,219-312-5,2408-88-0,Aquatic Acute 1,Notified C&L,38,H400:38
90370,"Chromate(2-), [2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-3H-pyrazol-3-onato(2-)][3-[[4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl]azo]-4-hydroxy-5-nitrobenzenesulfonato(3-)]-, disodium",278-113-1,75199-08-5,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,56,H319:34;H412:53;H413:2;Not classified:1
90371,"Ethylenediamine-N,N'-bis((2-hydroxyphenyl)acetic acid)",214-625-3,1170-02-1,Not Classified,REACH registration C&L,3,Not classified:3
90383,"Amines, C12-14-tert-alkyl, C12-20 and C14-18-unsatd. alkyl phosphates",300-206-3,93924-14-2,,Notified C&L,571,Not classified:571
90385,Disodium 5-[[4-[(2-bromo-1-oxoallyl)amino]-2-sulphonatophenyl]azo]-4-hydroxy-6-(methylamino)naphthalene-2-sulphonate,274-436-7,70210-39-8,Skin Sens. 1,REACH registration C&L,22,H317:10;H319:11;H315:11;H334:3;Not classified:1
90386,"1-chloro-2,5-dioxahexane",223-589-8,3970-21-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1A,REACH registration C&L,47,H319:47;H335:46;H315:47;H350:9;H226:47;H302:40;H330:2;H300:1;H310:1;H332:1
90390,"Dimethyl 5-[[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]azoterephthalate",249-955-7,29920-31-8,Not Classified,REACH registration C&L,47,Not classified:47
90403,3-methoxy-2-naphthoic acid,212-932-7,883-62-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
90404,(1-chlorocyclohexyl) cyclohexyl ketone,280-893-3,83803-75-2,Not Classified,REACH registration C&L,1,Not classified:1
90407,"4,6-dimethylpyrimidin-2-ylamine",212-181-5,767-15-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,44,H319:44;H302:38;H335:5;H315:6
90408,Pirenzepine,249-228-4,28797-61-7,Not Classified,REACH registration C&L,1,Not classified:1
90409,2-(pyridin-4-yl)acetonitrile,816-873-3,13121-99-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
90411,2-furohydrazide,222-046-2,3326-71-4,,Notified C&L,6,H319:6;H302:5;H335:5;H315:6
90418,"1,1,1-trifluorohexane-2,4-dione",206-924-2,400-54-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H312:2;H319:2;H302:2;H335:2;H315:2;H332:2;H226:1
90426,4-carboxyperoxybutyric acid,223-357-6,3851-97-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
90428,"Cyclohexane-1,3-dione",207-980-0,504-02-9,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,189,H412:180;H302:186;H318:179;H319:1;H335:2;H315:1;Not classified:1
90429,"Linseed oil, reaction products with dicyclopentadiene",294-481-6,91722-79-1,Not Classified,Notified C&L,1,Not classified:1
90430,4-methoxyphenylhydrazine hydrochloride,243-115-3,19501-58-7,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Notified C&L,52,H332:44;H312:42;H302:48;H317:40;H319:10;H335:9;H315:12;Not classified:2;H311:1;H301:1;H331:1
90435,α-hydroxypyridine-4-methanesulphonic acid,225-479-5,4872-28-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
90436,"N,N,N',N'-tetramethyltrimethylenediamine",203-818-8,110-95-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,168,H411:86;H312:86;H302:163;H314:163;H335:86;H318:87;H226:163;H331:86;H311:55;H330:22;H310:22;Not classified:5;H332:4
90441,methyl 5-(bis(methoxycarbonylmethylamino))-4-cyano-3-methoxycarbonylmethylthiophen-2-carboxylate,451-540-2,,Not Classified,Notified C&L,2,Not classified:2
90447,4-hydroxy-3-methoxycinnamylic alcohol,207-277-9,458-35-5,Not Classified,Notified C&L,1,Not classified:1
90449,"3,5-dichloronitrobenzene",210-557-3,618-62-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,81,H319:73;H400:40;H335:38;H315:40;H411:37;H302:40;H373:7;H311:3;H330:3;H301:3;H410:2
90451,Methyl 4-butoxyphenylacetate,249-392-7,29056-06-2,Acute Tox. 4,REACH registration C&L,3,H302:3
90452,"3,6-diazaoctanethylenediamin;triethylenetetramine",203-950-6,112-24-3,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H312:0;H412:0;H314:0;H317:0
90453,Ethyl 6-Methylsalicylate,613-820-4,6555-40-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
90454,"2,5-dimethyl-1,4-dithiane-2,5-diol",259-770-3,55704-78-4,Acute Tox. 4,Notified C&L,1376,H302:1366;H319:89;H315:89;H312:1;H335:1;H332:1
90461,dicopper oxide;copper (I) oxide,215-270-7,1317-39-1,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H318:0;H332:0;H400:0
90462,"norbormide (ISO);5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide",213-589-6,991-42-4,Acute Tox. 4,Harmonised C&L,0,H302:0
90463,4-acetamidosalicylic acid,200-069-9,50-86-2,Acute Tox. 4,Notified C&L,41,H302:40;H319:2;H335:1;H315:2;H312:1;H332:1
90469,"sulfotep (ISO);O,O,O,O-tetraethyl dithiopyrophosphate",222-995-2,3689-24-5,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H300:0;H400:0;H310:0
90470,C.I. Reactive Orange 82,615-609-2,71838-95-4,Not Classified,Notified C&L,13,Not classified:13
90471,"1,4-phenylenebis[(4-phenoxyphenyl)methanone]",620-097-9,54299-17-1,Acute Tox. 4,REACH registration C&L,6,H302:5;H410:2;H371:1
90472,7-methoxycoumarin,208-513-3,531-59-9,Not Classified,Notified C&L,90,Not classified:90
90477,Rafoxanide,245-148-9,22662-39-1,Not Classified,Notified C&L,2,Not classified:2
90478,"2-(chloromethyl)-1,3-dioxolane",219-908-5,2568-30-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H312:1;H319:1;H302:1;H315:1;H332:1;H226:1
90479,Dodecane-12-lactam,213-424-8,947-04-6,Not Classified,REACH registration C&L,12,Not classified:8;H412:4
90481,"Fatty acids, C8-10, compds. with triethanolamine",285-216-5,85049-45-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,13,H319:13;H315:13
90485,Montan wax,232-313-5,8002-53-7,Not Classified,REACH registration C&L,142,Not classified:130;H373:12
90486,"Tetrakis(2-ethylhexyl) benzene-1,2,4,5-tetracarboxylate",221-508-0,3126-80-5,Not Classified,REACH registration C&L,21,Not classified:21
90487,quizalofop-P-tefuryl (ISO); (+/-) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate,414-200-4,119738-06-6,Acute Tox. 4;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H351:0;H302:0;H361:0;H373:0;H400:0;H410:0
90490,2-bromo-4-nitrotoluene,231-809-9,7745-93-9,Acute Tox. 4,Notified C&L,47,H302:47;H319:9;H312:6;H335:7;H315:9;H332:2
90491,"Matte, lead",282-356-9,84195-51-7,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,28,H410:28;H373:28;H400:28
90494,"1,2,3-trichloropropane",202-486-1,96-18-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 1B;Repr. 1B,Harmonised C&L,0,H312:0;H302:0;H350:0;H332:0;H360:0
90497,"Nitric acid, zirconium salt",240-255-7,16092-48-1,Skin Corr. 1B;STOT SE 3,Notified C&L,2,H314:2;H335:2
90500,(S)-2-amino-4-methyl-N-2-naphthylvaleramide,211-990-0,732-85-4,Carc. 2,Notified C&L,39,H351:38;H350:1
90503,"Dihydrogen bis(dioctyl phosphito-O'')tetrakis(propan-2-olato)titanate(2-), branched and linear",271-575-5,68585-67-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,10,H319:10;H315:10;H226:1;H335:1
90507,Hexadecan-3-ol,209-781-4,593-03-3,Not Classified,Notified C&L,1,Not classified:1
90511,"Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, hydrogen bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulfonato(3-)]chromate(3-), compd. with 3-[(2-ethylhexyl)oxy]-1-propanamine",284-723-9,84962-27-6,Aquatic Chronic 2,REACH registration C&L,141,H411:84;H412:37;Not classified:20
90512,4-chlorobenzoic acid,200-805-9,74-11-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,105,H319:59;H302:72;H335:58;H315:67;Not classified:41;H311:8;H332:8;H400:8;H331:8
90515,"3'-Thymidylic acid, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-, mono(2-chlorophenyl) ester, compd. with N,N-diethylethanamine (1:1)",286-938-3,85393-37-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,38,H319:38;H312:38;H351:38;H302:38;H335:38;H315:38
90517,"Lithium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate",226-081-4,5266-20-6,Not Classified,Notified C&L,1,Not classified:1
90518,Estradiol undecylate,222-677-3,3571-53-7,Carc. 2;Repr. 1A;Lact.,Notified C&L,24,H362:24;H351:24;H360:24
90520,Isopropyl toluene-4-sulphonate,218-989-4,2307-69-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
90521,Thallium bromide,232-163-0,7789-40-4,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,45,H411:45;H300:45;H373:45;H330:45
90522,"[(2,3,5,6-η)-bicyclo[2.2.1]hepta-2,5-diene]dichloropalladium",235-583-2,12317-46-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
90526,"α,α,4-trimethylphenethyl alcohol",244-072-3,20834-59-7,Not Classified,Notified C&L,88,Not classified:88
90527,4-hydroxyphenylacetamide,241-235-0,17194-82-0,Acute Tox. 4,REACH registration C&L,49,H302:3;H319:46;H335:45;H315:46
90528,"Oils, vegetable, sulfonated, sodium salts",307-044-2,97489-04-8,Not Classified,REACH registration C&L,85,Not classified:81;H318:2;H315:3;H319:1
90529,"Fatty acids, C8-10, ethoxylated, reaction products with epoxidized soybean oil",605-145-9,158318-70-8,Not Classified,Notified C&L,1,Not classified:1
90532,"Savory, Satureja nepη, ext.",290-281-8,90106-58-4,Not Classified,Notified C&L,184,Not classified:184
90533,Neuraminidase,232-624-6,9001-67-6,Resp. Sens. 1,Notified C&L,118,H334:118
90539,Methylguanidine hydrochloride,245-147-3,22661-87-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H302:41;H335:41;H315:41
90540,3-methylaminomethylphenylamine,414-570-7,18759-96-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H302:0;H314:0;H410:0;H317:0;H400:0
90541,"1,9-dibromononane",224-913-0,4549-33-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:40;H315:42;H302:1
90548,"2,2-dimethyloxirane",209-193-8,558-30-5,Flam. Liq. 2;Skin Corr. 1C;Eye Irrit. 2;Muta. 2;Carc. 2,REACH registration C&L,166,H319:4;H351:86;H314:164;H341:87;H225:166;H318:83;H335:40;H315:2
90550,[No public or meaningful name is available],468-070-9,,Skin Corr. 1A;Skin Sens. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H317:1;H318:1
90551,"2,2'-bipiperidyl",208-514-9,531-67-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
90553,Sodium tetrachloroaurate,239-241-3,15189-51-2,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,90,H412:84;H302:88;H314:88;H317:83;H318:83;H319:2;H335:2;H315:2;H290:1
90554,Etofenamate,250-231-8,30544-47-9,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,28,H400:28;H410:28;H301:28
90557,LEUCOPHOR 8407E,400-500-2,,Not Classified,Notified C&L,31,Not classified:31
90558,"Glycerides, vegetable-oil, hydrogenated",309-701-9,100684-29-5,Not Classified,Notified C&L,4,Not classified:4
90562,Dihydrouracil,207-982-1,504-07-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
90567,4-fluoro-3-trifluoromethylphenol,432-560-0,61721-07-1,Skin Corr. 1A;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H411:0;H314:0;H317:0
90570,"4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphthalic anhydride",214-170-0,1107-00-2,Skin Corr. 1C;Eye Dam. 1;STOT SE 3,Notified C&L,126,H314:121;H335:83;H318:118;H319:5;H315:5;H290:1
90571,"potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat",402-150-6,,Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0
90573,"Hexanedioic acid, di-C16-18-alkyl esters",296-703-7,92969-90-9,Not Classified,Notified C&L,1,Not classified:1
90574,"Acetic acid, isothiocyanato-, ethyl ester",607-312-1,24066-82-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H319:45;H312:44;H302:44;H335:45;H315:45;H332:44
90579,"2-methyl-1,4-phenylene-bis[4-(6-acryloyloxyhexyloxy)benzoate]",419-310-6,125248-71-7,Skin Sens. 1,REACH registration C&L,4,H317:4
90581,"(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate",604-569-1,147126-62-3,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,2,H412:1;H302:2;H332:1;H411:1;H317:1;H318:1
90583,D-arabinose,233-708-5,10323-20-3,Not Classified,Notified C&L,1,Not classified:1
90584,Life Power® L1,435-940-4,,Not Classified,Notified C&L,35,Not classified:35
90588,"Trisodium [N,N-bis[2-[bis(carboxylatomethyl)amino]ethyl]glycinato(5-)]zincate(3-)",234-305-7,11082-38-5,Not Classified,Notified C&L,3,Not classified:3
90590,3-bromopropene,203-446-6,106-95-6,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Aquatic Acute 1,REACH registration C&L,62,H314:49;H301:51;H400:50;H331:40;H224:5;H225:57;H319:12;H335:11;H315:11;H330:17;H300:10;H310:10;H340:8;H350:12;H311:1;H341:1;H318:2
90591,"1,2-Naphtoquinonediazide-4-ulfonylchloride (or sulfonic acid) diester with 4;4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol and 1,2-Naphtoquinonediazide-4-sulfonylchloride (or sulfonic acid)monoester with 4;4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol and 1,2-Naphtoquinonediazide-4-ulfonylchloride (or sulfonic acid)triester with 4;4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol",433-630-3,,Flam. Sol. 1;Aquatic Chronic 4,Notified C&L,1,H228:1;H413:1
90598,"Glycerides, tall-oil mono-, di-, and tri-",307-751-6,97722-02-6,Not Classified,REACH registration C&L,153,Not classified:151;H413:2
90599,"Cardamom, Elettaria cardamomum miniscula, ext.",306-171-0,96507-91-4,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,86,H411:85;H319:86;H315:61;H317:86;H226:59;H412:1;H304:1
90605,Neodymium triiodide,237-467-7,13813-24-6,Skin Sens. 1;Resp. Sens. 1;Repr. 2,Notified C&L,38,H361:38;H334:38;H317:38
90613,"Disodium 4,4'-bis(2-hydroxynaphthalen-1-ylazo)biphenyl-2,6'-disulphonate",233-439-3,10169-02-5,Not Classified,REACH registration C&L,616,Not classified:73;H411:442;H319:455;H350:83;H334:10;H317:10;H412:4;H315:4
90617,"Octanoic acid, 2-phenoxyethyl ester",607-240-0,23511-73-1,Not Classified,REACH registration C&L,2,Not classified:2
90619,Hexadecyltrimethylammonium hydrogen sulphate,269-286-4,68214-07-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,109,H319:109;H312:69;H302:69;H335:69;H315:109;H332:69
90621,"Soybean oil, nonsaponifiable fraction",294-853-8,91770-67-1,Not Classified,Notified C&L,1,Not classified:1
90622,Benzoglutaric anhydride,211-873-4,703-59-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H302:1
90625,"Hexasodium 7,7'-[1,4-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino[2-[(aminocarbonyl)amino]-4,1-phenylene]azo]]bis(naphthalene-1,3,6-trisulphonate)",274-351-5,70161-15-8,Not Classified,Notified C&L,38,Not classified:38
90628,Disodium 6-hydroxy-5-[(4-sulphonatophenyl)azo]naphthalene-2-sulphonate,220-491-7,2783-94-0,Not Classified,REACH registration C&L,2882,Not classified:2353;H319:527;H335:527;H315:527;H411:4;H373:1;H412:1
90631,Methylphenidate,204-028-6,113-45-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Muta. 2,Notified C&L,1,H319:1;H302:1;H341:1;H315:1
90632,"(3α,4β,8α)-12,13-epoxytrichothec-9-ene-3,4,8,15-tetrol 4,15-diacetate 8-(3-methylbutyrate)",244-297-7,21259-20-1,Acute Tox. 1;Acute Tox. 1;Skin Irrit. 2;Acute Tox. 1,Notified C&L,41,H330:40;H300:40;H310:40;H315:40;H312:1;H302:1;H332:1
90634,(trimethoxysilyl)methyl prop-2-enoate,700-313-9,21134-38-3,Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4,Notified C&L,23,H332:23;H314:23;H317:23;H412:1;H318:1
90640,Bumetanide,249-004-6,28395-03-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H335:3;H315:3
90645,"Glycerides, sunflower-oil mono-, di- and tri-",294-520-7,91723-16-9,Not Classified,Notified C&L,7,Not classified:7
90647,Naphthenic acids,215-662-8,1338-24-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,1143,H319:1117;H317:131;H315:551;H411:885;H335:884;Not classified:28
90648,"(1-METHYL-2-(1,2,2-TRIMETHYLBICYCLO(3.1.0)-HEX-3-YLMETHYL)CYCLOPROPYL)METHANOL",427-900-1,198404-98-7,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1316,H400:1316;H410:1316
90652,2-isopropyl-9H-thioxanthen-9-one,226-827-9,5495-84-1,Not Classified,REACH registration C&L,338,Not classified:216;H302:56;H413:60;H317:14;H373:5
90653,"1,3-diphenyl-2-thiourea",203-004-2,102-08-9,Skin Sens. 1A;Repr. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,139,H411:55;H373:55;H361:55;H317:89;H300:43;H301:11;H412:2;H319:1;H335:1;H315:1
90656,Zinc diphosphide,234-867-3,12037-79-5,,Notified C&L,4,H300:4;H260:4
90659,Solsperse 5000,404-170-0,,Not Classified,Notified C&L,131,Not classified:131
90661,4-butylbenzoic acid,243-940-9,20651-71-2,,Notified C&L,7,H319:6;H302:5;H335:5;H315:6;Not classified:1
90665,"2-chloro-1,1-difluoroethylene",206-625-7,359-10-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
90666,Potassium dodecylbenzenesulphonate,248-296-2,27177-77-1,Skin Sens. 1;Eye Dam. 1,Notified C&L,567,H317:442;H318:514;H319:45;H302:84;H315:90;Not classified:8;H412:3
90667,Diammonium tartrate,221-618-9,3164-29-2,Not Classified,REACH registration C&L,5,Not classified:2;H319:3;H335:3;H315:3
90668,"1,2-bis(1-methylethyl)benzene",209-412-7,577-55-9,Aquatic Chronic 4,Notified C&L,39,H413:39
90669,"Sulfuric acid, mono-C10-16-alkyl esters, compds. with ethanolamine",272-675-1,68908-44-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,10,H318:10;H315:10;H302:1
90672,"6,11-dihydro-11-(1-methylpiperidin-4-ylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine dimaleate",223-615-8,3978-86-7,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4,Notified C&L,10,H319:10;H312:10;H302:10;H317:10;H332:10
90673,"Dodecanoic acid, ester with oxybis[propanediol]",615-087-6,70226-26-5,,Notified C&L,1,Not classified:1
90674,4-fluoro-m-toluidine,207-207-7,452-69-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:40;H315:46;H302:8;H311:4;H332:8;H373:6;H312:4
90676,1-methyl-3-nitro-1-nitrosoguanidine,200-730-1,70-25-7,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H319:0;H315:0;H350:0;H332:0
90679,"Bis[2-(2-ethoxyethoxy)ethyl] cyclohexane-1,4-dicarboxylate",618-829-7,922165-31-9,Not Classified,Notified C&L,1,Not classified:1
90682,Sodium hydroxymethylbenzenesulphonate,252-179-1,34742-11-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
90683,"2,2'-Iminodiethanol, propoxylated",500-085-9,35176-06-8,Not Classified,REACH registration C&L,12,Not classified:12
90684,N-acetyl-β-D-galactosamine,217-321-9,1811-31-0,Not Classified,Notified C&L,3,Not classified:3
90689,Disodium 6-amino-4-hydroxy-5-[(4-nitro-2-sulphonatophenyl)azo]naphthalene-2-sulphonate,229-230-1,6441-91-4,Not Classified,Notified C&L,24,Not classified:22;H319:2
90690,2-(dichloromethyl)pyridine,224-478-7,4377-35-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H302:1;H318:1;H335:1;H315:1
90691,(S)-1-bromo-2-methylbutane,208-583-5,534-00-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H225:38;H335:42;H315:42;H224:4
90695,1-chloro-2-methylpropene,208-158-4,513-37-1,Flam. Liq. 2;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;STOT SE 3;Carc. 1B,Notified C&L,40,H319:40;H335:39;H330:40;H311:40;H315:40;H225:40;H350:39;H351:1;H301:1
90696,Dienestrol di(acetate),201-520-2,84-19-5,Carc. 2,Notified C&L,38,H351:38
90698,"3,3'-(methylimino)bispropiononitrile",216-305-9,1555-58-4,Acute Tox. 4;Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2A;Carc. 1B,REACH registration C&L,85,H319:85;H302:85;H311:85;H317:85;H350:2
90700,Methyl (trimethoxysilyl)methyl)carbamate,449-370-9,23432-64-6,Acute Tox. 4;Repr. 1B,REACH registration C&L,31,H332:31;H360:31
90705,6-chloro-4-nitro-o-toluidine,237-589-0,13852-51-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
90713,"3,7-dimethyloct-1-ene",225-635-2,4984-01-4,Flam. Liq. 3,Notified C&L,38,H226:38
90715,Aluminium(3+) 12-hydroxyoctadecanoate,236-373-3,13329-66-3,Not Classified,Notified C&L,3,Not classified:3
90721,"Naphtha (petroleum), light straight-run;Low boiling point naphtha;[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C",265-046-8,64741-46-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
90722,2-hydroxydibenzofuran-3-carboxylic acid,204-247-7,118-36-5,Eye Irrit. 2,Notified C&L,38,H319:38
90723,"Kalanchoe pinnata, ext.",289-972-7,90046-05-2,Skin Sens. 1B,Notified C&L,1,H317:1
90726,Cyclo-di-μ-oxo(μ-phthalato)trilead,241-894-4,17976-43-1,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,25,H302:25;H410:25;H400:25;H332:25;H360:25;H373:25
90727,"Benzenesulfonic acid, C20-48-alkyl derivs., sodium salts",271-414-9,68555-09-9,,Notified C&L,1,Not classified:1
90729,methanesulphonic acid,200-898-6,75-75-2,Skin Corr. 1B,Harmonised C&L,0,H314:0
90737,Cerium oxide,234-374-3,11129-18-3,Not Classified,Notified C&L,10,Not classified:10
90741,4-hydrazinobenzoic acid monohydrochloride,246-330-0,24589-77-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
90742,(S)-2-amino-4-methylvaleramide monohydrochloride,233-952-2,10466-61-2,Not Classified,Notified C&L,1,Not classified:1
90747,2-benzamidobenzoic acid,611-604-4,579-93-1,Skin Sens. 1,Notified C&L,152,H317:114;H319:39;H302:39;H335:39;H315:39
90753,Homatropine hydrobromide,200-105-3,51-56-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,8,H312:3;H302:5;H332:4;H311:1;H331:1;H301:2;H318:1;H317:1;H315:1;H330:1;H310:1
90757,1-methylpiperidine-4-methylamine,230-477-2,7149-42-0,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1C,Notified C&L,43,H226:38;H302:41;H314:43;H312:1;H332:1;H319:1;H335:2;H315:1
90763,"2-Pyrrolidinecarbonitrile, 4-fluoro-1-[2-[[(1R,3S)-3-(1H-1,2,4-triazol-1-ylmethyl)cyclopentyl]amino]acetyl]-, (2S,4S)-, methanesulfonate (1:1)",617-938-7,869368-93-4,Not Classified,Notified C&L,1,Not classified:1
90765,(S)-3-(acetylthio)-2-methylpropionic acid,278-480-8,76497-39-7,Skin Corr. 1B,REACH registration C&L,43,H314:41;H318:38;H319:2;H335:1;H315:2
90768,2-ethylthiazole,239-755-8,15679-09-1,Flam. Liq. 3,Notified C&L,1,H226:1
90776,1-(ethylthio)acetone,244-143-9,20996-62-7,,Notified C&L,5,H226:5;H319:1;H335:1;H315:1
90777,"Ethanol, 2,2'-iminobis-, polymer with oxirane",613-042-5,62476-52-2,Not Classified,Notified C&L,1,Not classified:1
90778,Methoxyacetic anhydride,243-114-8,19500-95-9,,Notified C&L,2,H319:2;H315:2
90781,"Reaction products of diazotised 5-amino-2-anilinobenzenesulphonic acid coupled with resorcinol, subsequently coupled with diazotised 3-amino-4-hydroxy-5-nitrobenzenesulphonic acid, subsequently coupled with diazotised sodium 2-amino-4,6-dinitrophenoxide, subsequently coupled with diazotised 4-nitroaniline, sodium salts",601-986-0,12219-56-6,Eye Dam. 1,REACH registration C&L,2,H318:2
90782,Diisobutylamine,203-819-3,110-96-3,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,144,H312:13;H314:144;H318:88;H301:59;H226:144;H331:98;H412:124;H302:85
90783,Sodium N-(6-chloropyridazin-3-yl)sulphanilamidate,245-553-0,23282-55-5,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,3,H334:1;H302:1;H317:1;Not classified:1;H319:1;H335:1;H315:1
90790,"(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one",606-950-8,22189-32-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H319:50;H335:50;H315:49;Not classified:2;H317:1
90796,Carnauba wax,232-399-4,8015-86-9,Not Classified,Notified C&L,1286,Not classified:1264;H319:21;H226:1;H336:1;H304:1
90802,"Iron, complexes with diazotized 5-amino-2-(phenylamino)benzenesulfonic acid monosodium salt coupled with 4-[(2-hydroxy-3,5-dinitrophenyl)azo]-1,3-benzenediol, diazotized 4-nitrobenzenamine and diazotized 3-aminobenzenesulfonic acid monosodium salt",276-464-5,72207-77-3,Aquatic Chronic 3,REACH registration C&L,83,H412:42;Not classified:41
90804,"2,4,6-trinitrobenzaldehyde",210-114-4,606-34-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
90807,"Fatty acids, montan-wax, esters with 1,3-butanediol, partially sapond., calcium salts",297-838-4,93763-21-4,Not Classified,Notified C&L,51,Not classified:51
90812,"ethyl 3,3,3-trifluoro-2-oxopropanoate",603-440-7,13081-18-0,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,51,H226:51;H319:51;H302:44;H315:51;H335:49;H332:1
90814,2-methoxypropyl acetate,274-724-2,70657-70-4,Flam. Liq. 3;STOT SE 3;Repr. 1B,Harmonised C&L,0,H226:0;H335:0;H360:0
90816,"1,2,3-trichloropropene",202-487-7,96-19-5,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,2,H319:1;H302:1;H335:1;H330:1;H311:2;H315:1;H331:1;H227:1;H301:1
90823,Dihydro-4-phenylfuran-2(3H)-one,213-760-5,1008-73-7,Acute Tox. 5;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H303:1;H335:1;H315:1
90824,"2-Butenedioic acid (Z)-, (Z)-2-[(1-oxo-9-octadecenyl)amino]ethyl ester",270-936-4,68511-29-5,Not Classified,Notified C&L,1,Not classified:1
90826,"1,2,3-trichlorobenzene",201-757-1,87-61-6,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,107,H400:93;H410:93;H302:105;H317:92;H411:5;H319:3;H335:3;H315:3;H336:1;Not classified:1
90827,"Cheese, Cheddar, ext.",307-825-8,97765-70-3,Not Classified,Notified C&L,10,Not classified:10
90828,Potassium decafluoro(trifluoromethyl)cyclohexanesulphonate,269-002-9,68156-07-0,Not Classified,Notified C&L,5,Not classified:5
90829,o-tolylhydrazine,208-455-9,529-27-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:39;H335:39;H315:39;H312:1;H332:1
90830,reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol,411-130-6,,Eye Dam. 1,Harmonised C&L,0,H318:0
90832,Acetone azine,211-009-6,627-70-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B,Notified C&L,63,H319:38;H302:38;H335:38;H315:38;H311:63;H350:63;H226:63;H314:25;H330:25;H317:25;H318:25;H301:25
90833,"Dichlorobis([?]5-cyclopenta-2,4-dien-1-yl)vanadium",235-150-8,12083-48-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H315:39;H335:38;H301:43;H314:4;H311:1;H331:1
90841,"1,1,2,2-tetrafluoro-2-[(trifluorovinyl)oxy]ethanesulfonyl fluoride",608-369-5,29514-94-1,,REACH registration C&L,0,No data
90845,"Fatty acids, C6-19-branched, cobalt(2+) salts",270-066-5,68409-81-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,209,H411:136;H302:136;H317:136;H315:135;Not classified:73;H319:15;H361:13;H332:1
90850,Hypochlorous acid,232-232-5,7790-92-3,Not Classified,Notified C&L,1,Not classified:1
90852,Tetramethylurea,211-173-9,632-22-4,Acute Tox. 4;Repr. 2,Notified C&L,106,H302:103;H361:43;H360:48
90853,"4,4'-dichlorobenzophenone",202-030-1,90-98-2,Acute Tox. 4,Notified C&L,97,H302:92;H319:5;H335:5;H315:5
90855,"Butanoic acid, 2-[(3-nitrophenyl)methylene]-3-oxo-, ethyl ester, (2Z)-",601-072-1,111304-32-6,Not Classified,Notified C&L,1,Not classified:1
90856,"Ethanesulfonic acid, 2-(methylamino)-, N-tall-oil fatty acyl derivs., sodium salts",263-173-3,61791-41-1,,Notified C&L,5,H319:5
90859,"Sulfuric acid, mono-C10-16-alkyl esters, ammonium salts",268-364-5,68081-96-9,Eye Irrit. 2,Notified C&L,317,H319:126;H318:154;H315:133;H412:40;H302:65;Not classified:37;H335:21;H314:21
90861,"Diammonium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cobaltate(2-)",304-038-1,94233-08-6,Skin Sens. 1,REACH registration C&L,5,H317:5;H411:1;H319:1;H341:1;H334:1;H350:1;H360:1
90862,"Diammonium 2,2'-dithiodiacetate",269-323-4,68223-93-8,Acute Tox. 4,REACH registration C&L,39,H302:39
90865,"Disodium 2,4-diamino-3-{[4-(ethenylsulfonyl)phenyl]diazenyl}-5-{[4-(ethenylsulfonyl)-2-sulfonatophenyl]diazenyl}benzenesulfonate",919-701-6,503157-00-4,Skin Sens. 1B,REACH registration C&L,1,H317:1
90868,"Benzenesulfonic acid, hydroxymethoxy-, monopotassium salt, hydrate (2:1)",682-132-4,78247-49-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,3,H319:2;H302:2;H332:2;H315:2;Not classified:1
90869,Diisopropyl trisulphide,227-703-7,5943-34-0,Not Classified,Notified C&L,90,Not classified:90
90871,"Tetrahydro-1,3,4,6-tetrakis(methoxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione",241-480-3,17464-88-9,Not Classified,REACH registration C&L,181,Not classified:93;H312:56;H302:56;H332:56;H319:32
90872,"1,3-diphenylurea",203-003-7,102-07-8,Acute Tox. 4,REACH registration C&L,4,H302:3;Not classified:1;H312:1;H332:1
90873,"1,2,4-trimethylcyclopentane",220-564-3,2815-58-9,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H319:38;H302:38;H335:38;H315:38;H225:38;H400:38;H304:38
90875,5-amino-o-xylene-3-sulphonic acid,256-657-0,50619-00-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
90881,Ethyl isothiocyanatoformate,240-318-9,16182-04-0,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,48,H319:43;H335:42;H315:43;H334:43;H317:40;H226:48;H331:42;H312:5;H302:5;H314:4;H332:5;H311:1;H318:1;H301:2;H330:1
90886,C.I. Disperse Red 74,612-204-2,61703-11-5,Not Classified,Notified C&L,7,Not classified:7
90889,"Sulfuric acid, mono(C14-18 and C16-18-unsatd. alkyl) esters, sodium salts",288-206-9,85681-68-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,22,H319:22;H315:22
90890,"Tetrasodium N-[4-[[4-[[4-[[1-amino-8-hydroxy-3,6-disulphonato-7-[(4-sulphonatophenyl)azo]-2-naphthyl]azo]benzoyl]amino]phenyl]azo]-3-hydroxyphenyl]glycinate",288-534-2,85750-09-0,Not Classified,Notified C&L,2,Not classified:2
90895,"[(2R*, 4R*) -2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl]methyl methanesulfonate",700-314-4,82966-34-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
90898,"Fatty acids, C8-10, oxybis(2-hydroxy-3,1-propanediyl) esters",295-371-0,92044-91-2,Not Classified,REACH registration C&L,2,Not classified:2
90900,Disodium 4-hydroxy-3-[[2-methoxy-5-methyl-4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]naphthalenesulphonate,281-627-9,84000-71-5,Eye Dam. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H318:1
90904,"Labdanum, ext., Et esters",277-296-5,73138-66-6,Not Classified,Notified C&L,91,Not classified:89;H412:2;H317:2
90905,2-[(2-methyl-1-oxoallyl)oxy]ethyl 6-hydroxyhexanoate,285-463-9,85099-10-1,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,39,H312:38;H302:38;H335:38;H317:39;H318:38;H332:38;H319:1;H315:1
90907,Dichloromalononitrile,235-955-4,13063-43-9,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:38;H312:38;H335:42;H315:42;H332:38;H301:43;H311:5;H318:4;H331:5
90908,"Ethyl 2,3-dihydro-2-thioxothiazol-4-acetate",253-937-4,38449-49-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
90909,"Ethyl 3,5,5-trimethylhexanoate",266-959-4,67707-75-9,Aquatic Chronic 2,REACH registration C&L,1582,H411:40;H227:2;H412:1542;H317:1;H315:1
90910,"3,3,4,4,5,5,5-heptafluoropentan-2-ol",206-784-2,375-14-4,,Notified C&L,4,H319:4;H335:4;H315:4
90911,Benzofuran,205-982-6,271-89-6,Flam. Liq. 3;Carc. 2;Aquatic Chronic 3,Notified C&L,64,H226:64;H412:40;H351:61;Not classified:1
90913,"Pyrazin-2(1H)-one, sodium salt",246-216-0,24387-68-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,89,H319:89;H312:89
90918,2-[furan-2-ylmethyl-(imidazole-1-carbonyl)-amino]-butyric acid pent-4-enyl ester,600-245-9,101903-30-4,Acute Tox. 2;Repr. 1A;STOT SE 2;STOT RE 2,Notified C&L,91,H373:90;H371:90;H302:91;H360:90
90922,(2H3)ammonia,236-926-9,13550-49-7,Flam. Gas 2;Press. Gas (Liq.);Skin Corr. 1B;Acute Tox. 3;Aquatic Acute 1,Notified C&L,103,H221:103;H314:103;H280:65;H400:103;H331:103
90924,Isopentyl phenylglycolate,226-535-1,5421-04-5,Eye Irrit. 2,Notified C&L,39,H319:39;H315:1
90930,"4-(2,5,6,6-tetramethyl-1-cyclohexen-1-yl)-3-buten-2-one",201-220-1,79-70-9,Not Classified,Notified C&L,36,Not classified:36
90934,mevinphos (ISO);2-methoxycarbonyl-1-methylvinyl dimethyl phosphate,232-095-1,7786-34-7,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H300:0;H400:0;H310:0
90936,reaction mass of: tetradecanoic acid;poly(1-7)lactate esters of tetradecanoic acid,411-910-6,,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0;H317:0;H315:0
90937,"Xanthylium, 3,6-bis(diethylamino)-9-[2-(ethoxycarbonyl)phenyl]-, molybdatetungstatephosphate",215-414-9,1326-04-1,Self-heat. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,168,H319:84;H413:84;H400:71;H410:71;H318:69;Not classified:13;H317:1;H252:1
90939,"2-{3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl}ethyl hydrogen phosphate",600-039-9,10023-48-0,Skin Sens. 1,REACH registration C&L,1,H317:1
90940,4'-hydroxy-3'-methoxycinnamaldehyde,207-278-4,458-36-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
90941,"Lipoproteins, blood plasma",294-482-1,91722-80-4,Not Classified,Notified C&L,1,Not classified:1
90942,Disodium 6-amino-5-[[4-[(2-bromo-1-oxoallyl)amino]-2-sulphonatophenyl]azo]-4-hydroxynaphthalene-2-sulphonate,274-437-2,70210-40-1,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,24,H334:15;H317:15;H319:8;H315:8;Not classified:1
90944,"5,8-Dihydro-1-naphthyl acetate",610-759-5,51927-56-1,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H312:1;H302:1;H332:1
90945,Isopropyl laurate,233-560-1,10233-13-3,Not Classified,REACH registration C&L,174,Not classified:174
90946,Dibutylboron triflate,612-008-7,60669-69-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,122,H314:122;H318:84
90948,2-IODO-4-NITROANISOLE,611-079-1,5399-03-1,Aquatic Acute 1,Notified C&L,39,H400:38;H319:1;H335:1;H315:1
90950,(-)-α-(chloroformyl)benzylammonium chloride,254-668-5,39878-87-0,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Notified C&L,39,H334:39;H302:39;H317:39;H314:39
90955,"Benzene-1,3,5-tricarboxylic acid",209-077-7,554-95-0,Not Classified,REACH registration C&L,48,Not classified:1;H319:47;H335:46;H315:47
90966,"sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate",407-720-8,155160-86-4,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
90968,"4-oxo-4,5,6,7-tetrahydrobenzo[b]thiophene",236-510-7,13414-95-4,Acute Tox. 4,Notified C&L,1,H302:1
90969,"(6R,7R)-7-[((2Z)-2-[({2-[(1,1-dimethylethyl)oxy]-1,1-dimethyl-2-oxoethyl}oxy)imino]-2-{2-[(triphenylmethyl)amino]-1,3-thiazol-4-yl}acetyl)amino]-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",617-560-2,84377-83-3,Flam. Sol. 1;Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H228:1;H317:1
90970,Benzyltriethylammonium bromide,225-986-1,5197-95-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,43,H319:43;H315:43;H335:4
90971,N-(3-hydroxypropyl)phthalimide,212-931-1,883-44-3,Not Classified,Notified C&L,2,Not classified:2
90974,"α,α,α-2-tetrafluorotoluene",206-925-8,400-74-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:40;H315:46;H302:6;H311:4;H332:6;H312:2
90975,"phosfolan (ISO);diethyl 1,3-dithiolan-2-ylidenephosphoramidate",213-423-2,947-02-4,Acute Tox. 2;Acute Tox. 1,Harmonised C&L,0,H300:0;H310:0
90978,"Hexapotassium dihydrogen [hexane-1,6-diylbis[nitrilobis(methylene)]]tetrakisphosphonate",258-575-0,53473-28-2,Not Classified,Notified C&L,8,Not classified:8
90981,"4,4'-(1,2-diethylethylene)diphenyl dipropionate",225-400-4,4825-53-0,Carc. 2,Notified C&L,38,H351:38
90983,"Bis(3,5,5-trimethylhexanoyl) peroxide",223-356-0,3851-87-4,Org. Perox. C;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,11,H317:11;H242:11;H304:9;H315:11
90984,"N,N-dimethyl-N'-p-tolylsulphamide",266-491-0,66840-71-9,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1
90986,"Pyridine-2,6-diyldiamine",205-507-2,141-86-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,117,H319:117;H315:107;H335:106;H301:116;H312:40;H317:16;H373:4;H332:4;H411:1;H302:1;H372:1
90987,"Disodium [2-(2-chlorophenyl)-2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-3H-pyrazol-3-onato(2-)][2-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-5-nitrobenzene-1-sulphonato(3-)]chromate(2-)",278-112-6,75199-05-2,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,47,H411:46;H315:46;Not classified:1
90991,"tris(η5-cyclopenta-2,4-dien-1-yl)scandium",215-074-1,1298-54-0,Flam. Sol. 2;Water-react. 1,Notified C&L,38,H260:38;H228:38
90992,Nanofin,207-981-6,504-03-0,,Notified C&L,6,H225:6;H314:5;H319:1;H335:1;H315:1
91000,"2,6-bis(1-methylpropyl)cyclohexan-1-one",275-544-7,71501-12-7,Skin Sens. 1,Notified C&L,38,H317:38
91001,"1,1,2,2,3,3,4-heptafluorocyclopentane",430-710-1,15290-77-4,Aquatic Chronic 3,Harmonised C&L,0,H412:0
91004,"2-[[5-acetamide-4-[(2-chloro-4,6-dinitrophenyl)azo]-2-methoxyphenyl]benzylamino]ethyl acetate",240-470-6,16421-40-2,Not Classified,Notified C&L,1,Not classified:1
91005,"2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium sulphate (2:1)",281-474-8,83950-22-5,Acute Tox. 2;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H330:2;H410:2;H318:2;H300:2;H400:2
91007,Trisodium [μ-[2-[[1-hydroxy-6-[[[[5-hydroxy-6-[(2-hydroxy-5-sulphophenyl)azo]-7-sulpho-2-naphthyl]amino]carbonyl]amino]-3-sulpho-2-naphthyl]azo]benzoato(7-)]]dicuprate(3-),229-922-3,6837-87-2,Not Classified,Notified C&L,11,Not classified:11
91010,"Stearic acid, cobalt salt",237-016-4,13586-84-0,Skin Sens. 1;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,214,H412:187;H317:192;H372:7;H411:27;H334:2
91011,"N-[3-(tridecyloxy)propyl]propane-1,3-diamine",244-726-8,22023-23-0,,Notified C&L,1,Not classified:1
91012,(4-hydroxyphenyl)boronic acid,615-307-0,71597-85-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:48;H335:47;H315:48;H312:3;H302:5;H332:3
91013,"Tricarbonyl[(4a,5,6,7,8,8a-η)-1,2,3,4-tetrahydronaphthalene]chromium",235-274-2,12154-63-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H312:38;H302:38;H335:38;H315:38;H332:38
91014,Oxomemazine,222-996-8,3689-50-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,Notified C&L,6,H311:3;H330:2;H301:5;H302:1;H412:2;H317:2;H331:1
91021,Silver trifluoromethanesulphonate,220-882-2,2923-28-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:43;H335:41;H315:44;H400:5;H314:7;H318:3;Not classified:1
91022,4-Amino-N-methyl-α-toluenesulfonamide,600-932-3,109903-35-7,Acute Tox. 3;Skin Sens. 1,Notified C&L,44,H317:44;H301:38;H411:5;H319:6;H335:6;H315:6
91026,Dichlorodi-n-octylsilane,606-020-1,18416-07-4,Skin Corr. 1B,Notified C&L,43,H314:43;H290:1;H318:1
91028,2-hydroxy-p-toluic acid,200-068-3,50-85-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,51,H319:51;H302:50;H315:51;H335:46
91029,"1,3-dimethyl-1,3-diphenylurea",210-283-4,611-92-7,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H302:2
91031,"1,2,3-propanetriyl tris[(R)-12-(acetoxy)oleate]",202-935-1,101-34-8,Aquatic Chronic 4,REACH registration C&L,10,H413:2;Not classified:8
91034,Potassium glycinate,239-837-3,15743-44-9,Not Classified,Notified C&L,1,Not classified:1
91036,"Mucins, submandibular",282-357-4,84195-52-8,Not Classified,Notified C&L,1,Not classified:1
91037,(3-cyano-2-hydroxypropyl)trimethylammonium chloride,242-684-5,18933-33-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,40,H319:40;H335:40;H315:40
91039,desmedipham (ISO);ethyl 3-phenylcarbamoyloxyphenylcarbamate,237-198-5,13684-56-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
91041,"bis(2,4,6-trinitrophenyl)amine;hexyl",205-037-8,131-73-7,Expl. 1.1;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H330:0;H373:0;H300:0;H310:0;H201:0
91042,3'-aminobenzanilide,240-254-1,16091-26-2,,Notified C&L,1,H319:1;H335:1;H315:1
91043,"Glycerides, C14-18 and C14-18-unsatd., acetylated",285-219-1,85049-48-5,Not Classified,Notified C&L,1,Not classified:1
91047,Propyl nicotinate,231-662-0,7681-15-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
91048,1-(4-chloro-2-fluorophenyl)ethan-1-one,605-759-7,175711-83-8,Acute Tox. 4,Notified C&L,40,H302:39;H319:2;H335:2;H315:2
91050,4-vinylveratrole,228-962-9,6380-23-0,Eye Irrit. 2,Notified C&L,39,H319:39
91052,N-[4-(acetylamino)phenyl]-4-[[5-(aminocarbonyl)-2-chlorophenyl]azo]-3-hydroxynaphthalene-2-carboxamide,235-464-5,12236-64-5,Not Classified,REACH registration C&L,44,Not classified:44
91054,2-fluoro-4-iodotoluene,254-740-6,39998-81-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
91057,Sodium 4-hydroxybenzenesulphonate,212-550-0,825-90-1,Eye Irrit. 2,REACH registration C&L,98,H319:22;Not classified:76;H315:6;H335:1
91058,Substance H112287,405-770-5,,Eye Dam. 1,Notified C&L,1,H318:1
91060,"2-butanone-O,O',O''-(phenylsilylidyne)trioxime",433-360-6,34036-80-1,Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H373:0;H412:0;H317:0
91061,Butylmethylamine,203-791-2,110-68-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 4,Notified C&L,43,H302:43;H314:43;H311:38;H225:43;H332:38;H312:5;H318:1
91063,2-(4-chlorophenyl)-2-(1-cyclopropylethyl)-oxirane,619-021-7,94361-26-9,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,123,H400:123;H410:123;H317:123;H315:123
91065,3'-hydroxyacetoacetanilide,244-722-6,22016-03-1,Eye Dam. 1,Notified C&L,1,H318:1
91067,"2H-1-Benzopyran-5-propanenitrile, 2-cyclopropyl-7,8-dimethoxy-.alpha.-[(phenylamino)methylene]-",606-270-1,192315-08-5,Not Classified,REACH registration C&L,2,Not classified:2
91069,1-chloroethyl chloroformate,256-834-2,50893-53-3,,REACH registration C&L,54,H226:54;H331:45;H302:52;H314:53;H330:6;H319:1;H335:2;H315:1;H301:2;H341:1;H318:1;H310:1;H311:1
91070,"Mercury, compound with titanium (1:3)",234-306-2,11083-41-3,Flam. Sol. 1;Acute Tox. 2;Acute Tox. 1;Acute Tox. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4,H330:4;H410:4;H300:4;H400:4;H310:4;H373:4;H228:4
91072,"Cyclopropanecarboxylic acid, 2 phenyl-, hydrazide trans",604-482-9,14561-40-1,Acute Tox. 4;Muta. 2;Carc. 2;Aquatic Chronic 4,Notified C&L,1,H351:1;H302:1;H341:1;H413:1
91075,"tris(η5-cyclopenta-2,5-dien-1-yl)ytterbium",215-071-5,1295-20-1,Flam. Sol. 2;Water-react. 3,Notified C&L,42,H228:42;H261:38
91076,"Benzyl 4-[(1-butyl-5-cyano-1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridin-3-yl)azo]benzoate",278-115-2,75199-13-2,Skin Sens. 1B,REACH registration C&L,3,H317:2;Not classified:1
91077,"Soaps, stocks, pilchard-oil, acidulated",297-207-3,93348-64-2,Not Classified,Notified C&L,1,Not classified:1
91078,2-methyleneglutaronitrile,216-391-8,1572-52-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,73,H312:38;H302:38;H332:38;Not classified:33;H319:2;H315:2;H311:2;H301:2;H331:2
91081,4-(phenylazo)anilinium chloride,222-390-3,3457-98-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 1B,Notified C&L,39,H319:38;H312:38;H302:39;H335:38;H315:38;H350:38;H332:38
91082,Pyridine-4-acetic acid,248-990-5,28356-58-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
91083,"Alkenes, C24-28 α-",300-203-7,93924-11-9,Not Classified,REACH registration C&L,124,Not classified:124
91085,"Sulfonic acids, C14-17-sec-alkane, sodium salts",307-055-2,97489-15-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,227,H412:129;H302:227;H318:227;H315:227
91088,Trifluoroethylene,206-626-2,359-11-5,Flam. Gas 1;Press. Gas (Comp.),Notified C&L,41,H280:41;H220:41
91091,Methanesulphonyl fluoride,209-192-2,558-25-8,Acute Tox. 2;Skin Corr. 1B;Acute Tox. 1,Notified C&L,39,H300:39;H314:39;H330:39
91094,"L-Glutamic acid, N-coco acyl derivs., compds. with triethanolamine (1:1)",269-084-6,68187-29-1,Eye Dam. 1,REACH registration C&L,13,H318:2;Not classified:11
91096,Isopropyl trifluoroacetate,206-922-1,400-38-4,Flam. Liq. 2;Eye Irrit. 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,49,H319:3;H412:2;H225:49;H402:2;H335:41;H314:46;H315:1;H318:1
91098,"1,3,5-tri(isopropyl)hexahydro-1,3,5-triazine",234-142-1,10556-98-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H302:1;H332:1
91099,"(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.0",427-580-1,,Skin Irrit. 2,Harmonised C&L,0,H315:0
91101,N-benzyloxycarbonyl-L-aspartic acid,214-568-4,1152-61-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
91105,"Resin acids and Rosin acids, esters with trimethylolpropane",284-009-7,84776-83-0,Not Classified,REACH registration C&L,3,Not classified:3
91106,(1-bromovinyl)trimethylsilane,237-195-9,13683-41-5,Flam. Liq. 2,Notified C&L,39,H225:39
91112,"Potassium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionate",266-578-3,67118-55-2,Not Classified,Notified C&L,1,Not classified:1
91114,1-(2-hydroxy-6-methoxyphenyl)ethan-1-one,211-872-9,703-23-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
91115,"Smilax sarsaparilla, ext.",294-852-2,91770-66-0,Flam. Liq. 3,Notified C&L,113,H226:103;Not classified:10
91121,Lanthanum tris(2-ethylhexanoate),267-212-5,67816-09-5,,Notified C&L,5,H411:5;H315:5;H225:5;H373:5;H336:5;H304:5
91122,"Propanenitrile, 3-amino-, N-tallow alkyl derivs.",272-268-9,68784-70-3,Skin Corr. 1B;Aquatic Chronic 1,REACH registration C&L,51,H410:44;H314:44;Not classified:7;H400:2
91127,"N'-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine",248-872-3,28159-98-0,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,220,H400:190;H410:176;H317:214;Not classified:6
91128,3-(dimethylamino)-7-(methylamino)phenothiazin-5-ium tetrafluoroborate,279-128-6,79288-94-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
91130,"3,3'-(m-tolylimino)dipropiononitrile",242-686-6,18934-20-8,Acute Tox. 3,Notified C&L,38,H301:38
91134,"Pyrimidine, hexahydro-, 1-(C16-18-alkyl and C16-18-alkenyl) derivs.",292-167-3,90552-44-6,Not Classified,Notified C&L,441,Not classified:441
91136,"1,2-bis(2-chloroethoxy)ethane",203-952-7,112-26-5,Acute Tox. 3;Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,54,H319:9;H312:53;H301:51;H335:44;H315:44;H318:41;H302:3;Not classified:2;H330:1;H311:1;H332:1
91138,"4-ethenyl-2,3-dihydro-1-benzofuran",607-194-1,230642-84-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
91141,3-iodobenzoic acid,210-555-2,618-51-9,,Notified C&L,9,H319:9;H335:8;H315:9
91143,Perchloric (2H)acid,242-765-5,19029-50-6,Ox. Liq. 1;Skin Corr. 1A,Notified C&L,38,H271:38;H314:38
91144,but-1-ene,203-449-2,106-98-9,Press. Gas;Flam. Gas 1,Harmonised C&L,0,H220:0;Not classified:0
91145,"Benzoic acid, 3,5-dichloro-4-[[(hexadecyloxy)carbonyl]oxy]-, ethyl ester",601-393-7,115895-09-5,Aquatic Chronic 4,Notified C&L,1,H413:1
91146,Barium hydroxide,241-234-5,17194-00-2,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,531,H302:399;H332:281;H318:217;H314:326;H412:125;H290:125;H301:125;H319:16;H331:10;Not classified:8
91147,"Disodium 4,4'-bis[(4,6-dianilino-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonate",205-117-2,133-66-4,Not Classified,Notified C&L,125,Not classified:87;H412:36;H319:2;H315:1
91149,Methylenediamine dihydrochloride,260-602-6,57166-92-4,,Notified C&L,4,H319:4;H335:4;H315:4
91153,Octadecyl (Z)-docos-13-enoate,289-256-4,86601-84-5,Not Classified,Notified C&L,441,Not classified:441
91154,"(17β)-3-Methoxyestra-1,3,5(10)-trien-17-yl acetate",611-880-6,5976-55-6,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H410:1;H373:1;H400:1
91159,"5-(1-methyl-4-piperidyl)-5H-dibenzo[a,d]cyclohepten-5-ol hydrochloride",223-746-0,4046-24-6,Not Classified,REACH registration C&L,3,Not classified:2;H302:1
91163,"Decahydropyrazino[2,3-b]pyrazine",226-479-8,5409-42-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,39,H319:39;H334:39;H317:39;H315:39;H312:8;H302:8
91168,Ticarcillin,252-213-5,34787-01-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,39,H334:39;H317:39
91169,"Pulp, cellulose",265-995-8,65996-61-4,Not Classified,Notified C&L,176,Not classified:175;H317:1
91170,Cyclohexanecarboxylic anhydride,245-146-8,22651-87-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
91174,"2,3-dihydroxypropyl methacrylate",227-642-6,5919-74-4,Eye Irrit. 2;Repr. 2,REACH registration C&L,194,H319:136;H361:4;Not classified:57;H317:49;H335:35;H315:36
91180,"Castor oil, hydrogenated, calcium salt",266-121-8,66072-09-1,Not Classified,Notified C&L,3,Not classified:3
91187,1-methylcycloheptan-1-ol,223-179-9,3761-94-2,Acute Tox. 4,Notified C&L,43,H302:38;H319:5;H335:5;H315:5
91191,"Tetrahydrogen [29H,31H-phthalocyanine-2,9,16,23-tetrasulphonato(6-)-N29,N30,N31,N32]cobaltate(4-)",238-200-7,14285-59-7,Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,6,H319:6;H317:4
91194,Tiosinamine,203-683-5,109-57-9,Acute Tox. 3,Notified C&L,192,H301:192;H319:58;H315:58;H335:57;H317:4;Not classified:3;H311:2;H331:1
91195,"1,3,5-triazine-2,4-diamine",207-983-7,504-08-5,Acute Tox. 4;Resp. Sens. 1,Notified C&L,72,H302:38;H334:38;Not classified:33;H319:1;H315:1
91198,"3,3-dimethyl-8,9-dinorbornan-2-yl acetate",237-588-5,13851-11-1,Skin Sens. 1;Muta. 2;Carc. 2,Notified C&L,1730,H341:1287;H351:1287;H317:1287;Not classified:390;H319:40;H335:40;H315:40;H412:13
91199,3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanoic acid,604-786-1,151262-57-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
91201,"3-[(4-amino-6-bromo-5,8-dihydro-1-hydroxy-8-imino-5-oxo-2-naphtyl)amino]-N,N,N-trimethylanilinium chloride",268-544-3,68123-13-7,Not Classified,REACH registration C&L,68,Not classified:2;H318:65;H319:1;H312:1;H302:1;H332:1
91202,"S-benzothiazol-2-yl (Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)thioacetate",279-540-6,80756-85-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,60,H319:60;H335:59;H315:60;H334:1;H317:1;H412:1
91204,Methyl 4-(butylamino)benzoate,700-310-2,71839-12-8,,Notified C&L,2,Not classified:1;H302:1
91207,"N,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide",413-610-0,124172-53-8,Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H319:0;H412:0
91211,N-1-naphthyl-l-glutamine,249-007-2,28401-75-4,Muta. 2,Notified C&L,1,H341:1
91213,3-chloro-6-methoxypyridazine,217-019-7,1722-10-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
91214,3-ethyl-4-methylpyridine,208-453-8,529-21-5,,Notified C&L,4,H319:4;H302:4;H335:4;H315:4
91217,Calcium bromide,232-164-6,7789-41-5,Eye Dam. 1,REACH registration C&L,315,H318:273;H335:93;H315:126;H319:39;Not classified:3
91226,"Residues (petroleum), atm. tower;Heavy Fuel oil;[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C",265-045-2,64741-45-3,Carc. 1B,Harmonised C&L,0,H350:0
91227,diammonium peroxodisulphate;ammonium persulphate,231-786-5,7727-54-0,Ox. Sol. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H319:0;H302:0;H335:0;H315:0;H334:0;H317:0;H272:0
91228,"Sulfite liquors and Cooking liquors, spent, oxidized",271-024-9,68514-09-0,Not Classified,Notified C&L,1,Not classified:1
91229,"Amines, C20-22-alkyldimethyl",296-866-4,93164-85-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,REACH registration C&L,72,H400:72;H302:72;H314:72;H318:36
91230,C.I. Disperse Red 277,615-100-5,70294-19-8,Not Classified,Notified C&L,1,Not classified:1
91231,C9 branched alkyl phenol ethoxylate sulfuric acid sodium salt,614-757-5,68891-39-4,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,216,H412:105;H318:199;H411:40;H319:17;H315:26
91232,"2,3-difluoroaniline",224-847-2,4519-40-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H319:46;H312:40;H302:44;H335:41;H315:46;H332:40;H311:6;H373:4;H331:6;H301:2
91236,Ethyl dichlorophosphate,216-099-0,1498-51-7,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2,Notified C&L,41,H330:41;H314:41;H301:41;H318:1
91239,Potassium perrhenate,233-953-8,10466-65-6,Not Classified,REACH registration C&L,46,Not classified:2;H319:40;H272:44;H335:39;H315:40
91240,"4,4',4''-methylidynetrisphenol",210-040-2,603-44-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
91246,"2,3-dihydro-1,4-benzodioxin-6-carbaldehyde",249-763-3,29668-44-8,,Notified C&L,2,H319:1;H335:1;H315:1;Not classified:1
91248,Methamphetamine hydrochloride,200-106-9,51-57-0,Acute Tox. 3,Notified C&L,41,H301:39;H300:1;H302:1
91253,"2,2'-binaphthalene",210-320-4,612-78-2,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38;H318:38
91254,"3,3'-(phenylimino)bispropiononitrile",216-306-4,1555-66-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:38;H335:38;H315:38;H312:1;H302:1;H332:1;H311:1;H331:1;H301:1
91256,"Poly(oxy- 1,2-ethanediyl), .alpha.-sulfo-.omega.-hydroxy-C6-10-alkyl ethers, sodium salts",616-006-7,73665-22-2,Not Classified,Notified C&L,57,Not classified:23;H319:20;H315:34;H318:14
91257,2-benzyloxyethanol,210-719-3,622-08-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H302:40;H335:39;H315:39;H318:1
91261,Vecuronium bromide,256-723-9,50700-72-6,Acute Tox. 4,Notified C&L,58,H302:57;H312:17;H330:17;H300:1;H310:1;H319:1;H315:1;H331:1
91262,"6,7-dichloro-1,4-dihydroxyanthraquinone",214-954-2,1225-15-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
91266,Sodium 12-hydroxyoctadecanoate,236-374-9,13329-67-4,Not Classified,Notified C&L,41,Not classified:41
91269,"N,N'-bis[2-(dimethylamino)ethyl]-N,N'-dimethylethylenediamine",221-382-7,3083-10-1,Skin Corr. 1B,Notified C&L,43,H314:39;H319:4;H335:4;H315:4;H318:1
91270,"Formaldehyde, reaction products with N1-(2-aminoethyl)-1,3-propanediamine and bisphenol A",600-748-3,1064696-39-4,Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H314:1;H317:1
91273,"Disodium 4,5-dihydroxybenzene-1,3-disulphonate",205-741-5,149-45-1,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,49,H410:3;H319:47;H400:3;H335:40;H315:44;H317:2;H312:2;Not classified:1
91274,2-chloro-5-methyl-4-nitrophenol,254-802-2,40130-97-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
91276,"Tall oil, reaction products with tetraethylenepentamine",271-417-5,68555-22-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,3,H319:2;H335:2;H315:2;H411:1;H314:1;H317:2
91281,"Fatty acids, C14-18-branched and linear, esters with trimethylolpropane",284-959-2,85005-27-2,Not Classified,Notified C&L,7,Not classified:7
91282,"2,2-dimethyltrimethylene diacrylate;neopentyl glycol diacrylate",218-741-5,2223-82-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H311:0;H319:0;H317:0;H315:0
91285,O-hexyl-N-ethoxycarbonylthiocarbamate,432-750-3,109202-58-6,Acute Tox. 4;Skin Sens. 1;Muta. 1B;Carc. 1B;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H340:0;H302:0;H317:0;H350:0;H373:0
91291,"Resins, oleo-, black pepper",616-796-3,8002-56-0,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,93,H411:92;H319:93;H315:93;H317:92;H301:92;H226:92;H312:1;H302:1
91293,(E)-octadec-9-enol,208-037-6,506-42-3,Skin Irrit. 2,Notified C&L,38,H315:38
91294,4-tert-butylpyridine,223-614-2,3978-81-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:40;H315:42
91296,"(2α,6α,11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol hydrochloride",264-612-1,64024-15-3,Acute Tox. 4,Notified C&L,3,H302:3;H319:1;H315:1
91297,3-Bromo-5-chloro-2-hydroxybenzaldehyde,606-351-1,19652-32-5,,Notified C&L,6,H319:6;H335:5;H315:6
91304,N-methyl-N-(trimethylsilyl)trifluoroacetamide,246-331-6,24589-78-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H226:56;H319:56;H335:55;H315:56
91305,"Formaldehyde, reaction products with ethylenediamine",281-928-5,84066-92-2,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,3,H319:3;H317:3;H302:3;H332:2;H315:1
91306,Copper dihexanoate,236-758-6,13476-79-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H302:1
91309,1-chloro-2-(dichloromethyl)-3-fluorobenzene,263-562-8,62476-62-4,Skin Corr. 1B;STOT SE 3,Notified C&L,39,H314:39;H335:39
91311,"Kaolin, calcined",296-473-8,92704-41-1,Not Classified,REACH registration C&L,528,Not classified:422;H372:53;H373:52;H334:1;H317:1
91316,Proflavine hemisulphate,217-320-3,1811-28-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
91318,Transaminase enzyme powder,618-523-3,9030-47-1,Resp. Sens. 1,REACH registration C&L,41,H334:41;H317:39
91321,Chlorine trifluoride,232-230-4,7790-91-2,Ox. Gas 1;Press. Gas (Liq.);Skin Corr. 1A;Acute Tox. 2;Aquatic Acute 1,Notified C&L,116,H314:116;H280:116;H330:116;H400:116;H270:116
91322,"2-[2-[(4-methoxyphenyl)amino]vinyl]-1,3,3-trimethyl-3H-indolium chloride",247-206-9,25717-55-9,,Notified C&L,21,H319:16;H302:16;H411:5;Not classified:3;H315:3;H400:3;H410:3;H412:2
91323,"Dibenzo[b,f][1,4]thiazepin-11(10H)-one",438-020-0,,Aquatic Chronic 4,REACH registration C&L,6,H413:5;H319:1;H335:1;H315:1
91324,Trichloroisobutylsilane,242-053-4,18169-57-8,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1A,REACH registration C&L,67,H314:67;H225:5;H301:65;H226:62;H290:1;H318:1
91326,Di-p-toluohydrazide,216-232-2,1530-73-0,,Notified C&L,4,H319:4;H335:4;H315:4
91327,"4,4'-dibromobiphenyl",202-198-6,92-86-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,50,H351:40;H302:44;H335:47;H315:47;H410:43;H318:43;H400:43;H319:4;H412:4;Not classified:2;H312:1;H332:1
91328,"1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate",425-730-0,51178-75-7,Skin Sens. 1,Harmonised C&L,0,H317:0
91329,Heptafluorobutyryl chloride,206-785-8,375-16-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H314:44;H318:39;H290:1
91330,Sodium 1-(2-methylpropyl) 10-(sulphooxy)octadecanoate,267-388-3,67859-39-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H315:2
91331,Benzyldimethyloctylammonium chloride,213-502-1,959-55-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,39,H312:38;H400:38;H302:39;H314:38;H319:1;H315:1
91332,"2,1,3-benzothiadiazole",205-985-2,273-13-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
91335,"(2E,4E)-dodeca-2,4-dienol",242-372-9,18485-38-6,Not Classified,Notified C&L,88,Not classified:88
91339,silthiofam (ISO);,605-752-9,175217-20-6,STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H373:0
91344,S-(1-oxidotetrahydro-3-thiophen-yl)ethanethioate,601-737-6,120788-03-6,Skin Sens. 1,REACH registration C&L,1,H317:1
91345,"Benzoic acid, 2-hydroxy-4-iodo-",605-527-5,16870-28-3,Acute Tox. 3;Eye Dam. 1,Notified C&L,38,H318:38;H301:38
91348,"Orthoboric acid, compound with 2-amino-2-methylpropan-1-ol",300-896-6,93964-50-2,Not Classified,Notified C&L,444,Not classified:443;H319:1
91351,5-methylindan-4-ol,243-704-5,20294-31-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
91353,"2-Propenenitrile, polymer with N-(2-aminoethyl)-1,2-ethanediamine",603-914-3,135296-35-4,Not Classified,Notified C&L,9,Not classified:9
91356,"Disodium 5-(acetylamino)-4-hydroxy-3-[(o-tolyl)azo]naphthalene-2,7-disulphonate",229-231-7,6441-93-6,Not Classified,Notified C&L,2,Not classified:2
91357,Levothyroxine sodium,200-221-4,55-03-8,Repr. 2;STOT RE 1,Notified C&L,52,H361:49;H372:49;H312:2;H302:2;H332:2;H311:1;H319:1;H315:1;H301:1
91359,Benzyldimethyl[2-[(2-methyl-1-oxoallyl)oxy]ethyl]ammonium chloride,256-288-5,46917-07-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
91360,"1,3-diphenylguanidine",203-002-1,102-06-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H411:0;H319:0;H302:0;H361:0;H335:0;H315:0
91362,Non-3-en-2-one,238-248-9,14309-57-0,Eye Irrit. 2,Notified C&L,1460,H319:1325;Not classified:135;H335:1
91363,Mesitylene-2-sulphonohydrazide,240-319-4,16182-15-3,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H228:39;H335:38;H315:39
91365,(R)-4-fluorophenylglycine,300-363-8,93939-74-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
91366,"Fatty acids, castor-oil, sulfated, sodium salts",292-879-4,91002-04-9,Not Classified,Notified C&L,1,Not classified:1
91367,"Disodium 4,4'-diaminostilbene-2,2'-disulphonate",230-847-3,7336-20-1,Not Classified,Notified C&L,130,Not classified:130
91368,trans-1-Fluor-4-(4-heptylcyclohexyl)-benzol,616-388-5,76802-59-0,Met. Corr. 1;Skin Corr. 1B;Aquatic Chronic 4,Notified C&L,1,H413:1;H314:1;H290:1;Not classified:1
91369,"Benzonitrile, 2-hydroxy-, ammonium salt",601-315-1,114536-52-6,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1;H317:1;H314:1
91370,"5-bromo-4,6-dichloropyrimidine",272-305-9,68797-61-5,Acute Tox. 3;Skin Corr. 1B,Notified C&L,45,H314:45;H301:41;H311:1;H331:1
91371,hexamethylenediamine,204-679-6,124-09-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Harmonised C&L,0,H312:0;H302:0;H335:0;H314:0
91372,(3-chloro-2-hydroxypropyl) trimethylammonium chloride ...%,222-048-3,3327-22-8,Carc. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H351:0
91375,m-tolyl isothiocyanate,210-677-6,621-30-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H319:42;H312:46;H302:46;H335:42;H315:42;H332:46;H314:5;H301:1;H331:1
91379,[No public or meaningful name is available],451-210-8,,Not Classified,Notified C&L,1,Not classified:1
91384,Methyl 1-naphthyl ether,218-696-1,2216-69-5,Not Classified,REACH registration C&L,4,Not classified:3;H411:1
91387,2-ethyl-4-methylthiazole,239-757-9,15679-12-6,Acute Tox. 4,Notified C&L,1597,H302:1553;H226:73;H319:42;H335:40;H315:42;H312:1
91388,Pyrazine,206-027-6,290-37-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,162,H319:162;H225:79;H335:161;H315:162;H228:71;H332:1;H226:1
91390,"4-methyl-2-phenyl-1,3-dioxolane",219-906-4,2568-25-4,Not Classified,Notified C&L,155,Not classified:116;H319:39;H335:38;H315:39
91393,"1-[(2,6-dibromo-4-methylphenyl)amino]-4-hydroxyanthraquinone",269-454-7,68239-61-2,Not Classified,Notified C&L,1,Not classified:1
91398,Sulphur trioxide--trimethylamine (1:1),221-614-7,3162-58-1,Skin Corr. 1B,Notified C&L,46,H314:46;H302:2;H318:2
91405,"α-D-Glucofuranose, 1,2-O-(1-methylethylidene)-3-O-(phenylmethyl)-, 6-acetate 5-methanesulfonate",617-585-9,84563-90-6,Not Classified,Notified C&L,1,Not classified:1
91406,Cadmium dioleate,233-954-3,10468-30-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H312:1;H410:1;H302:1;H332:1
91407,Disodium 3-hydroxy-4-[(4-methyl-2-sulphonatophenyl)azo]-2-naphthoate,227-497-9,5858-81-1,Not Classified,REACH registration C&L,21,Not classified:21
91410,Clorprenaline,223-291-8,3811-25-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
91413,"Potassium 1,3-dioxo-1H,3H-naphtho[1,8-cd]pyran-6-sulphonate",275-547-3,71501-16-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
91415,2-sulphamoylbenzoic acid,211-174-4,632-24-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
91419,Gold trisodium bis(thiosulphate),233-563-8,10233-88-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H315:1
91425,"4,4'-Isopropylidenediphenol, ethoxylated",500-082-2,32492-61-8,Aquatic Chronic 3,REACH registration C&L,299,H412:147;H302:79;H319:59;H335:39;H315:60;Not classified:29;H317:1
91428,"Gasoline, vapor-recovery;Low boiling point naphtha;[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C",271-025-4,68514-15-8,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
91437,Dipotassium dihydrogen (1-hydroxyethylidene)bisphosphonate,244-210-2,21089-06-5,Acute Tox. 4,Notified C&L,36,H302:35;H319:14;H315:14;H290:1;H318:1;Not classified:1
91442,2-bromobutane,201-140-7,78-76-2,Flam. Liq. 2;Met. Corr. 1;Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,53,H412:13;H314:7;H290:7;H318:7;H225:53;H336:5;H319:3;H335:2;H315:3
91443,"Disodium 4-[(o-arsonophenyl)azo]-3-hydroxynaphthalene-2,7-disulphonate",222-993-1,3688-92-4,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,45,H400:41;H410:45;H331:45;H301:45;H373:4;H350:1
91444,2-aminobenzaldehyde,208-454-3,529-23-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40;H312:2;H302:2;H332:2
91445,"N-amidino-3,5-diamino-6-chloropyrazinecarboxamide monohydrochloride",217-958-2,2016-88-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,189,H319:142;H412:141;H315:142;H301:189;H311:1
91447,3-bromo-p-toluidine,231-807-8,7745-91-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:40;H301:44;H311:5;H302:1;H331:1
91450,Potassium 2-(aminothioxomethyl)dithiocarbazate,277-591-9,73771-62-7,Acute Tox. 3,Notified C&L,2,H311:1;H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
91451,"Bis(pentane-2,4-dionato-O,O')barium",235-151-3,12084-29-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,36,H302:36;H332:36
91452,"reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone",414-870-8,96792-67-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
91453,10-bromodecanol,258-572-4,53463-68-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
91454,"Trihydrogen [P,P-dibutyl diphosphato(2-)-O'']bis[P,P-dioctyl diphosphato(2-)-O''](propan-2-olato)titanate(3-), branched and linear, compound with dioctyl phosphonate, branched and linear",271-577-6,68585-69-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H315:1
91458,"2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium methyl sulphate",281-473-2,83950-21-4,Acute Tox. 2;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H330:2;H410:2;H318:2;H300:2;H400:2
91462,Sodium 3-hydroxy-2-naphthoate,238-063-3,14206-62-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,83,H319:83;H302:83
91465,(2-aminoethyl)carbamic acid,203-684-0,109-58-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H317:38;H335:38;H315:38
91473,Tetramethylammonium nitrate,217-723-4,1941-24-8,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H272:43;H335:43;H315:43
91475,"Naphthenic acids, potassium salts",266-120-2,66072-08-0,Not Classified,Notified C&L,3,Not classified:2;H319:1
91478,rosin; colophony,277-299-1,73138-82-6,Skin Sens. 1,Harmonised C&L,0,H317:0
91485,"Poly[(2-aminoethyl)aminopropyl] methoxy(di Me)siloxane, polymers with [(2-aminoethyl)aminopropyl] phenylsilsesquioxane, OH-term.",610-378-4,477725-72-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,23,H319:22;H315:23;H318:1
91486,"4-bromo-N,N-dimethylaniline",209-582-2,586-77-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,59,H319:58;H312:58;H302:59;H315:58;H332:58;H335:2;H351:1
91492,Disodium 6-amino-5-[[5-[(2-bromo-1-oxoallyl)amino]-2-sulphonatophenyl]azo]naphthalene-2-sulphonate,274-438-8,70210-41-2,Not Classified,Notified C&L,2,Not classified:2
91493,N-methyldodecylamine,230-771-0,7311-30-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42,H314:42;H318:38
91503,"Sodium 2,6-difluorobenzoate",612-558-8,6185-28-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
91508,"flutolanil (ISO); N-[3-(propan-2-yloxy)phenyl]-2-(trifluoromethyl)benzamide; α,α,α-trifluoro-3′-isopropoxy-o-toluanilide",613-921-3,66332-96-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156,H400:124;H410:124;H411:32
91509,"N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide",610-733-3,518048-05-0,Not Classified,REACH registration C&L,2,Not classified:2
91515,"Alcohols, C12-20 and C12-20-unsatd.",288-209-5,85681-70-5,Not Classified,Notified C&L,1,Not classified:1
91516,"3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;isophorone di-isocyanate",223-861-6,4098-71-9,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;STOT SE 3;Resp. Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H319:0;H335:0;H315:0;H334:0;H317:0;H331:0
91521,Butyl hydrogen phthalate,205-036-2,131-70-4,Repr. 1B,Notified C&L,40,H360:39;H411:1;H319:1;H315:1
91523,3-chloro-o-toluidine,201-756-6,87-60-5,Acute Tox. 4;Acute Tox. 3;Skin Sens. 1B;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,Notified C&L,140,H411:87;H302:136;H311:86;H317:86;H318:86;H373:93;H334:38;H314:39;H319:9;H312:10;H315:9;H332:10;H301:4;H412:2;H370:2;H372:2;H335:2
91524,"(S)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-methylisoquinolinium chloride",212-934-8,883-87-4,Acute Tox. 2,Notified C&L,1,H300:1
91525,Gold(1+) trisodium disulphite,242-846-5,19153-98-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,72,H319:72;H335:71;H315:72
91527,"2,4,6-triallyloxy-1,3,5-triazine",202-936-7,101-37-1,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,213,H411:213;H302:213;H319:4;H335:4;H315:4;H332:4;Not classified:2;H312:2
91528,2-bromoacrylonitrile,213-054-7,920-34-3,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H226:38;H302:38;H314:38
91529,6-methylhept-5-en-2-one,203-816-7,110-93-0,Flam. Liq. 3,REACH registration C&L,1746,H226:1746;H319:1343;H315:2;H335:2;H311:1;H301:1;H400:1;H331:1;H412:1;H317:1
91531,"Aluminium Chloride,basic,reaction product with silica",614-074-2,675106-31-7,Not Classified,REACH registration C&L,21,Not classified:21
91532,4-ethylbenzophenone,242-101-4,18220-90-1,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,38,H411:38;H315:38
91534,Meladrazine,237-736-9,13957-36-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H302:2;H335:2;H315:2
91535,"Litchi, ext.",294-483-7,91722-81-5,Flam. Liq. 3,Notified C&L,29,H226:25;Not classified:4
91540,Sodium bis[methyl [7-hydroxy-8-[[2-hydroxy-5-mesylphenyl]azo]-1-naphthyl]carbamato(2-)]chromate(1-),276-070-3,71839-85-5,Aquatic Chronic 2,Notified C&L,318,H411:276;H400:22;H410:22;H317:41;Not classified:1
91541,Bromo(phenyl)acetic acid,225-477-4,4870-65-9,Skin Corr. 1B;STOT SE 3,Notified C&L,39,H314:39;H335:38;H290:1;H318:1
91549,"Dimethyl 3,3'-dithiobispropionate",239-452-0,15441-06-2,,Notified C&L,33,Not classified:33
91550,"L-Arginine, N2-[(phenylmethoxy)carbonyl]-, monohydrochloride",611-409-4,56672-63-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:2;H315:2;Not classified:1
91552,"Rape oil, reaction products with soybean oil and sulfur",274-279-4,70025-22-8,Not Classified,Notified C&L,1,Not classified:1
91557,3-methylamino-7-dimethylaminophenothiazin-5-ium chloride,208-511-2,531-55-5,,Notified C&L,5,H341:4;Not classified:1
91563,"Disodium 5,5'-[(1-methylethylidene)bis(4,1-phenyleneoxysulphonyl-2,1-phenyleneazo)]bis[6-aminonaphthalene-1-sulphonate]",274-354-1,70161-18-1,Skin Sens. 1,REACH registration C&L,11,H317:5;H411:4;Not classified:2
91568,"5,8,13,13a-tetrahydro-9,10-dimethoxy-6H-benzo[g]benzo-1,3-dioxolo[5,6-a]quinolizine",208-338-2,522-97-4,Acute Tox. 4,Notified C&L,40,H302:39;Not classified:1
91570,"2-ethylhexanoic acid, cobalt salt",237-015-9,13586-82-8,Not Classified,Notified C&L,148,Not classified:83;H411:64;H302:26;H317:65;H315:64;H319:4;H400:1;H410:2
91576,3-amino-2-methylpropiononitrile,202-484-0,96-16-2,Skin Corr. 1B,Notified C&L,1,H314:1
91577,α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane),415-290-8,193159-06-7,Skin Sens. 1,Harmonised C&L,0,H317:0
91578,Sulfonated nigrosine spirit soluble barium salt,270-933-8,68510-98-5,Not Classified,Notified C&L,14,Not classified:12;H319:2;H315:2
91580,"7,9-Dioxo-8-azaspiro[4.5]decane-6,10-dicarbonitrile,mixture of (Â±) and meso",610-087-2,42940-56-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H312:38;H302:38;H335:38;H315:38;H332:38
91585,Benzylethyldimethylammonium chloride,225-985-6,5197-80-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
91586,"Oils, menhaden",232-311-4,8002-50-4,Not Classified,REACH registration C&L,126,Not classified:116;H302:10
91587,Diisooctyl azelate,247-774-8,26544-17-2,Not Classified,Notified C&L,17,Not classified:17
91593,Aluminium acrylate,239-836-8,15743-20-1,,Notified C&L,4,H411:4;H319:4;H335:4;H315:4
91596,2-methylbutyronitrile,242-687-1,18936-17-9,Flam. Liq. 3;Acute Tox. 2;Asp. Tox. 1;Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,52,H412:1;H311:50;H300:52;H226:41;H331:50;H304:39;H225:11;H319:2;H315:2;H330:2;H310:2
91597,"Sodium O,O-di-sec-butyl dithiophosphate",251-598-7,33619-92-0,Skin Corr. 1C,REACH registration C&L,6,H314:6
91598,o-(prop-1-enyl)phenol,228-961-3,6380-21-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
91603,"Caseins, borated",614-298-0,68131-51-1,Not Classified,Notified C&L,1,Not classified:1
91604,2-benzylcyclohexan-1-one,213-420-6,946-33-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
91606,Trichloro(p-chlorophenyl)silane,212-551-6,825-94-5,Skin Corr. 1B,Notified C&L,38,H314:38
91607,"N-[2-(dimethylamino)ethyl]-N'-[2-[[2-(dimethylamino)ethyl]methylamino]ethyl]-N,N'-dimethylethylenediamine",221-383-2,3083-11-2,Eye Dam. 1,Notified C&L,33,H318:33
91609,3-benzamido-4-[(p-nitrophenyl)azo]phenyliminodiethyl diacetate,249-830-7,29765-00-2,Not Classified,Notified C&L,18,Not classified:18
91615,"Oils, vegetable, sulfonated, ammonium salts",307-042-1,97489-02-6,Not Classified,Notified C&L,3,Not classified:3
91619,Tris(amidinouronium) phosphate,226-533-0,5420-79-1,,Notified C&L,1,Not classified:1
91620,"Naphthenic acids, iron salts",215-660-7,1338-14-3,,Notified C&L,9,H226:6;H350:4;H304:4;H335:2;H315:3;H413:2
91624,Cyano-Fluorchinoloncarbonsäure,453-800-0,,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H319:1
91626,3-amino-4-hydroxybenzoic acid,216-390-2,1571-72-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H302:39;H335:42;H315:43;H312:1;H332:1
91630,N-[(tert-butoxy)carbonyl]-L-tyrosine,223-613-7,3978-80-1,,Notified C&L,7,H319:4;H335:4;H315:4;Not classified:3
91633,"1H-Inden-1-one, 6-(2,5-dimethylbenzoyl)-3-hydroxy-2-(3-hydroxy-2-quinolinyl)-",606-392-5,198625-33-1,,Notified C&L,33,Not classified:33
91634,(2H4)methane,209-191-7,558-20-3,Flam. Gas 1;Press. Gas (Comp.),Notified C&L,82,H280:82;H220:82
91640,Trimethylsilyl trifluoroacetate,206-923-7,400-53-3,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,41,H225:41;H314:41;H318:2
91642,"Tall oil, reaction products with diethanolamine",307-056-8,97489-16-2,Not Classified,Notified C&L,1,Not classified:1
91645,3-ethynylaniline,258-944-6,54060-30-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H226:42;H319:50;H335:44;H315:50;H312:5;H302:5;H332:1
91647,"Alcohols, C16-20 (even numbered, linear), ethoxylated (< 2.5 EO)",600-724-2,106232-82-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,36,H302:34;H318:35;H301:1;H411:1
91649,2-chloro-4-fluorotoluene,207-209-8,452-73-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H226:44;H319:43;H335:42;H315:43
91652,"1,2-dibromobutane",208-581-4,533-98-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:43;H312:43;H302:43;H335:42;H315:43;H332:43
91654,"Marjoram, Spanish, ext.",294-485-8,91722-83-7,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,2,H226:2;H411:2;H317:2;H315:2
91663,"Nona-2,6-dien-1-ol",232-097-2,7786-44-9,Not Classified,Notified C&L,1423,Not classified:1423
91666,"Disodium 1-(2,4-dimethylphenylazo)-2-hydroxynaphthalene-3,6-disulphonate",223-178-3,3761-53-3,Carc. 2,Notified C&L,200,H351:200;H341:1;H319:1;H335:1;H315:1
91668,5-methylresorcinol,207-984-2,504-15-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:48;H302:49;H335:47;H315:48;H312:1;H332:2
91670,2-hexyloxyethanol;ethylene glycol monohexyl ether;n-hexylglycol,203-951-1,112-25-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Harmonised C&L,0,H312:0;H302:0;H314:0
91675,"1H-Pyrrole-2,5-dione, 1-(3-aminopropyl)-, N-tallow alkyl derivs.",292-168-9,90552-45-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
91677,1-ethyl-3-methyl-1H-imidazol-3-ium acetate,604-344-8,143314-17-4,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,88,H317:85;H315:87;H319:2;Not classified:1
91679,1-(2-hydroxyethyl)piperidine-4-propanol,243-305-6,19780-85-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
91680,m-chlorobenzamide,210-554-7,618-48-4,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,43,H319:43;H302:43;H317:38;H335:5;H315:5;H312:1;H332:1
91681,3-methoxypropiononitrile,203-790-7,110-67-8,Eye Irrit. 2,REACH registration C&L,147,H319:144;H335:49;H315:40;Not classified:3
91683,1-(2-butoxy-1-methylethoxy)propan-2-ol,249-951-5,29911-28-2,Not Classified,REACH registration C&L,1563,Not classified:1268;H319:146;H318:86;H332:63;H330:63
91685,"butane;butane (containing ≥ 0,1 % butadiene (203-450-8))",203-448-7,106-97-8,,,0,H220:0;Not classified:0
91686,Tridecasodium hypochloritetetrakis(phosphate),234-307-8,11084-85-8,,Notified C&L,42,H319:42;H315:42;H335:1
91687,Trichlormethiazide,205-118-8,133-67-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,40,H334:38;H317:38;Not classified:1;H319:1;H315:1
91688,"Distillates (petroleum), straight-run middle",265-044-7,64741-44-2,Asp. Tox. 1;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,899,H332:75;H373:72;H411:66;H304:796;H226:352;H302:83;H315:100;H413:115;Not classified:58;H336:58;H412:32;H361:29;H319:15;H318:1;H335:3;H301:1
91689,Testosterone isobutyrate,214-622-7,1169-49-9,,Notified C&L,2,H302:2;H361:1;H319:1;H312:1;H351:1;H335:1;H315:1;H332:1
91691,"Bis(1,5-cyclooctadiene)nickel",215-072-0,1295-35-8,Flam. Sol. 1;Resp. Sens. 1;Carc. 2,Notified C&L,47,H351:38;H228:47;H334:39;H350:8;H317:8;Not classified:1;H341:1;H372:1
91694,"Quaternary ammonium compounds, (2-hydroxypropyl)dimethylsoya alkyl, chlorides",270-459-1,68440-53-9,Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H302:1;H314:1
91696,"5-ethyldihydro-5-(2-methylallyl)-2-thioxo-1H,5H-pyrimidine-4,6-dione",204-095-1,115-56-0,Acute Tox. 1,Notified C&L,38,H300:38
91700,"Acetic acid, 2-hydroxy-2-sulfino-, sodium salt (1:2)",606-977-5,223106-41-0,Eye Irrit. 2,Notified C&L,517,H319:441;Not classified:76
91701,"N,N,N',N'-tetrakis(2,3-epoxypropyl)cyclohexane-1,3-dimethylamine",265-994-2,65992-66-7,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1,Notified C&L,11,H314:11;H317:11;H301:11;H318:1
91702,1-methyl-4-(1-methylethylidene)cyclohexan-1-ol,209-584-3,586-81-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,31,H319:28;H315:31
91707,Terbium triiodide,237-469-8,13813-40-6,Skin Sens. 1;Repr. 2,Notified C&L,43,H361:38;H317:38;H319:5;H335:5;H315:5
91710,"3,4-diethoxybenzoic acid",226-478-2,5409-31-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
91714,CARTASOL TUERKIS K-ZBL BASE,401-250-7,,Not Classified,Notified C&L,31,Not classified:31
91715,"Alkenes, C20-24 α-",300-202-1,93924-10-8,Asp. Tox. 1,REACH registration C&L,691,H304:576;H413:59;Not classified:56
91716,hydrocarbons C,307-753-7,97722-04-8,Carc. 1B,Harmonised C&L,0,H350:0
91718,5-acetamidosalicylic acid,200-107-4,51-59-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:38;H302:39
91721,Diethyl 2-[2-bromoethyl]-2-ethoxycarbonylmalonate,414-710-7,,Not Classified,Notified C&L,1,Not classified:1
91725,"2,2,5,5-tetramethylpyrrolidine-3-carboxamide",211-871-3,702-96-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
91727,"Choline 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate",246-213-4,24381-49-5,Not Classified,Notified C&L,1,Not classified:1
91728,"Shorea stenoptera, ext.",294-851-7,91770-65-9,Not Classified,Notified C&L,1,Not classified:1
91732,2-tolualdehyde,208-452-2,529-20-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,76,H302:48;H318:63;H335:49;H315:47;H319:34;H314:26;H312:4;H332:4;H412:1;H311:1
91735,"N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide",421-780-2,150919-56-5,Aquatic Chronic 4,Harmonised C&L,0,H413:0
91737,"2-(allylthio)-4,5-dihydrothiazole",222-679-4,3571-74-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
91739,C.I. Direct Blue 279,615-830-4,72827-89-5,Not Classified,Notified C&L,5,Not classified:5
91740,PHMB,608-042-7,27083-27-8,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1B;Acute Tox. 2;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H351:0;H302:0;H330:0;H410:0;H317:0;H372:0;H318:0;H400:0
91743,"3-[[2-(2,5-dioxopyrrolidin-1-yl)ethyl](3-methylphenyl)amino]propiononitrile",218-742-0,2223-89-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
91746,"Dehydrogenase, malate",232-622-5,9001-64-3,Resp. Sens. 1,Notified C&L,65,H334:63;Not classified:2
91747,Cadmium bromide,232-165-1,7789-42-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H312:43;H302:43;H400:43;H332:43;H410:43
91748,"[ethane-1,2-diylbis[[3-[bis(phosphonomethyl)amino]propyl]imino]bis(methylene)]bisphosphonic acid",278-074-0,75125-54-1,Met. Corr. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H290:1;H315:1
91752,"Tallow, potassium salt",269-679-0,68309-88-6,Not Classified,Notified C&L,4,Not classified:4
91755,"Isononanoic acid, mixed esters with heptanoic acid and pentaerythritol",601-553-6,118685-29-3,Not Classified,Notified C&L,1,Not classified:1
91761,Ethyl dichlorophosphite,216-098-5,1498-42-6,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,42,H225:42;H314:42
91765,Tetrapropyltin,218-536-0,2176-98-9,,Notified C&L,5,H334:4;H317:4;H311:1;H330:1;H301:1
91767,"1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-norcoco alkyl derivs.",263-170-7,61791-38-6,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,577,H302:496;H314:526;H410:28;H318:475;H400:7;H319:40;H315:40;Not classified:11;H412:1;H360:1;H317:1
91777,M-119,443-370-2,,Eye Dam. 1,Notified C&L,1,H318:1
91779,"4-[bis(p-hydroxyphenyl)methylene]cyclohexa-2,5-dien-1-one",210-041-8,603-45-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:47;H315:48
91780,"Anthracene-1,2,10-triol",209-410-6,577-33-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
91787,Aspartame,245-261-3,22839-47-0,Not Classified,Notified C&L,191,Not classified:185;H312:5;H332:5;H372:1
91788,Tetryzoline,201-522-3,84-22-0,Acute Tox. 4,REACH registration C&L,1,H302:1
91792,Methyl hydrogen phthalate,224-476-6,4376-18-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
91797,"1-amino-4-[[4-[[4-chloro-6-[[3(or4)-sulphophenyl]amino]-1,3,5-triazin-2-yl]amino]-3-sulphophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",235-465-0,12236-82-7,Not Classified,Notified C&L,1,Not classified:1
91799,1-(4-chloro-phenyl)-2-cyclopropyl-propan-1-one,620-288-7,94361-25-8,Aquatic Chronic 2,Notified C&L,156,H411:156
91803,Methyl 2-oxopyrrolidin-1-acetate,261-926-0,59776-88-4,Not Classified,REACH registration C&L,41,Not classified:2;H302:39;H318:38;H335:38;H315:38
91806,"Sulfuric acid, mono-C14-18-alkyl esters, sodium salts",268-366-6,68081-98-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,36,H318:36;H315:36
91812,"lambda-cyhalothrin (ISO);reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1)",415-130-7,91465-08-6,Acute Tox. 3;Acute Tox. 4;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H330:0;H410:0;H301:0;H400:0
91815,"p,α-dimethylstyrene",214-795-9,1195-32-0,Asp. Tox. 1,Notified C&L,1461,H304:1301;Not classified:104;H319:71;H335:70;H315:71;H411:14
91820,Carbon tetrafluoride,200-896-5,75-73-0,Press. Gas (Comp.),REACH registration C&L,160,H280:160
91821,"Butanoic acid, 4-amino-4-oxo-2-sulfo-, N-tallow alkyl derivs., disodium salts",290-850-0,90268-48-7,Eye Dam. 1,Notified C&L,34,H318:29;Not classified:4;H315:1;H319:1
91823,Hydroxychloroquine,204-249-8,118-42-3,Acute Tox. 4,REACH registration C&L,39,H302:39
91825,"Tetrakis(2,2,6,6-tetramethyl-4-piperidyl) butane-1,2,3,4-tetracarboxylate",264-611-6,64022-61-3,Not Classified,Notified C&L,1,Not classified:1
91828,m-tolyl isocyanate,210-676-0,621-29-4,Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,72,H314:28;H335:71;H330:70;H410:26;H317:65;H318:27;H400:26;H319:44;H315:44;H334:46;H302:5;H301:1;H331:1;H412:1;H312:1;H332:1
91829,4-p-tolylbutyric acid,224-848-8,4521-22-6,Acute Tox. 4,Notified C&L,43,H302:38;H319:5;H335:4;H315:5
91830,"2,2,4,6,6-pentamethylheptane",236-757-0,13475-82-6,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 4,REACH registration C&L,192,H226:147;H304:122;H413:62;H410:38;H319:38;H400:38;H336:27;Not classified:7
91831,"2-ethylhexanoic acid, cerium salt",246-332-1,24593-34-8,Repr. 2;Aquatic Chronic 3,REACH registration C&L,141,H412:11;H361:11;Not classified:90;H315:38;H413:15
91834,"Butanamide, 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-oxo-, N,N'-bis(phenyl and 2,4-xylyl) derivs.",276-461-9,72207-62-6,Not Classified,Notified C&L,114,Not classified:114
91836,benzyl N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-6-oxo-1H-pyrimidin-2-yl]propan-2-yl]carbamate,620-178-9,519028-33-2,Not Classified,REACH registration C&L,1,Not classified:1
91841,N-benzyl-4-nitroaniline,238-249-4,14309-92-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
91845,Estradiol dipropionate,204-026-5,113-38-2,Carc. 2,Notified C&L,79,H351:79;H362:24;H360:40;H312:16;H302:16;H332:16
91849,Molsidomine,247-207-4,25717-80-0,Acute Tox. 4,Notified C&L,45,H302:45
91850,"Hexahydro-1,3,5-tris(1-oxoallyl)-1,3,5-triazine",213-501-6,959-52-4,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;Aquatic Chronic 2,REACH registration C&L,44,H411:3;H302:6;H315:5;H311:3;H334:44;H317:44;H318:5;H314:39;H310:41;H331:38;H330:1
91851,2-chloromethyl 2-(trimethylsilyl)ethyl ether,278-483-4,76513-69-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,46,H226:46;H314:45;H318:5;H312:1;H319:1;H315:1;H372:1;H301:1;H410:1
91852,"(E)-2,4-dimethylpent-2-enoic acid",613-967-4,66634-97-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
91853,Heptafluorobutyric acid,206-786-3,375-22-4,Skin Corr. 1A;Eye Dam. 1,Notified C&L,169,H314:168;H318:120;Not classified:3;H335:2;H370:1;H290:1
91854,Allyltributylphosphonium chloride,216-231-7,1530-48-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Repr. 1B;Aquatic Chronic 2,REACH registration C&L,5,H411:3;H302:5;H315:5;H318:5;H360:2
91856,"1,3,5-triazine",206-028-1,290-87-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H302:44;H318:40;H335:38;H315:39;H360:6;H314:5;H330:1
91858,"2-(dimethylamino)-5,6-dimethyl-1H-pyrimidin-4-one",255-074-9,40778-16-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,156,H319:156;H302:156
91860,2-isopropyl-4-methylthiazole,239-758-4,15679-13-7,Acute Tox. 4,Notified C&L,1753,H302:1656;H226:178;H319:92;H335:92;H315:92;H225:1
91865,"Thieno[3,2-c]pyridine",205-984-7,272-14-0,Not Classified,Notified C&L,14,Not classified:11;H319:2;H302:3;H335:2;H315:2;H332:1
91867,"2-(tetrapropenyl)succinic acid, monoester with propane-1,2-diol",257-836-6,52305-09-6,Aquatic Chronic 3,Notified C&L,655,H412:616;H319:62;H318:25;H315:45;H302:20;Not classified:14
91869,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18,18-tritriacontafluorooctadecanol",265-439-4,65104-67-8,Eye Irrit. 2,Notified C&L,47,H319:47
91871,"1,3-dinitronaphthalene",210-116-5,606-37-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
91874,"dioxabenzofos (ISO);2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide",223-292-3,3811-49-2,Acute Tox. 3;Acute Tox. 3;STOT SE 1;Aquatic Chronic 2,Harmonised C&L,0,H311:0;H370:0;H411:0;H301:0
91875,2-[2-(2-hydroxyethoxy)ethoxy]ethyl stearate,233-562-2,10233-24-6,Not Classified,Notified C&L,7,Not classified:7
91876,2-chloro-5-(trifluoromethyl)benzenediazonium tetrachlorozincate (2:1),286-402-9,85237-43-0,Not Classified,Notified C&L,9,Not classified:9
91877,"Sodium 1,2,3-triazole-5-thiolate",261-568-5,59032-27-8,Not Classified,Notified C&L,5,Not classified:2;H411:1;H334:1;H317:1;H319:2;H315:2;H302:1;H335:1
91880,"Carbohydrates and Sugars, hexitols, anhydro",309-665-4,100683-96-3,Not Classified,Notified C&L,1,Not classified:1
91881,"Bicyclo[3.2.1]oct-3-en-2-one, 3-[2-chloro-4-(methylsulfonyl)benzoyl]-4-(phenylthio)-",605-078-5,156963-66-5,,Notified C&L,55,Not classified:55
91882,"1,1,3,3,5,5,7,7-octamethyltetrasiloxane",213-669-0,1000-05-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
91887,"Benzenemethanol, 2-fluoro-4-methoxy-",609-840-8,405-09-4,,Notified C&L,6,H319:6;H315:6;H335:2
91888,"3,4-diaminopyridine",200-220-9,54-96-6,Acute Tox. 2;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,51,H319:50;H335:42;H330:50;H311:44;H315:44;H300:50;H312:4;Not classified:2;H318:1;H301:1
91889,"2,5-diethoxyaniline",202-369-5,94-85-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:40;H335:39;H315:40;H312:6;H302:6;H332:6
91893,"6'-(diethylamino)-3'-methyl-2'-(octylamino)spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",268-131-8,68003-47-4,Not Classified,Notified C&L,1,Not classified:1
91894,"2-chloro-4-fluoro-N-[[]methyl(propan-2-yl)sulfamoyl]-5-[[]3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidin-1-yl]benzamide",619-504-2,372137-35-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,293,H400:210;H410:210;Not classified:83;H361:16
91896,"Formaldehyde, oligomeric reaction products with phenol and triethylenetetramine",500-083-8,32610-77-8,Not Classified,Notified C&L,205,Not classified:156;H319:44;H413:5;H335:6;H315:6;H317:10;H314:4;H312:3;H412:3;H302:3;H341:1;H311:1;H318:1;H332:1;H373:1
91900,3-(2-phenylhydrazin-1-ylidene)cyclohexan-1-one,608-095-6,27385-45-1,Acute Tox. 3,Notified C&L,2,H301:1;H319:1;H302:1;H335:1;H315:1
91904,Pyrantel hydrogen tartrate,251-501-8,33401-94-4,Acute Tox. 3,Notified C&L,39,H301:39
91908,"Malt, ext.",232-310-9,8002-48-0,Flam. Liq. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,1418,H412:1287;H335:1287;H315:1287;H318:1287;H225:1293;Not classified:95;H351:25;H332:25;H224:25;H226:6
91910,3-(methoxycarbonyl)benzoic acid,619-855-1,1877-71-0,Not Classified,Notified C&L,29,Not classified:23;H319:6;H335:5;H315:6
91911,Lithium iron phosphate,604-917-2,15365-14-7,Not Classified,Notified C&L,86,Not classified:83;H413:3
91918,1-(4-ethoxyphenylethynyl)-trans-4-(4-propylcyclohexyl)benzene,440-530-3,116903-48-1,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
91919,"Angelica sylvestris chinensis, ext.",296-244-2,92456-66-1,Not Classified,Notified C&L,1,Not classified:1
91921,"1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-nortall-oil alkyl derivs.",263-171-2,61791-39-7,Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,530,H400:10;H410:10;H314:489;H318:460;H302:444;Not classified:28;H319:13;H315:13;H317:1;H360:1
91924,Hexan-3-one,209-645-4,589-38-8,Flam. Liq. 3,Notified C&L,1448,H226:1412;H319:42;H335:41;H315:41;H225:35;H331:10
91925,"Castor oil, hydrogenated, reaction products with hydrotreated heavy naphthenic petroleum distillates, hydrotreated petroleum residual oils and tallow, lithium salt",270-068-6,68409-83-6,Not Classified,Notified C&L,1,Not classified:1
91928,"Naphth[1,2-d][1,2,3]oxadiazole-5-sulphonic acid",201-523-9,84-23-1,Not Classified,Notified C&L,2122,Not classified:2122
91929,Thianthrene,202-197-0,92-85-3,Not Classified,Notified C&L,39,Not classified:38;H319:1;H335:1;H315:1
91934,1H-indene-3-carboxylic acid,238-064-9,14209-41-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:1;H302:1;H332:1;H319:1;H335:1;H315:1
91937,8-ethoxyquinoline,216-308-5,1555-94-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H302:38;H318:38;H335:42;H315:42;H319:4
91940,Barium 4-dodecylphenolate,300-141-0,93922-04-4,Acute Tox. 4;Acute Tox. 4;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,92,H302:92;H410:8;H332:92;H360:8;H400:8
91943,"2,6-dimethylmorpholine",205-509-3,141-91-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,191,H312:150;H302:91;H314:93;H318:190;H226:191;H311:41
91956,C.I. Acid Violet 54,601-022-9,11097-74-8,Not Classified,Notified C&L,5,Not classified:4;H319:1;H412:1
91957,"Tripotassium 7-[[4-[[4-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]phenyl]azo]phenyl]azo]naphthalene-1,3,5-trisulphonate",275-914-8,71720-86-0,Not Classified,Notified C&L,37,Not classified:37
91963,"1-amino-9,10-dihydro-4-[[4-[[(4-methylphenyl)sulphonyl]oxy]phenyl]amino]-9,10-dioxoanthracene-2-sulphonic acid",272-428-8,68834-02-6,Not Classified,Notified C&L,3,Not classified:3
91966,Dibemethine,203-001-6,102-05-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,63,H319:38;H335:63;H315:38;H334:38;H301:38;H400:38;H312:25;H412:25;H302:25;H314:25;H318:25
91974,"4-isopropyloxazolidine-2,5-dione",220-566-4,2816-12-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H302:2;H335:2;H315:2
91976,Decylamine,217-957-7,2016-57-1,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,45,H311:45;H400:44;H314:41;H301:45;H318:1
91977,"Carbonic acid, compound with 2-amino-2-(hydroxymethyl)propane-1,3-diol (1:2)",268-546-4,68123-29-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:41;H315:41
91978,Prednicarbate,277-590-3,73771-04-7,Not Classified,Notified C&L,6,Not classified:4;H360:1;H361:2;H373:1
91980,4-methoxybenzophenone,210-285-5,611-94-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
91981,Ethyl 5-methyl-3-oxohexanoate,251-802-4,34036-16-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
91982,Diphenyliodonium hexafluoroarsenate,263-638-0,62613-15-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H311:1;H301:1;H331:1;H330:1;H300:1;H400:1;H350:1;H410:1
91986,N-(4-(acetylsulphamoyl)phenyl)phthalamic acid,205-035-7,131-69-1,Not Classified,Notified C&L,2,Not classified:2
91988,"2,4-dinitrobenzenesulphonyl chloride",216-749-3,1656-44-6,Skin Corr. 1B,Notified C&L,45,H314:45;H350:1;H373:1;H340:1
91995,Glutaric acid,203-817-2,110-94-1,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,361,H314:42;H318:42;H319:275;Not classified:46;H335:4;H315:5
91996,2-isopropoxyethanol;ethylene glycol monoisopropyl ether,203-685-6,109-59-1,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Harmonised C&L,0,H319:0;H312:0;H332:0
92000,"Pentasodium bis[4-[[6-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-1-hydroxy-2-naphthyl-3-sulpho]azo]-3-hydroxy-7-nitronaphthalene-1-sulphonato(4-)]cobaltate",293-816-3,91144-26-2,Not Classified,Notified C&L,61,Not classified:61
92001,9-bromofluorene,217-722-9,1940-57-4,Skin Corr. 1B,Notified C&L,44,H314:44;H318:1
92002,"3,3'-Diindolylmethane",606-355-3,1968-05-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,41,H319:41;H413:39;H335:41;H315:41;H302:1
92005,"Tetralithium 3,3'-[azoxybis[(2-methoxy-4,1-phenylene)azo]]bis[4,5-dihydroxynaphthalene-2,7-disulphonate]",283-178-4,84559-92-2,Aquatic Chronic 3,Notified C&L,1,H412:1
92011,"[4S-(4α,4aα,8aβ)]-octahydro-4,8a-dimethyl-4a(2H)-naphthol",243-239-8,19700-21-1,Acute Tox. 4,Notified C&L,88,H302:88
92012,"Disodium 1-amino-4-[[3-[(2,3-dibromo-1-oxopropyl)amino]-2,4,6-trimethyl-5-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",274-439-3,70210-42-3,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,14,H412:10;H317:12;Not classified:2
92014,"3,3,11,11-tetramethoxy-2,12-dioxa-7-thia-3,11-disilatridecane",249-391-1,29055-11-6,Not Classified,Notified C&L,5,Not classified:5
92016,Lidocaine hydrochloride,200-803-8,73-78-9,Acute Tox. 4,Notified C&L,65,H302:36;H319:27;H412:25;H335:27;H315:27;H334:25;H301:29
92017,1-bromo-4-nitrobenzene,209-583-8,586-78-7,Acute Tox. 4,Notified C&L,44,H302:43;H319:6;H312:5;H335:5;H315:6;H332:5;H373:4;H311:1;H301:1;H331:1
92018,Potassium carbonate,209-529-3,584-08-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2670,H319:2611;H335:1108;H315:1211;H302:528;Not classified:26;H318:5;H301:4;H310:1;H314:2;H312:1;H332:2
92022,Trimethobenzamide hydrochloride,209-075-6,554-92-7,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,39,H334:38;H302:39;H317:38
92024,"2-ethylpentyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate",603-084-2,125643-61-0,Aquatic Chronic 4,Notified C&L,344,H413:342;Not classified:2
92027,"9-methoxy-2,5,11-trimethyl-6H-pyrido[4,3-b]carbazolium acetate",308-789-6,98510-80-6,Eye Irrit. 2,Notified C&L,38,H319:38
92032,"2,3-xylidine",201-755-0,87-59-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Notified C&L,104,H411:103;H311:103;H301:103;H373:102;H331:102;Not classified:2;H341:1;H319:1;H302:1;H315:1
92033,"Disodium piperazine-1,4-diethanesulphonate",278-562-3,76836-02-7,Not Classified,REACH registration C&L,48,Not classified:46;H319:2;H335:2;H315:2
92034,Vinyl tert-decanoate,247-773-2,26544-09-2,Not Classified,Notified C&L,14,Not classified:13;H410:1
92035,"Dihydrogen bis(ditridecyl phosphito-O'')tetrakis(octan-1-olato)titanate(2-), branched and linear",271-576-0,68585-68-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,113,H319:63;H312:52;H302:52;H335:53;H315:63;H332:52;Not classified:50
92036,"2-Butenedioic acid (2Z)-, 1,4-dibutyl ester, polymer with ethenyl acetate",607-496-3,25035-90-9,Not Classified,Notified C&L,37,Not classified:37
92038,2-(2-(2-chloroethoxy)ethoxy)ethanol,225-984-0,5197-62-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,40,H319:40;H315:40;H335:38
92039,2-methylbutyraldehyde,202-485-6,96-17-3,Flam. Liq. 2;Skin Sens. 1;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,1794,H411:1506;H319:1793;H335:1429;H317:1424;H225:1793;H315:88;Not classified:1;H318:1;H224:1;H410:1
92042,(ferrocen-1-yl)methyltrimethylammonium iodide,235-152-9,12086-40-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
92043,SILOXANE S200,442-260-1,,Not Classified,Notified C&L,1,Not classified:1
92046,"Carbamic acid, [methyl-3-[[[[3-(triethoxysilyl)propyl]amino]carbonyl]amino]phenyl]-, isotridecyl ester",617-881-8,865619-40-5,Not Classified,Notified C&L,1,Not classified:1
92048,2-iodo-4-nitrotoluene,231-808-3,7745-92-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H312:39;H302:39;H332:39;H319:5;H335:4;H315:5
92050,12-oxo-N-phenyl-12H-phthaloperinesulphonamide,278-114-7,75199-11-0,Not Classified,Notified C&L,2037,Not classified:2037
92054,Quaternary silicone ammonium compound~,610-456-8,495403-02-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,35,H411:35;H319:35;H317:35;H315:35
92057,"2,4,6-Triisopropylbenzenesulfonyl Azide (wetted with ca. 10% Water) (unit weight on dry weight basis)",609-323-7,36982-84-0,Self-react. B;Acute Tox. 3,Notified C&L,46,H301:39;H241:38;H319:7;H335:6;H315:7
92061,"Iron, 4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonate sodium complexes",296-705-8,92969-92-1,Not Classified,Notified C&L,23,Not classified:22;H319:1
92070,"α-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(1,2,2,2-tetrabromoethyl)cyclopropanecarboxylate",266-493-1,66841-25-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H319:38;H302:38;H315:38;H400:38;H410:38;Not classified:3
92071,"3,5-dimethoxybenzaldehyde",230-772-6,7311-34-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:47;H315:48
92073,1-amino-4-hydroxy-2-[(6-hydroxyhexyl)oxy]anthraquinone,251-889-9,34231-26-0,Not Classified,REACH registration C&L,21,Not classified:21
92075,"Tetrasodium 2-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-5-sulphonato-1-naphthyl]azo]-6-sulphonato-1-naphthyl]azo]benzene-1,4-disulphonate",274-353-6,70161-17-0,Not Classified,Notified C&L,2,Not classified:2
92076,"Sodium bis[2-chloro-4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-5-hydroxybenzenesulphonamidato(2-)]chromate(1-)",266-577-8,67109-27-7,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,16,H411:7;H319:1;H320:1;Not classified:9
92080,2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethylamine dihydrochloride,254-033-2,38603-72-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H302:1;H332:1
92081,"6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-ol",227-705-8,5947-36-4,Not Classified,REACH registration C&L,225,Not classified:225
92083,p-tert-butyl-2-methylcinnamaldehyde,237-014-3,13586-68-0,Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,84,H400:83;H410:83;H361:83;H319:1;H315:1
92085,N-methyl-N-octyldecylamine,244-724-7,22020-14-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,20,H400:20;H318:20;H315:20
92086,Yohimbic acid,208-337-7,522-87-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,2,H311:2;H331:2;H301:2
92087,"3,3-ethylenedithiooestr-4-ene-3,17-dione, cyclic",277-912-2,74531-92-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,1,H312:1;H351:1;H302:1;H361:1;H332:1
92090,"Di-μ-carbonyldicarbonylbis(η5-cyclopenta-2,4-dien-1-yl)diiron",235-276-3,12154-95-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,45,H302:40;H332:40;H311:4;H330:4;H228:4;H301:4;H312:2;H319:1;H335:1;H315:1
92092,5-Triethylsilyl-4-pentyn-1-ol,605-703-1,174064-02-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
92093,"1-methyl-2,6-bis-(2-hydroxyethylamino)benzene",443-210-1,149330-25-6,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,45,H412:44;H317:44;H319:10
92094,"Benzaldehyde, 2,5-difluoro-4-methoxy-",618-086-9,879093-08-0,,Notified C&L,5,H319:5;H335:5;H315:5
92096,O-tert-butylhydroxylamine hydrochloride,254-590-1,39684-28-1,Flam. Sol. 2,Notified C&L,40,H228:39;H319:2;H315:2;H335:1
92101,Methyl (3-hydroxyphenyl)-carbamate,237-196-4,13683-89-1,Not Classified,REACH registration C&L,2,Not classified:1;H319:1;H335:1;H315:1
92104,Sodium 6-amino-4-hydroxy-5-[[2-(trifluoromethyl)phenyl]azo]naphthalene-2-sulphonate,267-090-3,67786-14-5,Aquatic Chronic 2,REACH registration C&L,55,H411:12;Not classified:27;H412:14;H413:2
92107,(-)-Benzyl (R)-glycidyl ether,604-513-6,14618-80-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:39;H315:44;H341:4
92108,"2,6-dichloro-4-(chloroimino)cyclohexa-2,5-dienone",202-937-2,101-38-2,Self-react. C;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H242:40;H335:39;H315:41;H272:1;Not classified:1
92109,(R)-5-(2-Aminopropyl)-2-methoxybenzenesulfonamide,601-159-4,112101-81-2,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,10,H411:6;H317:8;H318:6;H302:1;H319:1;H335:1;H315:1
92113,"3-(2,5-dihydro-2,5-dioxo(1H)-pyrrole-1-yl)benzoic acid",241-118-4,17057-07-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
92116,"11-(chloroacetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one",249-227-9,28797-48-0,Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,4,H319:4;H317:4
92117,"2,4-dinitro-N-phenylaniline",213-508-4,961-68-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:38
92119,6-fluoro-DL-tryptophan,231-788-6,7730-20-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
92121,(R)-4-(isopropyl)-1-methylcyclohexene,214-794-3,1195-31-9,Flam. Liq. 3,Notified C&L,38,H226:38
92122,Cobalt dibromide,232-166-7,7789-43-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 1B,Notified C&L,46,H319:44;H312:38;H302:45;H335:38;H315:42;H334:41;H317:41;H350:38;H332:38;H410:2;H400:3;H318:2;H290:1;H301:1;H411:1;H361:1
92125,"Butylnaphthalenesulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",287-165-4,85409-93-4,Not Classified,Notified C&L,1,Not classified:1
92128,"Bis(2-ethylhexyl) 1,4,5,6,7,7-hexachlorobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate",225-405-1,4827-55-8,Eye Irrit. 2,Notified C&L,63,H319:62;Not classified:1
92131,o-toluonitrile,208-451-7,529-19-1,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,127,H412:127;H315:127;H319:5
92135,Benzhydrylammonium chloride,226-084-0,5267-34-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,47,H319:47;H335:46;H315:47;H302:1
92141,"2-Propanol, 1,1'-[[3-[(3-aminopropyl)amino]propyl]imino]bis-, N-tallow alkyl derivs.",307-276-4,97592-79-5,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,2,H410:2;H302:2;H318:2;H314:2;H400:1
92146,Cicloxilic acid,260-966-6,57808-63-6,Acute Tox. 4,Notified C&L,2,H302:1;H319:1;H335:1;H315:1
92150,D-glycero-L-manno-heptono-γ-lactone,244-960-0,22404-04-2,Acute Tox. 4,Notified C&L,38,H302:38
92153,"3,9-dibenzyl-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 3,9-dioxide",243-869-3,20544-37-0,Not Classified,REACH registration C&L,2,Not classified:2
92154,"Butanamide, 2-[[3,3'-dichloro-4'-[[1-[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-3-oxo-N-phenyl-",607-270-4,23792-68-9,Not Classified,Notified C&L,69,Not classified:69
92155,Benzamide,200-227-7,55-21-0,Acute Tox. 4;Muta. 2,Notified C&L,99,H302:68;H341:67;Not classified:33
92159,"1-ethyl-1,2-dihydro-5H-tetrazol-5-one",273-844-2,69048-98-2,Not Classified,Notified C&L,2,Not classified:1;H319:1;H303:1;H335:1;H315:1
92160,Methyl 2-chloromethylbenzoate,251-805-0,34040-62-5,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H314:1;H290:1;H318:1
92163,2-iodo-2-methylpropane,209-190-1,558-17-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,44,H319:44;H335:43;H315:44;H225:44;H400:39;H341:4
92164,"4,4'-azobisbenzoic acid",209-589-0,586-91-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
92166,"2,9-bis(3,5-dimethylphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone",225-590-9,4948-15-6,Not Classified,REACH registration C&L,393,Not classified:392;H413:1
92169,2-phenoxyethyl 4-aminobenzoate,430-880-5,88938-23-2,Aquatic Chronic 2,Harmonised C&L,0,H411:0
92170,Diethyl 5-nitroisophthalate,234-144-2,10560-13-1,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H335:1;H315:1
92176,Sorbitan oleate,215-665-4,1338-43-8,Not Classified,Notified C&L,1163,Not classified:1161;H319:2;H335:1;H315:1
92177,Ammonium 4-chloro-m-cresolate,286-583-4,85283-55-2,Not Classified,Notified C&L,31,Not classified:31
92178,C.I. Acid Yellow 232,603-849-0,134687-50-6,Not Classified,Notified C&L,2,Not classified:2
92179,"hexasodium 5-[(4-{3-[(8-benzamido-1-hydroxy-3,6-disulfonato-2-naphthyl)diazenyl]-4-sulfonatoanilino}-6-[(2-sulfonatoethyl)amino]-1,3,5-triazin-2-yl)amino]isophthalate",482-150-0,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
92180,hydroxylamine phosphate,244-077-0,20845-01-6,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Carc. 2;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H319:0;H312:0;H351:0;H302:0;H315:0;H373:0;H317:0;H400:0;H201:0
92183,"Esterase, acetyl choline",232-559-3,9000-81-1,Resp. Sens. 1,Notified C&L,116,H334:116
92184,1-tetradecylquinolinium bromide,278-622-9,77101-52-1,Not Classified,Notified C&L,1,Not classified:1
92185,Cadmium distearate,218-743-6,2223-93-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,153,H312:153;H302:153;H400:153;H332:115;H410:153;H330:38
92186,3-Cyclopropyl-3-Oxopropionic Acid Methyl Ester,608-722-3,32249-35-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,3,H319:3;H312:2;H412:3;H302:3;H335:3;H315:3
92189,Pyridazine,206-025-5,289-80-5,,Notified C&L,5,H319:5;H335:5;H315:5;H302:1
92190,2-Amino-6-(trifluoromethoxy)benzothiazole,605-724-6,1744-22-5,Acute Tox. 3,Notified C&L,135,H301:130;H300:5;H411:2;H373:2;H318:2;H319:2;H335:2;H315:2
92191,5-hydroxyindole-2-carboxylic acid,244-468-6,21598-06-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:45;H315:45;H312:1;H302:1
92194,"9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium [4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonato(3-)]chromate(1-)",275-632-5,71566-33-1,Not Classified,Notified C&L,2,Not classified:2
92197,L-menthyl formate,263-345-8,61949-23-3,Not Classified,Notified C&L,88,Not classified:88
92200,Potassium stearate,209-786-1,593-29-3,Not Classified,Notified C&L,220,Not classified:210;H319:9;H315:9;H314:1
92212,4-Bromo-3-ethoxyaniline hydrochloride,617-591-1,846023-33-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H302:42;H335:42;H315:42;H312:4;H332:4
92217,"1,5-dimethylcycloocta-1,5-diene",223-173-6,3760-14-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H226:39;H319:39;H335:38;H315:39
92224,"4-Hexen-3-one,5-amino-2-[bis(phenylmethyl)amino]-1,6-diphenyl-, (2S)-",605-070-1,156732-13-7,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,42,H319:42;H413:42
92226,"(S)-2-Amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole",600-593-1,104632-26-0,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,4,H412:2;H302:3;H317:1;Not classified:1;H312:1;H332:1
92227,3-amino-4-chlorobenzamide,243-231-4,19694-10-1,Acute Tox. 4,REACH registration C&L,76,H302:34;H319:42;H335:42;H315:42
92228,"Quaternary ammonium compounds, (2-hydroxy-1,3-propanediyl)bis[coco alkyldimethyl, dichlorides",614-803-4,68918-72-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
92230,Methyl 3-acetyl-4-[(propan-2-yl)oxy]benzoate,607-826-6,259147-67-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
92231,Tripelennamine,202-100-1,91-81-6,Acute Tox. 4;Eye Dam. 1;Acute Tox. 3;Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,24,H411:24;H302:24;H361:24;H318:24;H373:24;H331:24
92232,"2,6-dimethylbenzoic acid",211-177-0,632-46-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H302:1
92233,4-(cyanoacetyl)morpholine,239-112-1,15029-32-0,Acute Tox. 4,Notified C&L,44,H302:44;H319:5;H335:5;H315:5;H312:1;H332:1
92235,"(1S,2S)-1-Hydroxy-1,1'-bicyclohexyl)-2-carboxylic acid",614-178-8,67928-53-4,Acute Tox. 4,Notified C&L,1,H302:1
92237,5-chloro-2-fluorotoluene,207-204-0,452-66-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H226:45;H319:45;H335:44;H315:45
92238,"N-hydroxynorborn-5-ene-2,3-dicarboximide",244-538-6,21715-90-2,Not Classified,REACH registration C&L,47,Not classified:2;H319:45;H335:44;H315:45
92239,"Phosphoric acid, octyl ester, branched, potassium salt",272-026-2,68649-40-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
92245,Sodium 2-chloro-1-hydroxyethanesulphonate,235-958-0,13064-50-1,,Notified C&L,5,H301:5
92246,"2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)prop-1-enyl]-1,3,3-trimethyl-3H-indolium chloride",228-668-0,6320-14-5,Acute Tox. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,7,H319:3;H300:3;H412:3;Not classified:4
92247,2-chloro-4-methylthiazole,248-046-2,26847-01-8,Flam. Liq. 4;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H227:1;H332:1
92248,4-methylhex-2-ene,222-281-0,3404-55-5,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,1,H225:1;H304:1
92250,1-chloroethyl ethyl carbonate,256-832-1,50893-36-2,Not Classified,REACH registration C&L,43,Not classified:2;H319:41;H335:40;H315:41;H227:1
92252,Dichlorodifluoromethane,200-893-9,75-71-8,Press. Gas (Liq.);Aquatic Chronic 3;Ozone 1,REACH registration C&L,132,H412:1;H280:126;H420:2;Not classified:5;H059:2
92253,"Dihydrogen bis[P,P-dioctyl diphosphato(2-)-O'',O''''][ethane-1,2-diolato(2-)-O,O']titanate(2-), branched and linear",271-570-8,68585-63-7,Skin Sens. 1,Notified C&L,12,H317:10;H226:2;H319:2;H335:2;H315:2
92254,"(R)-N,α-dimethylphenethylamine hydrochloride",212-552-1,826-10-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Repr. 2,Notified C&L,40,H311:39;H331:39;H361:39;H301:40
92255,"Oils, peach",616-804-5,8002-78-6,Not Classified,Notified C&L,1,Not classified:1
92257,Diholmium(3+) trisulphate,239-697-3,15622-40-9,Eye Irrit. 2,Notified C&L,44,H319:43;H335:5;H315:5;Not classified:1
92258,Bone meal,270-061-8,68409-75-6,Not Classified,Notified C&L,1,Not classified:1
92262,"Fatty acids, C14-18 and C16-18 unsatd., compds. with triethanolamine",268-369-2,68082-25-7,Not Classified,Notified C&L,3,Not classified:3
92264,Ruthenium trihydroxide,235-221-3,12135-42-1,Aquatic Chronic 4,REACH registration C&L,2,H413:2
92267,[N-(2-Amino-ethyl)-4-methyl-benzenesulfonamido]chloro(p-cymene)ruthenium(II),435-290-1,208988-63-0,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,Not classified:1;H319:1;H412:1;H402:1
92269,"Alcohols, C12-13, branched and linear, ethoxylated",500-457-0,160901-19-9,Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,46,H400:13;H412:45;H302:33;H318:36
92270,(±)-1-methyl-5-oxopyrrolidine-2-acetic acid,262-154-7,60307-25-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
92274,"1,5-diphenyl-3-thiocarbonohydrazide",210-717-2,622-03-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
92277,"Benzenemethanamine, N-(1-methylethyl)-, hydrobromide (1:1)",605-791-1,176971-59-8,,Notified C&L,1,Not classified:1
92280,"(E)-1-(2,4,4-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one",254-663-8,39872-57-6,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,94,H411:13;H315:13;Not classified:81
92283,"(tricyclo(3,3,1,1',3,7)decan-1-yl) fluoroformate",263-400-6,62087-82-5,Skin Corr. 1B,Notified C&L,38,H314:38
92287,"2,5-dibromohexane",246-457-1,24774-58-1,,Notified C&L,5,H319:5;H315:5
92289,Protriptyline hydrochloride,214-956-3,1225-55-4,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:38;H312:38;H335:38;H315:38;H332:38;H301:38;Not classified:1
92291,Dihydroxyaluminium glycinate,237-193-8,13682-92-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:50;H335:50;H315:50
92303,Cellulose nitrate,927-193-2,,Expl. 1.1,Notified C&L,1,H201:1
92304,"2-bromo-1,4-difluorobenzene",206-920-0,399-94-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:46;H335:45;H315:46;H226:1
92306,"Fatty acids, C12-20 and C12-20-unsatd., esters with triethanolamine",292-808-7,91001-39-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,9,H319:7;H315:7;Not classified:2
92310,"4-[[4-(dimethylamino)phenyl][4-(methylimino)cyclohexa-2,5-dien-1-ylidene]methyl]-N,N-dimethylaniline monohydrochloride",210-042-3,603-47-4,Acute Tox. 4;Eye Dam. 1;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,72,H351:5;H302:60;H410:15;H318:15;H400:11;Not classified:11;H319:5;H335:3;H315:3;H411:1;H301:1;H412:1
92312,Methyl 3-hydroxy-2-naphthoate,212-936-9,883-99-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43;H312:1;H302:1;H332:1
92314,Naphthalene-1-methylamine,204-244-0,118-31-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:40;H335:38;H315:40;H314:4
92315,Bis(2-chloroethyl)carbamoyl chloride,221-075-8,2998-56-3,Carc. 2;Repr. 1B,Notified C&L,35,H351:29;H360:29;H314:6;H318:6
92317,papain,232-627-2,9001-73-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H319:0;H334:0;H335:0;H315:0
92318,"Tris(decyl) benzene-1,2,4-tricarboxylate, branched",273-924-7,69227-02-7,Not Classified,Notified C&L,1,Not classified:1
92319,Oxipurinol,219-570-9,2465-59-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H335:40;H315:40;H302:3
92321,"[2,2-bis(3-methylbutoxy)ethyl]benzene",271-419-6,68555-28-2,Not Classified,Notified C&L,113,Not classified:113
92323,2-ethylhexanoic acid,205-743-6,149-57-5,Repr. 2,Harmonised C&L,0,H361:0
92324,5-amino-2-chlorobenzoic acid,201-916-5,89-54-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
92328,"1,2,2-trimethylpropylamine",223-353-4,3850-30-4,,Notified C&L,6,H225:6;H314:6;H318:1
92333,"2,5-dihydroxy-3-undecyl-p-benzoquinone",208-979-8,550-24-3,Repr. 2,Notified C&L,2,H361:2;Not classified:1
92336,Alginate SG 300,618-413-5,9005-35-0,Not Classified,Notified C&L,88,Not classified:88
92338,Sodium 3-methylsalicylate,251-202-2,32768-20-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
92339,Teniposide,249-831-2,29767-20-2,Carc. 1B,Notified C&L,42,H350:42;H340:1;H372:2;H301:1;H360:1;H361:1;H341:1;H371:1
92342,"Polysulfides, bis(3-(triethoxysilyl)propyl)",606-716-5,211519-85-6,Not Classified,Notified C&L,30,Not classified:29;H319:1;H412:1;H335:1;H315:1;H320:1;H402:1
92343,"N-(3,4-Difluorophenyl)acetamide,",610-272-8,458-11-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38
92344,Bis[5-amino-9-(diethylamino)benzo[a]phenoxazin-7-ium] sulphate,222-832-5,3625-57-8,Not Classified,Notified C&L,5,Not classified:5
92346,1-tert-butylamino-3-(o-cyclopentylphenoxy)propan-2-ol hydrochloride,248-874-4,28163-36-2,Acute Tox. 4,Notified C&L,38,H302:38
92347,"Barium [29H,31H-phthalocyaninedisulphonato(4-)-N29,N30,N31,N32]cuprate(2-)",266-653-0,67340-41-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,8,H302:8;H332:8
92349,"Tallow, stearins",293-759-4,91082-46-1,Not Classified,Notified C&L,1,Not classified:1
92350,"N,α-dimethylcyclohexaneethylamine",202-939-3,101-40-6,Acute Tox. 3,Notified C&L,1,H301:1
92351,4'-hydroxybutyrophenone,213-766-8,1009-11-6,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H315:1
92352,"2,1,3-benzothiadiazol-4-ylamine",212-186-2,767-64-6,Acute Tox. 4,Notified C&L,134,H302:133;H319:7;H335:6;H315:7;H301:1
92353,"tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate",402-590-9,109125-56-6,Eye Dam. 1,Harmonised C&L,0,H318:0
92354,4-(hydroxymethyl)resorcinol,251-597-1,33617-59-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H302:2;H335:2;H315:2
92357,"Fatty acids, C16-22, compds. with 2-(dimethylamino)ethanol",297-833-7,93763-15-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,22,H314:22;H318:22
92358,"Fatty acids, C16-18, 2-ethylhexyl esters",292-951-5,91031-48-0,Not Classified,REACH registration C&L,148,Not classified:148
92361,[No public or meaningful name is available],457-550-3,,Not Classified,Notified C&L,83,Not classified:83
92362,"1-amino-4,5-dihydroxy-8-(phenylamino)anthraquinone",243-634-5,20241-77-4,Not Classified,Notified C&L,1,Not classified:1
92365,N-[1-(hydroxymethyl)-2-(4-nitrophenyl)-2-oxoethyl]acetamide,221-503-3,3123-13-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
92368,"2,2'-thiobisacetamide",238-657-2,14618-65-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
92369,Methyl p-aminosalicylate,223-958-3,4136-97-4,,Notified C&L,7,H319:6;H302:7;H335:5;H315:6;H332:1
92370,"1,3-difluoro-5-nitrobenzene",218-867-0,2265-94-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41;H227:1
92375,2-thiobarbituric acid,207-985-8,504-17-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,17,H319:16;H335:16;H315:16;Not classified:1
92376,"2-Pyrazinecarboxamide, N-[2-[4-(aminosulfonyl)phenyl]ethyl]-5-methyl-",608-855-7,33288-71-0,Not Classified,REACH registration C&L,7,Not classified:5;H412:1;H302:1;H341:1
92381,p-nitrocumene,217-326-6,1817-47-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:39;H315:39;H312:1;H302:1;H332:1
92382,Phenylthiotrimethylsilane,224-916-7,4551-15-9,Flam. Liq. 3;Skin Irrit. 2;Acute Tox. 4,Notified C&L,43,H226:43;H332:39;H315:43;H319:5;H335:4;H312:1;H302:1
92383,Glutens,232-317-7,8002-80-0,Not Classified,Notified C&L,62,Not classified:62
92384,"1,2-Benzenedicarboxylic acid, 4-(2,5-dimethylbenzoyl)-",606-390-4,198625-32-0,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,33,H412:33;H318:33
92389,"reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;imiprothrin (ISO); reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate",428-790-6,72963-72-5,Aquatic Chronic 1;Acute Tox. 4;Acute Tox. 4;Carc. 2;STOT SE 2;Aquatic Acute 1,Harmonised C&L,0,H351:0;H302:0;H371:0;Not classified:0;H400:0;H332:0;H410:0
92390,2-n-hexadecylhydroquinone,406-400-5,4595-26-0,Skin Irrit. 2;Skin Sens. 1;STOT RE 2;Aquatic Chronic 4,Harmonised C&L,0,H373:0;H317:0;H413:0;H315:0
92391,C.I. Reactive Black 31,603-199-8,12731-63-4,Not Classified,Notified C&L,1,Not classified:1
92393,Icosanoic acid,208-031-3,506-30-9,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,129,H319:100;H315:100;H335:99;Not classified:29
92395,5-methylhexan-2-ol,211-004-9,627-59-8,Flam. Liq. 3,Notified C&L,43,H226:43
92397,3-methylbenzothiazol-2(3H)-one hydrazone monohydrochloride,224-393-5,4338-98-1,Acute Tox. 3,Notified C&L,1,Not classified:1;H301:1
92401,Methyl 2-nitrobenzoate,210-111-8,606-27-9,Not Classified,Notified C&L,25,Not classified:25
92402,5-propyloxan-2-one,478-950-4,,Not Classified,REACH registration C&L,1,Not classified:1
92405,"Distillates (petroleum), intermediate paraffinic, carbon-treated;Gasoil - unspecified;[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",309-668-0,100683-98-5,Carc. 1B,Harmonised C&L,0,H350:0
92406,N-acetyl-DL-cysteine,230-609-9,7218-04-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
92411,"2-Butanone, self-condensation products",290-858-4,90268-56-7,Not Classified,Notified C&L,233,Not classified:233
92412,"5-bromo-1,10-phenanthroline",254-742-7,40000-20-2,,Notified C&L,1,H302:1;H318:1
92413,"Carbamic acid, (2-aminophenyl)phenyl-, ethyl ester",617-870-8,86514-37-6,,Notified C&L,1,H302:1
92416,NO. 650 VIOLET,421-000-0,,Not Classified,Notified C&L,1,Not classified:1
92417,Nitrogen trifluoride,232-007-1,7783-54-2,Ox. Gas 1;Press. Gas (Liq.);Acute Tox. 4;STOT RE 2,REACH registration C&L,84,H332:84;H373:26;H280:84;H270:84
92418,Pyrrolidine-1-carbonitrile,216-234-3,1530-88-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H319:1;H315:1;H311:1;H301:1;H331:1
92422,1-naphthonitrile,201-679-8,86-53-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:39;H312:38;H302:42;H335:38;H315:39;H332:42;H311:5;H301:1;H331:1
92423,6-tert-butyl-m-cresol,201-842-3,88-60-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,160,H302:160;H314:122;H319:38;H335:38;H315:38;H318:67;H411:33;H312:2;H361:2;H371:2;H373:1
92424,2-Butoxy-1-propanol,605-138-0,15821-83-7,Not Classified,Notified C&L,801,Not classified:540;H226:158;H319:261;H315:261
92425,Tetrahydro-6-undecyl-2H-pyran-2-one,230-924-1,7370-44-7,Not Classified,Notified C&L,88,Not classified:88
92426,"1,2,3,4,5,6,7,8,9,10,11,12,13,13,14,14-hexadecachloro-1,4,4a,4b,5,8,8a,12b-octahydro-1,4:5,8-dimethanotriphenylene",279-547-4,80789-64-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H302:38;H332:38
92428,(9R)-6'-methoxycinchonan-9-ol,209-340-6,572-59-8,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,38,H334:38;H302:38;H317:38
92429,α-methylcinnamaldehyde,202-938-8,101-39-3,Skin Sens. 1,Notified C&L,1783,H317:1777;H319:6;H335:4;H315:6
92431,methyl 2-(acetylamino)-3-chloropropionate,442-860-3,87333-22-0,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H317:0
92432,1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine,406-360-9,104218-44-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
92435,"2,2'-azobisphenol",218-082-3,2050-14-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
92441,"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoate",700-242-3,62037-80-3,Acute Tox. 4;Eye Dam. 1;STOT RE 2,Notified C&L,5,H373:5;H302:5;H318:5;H312:1;H332:1
92445,Penicillinase,232-628-8,9001-74-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,40,H334:40;H317:40;H340:1
92446,"Propane, 1,1,1,3,3,3-hexafluoro-2-methoxy- (9CI)",603-501-8,13171-18-1,Not Classified,REACH registration C&L,3,Not classified:1;H319:1;H225:2;H315:1
92449,2-phenylquinoline,210-326-7,612-96-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
92450,"Sodium 3-[[3-[(3-amino-4-nitrophenyl)azo]-2,4-dihydroxyphenyl]azo]-4-methoxybenzenesulphonate",267-091-9,67786-15-6,,Notified C&L,35,Not classified:34;H410:1
92452,"(2,5-dichlorophenyl)hydrazine monohydrochloride",256-729-1,50709-35-8,Skin Corr. 1B,Notified C&L,42,H314:38;H319:4;H312:4;H302:4;H332:4
92455,"Tetrahydrogen [3-[(3-chloro-2-hydroxy-5-sulphophenyl)azo]-5-[[4-chloro-6-(3-sulphoanilino)-1,3,5-triazin-2-yl]amino]-4-hydroxynaphthalene-2,7-disulphonato(6-)]cuprate(4-)",299-270-2,93858-39-0,Not Classified,Notified C&L,1,Not classified:1
92456,"6,13-dichloro-3,10-bis{}{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt",418-000-8,163062-28-0,Eye Dam. 1,Harmonised C&L,0,H318:0
92457,Triphenylgermanium,220-569-0,2816-43-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H302:38;H332:38
92472,"Phosphatidylcholines, soya",306-547-4,97281-47-5,Not Classified,Notified C&L,4,Not classified:4
92476,"1,1,1-Tris(omega-(2,2-dimethyl-3-lauroyloxy-propylidene-amin o)-poly(oxy(methyl-1,2-ethanediyl))methyl)propane",464-080-2,613246-79-0,Aquatic Chronic 2,REACH registration C&L,52,H411:6;H412:46;H318:46
92479,benzoic acid,200-618-2,65-85-0,Skin Irrit. 2;Eye Dam. 1;STOT RE 1,Harmonised C&L,0,H318:0;H372:0;H315:0
92480,4-4' diidroxyphenil sulphone condensed,600-374-0,102958-53-2,Aquatic Chronic 2,Notified C&L,196,H411:179;H319:17;H315:17
92483,"Trisodium [5-acetamido-4-hydroxy-3-[[2-hydroxy-5-methoxy-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonato(5-)]cuprate(3-)",288-045-4,85631-95-4,Not Classified,Notified C&L,1,Not classified:1
92489,Tetrapropylammonium periodate,285-973-1,85169-30-8,Flam. Sol. 1;Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H272:38;H228:38
92494,"Castor oil, oligomeric reaction products with toluene diisocyanate",500-169-5,67700-43-0,Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1;Carc. 2,Notified C&L,36,H334:36;H351:36;H331:17;H317:36;H330:17;H319:2;H315:2
92496,2-bromo-4-nitroanisole,225-983-5,5197-28-4,,Notified C&L,7,H319:6;H335:5;H315:6;H311:1;H331:1;H301:1
92498,"10-Undecenamide, N-[3-(dimethylamino)propyl]-",613-971-6,66654-01-1,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H302:1;H314:1;H410:1;H317:1;H318:1;H400:1
92500,Iron(II) oxalate,208-217-4,516-03-0,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,35,H312:35;H302:35
92501,3-methyl-1-vinyl-1H-imidazolium chloride,236-752-3,13474-25-4,Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,85,H411:85;H401:2
92504,"4-chloro-2,6-dimethoxypyrimidine",228-669-6,6320-15-6,,Notified C&L,5,H319:5;H335:4;H315:5
92506,"Oxirane, 2-methyl-, polymer with oxirane, octyl ether",612-521-6,61827-84-7,Eye Dam. 1,Notified C&L,24,H318:23;Not classified:1;H302:1
92507,tert-butyltrichlorosilane,242-059-7,18171-74-9,Flam. Sol. 1;Skin Corr. 1B,Notified C&L,39,H228:39;H314:39
92512,"Trisodium [2-[[α-[[2-hydroxy-5-sulpho-3-[(2,5,6-trichloro-4-pyrimidinyl)amino]phenyl]azo]benzyl]azo]-5-sulphobenzoato(5-)]cuprate(3-)",274-356-2,70161-20-5,Eye Irrit. 2,REACH registration C&L,43,H319:40;Not classified:2;H334:1;H317:1
92515,isopentane;2-methylbutane,201-142-8,78-78-4,Flam. Liq. 1;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H336:0;H304:0;H224:0
92516,"Citric acid, calcium salt",231-703-2,7693-13-2,Not Classified,Notified C&L,1,Not classified:1
92519,Sodium 3-(4-methyl-2-nitrophenoxy)propanesulphonate,279-282-4,79817-52-0,Not Classified,REACH registration C&L,6,Not classified:6
92520,"1-fluoro-2,4-dinitrobenzene",200-734-3,70-34-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;STOT RE 2,Notified C&L,48,H319:41;H302:40;H335:41;H315:44;H317:48;H373:42;H341:4;H311:7;H330:5;H318:5;H301:7;H340:1;H314:1;H300:1;H310:1;H351:2;H331:3
92521,"Epimerase, aldose 1-",232-872-5,9031-76-9,,Notified C&L,1,H334:1
92522,2-bromo-5-fluorotoluene,207-203-5,452-63-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H226:43;H319:47;H335:45;H315:47
92523,"20-hydroxyiminopregna-5,16-dien-3-β-yl acetate",218-530-8,2174-13-2,,Notified C&L,1,H302:1
92525,"Heptanoic acid, mixed esters with dipentaerythritol, 2-ethylhexanoic acid and pentaerythritol",282-771-5,84418-59-7,Not Classified,Notified C&L,17,Not classified:17
92526,Cortivazol,214-175-8,1110-40-3,Repr. 2;STOT RE 2,Notified C&L,1,H373:1;H361:1
92528,"Molecular sieves, 4 Ã…",615-217-1,70955-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H335:43;H315:43;Not classified:1
92529,"(2S-cis)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one",255-795-9,42399-40-6,Acute Tox. 4;Eye Irrit. 2B,REACH registration C&L,3,H302:3;H320:2;H361:1
92530,Tetra-µ3-carbonyldodecacarbonyl-octahedro-hexarhodium,249-009-3,28407-51-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H312:43;H302:43;H332:43
92531,"Ethyl 3-(3,4-dihydroxyphenyl)propionate",223-585-6,3967-57-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38;H317:38
92532,ethyl α-bromocyclobutanecarboxylate,252-384-6,35120-18-4,Skin Corr. 1B,Notified C&L,41,H314:40;H319:1;H312:1;H302:1;H335:1;H315:1;H332:1;H290:1;H318:1
92537,POLYAMIDE 6,607-506-6,25038-54-4,Not Classified,Notified C&L,60,Not classified:39;H319:21;H315:20;H413:1
92540,"(2,4,7-trinitrofluoren-9-ylidene)malonitrile",214-629-5,1172-02-7,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H201:1;H312:1;H302:1;H332:1
92541,Triheptylamine,219-316-7,2411-36-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:38;H315:39;Not classified:1
92547,"Glycerides, palm-oil mono-, di- and tri-, hydrogenated",294-631-0,91744-66-0,Not Classified,Notified C&L,29,Not classified:29
92548,"Anode, copper",918-168-7,,Not Classified,REACH registration C&L,69,Not classified:35;H319:34;H351:34;H302:34;H317:34;H373:34
92550,3-hydroxy-4-nitrobenzaldehyde,211-879-7,704-13-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
92551,Tetraethylammonium nitrate,217-725-5,1941-26-0,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H272:47;H335:46;H315:47
92553,(2R)-{[(benzyloxy)carbonyl]amino}(cyclohexyl)acetic acid,615-026-3,69901-85-5,STOT RE 2,Notified C&L,1,H373:1
92554,3-methylpentan-1-ol,209-644-9,589-35-5,Flam. Liq. 3,Notified C&L,1465,H226:1331;Not classified:134;H319:45;H335:44;H315:45;H302:4
92555,"2,2,3,3-tetrachlorohexafluorobutane",206-787-9,375-34-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:38;H335:1;H315:1
92561,2-imidazol-4-ylethylamine,200-100-6,51-45-6,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,41,H319:38;H335:38;H315:38;H334:38;H317:38;H301:38;Not classified:3
92566,"Amides, from C18-unsatd. fatty acid dimers, tall-oil fatty acids and triethylenetetramine, reaction products with bisphenol A-epichlorohydrin polymer",619-774-1,68953-09-3,Not Classified,Notified C&L,56,Not classified:54;H317:2;H319:1;H315:1
92567,octanoic acid,204-677-5,124-07-2,Skin Corr. 1C;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H314:0
92573,Bis(2-butoxyethyl) hydrogen phosphate,238-140-1,14260-97-0,Not Classified,Notified C&L,35,Not classified:34;H314:1
92574,"Fatty acids, C18-unsatd., dimers, ethoxylated",614-587-1,68551-92-8,Not Classified,Notified C&L,106,Not classified:106
92575,"trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate",411-770-6,136213-71-3,Aquatic Chronic 3,Harmonised C&L,0,H412:0
92579,"2,2'-methylenebis(6-nonyl-p-cresol)",232-092-5,7786-17-6,Not Classified,REACH registration C&L,53,Not classified:20;H226:33
92580,"Benzeneacetic acid, α-ethylidene-4-nitro-",618-685-5,90924-63-3,Eye Irrit. 2;Muta. 2;Aquatic Chronic 3,REACH registration C&L,1,H319:1;H412:1;H341:1
92581,L-alpha-Cyclohexylglycine,604-343-2,14328-51-9,Not Classified,Notified C&L,3,Not classified:1;H319:2;H335:2;H315:2
92582,"Fatty acids, C12-22 and C12-22-unsatd., reaction products with boric acid compd. with diethanolamine",287-980-5,85631-32-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:1;H315:1;H400:1;H410:1;H314:1
92583,"Selenious acid, phenylmethyl ester",309-043-2,99811-54-8,Acute Tox. 3;Acute Tox. 2;STOT RE 2,Notified C&L,1,H330:1;H373:1;H301:1
92586,"(17-acetyl-6-chloro-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl) acetate",607-437-1,2477-73-8,Carc. 2;Repr. 2,Notified C&L,1,H351:1;H361:1
92593,Moroxydine hydrochloride,221-612-6,3160-91-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
92597,"3,4,5,6-tetrachloropyridine-2-carboxylic acid",233-956-4,10469-09-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,218,H312:156;H302:156;H318:156;H315:218;H319:62;H335:62
92599,"Disodium 3-[[4-(acetylamino)phenyl]azo]-4-hydroxynaphthalene-2,7-disulphonate",227-495-8,5858-61-7,Not Classified,Notified C&L,1,Not classified:1
92602,2-(3-bromophenyl)propanoic acid,610-957-1,53086-52-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
92607,"1,1,1,3,3,3-hexamethyldisilazane",213-668-5,999-97-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,547,H412:291;H302:479;H311:392;H225:390;H332:456;H314:365;H318:129;H312:85;Not classified:35;H319:35;H335:67;H315:48;H336:32;H331:18;H250:2;H301:1
92609,β-(dimethylamino)-β-ethylphenethyl alcohol,254-272-2,39068-94-5,Not Classified,REACH registration C&L,14,Not classified:13;H319:1;H302:1;H335:1;H315:1
92611,"21a-Homo-6 alpha,7 alpha,15 alpha,16 alpha-tetrahydro-bis-3' H-cyclopropa[1',2':6,7;1'',2'':15,16]-5 beta,17 alpha-pregn-20-yne-3 beta,5,17,21a-tetrol",617-349-5,82543-17-7,Not Classified,REACH registration C&L,3,Not classified:2;H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
92615,"1,1-dimethoxyethane;dimethyl acetal",208-589-8,534-15-6,Flam. Liq. 2,Harmonised C&L,0,H225:0
92616,Tetraethylammonium perchlorate,219-904-3,2567-83-1,Org. Perox. B;Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43;H241:38;H272:42;H271:1
92617,"1,3'-Bipyridinium, 1'-[3-(dimethylamino)propyl]-6'-hydroxy-4'-methyl-2'-oxo-, inner salt",600-582-1,104583-33-7,Not Classified,Notified C&L,36,Not classified:36
92619,Nicotinaldehyde,207-900-4,500-22-1,Skin Sens. 1B;Resp. Sens. 1;Muta. 2,Notified C&L,197,H341:156;H334:158;H317:196;H412:38;H302:38;H335:38;H315:40;H318:40;H226:39;H319:1;H227:1;H314:1
92622,3-Acetyl-2-(aminosulfonyl)-5-chlorothiophene,605-240-5,160982-10-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
92625,"3,4,5-trimethoxybenzonitrile",217-550-4,1885-35-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H319:40;H312:44;H302:44;H335:39;H315:40;H332:40
92626,(2S)-1-(2-phenylacetyl)pyrrolidine-2-carboxylic acid,928-037-6,2752-38-7,Eye Irrit. 2,REACH registration C&L,2,H319:2
92628,Cyclopentanecarbonitrile,224-229-2,4254-02-8,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:41;H335:40;H315:41;H301:41;H226:45;H312:4;H302:4;H332:4;H311:1;H331:1
92631,4-(ethylamino)piperidine-4-carboxamide,282-134-1,84100-54-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,67,H319:67;H335:38;H315:38
92636,"1,1,1-tribromo-2-methylpropan-2-ol",200-931-4,76-08-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
92638,3-(2-hydroxyethyl)-p-phenylenediammonium sulphate,298-995-1,93841-25-9,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,63,H411:56;H319:4;H315:6;H320:4;H317:45;H332:4;H301:61;H373:42;Not classified:2
92640,2-[2-(nonylphenoxy)ethoxy]ethanol,248-291-5,27176-93-8,Not Classified,Notified C&L,2,Not classified:1;H410:1;H319:1;H400:1;H315:1
92652,N-(tetrahydro-2-oxothienyl)acetamide,214-793-8,1195-16-0,Acute Tox. 3,Notified C&L,39,H301:39
92654,Tributyl(p-nitrobenzyl)phosphonium bromide,228-130-5,6140-98-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
92655,"Methyl 3,4-difluorobenzoate",609-313-2,369-25-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H302:38;H318:38;H335:43;H315:43;H319:5
92656,"1-amino-4,8-dihydroxy-5-(phenylamino)anthraquinone",228-890-8,6370-89-4,Not Classified,Notified C&L,1,Not classified:1
92658,"Fatty acids, C8-18 and C18-unsatd., calcium salts",283-960-5,84776-34-1,Not Classified,Notified C&L,8,Not classified:8
92660,"α,α-bis[4-(dimethylamino)phenyl]-4-(phenylamino)naphthalene-1-methanol",229-851-8,6786-83-0,Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,132,H317:55;H318:53;H400:57;H410:60;H302:54;H332:46;Not classified:21;H350:4;H341:4;H225:2;H319:1;H335:2;H315:1;H351:1;H301:1;H411:1
92661,cis-4-methylcyclohexanol,231-789-1,7731-28-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H319:38;H312:38;H302:39;H335:38;H315:39;H332:40;H336:1
92662,"2,4,6-tri-tert-butylaniline",213-507-9,961-38-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H312:5;H302:5;H332:5
92665,C.I. Acid Brown 106,612-236-7,61724-11-6,Not Classified,Notified C&L,32,Not classified:32
92667,"Alginic acid, ammonium salt",618-411-4,9005-34-9,Not Classified,Notified C&L,3,Not classified:3
92670,"Hydrocarbons, C14-C17, n-alkanes",917-828-1,,Asp. Tox. 1,REACH registration C&L,58,H304:58
92672,Opopanax (gum),232-558-8,9000-78-6,Asp. Tox. 1;Aquatic Chronic 3,Notified C&L,1494,H412:1286;H304:1479;H317:149;H315:193;Not classified:1
92673,Copper dibromide,232-167-2,7789-45-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,59,H302:58;H314:59;H410:11;H318:5;H400:10
92678,Sodium L-glutamate,240-313-1,16177-21-2,Not Classified,Notified C&L,25,Not classified:25
92680,2-methylpropyl-2-ethyl-2-methylbutanoate,619-240-8,96723-99-8,Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,1,H300:1;H400:1;H412:1;H310:1
92681,4-chlorobenzhydrylamine hydrochloride,226-085-6,5267-39-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
92682,"2-ethylhexyl 2-(2,4-dichlorophenoxy)propionate",279-123-9,79270-78-3,Aquatic Acute 1,Notified C&L,54,H400:54;H410:16;H302:16;H317:16
92685,Octadecyl isononanoate,284-425-9,84878-34-2,Not Classified,Notified C&L,47,Not classified:47
92688,Ammonium palmitate,209-785-6,593-26-0,Not Classified,Notified C&L,1,Not classified:1
92694,"Tallow, reaction products with diethanolamine and maleic anhydride",293-758-9,91082-45-0,Not Classified,Notified C&L,1,Not classified:1
92697,p-(1-pyrrolidinyl)phenol,213-765-2,1008-97-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
92700,hexythiazox (ISO);hexythiazox (ISO); trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide,616-638-3,78587-05-0,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
92701,"4-diazo-3,4-dihydro-7-nitro-3-oxonaphthalene-1-sulphonic acid",264-347-1,63589-25-3,Self-react. D;Skin Corr. 1A,REACH registration C&L,48,H242:41;H314:42;Not classified:4;H412:1;H228:1;H318:2;H315:2;H319:1
92702,Diethylnitrosoamine,200-226-1,55-18-5,Acute Tox. 3;Carc. 1B,Notified C&L,50,H350:49;H301:49;H341:5;H412:2;Not classified:1;H340:1;H227:1;H402:1
92707,α-(4-methoxyphenyl)morpholine-4-acetonitrile,239-245-5,15190-13-3,Acute Tox. 4,Notified C&L,38,H302:38
92708,"2,6-dimethylhepta-2,5-dien-4-one",207-986-3,504-20-1,Not Classified,Notified C&L,1,Not classified:1
92710,"benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide",431-600-4,112226-61-6,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
92713,3-hydroxy-2-methylpropiononitrile,219-902-2,2567-01-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
92717,(R)-2-Amino-N-benzyl-3-methoxypropionamide,606-353-2,196601-69-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
92719,"(1α,2α,5α)-2,2,6-trimethylbicyclo[3.1.1]heptan-2-ol",225-591-4,4948-28-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,304,H319:304;H315:304;H335:71
92720,"1-(2-chloroethyl)-4-ethyl-1,4-dihydro-5H-tetrazol-5-one",273-845-8,69049-03-2,,Notified C&L,4,H319:4;H335:4;H315:4
92723,"Sodium 4-[[4-chloro-6-isopropoxy-1,3,5-triazin-2-yl]amino]benzenesulphonate",270-226-4,68413-55-8,Skin Sens. 1,Notified C&L,37,H317:37
92727,Bulbocapnine hydrochloride,211-178-6,632-47-3,Acute Tox. 4,Notified C&L,38,H302:38
92730,"6-nonyl-1,3,5-triazine-2,4-diamine",227-645-2,5921-65-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:1;H410:1;Not classified:1
92733,3-methylhexane,209-643-3,589-34-4,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H410:0;H225:0;H400:0;H336:0;H304:0
92736,IRON OXIDE ISOSTEARATE,476-890-3,,Not Classified,Notified C&L,1,Not classified:1
92739,Barium(2+) 12-hydroxyoctadecanoate,244-469-1,21598-22-1,Not Classified,REACH registration C&L,16,Not classified:4;H302:12
92744,"3-Buten-2-ol, 4-(3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-yl)-3-methyl-",603-152-1,126646-06-8,Not Classified,Notified C&L,88,Not classified:88
92747,O-α-D-glucopyranosyl-(1→4)-O-α-D-glucopyranosyl-(1→4)-O-α-D-glucopyranose,214-174-2,1109-28-0,Not Classified,Notified C&L,4,Not classified:4
92752,1-Amino-2-(p-tert-amylphenoxy)-4-anilin-anthraquinone,604-493-9,145775-28-6,Aquatic Chronic 2,Notified C&L,31,H411:31
92753,"2-ethylhexyl 2,4,5-trichlorophenoxyacetate",217-675-4,1928-47-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H302:38;H335:38;H315:38;H410:38;H400:38
92758,(Z)-4-ethyl-oct-2-enoic acid,262-155-2,60308-75-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,87,H319:87;H302:87;H315:87
92762,Sodium pyruvate,204-024-4,113-24-6,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,188,H319:35;H317:34;Not classified:153;H315:1
92763,"1,3-diphenoxypropan-2-ol",210-718-8,622-04-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:42;H302:42;H335:4;H315:4
92766,"1,4-bis[(3-hydroxypropyl)amino]anthraquinone",266-954-7,67701-36-4,Aquatic Chronic 2,Notified C&L,7,H411:7
92767,"D-Glucose, 4-O-α-D-glucopyranosyl-, hydrate (1:1)",613-294-6,6363-53-7,,Notified C&L,68,Not classified:68
92773,N-acetyl-3-phenyl-L-alanine,217-959-8,2018-61-3,Not Classified,Notified C&L,1,Not classified:1
92774,"3,5-Dibromo-4-methylbenzoic Acid Methyl Ester",616-164-7,74896-66-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
92776,"Benzene, 1,3-diisocyanato-2-methyl-, polymer with 2,4-diisocyanato-1-methylbenzene",608-609-9,31370-61-3,Skin Sens. 1;Eye Irrit. 2,Notified C&L,33,H319:33;H317:33
92777,"2,3-dibromobutane",226-476-1,5408-86-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H319:45;H312:40;H302:40;H335:44;H315:45;H332:40
92781,"Fatty acids, C16-18 and C18-unsatd., epoxidized, Me esters, oligomeric reaction products with trimethylolpropane",606-155-6,188831-96-1,Not Classified,REACH registration C&L,92,Not classified:86;H361:6
92782,Benzyl phenylacetate,203-008-4,102-16-9,Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1673,H412:1;H314:1;H318:1;Not classified:1634;H400:38
92785,"Phosphoric acid, mono-C10-14-alkyl esters, dipotassium salts",272-027-8,68649-41-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,5,H319:4;H315:4;Not classified:1
92788,"Castor oil, polymer with 1,1'-methylenebis[4-isocyanatobenzene] and polypropylene glycol",614-565-1,68525-78-0,Not Classified,Notified C&L,14,Not classified:14
92794,"Nonanedioic acid, polymer with 1,2-propanediol",608-355-9,29408-67-1,Not Classified,Notified C&L,6,Not classified:6
92795,trans-4-methylcyclohexanecarboxylic acid,235-959-6,13064-83-0,,Notified C&L,6,H319:6;H335:5;H315:6
92800,"Ethyl 3-Amino-4,4,4-trifluorocrotonate",609-360-9,372-29-2,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,58,H319:42;H312:40;H302:51;H335:41;H332:40;H412:11;H315:13;H318:11;H331:11;H314:4;Not classified:1
92801,"Lavander, Lavandula officinalis, ext., sulfurized, palladium salt",307-508-4,97660-01-0,Not Classified,Notified C&L,26,Not classified:25;H317:1;H315:1
92803,"Tetrasodium 7,7'-[ureylenebis[(2-methyl-p-phenylene)azo]]dinaphthalene-1,3-disulphonate",249-168-9,28706-21-0,Not Classified,Notified C&L,1,Not classified:1
92804,o-chlorobenzenethiol,228-667-5,6320-03-2,Skin Corr. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,101,H400:4;H410:4;H314:101;H318:4;H302:8
92805,nickel(II) stearate;nickel(II) octadecanoate,218-744-1,2223-95-2,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H341:0;H410:0;H334:0;H317:0;H372:0;H350:0;H360:0;H400:0
92808,2-[[4-(dimethylamino)phenyl]azo]-6-methoxy-3-methylbenzothiazolium chloride,249-832-8,29767-87-1,Eye Irrit. 2,Notified C&L,2,H319:2
92815,"Mixed potassium sodium 2-{3-tert-butyl-4-cyano-5-[{4-methyl-6-[(6-sulfo-1,3-benzothiazol-2-yl)(2,4,6-trimethyl-3-sulfophenyl)amino]-2-[(2,4,6-trimethyl-3-sulfophenyl)amino]pyridin-3-yl}diazenyl]-1Hpyrazol-1-yl}-1,3-benzothiazole-6-sulfonate",445-480-6,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:2;H319:2;H317:2
92816,"3,4,5-trimethoxyanthranilic acid",263-344-2,61948-85-4,Skin Sens. 1,Notified C&L,43,H317:38;H319:5;H335:4;H315:5
92818,"Benzenesulfonic acid, mono-C15-36-branched alkyl derivs., sodium salts",290-676-5,90218-04-5,Not Classified,Notified C&L,475,Not classified:474;H413:1
92822,Dihexadecyldimethylammonium chloride,217-325-0,1812-53-9,,Notified C&L,2,H314:1;Not classified:1
92830,4-(4-Allyloxy-benzenesulfonyl)-phenol,479-880-7,97042-18-7,Aquatic Chronic 1,Notified C&L,1,H410:1
92832,"Xanthylium, 9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethyl-, molybdatephosphate",263-795-5,63022-07-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,17,H400:17;H410:17
92834,(carboxymethyl)dimethyl[3-[(1-oxoundecenyl)amino]propyl]ammonium hydroxide,308-783-3,98510-75-9,Eye Dam. 1,REACH registration C&L,2,H318:1;H319:1
92836,"2-(hydroxymethyl)-2-[(oleoyloxy)methyl]-1,3-propanediyl dioleate",254-664-3,39874-62-9,,Notified C&L,1,Not classified:1
92837,Tris(dimethylamino)borane,224-474-5,4375-83-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,60,H319:60;H225:60;H335:60;H315:60
92839,"2,4-Bis((dodecylthio)methyl)-6-methylphenol",438-600-3,110675-26-8,Not Classified,Notified C&L,85,Not classified:85
92840,"Trisodium [3-[[2,4-dihydroxy-5-[[2-hydroxy-5-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]phenyl]azo]naphthalene-1,5-disulphonato(5-)]cuprate(3-)",288-047-5,85631-96-5,Not Classified,Notified C&L,3,Not classified:3
92841,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with methacrylic acid",500-089-0,36425-15-7,,Notified C&L,59,Not classified:45;H319:14;H315:14
92845,Didodecyl nonylphenyl phosphite,252-457-2,35239-35-1,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1;H317:1
92850,Dichloroethylphosphine,216-096-4,1498-40-4,Flam. Liq. 3;Pyr. Liq. 1;Skin Corr. 1B,Notified C&L,42,H226:42;H250:42;H314:42;H330:4;H252:4
92857,"Oils, palm",232-316-1,8002-75-3,Not Classified,Notified C&L,127,Not classified:127
92858,2-phenylbenzothiazole,212-935-3,883-93-2,Eye Irrit. 2,Notified C&L,38,H319:38
92859,"N,N,N',N',N'',N''-hexamethyl-4,4',4''-methylidynetrianiline",210-043-9,603-48-5,Not Classified,Notified C&L,135,Not classified:88;H319:41;H335:39;H315:40;H400:6;H410:6
92863,Estramustine,221-076-3,2998-57-4,Carc. 2;Repr. 1B,Notified C&L,32,H351:30;H360:30;H302:1;Not classified:1
92865,"Tar acids, cresylic, residues;Distillate Phenols;[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80°C (176°F). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.]",271-418-0,68555-24-8,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
92873,"Phenol, 2-(4,6-diamino-1,3,5-triazin-2-yl)-",608-351-7,29366-78-7,Not Classified,Notified C&L,1,Not classified:1
92876,Chlorotrifluoromethane,200-894-4,75-72-9,Press. Gas (Liq.),Notified C&L,112,H280:112;H420:38
92880,Tetrahydro-6-(3-pentenyl)-2H-pyran-2-one,251-201-7,32764-98-0,Not Classified,REACH registration C&L,1603,Not classified:316;H319:1286;H412:1
92882,"Poly(oxy-1,4-butanediyl), .alpha.-(oxiranylmethyl).omega.-(oxiranyl- methoxy)-",608-023-3,26951-52-0,Aquatic Chronic 3,Notified C&L,124,H412:83;H319:41;H317:41;H315:41
92890,"2,2-dimethylhex-3-ene",221-504-9,3123-93-1,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H225:38;H304:38
92892,"2,2-bis(allyloxymethyl)butyl methacrylate",243-635-0,20241-99-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
92895,"Octadecanoic acid, 1,1'-[[(2-hydroxyethyl)imino]di-2,1-ethanediyl] ester",603-793-7,13412-15-2,Not Classified,Notified C&L,31,Not classified:31
92896,Platinum dihydroxide,235-220-8,12135-23-8,Aquatic Chronic 4,Notified C&L,83,H413:83
92897,"4,4-dimethoxybutyronitrile",238-658-8,14618-78-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H312:38;H302:38;H332:38;H319:1
92900,Propylene glycol dimethacrylate,616-239-4,7559-82-2,Skin Sens. 1B;STOT SE 3,Notified C&L,13,H317:13;H335:13
92902,"(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(1E)-2-(1R,3R,4S)-4-chloro-3- methoxycyclohexyl-1-methylvinyl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy- 13,19,21,27-tetramethyl- 11,28-dioxa-4-aza-tricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetraone.",603-999-7,137071-32-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H312:1;H302:3;H332:1;H351:1;H361:1;H373:1
92903,"4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, [2S-(2α,5α,6β)]-, compd. with N,N'-bis(phenylmethyl)-1,2-ethanediamine (2:1)",245-855-2,23736-58-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,5,H334:5;H317:5
92906,"17,17-(2,2-Dimethyltrimethylenedioxy)androst-5-en-3 beta-ol",617-864-5,864672-26-4,Not Classified,Notified C&L,1,Not classified:1
92907,"2,4-dihydroxy-N-(2-methoxyphenyl)benzamide",419-090-1,129205-19-2,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
92908,Pyridine-3-carboximidamide Monohydrochloride,615-990-5,7356-60-7,,Notified C&L,5,H319:5;H335:4;H315:5
92911,"Carbamic acid, N-[2-(4-bromophenyl)ethyl]-, 1,1-dimethylethyl ester",601-674-4,120157-97-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
92912,(-)-(R)-1-((4-Chlorophenyl)(phenyl)methyl)piperazine,608-439-5,300543-56-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:2;H335:2;H315:2;H413:1;H400:1;H302:2
92913,2-bromophenylhydrazine hydrochloride,256-728-6,50709-33-6,Skin Corr. 1B,Notified C&L,48,H314:43;H319:5;H302:5;H335:4;H315:5;H312:1;H332:1;H318:2
92920,"2-[(2,4-dinitrophenyl)methyl]pyridine",214-567-9,1151-97-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H302:38;H335:42;H315:43
92923,"Fatty acids, lanolin, lithium salts",268-919-1,68154-72-3,Eye Irrit. 2,REACH registration C&L,4,H319:1;Not classified:3
92924,Dichloromethylpentylsilane,237-194-3,13682-99-0,Eye Irrit. 2,Notified C&L,38,H319:38
92933,(diisocyanatomethyl)benzene,603-551-0,1321-38-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,1,H319:1;H334:1;H317:1;H315:1
92935,"2,4-dimethoxybenzyl alcohol",230-775-2,7314-44-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
92937,3-[(3-pyridylmethyl)amino]propiononitrile,251-596-6,33611-48-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H319:39;H312:39;H302:40;H335:40;H315:40;H332:40;H318:1
92940,"Bis(acetato-O)[μ-(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl)]dimercury",222-673-1,3570-80-7,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Repr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H330:38;H410:38;H300:38;H400:38;H310:38;H360:38;H373:38
92944,"(S)-2-carboxy-1,1-dimethylpyrrolidinium chloride",223-957-8,4136-37-2,Acute Tox. 4,Notified C&L,4,H332:3;H302:1
92946,o-nitrobenzohydrazide,210-110-2,606-26-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
92948,"Distillates (petroleum), carbon-treated light paraffinic;Gasoil - unspecified;[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",309-667-5,100683-97-4,Carc. 1B,Harmonised C&L,0,H350:0
92950,"acetone;[3-[2-[benzyl(tert-butyl)amino]acetyl]-5-(dimethylcarbamoyloxy)phenyl] N,N-dimethylcarbamate",921-654-1,,Not Classified,Notified C&L,1,Not classified:1
92956,m-xylene-4-sulphonic acid,201-843-9,88-61-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
92957,Methyl 3-methylsalicylate,245-557-2,23287-26-5,,Notified C&L,5,H319:5;H335:5;H315:5
92960,Trimethyl(vinylbenzyl)ammonium chloride,247-850-0,26616-35-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
92961,"Lead, dross, copper-rich",273-925-2,69227-11-8,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,9,H302:9;H341:9;H362:9;H410:9;H334:9;H317:9;H372:9;H350:9;H332:9;H360:9;H400:9
92964,Copper II ethoxide,,2850-65-9,,Notified C&L,4,H319:4;H302:4;H335:4;H315:4;H228:4
92965,"1,2,4-Triazole-1-carboximidamide Hydrochloride",606-331-2,19503-26-5,Acute Tox. 3;Eye Irrit. 2,Notified C&L,40,H319:40;H301:39;H412:1;H302:1;H317:1
92966,"reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (""para-isomer"" including cis- and trans- isomers);methyl 1,3-dimethylcyclohexanecarboxylate (""meta-isomer"" including cis- and trans-isomers)",444-920-4,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
92967,Piperidinocarbonitrile,216-233-8,1530-87-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:39;H312:38;H302:38;H335:38;H315:39;H332:38;H311:1;H301:1;H331:1
92969,Phosphorous trifluoride,232-008-7,7783-55-3,Press. Gas (Liq.);Skin Corr. 1A;Acute Tox. 2,Notified C&L,122,H331:118;H314:122;H280:118;H330:122;H312:4;H302:4
92975,"(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.0³,⁸]tetradecan-7-one; dichloro-λ²-bromane",613-422-0,64058-48-6,Acute Tox. 4,Notified C&L,120,H302:91;H317:29
92981,N-(5-chloro-2-methylphenyl)piperazine,278-560-2,76835-20-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H312:2;H302:2;H318:2;H314:1
92982,Fumaroyl chloride,211-005-4,627-63-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,46,H312:46;H302:46;H332:45;H314:46;H290:1;H318:1
92983,"(8α,9S)-6'-methoxycinchonan-9-ol",209-341-1,572-60-1,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,38,H334:38;H302:38;H317:38
92985,2-methylbutylamine,202-483-5,96-15-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,39,H312:38;H302:38;H314:39;H225:39;H332:38;H318:1
92987,"5-benzoyl-7-bromo-2,3-dihydro-1H-Pyrrolizine-1-carboxylic acid",700-241-8,84023-60-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:1;H311:1;H301:1
92990,"(R)-2-fluoro-α-methyl[1,1'-biphenyl]-4-acetic acid",257-264-7,51543-40-9,Acute Tox. 3,Notified C&L,128,H301:128;H319:1;H315:1;H335:1
92993,"2-ethylhexyl 12-ethyl-5,5-dioctyl-9-oxo-10-oxa-4,6-dithia-5-stannahexadecanoate",261-645-3,59185-95-4,Acute Tox. 4;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H302:2;H372:2
92995,Bismuth(3+) neodecanoate,251-964-6,34364-26-6,Not Classified,REACH registration C&L,431,Not classified:102;H319:274;H302:136;H335:84;H315:86;H332:84;H412:53;H413:2
92997,"4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide",609-456-0,376348-65-1,STOT RE 2;Aquatic Chronic 3,Notified C&L,31,H373:31;H412:29
92999,pepsin A,232-629-3,9001-75-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H319:0;H334:0;H335:0;H315:0
93001,"Hydrocarbons, C5-C7, n-alkanes, isoalkanes, n-hexane rich",930-397-4,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H361:1;H315:1;H225:1;H373:1;H336:1;H304:1
93006,"4-trans-Pentyl-4-trans-(3,4,5-trifluorphenyl)-[1,1-bicyclohexyl]",604-031-6,137644-54-3,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
93009,"Naphthalenesulfonic acid, methyl-, sodium salt (1:1), polymer with formaldehyde",618-442-3,9008-64-4,Eye Dam. 1,Notified C&L,39,H318:33;Not classified:4;H319:2;H412:2;H315:2
93012,"B i s - 1 , 5 - c y c l o o c t a d i e n r h o d i u m ( I ) tetrafluoroborat",609-074-4,35138-22-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,36,H319:35;H302:34;H335:35;H315:35;H334:33;H317:34;H228:2;H290:1
93013,3-(benzylamino)propionamide,240-549-5,16490-80-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H302:1;H318:1;H335:1;H315:1
93014,"Dialuminium tris[2-(4,5-dibromo-6-oxido-3-oxoxanthen-9-yl)]benzoate",240-010-4,15876-57-0,Not Classified,Notified C&L,11,Not classified:11
93018,1-(hydroxymethyl)pyrrolidin-2-one,239-451-5,15438-71-8,Eye Irrit. 2,Notified C&L,40,H319:40;H335:2;H315:2
93020,Orotic acid,200-619-8,65-86-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,59,H319:52;H302:55;H335:48;H315:52;Not classified:4;H312:1;H332:1;H314:1
93022,"Sodium hydrogen N,N-dibutyl-10-(sulphonatooxy)octadecanamidate",263-402-7,62093-93-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:2;H319:2;H315:2
93024,"methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid)",401-890-7,77402-03-0,Acute Tox. 4;Eye Irrit. 2;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H319:0;H340:0;H302:0
93027,4-Butoxybenzonitrile,610-770-5,5203-14-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H312:42;H302:42;H335:38;H315:38
93029,4-[(4-HYDROXYPYRIMIDIN-2-YL)AMINO]BENZONITRILE,606-195-4,189956-45-4,Eye Dam. 1,REACH registration C&L,2,H318:2
93031,Trimethylsilyl (dimethoxyphosphinoyl)acetate,285-972-6,85169-29-5,Flam. Liq. 2,Notified C&L,38,H225:38
93033,2-phenylethylisocyanate,413-080-0,1943-82-4,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0;H314:0;H334:0;H317:0;H331:0
93036,3-methylbutyl valerate,218-081-8,2050-09-1,Flam. Liq. 3;Aquatic Chronic 2,Notified C&L,93,H226:79;H411:92;H319:1;H315:1
93038,Aluminium nitrate,236-751-8,13473-90-0,Eye Dam. 1,REACH registration C&L,267,H318:204;H361:97;H301:33;H319:38;H271:27;H315:38;Not classified:24;H272:26;H335:4;H302:1
93039,"Dodecaborate(2-), dodecahydro-, cesium (1:2)",601-668-1,12008-75-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
93040,3-hydroxy-α-methyl-3-phenylalanine,206-172-5,305-96-4,Eye Irrit. 2,Notified C&L,38,H319:38
93043,4-[(2-chloro-4-nitrophenyl)azo]-N-ethyl-N-[2-[1-(2-methylpropoxy)ethoxy]ethyl]aniline,288-538-4,85750-13-6,Not Classified,REACH registration C&L,22,Not classified:22
93044,"Hydrocarbons, C",307-755-8,97722-06-0,Carc. 1B,Harmonised C&L,0,H350:0
93047,bituminous coal,921-592-5,308062-82-0,,Notified C&L,6,Not classified:6
93050,Chloro(dichloromethyl)dimethylsilane,242-058-1,18171-59-0,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,43,H226:43;H302:39;H314:43;H411:1;H318:1
93054,"dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate",448-700-9,500791-70-8,Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H317:0;H318:0;H400:0;H410:0
93055,tert-butyl 4-chloro-3-oxobutyrate,277-910-1,74530-56-6,Skin Sens. 1A;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
93056,2-nitrophenyl β-D-glucopyranoside,220-568-5,2816-24-2,Not Classified,Notified C&L,2,Not classified:2
93057,"Disodium [(9,10-dihydro-9,10-dioxo-1,4-anthrylene)bis(imino-4,1-phenyleneoxy)]bis(benzenesulphonate)",274-355-7,70161-19-2,Aquatic Chronic 1,Notified C&L,4,H410:3;Not classified:1
93060,"Isononanoic acid, compound with 2-aminoethanol (1:1)",267-169-2,67801-50-7,Aquatic Chronic 3,Notified C&L,485,H412:457;H319:28;H302:27;Not classified:1;H315:2
93064,"1,1'-(propylenedioxy)dipropan-2-ol",216-670-4,1638-16-0,Not Classified,Notified C&L,2,Not classified:2
93065,"Disodium 4-hydroxy-3-[(2-methoxyphenyl)azo]naphthalene-2,7-disulphonate",227-496-3,5858-63-9,Skin Irrit. 2,Notified C&L,1,H315:1
93066,"Glycerides, sunflower-oil mono-, di- and tri-, hydrogenated",294-524-9,91723-20-5,Not Classified,Notified C&L,23,Not classified:23
93068,10-methoxy-6-methylergoline-8β-methanol,252-385-1,35121-60-9,Acute Tox. 4;STOT SE 2;Aquatic Chronic 3,REACH registration C&L,2,H412:1;H371:1;H302:2;H312:1;H332:1
93069,"Tetrasodium [μ-[[3,3'-[(3,3'-dihydroxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonato]](8-)]]dicuprate(4-)",249-008-8,28407-37-6,Eye Irrit. 2;Aquatic Chronic 1,REACH registration C&L,102,H319:2;H410:2;H350:83;H351:13;H302:8;Not classified:4;H411:2
93072,Methylated sulfonated primuline base,215-418-0,1326-12-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
93076,Non-2-enoic acid,223-171-5,3760-11-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1418,H319:1374;H335:1374;H315:1374;H317:38;H318:39;H314:5;H290:1;Not classified:1
93078,"1,3-dimethyl-2-thiourea",208-588-2,534-13-4,Skin Sens. 1,Notified C&L,148,H317:129;H301:38;H312:17;H302:19;Not classified:1
93080,"17 alpha-(3-Hydroxypropyl)-6 beta,7 beta;15 beta,16 beta-dimethylene-5 beta-androstane-3 beta,5,17 beta-triol",617-350-0,82543-18-8,Aquatic Chronic 3,REACH registration C&L,5,H412:4;H319:1;H312:1;H302:1;H335:1;H315:1;H332:1
93083,"Fatty acids, montan-wax, ethoxylated",614-526-9,68476-04-0,Not Classified,Notified C&L,34,Not classified:34
93084,Ergotamine,204-023-9,113-15-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Repr. 2,Notified C&L,2,H361:2;H330:1;H311:1;H301:1;H331:1;H312:1;H302:1;H332:1
93085,Pyrimidine,206-026-0,289-95-2,Flam. Liq. 3;Eye Dam. 1,REACH registration C&L,59,H226:58;H318:14;H228:1;H319:1;H335:1;H315:1
93086,4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide,425-860-8,125971-57-5,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
93088,[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid,419-270-1,123599-82-6,Eye Irrit. 2,Harmonised C&L,0,H319:0
93090,"1,1,2,2,3,3,4,4-octafluoro-1,4-diiodobutane",206-788-4,375-50-8,Skin Sens. 1B;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,61,H410:4;H400:4;H336:4;H317:4;Not classified:47;H319:8;H335:7;H315:8;H312:4;H332:4;H372:2;H302:2
93092,"3-[(4-amino-2,5-dimethoxyphenyl)azo]-4-hydroxybenzenesulphonic acid",288-764-3,85895-89-2,Not Classified,REACH registration C&L,2,Not classified:2
93093,"Amides, C16-18 and C18-unsatd., N,N-bis(hydroxyethyl)",271-653-9,68603-38-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,452,H411:166;H319:351;H315:372;H400:83;H318:100;H373:38;Not classified:1;H317:1
93096,trichloronitromethane;chloropicrin,200-930-9,76-06-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Harmonised C&L,0,H319:0;H302:0;H335:0;H330:0;H315:0
93097,"2-Thiophenesulfonamide, 3-(2-bromoacetyl)-5-chloro-",605-241-0,160982-11-6,Not Classified,Notified C&L,1,Not classified:1
93099,"Primrose, ext.",295-823-7,92129-21-0,Flam. Liq. 2,Notified C&L,1,H225:1
93103,"Bis[(5-ethyl-1,3-dioxan-5-yl)methyl] thioperoxydicarbonate",258-571-9,53461-86-2,,Notified C&L,34,Not classified:34
93106,Vermiculite (Mg0.33[Mg2-3(Al0-1Fe0-1)0-1](Si2.33-3.33Al0.67-1.67)(OH)2O10.4H2O),603-518-0,1318-00-9,Not Classified,Notified C&L,13,Not classified:13
93108,1-(2-oxo-2-phenylethyl)pyridinium bromide,240-919-6,16883-69-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
93111,(E)-3-methyl-5-cyclopentadecen-1-one,429-900-5,82356-51-2,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H317:0
93121,1-bromo-2-methylpropane,201-141-2,78-77-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,95,H319:67;H225:95;H335:67;H315:68;H361:1;H318:1
93128,"Fatty acids, C16-18 and C18-unsatd., calcium salts",283-961-0,84776-35-2,Not Classified,Notified C&L,8,Not classified:8
93130,"11β,21-dihydroxy-2'-methyl-16α-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione",303-069-8,94158-00-6,Repr. 1A;STOT RE 2,Notified C&L,24,H373:24;H360:24
93131,"Tetrasodium [bis[[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]amino]sulphonyl]-29H,31H-phthalocyaninedisulphonato(6)-N29,N30,N31,N32]nickelate(4-)",306-462-2,97280-68-7,Not Classified,Notified C&L,10,Not classified:5;H320:5;H334:5;H335:5
93132,"Fatty acids, vegetable-oil, ethoxylated",614-592-9,68552-95-4,Not Classified,Notified C&L,5,Not classified:5
93134,"Disodium 2-(2,4,5,7-tetraiodo-6-oxido-3-oxoxanthen-9-yl)benzoate",240-474-8,16423-68-0,Aquatic Chronic 2,REACH registration C&L,424,H411:5;H412:50;H302:353;H413:75;Not classified:22
93136,"3-Azabicyclo[3.1.0]hexane, 1-(4-methylphenyl)-",615-260-6,71195-57-8,Not Classified,Notified C&L,1,Not classified:1
93139,"Benzeneacetic acid, α-formyl-, methyl ester, ion(1-), sodium",618-963-6,93692-26-3,,Notified C&L,1,Not classified:1
93146,Asparagine,200-735-9,70-47-3,Not Classified,REACH registration C&L,152,Not classified:152
93147,"2,2'-Dithiodipropionic Acid",678-403-1,4775-93-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
93150,"1,1,3-trichloropropene",219-903-8,2567-14-8,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H226:40;H319:40;H302:40;H312:1;H335:2;H315:2;H332:1
93152,Methyl 2-(dimethylamino)-2-phenylbutyrate,254-271-7,39068-93-4,Not Classified,REACH registration C&L,5,Not classified:4;H319:1;H335:1;H315:1
93153,"2-ethyl-2-[[(1-oxooctyl)oxy]methyl]-1,3-propanediyl dioctanoate",225-404-6,4826-87-3,Not Classified,Notified C&L,10,Not classified:10
93155,"benzidine;1,1'-biphenyl-4,4'-diamine;4,4'-diaminobiphenyl;biphenyl-4,4'-ylenediamine",202-199-1,92-87-5,Acute Tox. 4;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H350:0;H400:0;H410:0;H302:0
93159,"2,3,4-trimethoxybenzonitrile",256-049-5,43020-38-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H319:38;H312:42;H302:42;H335:38;H315:38;H332:38
93162,"Alkenes, C7-9, hydroformylation products, distn. residues, heavy cracked fraction",308-482-7,98072-31-2,Aquatic Chronic 4,Notified C&L,168,H413:146;Not classified:22
93164,"(ethyl acetoacetato-O1',O3)(pentane-2,4-dionato-O,O')[propane-1,3-diolato(2-)-O,O']titanium",279-899-9,82089-64-3,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,3,H412:2;H302:2;H315:2;H317:2;H318:2;H226:2;Not classified:1
93166,"Esterification products of 4,4'-isopropylidenediphenol, ethoxylated and 2-methylprop-2-enoic acid",609-946-4,41637-38-1,Aquatic Chronic 4,REACH registration C&L,285,H413:80;H319:192;H317:189;H335:173;H315:191;Not classified:12;H411:3;H320:1;H332:1;H360:1
93167,Methyl 3-aminobenzoate,224-842-5,4518-10-9,,Notified C&L,7,H319:7;H335:5;H315:7
93168,DL-thyroxin,200-101-1,51-48-9,Acute Tox. 4,Notified C&L,22,H302:13;H361:6;H372:6;H312:1;H332:1;H370:1;H373:2;Not classified:1
93171,3-ethylaminophenol,210-678-1,621-31-8,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,39,H412:38;H302:39;H319:1;H335:1;H315:1
93180,"Fatty acids, C8-10-branched, calcium salts",285-211-8,85049-41-8,Not Classified,Notified C&L,1,Not classified:1
93183,Iron dibromide,232-168-8,7789-46-0,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H319:38;H332:38;H335:38;H315:38;H302:5;H314:6
93185,"Disodium 2,2'-(azodi-p-phenylene)bis[6-methylbenzothiazole-7-sulphonate]",233-311-7,10114-47-3,Not Classified,REACH registration C&L,105,Not classified:102;H319:3
93188,4-fluorophenylhydrazine hydrochloride,220-886-4,2924-16-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H319:46;H312:40;H302:45;H335:46;H315:46;H332:40;H311:1;H301:1;H331:1
93192,2-methylbenzo[b]thiophene,214-792-2,1195-14-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
93193,"tefluthrin (ISO);2,3,5,6-tetrafluoro-4-methylbenzyl (1RS,3RS)-3-[(Z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropanecarboxylate",616-699-6,79538-32-2,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H300:0;H400:0;H310:0;H410:0
93194,Methyl 3-methyl-2-furoate,228-131-0,6141-57-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
93197,Isobutyl phenylacetate,203-007-9,102-13-6,Not Classified,REACH registration C&L,1688,Not classified:1650;H319:38;H335:38;H315:38
93198,"Adenosine 5'-(trihydrogen diphosphate), disodium salt",240-314-7,16178-48-6,Not Classified,Notified C&L,1,Not classified:1
93199,"2-Naphthalenesulfonic acid, reaction products with formaldehyde and 4,4'-sulfonylbis[phenol]",272-024-1,68649-25-2,Not Classified,Notified C&L,2,Not classified:1;H319:1
93203,"2-chloro-1-(2,4,5-trichlorophenyl)vinyl dimethyl phosphate",213-506-3,961-11-5,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H400:38;H410:38;H302:41;H332:41;H312:3
93206,"1,6-diphenylhexa-1,5-diene-3,4-diol",224-541-9,4403-20-7,Acute Tox. 4,Notified C&L,38,H302:38
93207,"Fatty acids, C8-10-branched, lead salts, basic",270-063-9,68409-79-0,Not Classified,Notified C&L,5,Not classified:5
93211,Ethyl 8'-apo-β-caroten-8'-oate,214-173-7,1109-11-1,Not Classified,Notified C&L,84,Not classified:83;H413:1
93213,"2,2,6,6-tetramethyl-4-piperidone",212-554-2,826-36-8,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,131,H412:92;H302:131;H314:92;H317:92;H290:90;H318:90;H319:39;H335:38;H315:39;Not classified:2
93218,"1-Propanamine, 3-(tridecyloxy)-, branched",270-938-5,68511-40-0,Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,449,H314:442;H410:441;H317:441;H318:441;H400:442;Not classified:7;H302:1
93221,"4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 8-chloro-6-(2-fluorophenyl)-1-methyl-, ethyl ester",620-286-6,59469-49-7,Not Classified,Notified C&L,1,Not classified:1
93222,Ammonium sulphide,235-223-4,12135-76-1,Skin Corr. 1B,Notified C&L,1460,H314:1460;H400:72;H228:38;H226:121;H318:61;H332:10;H301:10;H225:2;Not classified:1
93224,(S)-(-)-3-Chloro-1-phenyl-1-propanol,626-422-0,100306-34-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
93225,"Ferrate(4-), hexakis(cyano-C)-, methylated 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]benzenamine copper(2+) salts",235-468-7,12237-62-6,Aquatic Chronic 2,REACH registration C&L,158,H411:7;H410:145;H319:121;H400:142;Not classified:5;H318:1;H412:1;H317:1;H302:1;H335:1;H332:1
93228,Caramiphen hydrochloride,204-758-5,125-85-9,Acute Tox. 4,Notified C&L,38,H302:38
93229,5-fluorouracil-4-carboxylic acid,211-876-0,703-95-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:43;H302:45;H335:43;H315:43;H312:1;H332:1
93230,"1,3-bis(2,3-diaminophenylazo)benzene hydrochloride",233-314-3,10114-58-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,64,H411:40;H318:38;H315:39;Not classified:16;H319:7;H314:3;H400:1;H410:1;H412:1
93231,"hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide)",430-650-4,151841-65-5,Aquatic Chronic 2,Harmonised C&L,0,H411:0
93232,6-BROMOINDOLE,610-835-8,52415-29-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
93235,"oxalic acid, nickel salt",243-867-2,20543-06-0,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H410:0;H317:0;H372:0;H350:0;H400:0
93238,4-methyloxazole-5-carboxamide,225-472-7,4866-00-6,Not Classified,REACH registration C&L,2,Not classified:1;H319:1;H335:1;H315:1
93241,Hyoscine hydrochloride,200-225-6,55-16-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2,Notified C&L,38,H300:38;H310:38;H330:38
93243,"2,4-dihydro-2-[4-[(2-hydroxyethyl)sulphonyl]phenyl]-5-methyl-3H-pyrazol-3-one",244-678-8,21951-34-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,165,H319:156;H335:156;H315:156;Not classified:9
93244,Nonanediyl diacetate,254-661-7,39864-15-8,Not Classified,Notified C&L,88,Not classified:88
93245,1-[2-chloro-3-(2-methylpropoxy)propyl]pyrrolidine,256-382-6,49571-02-0,Not Classified,Notified C&L,1,Not classified:1
93247,"1-chloro-1,2-difluoroethylene",206-622-0,359-04-6,Ozone 1;Flam. Gas 1;Press. Gas (Liq.),Notified C&L,71,H280:71;H220:71;H059:71
93250,"Potassium 2-(3-trifluoromethoxy-1,1,2,2,3,3-hexafluoropropoxy)-2,3,3,3-tetrafluoropropionate",444-340-1,,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT SE 3,REACH registration C&L,2,H302:2;H318:2;H335:2;H314:2
93251,"Actinidia chinensis, ext.",296-241-6,92456-63-8,Not Classified,Notified C&L,79,Not classified:27;H225:25;H226:25;H319:2;H334:2;H335:2;H315:2
93253,L-ornithine,200-731-7,70-26-8,Not Classified,REACH registration C&L,6,Not classified:6
93255,N-phenylcarbazole,214-564-2,1150-62-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,39,H413:38;H318:39;H335:39;H315:39
93256,Ethyl o-anisate,230-843-1,7335-26-4,Not Classified,Notified C&L,265,Not classified:265
93259,Ethyl myristate,204-675-4,124-06-1,Not Classified,Notified C&L,351,Not classified:351
93261,"Pyridine-2-thiol 1-oxide, sodium salt",223-296-5,3811-73-2,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,879,H319:872;H302:873;H315:870;H311:64;H410:109;H332:810;H400:825;H312:758;H335:47;H411:14;H317:16;H372:13;H331:13;Not classified:5;H318:1
93263,Antimony chloride oxide,235-347-9,12182-69-3,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1;H332:1
93265,Sorbitan laurate,215-663-3,1338-39-2,Not Classified,REACH registration C&L,351,Not classified:341;H319:10;H318:10;H315:10
93267,Ethyl isocyanoacetate,221-077-9,2999-46-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,52,H302:48;H332:48;H319:10;H312:7;H335:9;H315:10;H311:4;Not classified:1;H301:3;H331:3
93275,"2-Pyrrolidinecarboxamide, (2R)-",613-116-7,62937-45-5,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
93276,Carbonylhydrotris(triphenylphosphine)rhodium,241-230-3,17185-29-4,Aquatic Chronic 4,REACH registration C&L,47,H413:3;H311:39;H331:39;H301:39;H319:5;H302:4;H335:5;H315:5
93278,1H-tetrazole,206-023-4,288-94-8,Expl. 1.1,Notified C&L,40,H201:39;H272:5;H319:1;H315:1;Not classified:1
93279,"2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol",411-380-6,147315-50-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
93280,Triethylsilyl trifluoromethanesulphonate,279-124-4,79271-56-0,Skin Corr. 1B,Notified C&L,44,H314:44;H318:1
93281,"N-(2,4-dinitrophenyl)-L-serine",216-745-1,1655-64-7,Flam. Sol. 1,Notified C&L,1,H228:1
93295,2-(azidin-1-yl)ethanol,214-009-4,1072-52-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Notified C&L,39,H311:38;H314:39;H301:39;H318:1;H310:1
93296,Tridecan-2-one,209-784-0,593-08-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1592,H400:1555;H410:1553
93297,Hexadecyl isononanoate,284-424-3,84878-33-1,Not Classified,Notified C&L,47,Not classified:47
93299,"m-phenoxybenzyl trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate",263-347-9,61949-77-7,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,123,H302:123;H410:123;H317:123;H332:123;H400:122
93302,1-(4-pyridyl)piperazine,213-764-7,1008-91-9,Skin Corr. 1B,Notified C&L,47,H314:47;H318:1
93308,Isopropyl nitrate,216-983-6,1712-64-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,42,H319:4;H225:42;H335:4;H315:4
93309,Pyrrolidine-1-carbaldehyde,223-175-7,3760-54-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H302:2;H335:2;H315:2
93310,4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide),411-850-0,119018-29-0,Aquatic Chronic 3,Harmonised C&L,0,H412:0
93311,"Methyl (9E,12E)-octadeca-9,12-dienoate",219-901-7,2566-97-4,Not Classified,Notified C&L,5,Not classified:5
93312,4-pyridylamine,207-987-9,504-24-5,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,77,H411:16;H319:72;H302:6;H335:65;H315:70;H300:76;H314:3;H311:12;H318:3;H331:4;H401:1;H334:1;Not classified:1
93313,barium sulphide,244-214-4,21109-95-5,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H400:0;H302:0;H332:0
93317,"5-Hydroxy-15 beta,16 beta-methylene-3 beta-pivaloyloxy-5 beta-androst-6-en-17-one",617-345-3,82543-14-4,Not Classified,REACH registration C&L,2,Not classified:2
93322,"1-benzyl-2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepinium chloride",256-419-6,49663-94-7,Eye Irrit. 2,Notified C&L,2,H319:1;Not classified:1
93323,"Benzenesulfonic acid, hydroxymethyl-, reaction products with formaldehyde, phenol and urea, ammonium salts",290-732-9,90218-56-7,Not Classified,Notified C&L,36,Not classified:36
93326,"2-Acetone, polymer with phenol",500-086-4,35238-34-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Repr. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H319:1;H361:1;H315:1;H317:1
93328,"6,6'-diphenylfulvene",218-533-4,2175-90-8,Not Classified,REACH registration C&L,3,Not classified:3
93332,2-fluoro-5-iodotoluene,207-206-1,452-68-6,,Notified C&L,6,H319:6;H315:6;H335:1
93336,Sodium 6-[(4-aminophenyl)azo]-5-hydroxynaphthalene-1-sulphonate,227-492-1,5858-51-5,Not Classified,REACH registration C&L,2057,Not classified:11;H302:2045;H319:1;H335:1;H315:1
93337,Non-2-yn-1-ol,227-646-8,5921-73-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H226:1
93338,Cinnamonitrile,217-552-5,1885-38-7,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1,REACH registration C&L,333,H312:287;H317:288;H301:286;H319:45;H335:44;H315:45;H332:14;H302:5
93340,"2-[(3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-yl)oxy]ethyl acrylate",265-991-6,65983-31-5,Skin Irrit. 2,Notified C&L,68,H315:68;H411:13;H319:17;H335:15
93342,antimony trifluoride,232-009-2,7783-56-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H311:0;H411:0;H331:0;H301:0
93343,"Tar bases, quinoline derivs.;Distillate Bases",271-020-7,68513-87-1,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
93344,"N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxynaphthalene-2-carboxamide",248-048-3,26848-40-8,Eye Dam. 1,REACH registration C&L,34,H318:34
93346,(mercaptoethyl)ammonium hydrogen tartrate,248-641-7,27761-19-9,Acute Tox. 4;Repr. 2,Notified C&L,4,H302:4;H361:3;H319:1;H335:1;H315:1
93351,"2,4-dibromoanisole",244-536-5,21702-84-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,124,H411:83;H302:83;H317:83;H319:41;H335:40;H315:41
93353,"4,4'-[1,3-phenylenebis(azo)]bisbenzene-1,3-diamine",213-888-1,1052-38-6,Aquatic Chronic 4,REACH registration C&L,103,H413:6;H318:85;H315:87;H319:7;Not classified:3;H412:3;H314:2;H411:1;H312:1;H302:1;H335:1;H332:1
93355,"2-methylbenzene-1,4-diyl bis{4-[3-(acryloyloxy)propoxy]benzoate}",425-560-7,,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,3,H317:3;H413:2
93361,"Hexanedioic acid, di-C8-10-alkyl esters",296-702-1,92969-89-6,Not Classified,Notified C&L,1,Not classified:1
93368,"(dimethyl)[10H-pyrido[3,2-b][1,4]benzothiazine-10-propyl]ammonium chloride",214-958-4,1225-65-6,Acute Tox. 4,Notified C&L,38,H302:38
93373,Brotizolam,260-964-5,57801-81-7,STOT SE 3;Repr. 2;Lact.,Notified C&L,1,H336:1;H362:1;H361:1
93375,Ibufenac,216-302-2,1553-60-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
93385,Bisacodyl,210-044-4,603-50-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H319:54;H335:47;H315:53;H302:6;H332:2
93387,"N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenylpropionamide hydrochloride",273-846-3,69049-06-5,Acute Tox. 3;Acute Tox. 3,Notified C&L,47,H331:38;H301:38;H300:8;H336:7;H310:7;H330:8;Not classified:1
93388,"2-ethylhexanoic acid, molybdenum salt",251-807-1,34041-09-3,Eye Irrit. 2;Repr. 2,REACH registration C&L,7,H319:3;H361:3;H332:3;H315:3;H373:1;H335:1;Not classified:1
93389,Linalyl anthranilate,230-472-5,7149-26-0,Not Classified,Notified C&L,271,Not classified:233;H319:38;H335:38;H315:38
93391,1H-pyrazole-4-carboxylic acid,253-641-5,37718-11-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H335:48;H315:49
93403,"Methanaminium, N-[4-[[4-(dimethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, ethanedioate",241-922-5,18015-76-4,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,60,H302:58;H361:57;H410:58;H317:5;H318:58;H400:58;Not classified:2;H312:1;H315:1
93404,Ethyl cyano(hydroxyimino)acetate,223-351-3,3849-21-6,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,20,H302:16;H315:11;Not classified:2;H319:5;H312:4;H332:4;H335:4;H311:1
93406,"Barium bis[oxalato(2-)-O,O']oxotitanate(2-)",238-539-0,14523-21-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H312:1;H302:1;H332:1
93407,Benzyldimethyl[2-[(1-oxoallyl)oxy]ethyl]ammonium chloride,256-283-8,46830-22-2,Aquatic Chronic 3,REACH registration C&L,3,H412:3;H319:2;H317:2
93408,"Juniper, Juniperus sabina, ext.",289-971-1,90046-04-1,Flam. Liq. 3,Notified C&L,2,H226:1;H410:1;H304:1
93410,2-ethoxy-1-naphthoic acid,218-745-7,2224-00-2,,Notified C&L,6,H319:5;H335:4;H315:5;H302:1
93413,"N-(1,1,3,3-tetramethylbutyl)acrylamide",224-169-7,4223-03-4,Acute Tox. 4,REACH registration C&L,57,H302:56;H319:1;H335:1;H315:1
93416,Trimethyl orthoformate,205-745-7,149-73-5,Flam. Liq. 2;Eye Irrit. 2,REACH registration C&L,252,H319:250;H225:250;H335:68;H315:29;H224:20;Not classified:3
93422,6-hydroxy-m-toluic acid,201-918-6,89-56-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:47;H302:47;H335:46;H315:47;H312:1;H332:1
93425,"6-aminonaphthalene-1,3-disulphonic acid",204-246-1,118-33-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,40,H319:2;H302:40;H315:2
93427,"1,8-dihydroxy-4-nitro-5-(phenylamino)anthraquinone",243-632-4,20241-76-3,Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,71,H319:9;H317:67;Not classified:4
93429,5-hexenyltrimethoxysilane,261-419-4,58751-56-7,Not Classified,Notified C&L,4,Not classified:4
93432,"Potassium Dodecaborate, Dodecahydro",601-670-2,12008-77-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
93433,Cyclopentyl methyl ether,445-090-6,5614-37-9,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,14,H319:14;H225:14;H302:13;H315:14;H412:11
93434,"6,6-dimethylhept-1-en-4-yn-3-ol",616-644-6,78629-20-6,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2,H411:1;H302:2;H315:1;H401:1;H410:1;H320:1;H317:1;H400:1;H227:1;H373:1;H312:1;H332:1
93435,"1-(bis(2-(1,3-dimethylbutylideneamino)ethyl)amino)-3-phenoxypropan-2-ol",271-340-7,68541-07-1,Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Carc. 2;Aquatic Chronic 2,REACH registration C&L,56,H411:6;H351:6;H314:28;H317:28;H318:28;H319:23;H302:45;H315:23;H412:22;H332:22;Not classified:5
93438,Bromophenol,251-200-1,32762-51-9,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,13,H411:13;H312:13;H302:13
93440,Hexaphenyldiplumbane,221-505-4,3124-01-4,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H330:38;H410:42;H300:38;H400:42;H310:38;H360:42;H373:42;H302:4;H332:4
93441,"[4-[[4-(diethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]diethylammonium chloride",222-676-8,3571-36-6,Not Classified,Notified C&L,1,Not classified:1
93444,(R)-(+)-N-Benzyl-1-phenylethylamine,609-537-0,38235-77-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,48,H319:48;H302:44;H315:48;H335:5
93446,N6-(1-oxooctyl)-L-lysine,245-854-7,23735-96-8,Not Classified,Notified C&L,1,Not classified:1
93448,"Amines, N-(3-aminopropyl)-N-tallow alkyltrimethylenedi-",288-048-0,85632-63-9,Skin Corr. 1A;Eye Dam. 1;STOT RE 2,Notified C&L,499,H373:446;H314:499;H318:446;H400:33;H410:53;H302:53
93456,"Icosa-5,8,11,14-tetraenoic acid",208-033-4,506-32-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,37,H319:33;H312:32;H302:32;H335:32;H315:33;H332:32;Not classified:4
93457,Paraffin waxes and Hydrocarbon waxes,232-315-6,8002-74-2,Not Classified,REACH registration C&L,2336,Not classified:2012;H319:166;H370:71;H335:59;H302:23;H336:11;H304:10;H413:3;H315:1;H410:1
93461,"Polyphosphoric acids, polymers with isopropanolamine, tall oil and triethanolamine",614-555-7,68514-88-5,Not Classified,Notified C&L,35,Not classified:35
93462,"2,3-dibromopropan-1-ol;2,3-dibromo-1-propanol",202-480-9,96-13-9,Acute Tox. 4;Acute Tox. 3;Acute Tox. 4;Carc. 1B;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H412:0;H302:0;H361:0;H311:0;H350:0;H332:0
93463,3-methylhex-1-ene,222-283-1,3404-61-3,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,40,H225:40;H304:39
93464,Potassium p-vinylbenzenesulphonate,224-919-3,4551-90-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
93465,6-sec-butyl-2-ethylaniline,275-989-7,71758-10-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
93472,"2,6-dinitrobenzaldehyde",210-113-9,606-31-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
93476,2-tert-butyl-p-cresol,219-314-6,2409-55-4,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,174,H411:33;H314:161;H318:51;H335:91;Not classified:7;H312:5;H302:6;H319:6;H315:6;H401:1;H317:1
93477,2-amino-5-chloro-4-ethylbenzenesulphonic acid,201-840-2,88-56-2,Skin Sens. 1;Eye Dam. 1,Notified C&L,46,H317:38;H318:38;Not classified:8
93478,"4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)",427-350-0,182235-14-9,Aquatic Chronic 2,Harmonised C&L,0,H411:0
93481,Sodium bis[1-[(5-chloro-2-hydroxyphenyl)azo]-2-naphtholato(2-)]chromate(1-),278-111-0,75199-03-0,Aquatic Chronic 2,Notified C&L,9,H411:9
93482,"1-chloro-1,1-difluoroethane",200-891-8,75-68-3,Flam. Gas 1;Press. Gas (Liq.);Aquatic Chronic 3;Ozone 1,REACH registration C&L,150,H412:38;H280:118;H220:150;H420:73;H059:74;H336:32;H319:3;H335:3;H315:3
93483,Lisinopril,278-488-1,76547-98-3,Eye Irrit. 2;Repr. 2,Notified C&L,7,H319:5;H361:2;H315:2;H362:2;H360:4;H373:2;Not classified:1
93486,"1H-pyrrolo[2,3-b]pyridine",205-981-0,271-63-6,,Notified C&L,53,Not classified:39;H302:11;H318:11;H335:13;H315:14;H319:3
93487,"Distillate of avocado oil, Persea gratissima, Lauraceae",,,Aquatic Chronic 3,Notified C&L,1,H412:1
93489,Isooctyl laurate,283-798-5,84713-06-4,Not Classified,Notified C&L,1,Not classified:1
93494,"2,3-dimethyl-6-nitrobenzothiazolium p-toluenesulphonate",249-834-9,29770-14-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
93496,"trans-3,5,5-trimethylcyclohexan-1-ol",212-183-6,767-54-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,26,H319:25;H315:26;H318:1
93499,"[1,1'-biphenyl]-4-carbohydrazide",242-451-8,18622-23-6,,Notified C&L,7,H319:7;H335:6;H315:7
93500,Pentyl salicylate,218-080-2,2050-08-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1743,H400:255;H410:332;H302:204;H411:1405;H319:8;H315:9;Not classified:7;H412:1
93501,"Resin acids and Rosin acids, fumarated, esters with glycerol",307-051-0,97489-11-7,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,90,H319:89;H317:89;H413:70;Not classified:1
93506,2-(2-(4-methyl-3-cyclohexen-1-yl)propyl)cyclopentanone,404-240-0,95962-14-4,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1480,H410:1480;H319:14;H400:1442;H412:27
